
<html lang="en"     class="pb-page"  data-request-id="a205146a-1b1d-43cf-9c1d-266e4177823b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2017.60.issue-5;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.6b01254;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines" /></meta><meta name="dc.Creator" content="Christopher R.  Coxon" /></meta><meta name="dc.Creator" content="Elizabeth  Anscombe" /></meta><meta name="dc.Creator" content="Suzannah J.  Harnor" /></meta><meta name="dc.Creator" content="Mathew P.  Martin" /></meta><meta name="dc.Creator" content="Benoit  Carbain" /></meta><meta name="dc.Creator" content="Bernard T.  Golding" /></meta><meta name="dc.Creator" content="Ian R.  Hardcastle" /></meta><meta name="dc.Creator" content="Lisa K.  Harlow" /></meta><meta name="dc.Creator" content="Svitlana  Korolchuk" /></meta><meta name="dc.Creator" content="Christopher J.  Matheson" /></meta><meta name="dc.Creator" content="David R.  Newell" /></meta><meta name="dc.Creator" content="Martin E. M.  Noble" /></meta><meta name="dc.Creator" content="Mangaleswaran  Sivaprakasam" /></meta><meta name="dc.Creator" content="Susan J.  Tudhope" /></meta><meta name="dc.Creator" content="David M.  Turner" /></meta><meta name="dc.Creator" content="Lan Z.  Wang" /></meta><meta name="dc.Creator" content="Stephen R.  Wedge" /></meta><meta name="dc.Creator" content="Christopher  Wong" /></meta><meta name="dc.Creator" content="Roger J.  Griffin" /></meta><meta name="dc.Creator" content="Jane A.  Endicott" /></meta><meta name="dc.Creator" content="Céline  Cano" /></meta><meta name="dc.Description" content="Purines and related heterocycles substituted at C-2 with 4′-sulfamoylanilino and at C-6 with a variety of groups have been synthesized with the aim of achieving selectivity of binding to CDK2 over ..." /></meta><meta name="Description" content="Purines and related heterocycles substituted at C-2 with 4′-sulfamoylanilino and at C-6 with a variety of groups have been synthesized with the aim of achieving selectivity of binding to CDK2 over ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 14, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.6b01254" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01254" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.6b01254" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.6b01254" /></link>
        
    
    

<title>Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.6b01254" /></meta><meta property="og:title" content="Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0011.jpeg" /></meta><meta property="og:description" content="Purines and related heterocycles substituted at C-2 with 4′-sulfamoylanilino and at C-6 with a variety of groups have been synthesized with the aim of achieving selectivity of binding to CDK2 over CDK1. 6-Substituents that favor competitive inhibition at the ATP binding site of CDK2 were identified and typically exhibited 10–80-fold greater inhibition of CDK2 compared to CDK1. Most impressive was 4-((6-([1,1′-biphenyl]-3-yl)-9H-purin-2-yl)amino) benzenesulfonamide (73) that exhibited high potency toward CDK2 (IC50 0.044 μM) but was ∼2000-fold less active toward CDK1 (IC50 86 μM). This compound is therefore a useful tool for studies of cell cycle regulation. Crystal structures of inhibitor–kinase complexes showed that the inhibitor stabilizes a glycine-rich loop conformation that shapes the ATP ribose binding pocket and that is preferred in CDK2 but has not been observed in CDK1. This aspect of the active site may be exploited for the design of inhibitors that distinguish between CDK1 and CDK2." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.6b01254"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.6b01254">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.6b01254&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.6b01254&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.6b01254&amp;href=/doi/10.1021/acs.jmedchem.6b01254" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 1746-1767</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.6b01253" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.6b01392" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+R.++Coxon">Christopher R. Coxon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth++Anscombe">Elizabeth Anscombe</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzannah+J.++Harnor">Suzannah J. Harnor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0003-1646-593X" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mathew+P.++Martin">Mathew P. Martin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Benoit++Carbain">Benoit Carbain</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bernard+T.++Golding">Bernard T. Golding</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian+R.++Hardcastle">Ian R. Hardcastle</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lisa+K.++Harlow">Lisa K. Harlow</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Svitlana++Korolchuk">Svitlana Korolchuk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Matheson">Christopher J. Matheson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+R.++Newell">David R. Newell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin+E.+M.++Noble">Martin E. M. Noble</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mangaleswaran++Sivaprakasam">Mangaleswaran Sivaprakasam</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Susan+J.++Tudhope">Susan J. Tudhope</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+M.++Turner">David M. Turner</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lan+Z.++Wang">Lan Z. Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+R.++Wedge">Stephen R. Wedge</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Wong">Christopher Wong</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger+J.++Griffin">Roger J. Griffin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+A.++Endicott">Jane A. Endicott</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span><span class="author-xref-symbol "><sup>∥</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=C%C3%A9line++Cano">Céline Cano</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2032-2272" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Newcastle Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle upon Tyne NE1 7RU, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, U.K.</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Newcastle Cancer Centre, Northern Institute for Cancer Research, Newcastle University Medical School, Paul O’Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.</span></div><div class="corresp-info"><strong>*</strong>For chemistry, C.C.: phone, (44) 191 208 7060; E-mail, <a href="/cdn-cgi/l/email-protection#1675737a7f787338757778795678757a38777538637d"><span class="__cf_email__" data-cfemail="7c1f1910151219521f1d12133c121f10521d1f520917">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For structural biology, J.A.E.: phone, (44) 191 208 4422; fax, (44) 191 208 4301; E-mail, <a href="/cdn-cgi/l/email-protection#5b313a353e753e353f3238342f2f1b353837753a38752e30"><span class="__cf_email__" data-cfemail="adc7ccc3c883c8c3c9c4cec2d9d9edc3cec183ccce83d8c6">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01254&amp;href=/doi/10.1021%2Facs.jmedchem.6b01254" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 1746–1767</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 22, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 August 2016</li><li><span class="item_label"><b>Published</b> online</span>14 February 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 March 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.6b01254" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01254</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.6b01254"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">8264</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">45</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.6b01254" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;R. Coxon&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;Anscombe&quot;},{&quot;first_name&quot;:&quot;Suzannah&quot;,&quot;last_name&quot;:&quot;J. Harnor&quot;},{&quot;first_name&quot;:&quot;Mathew&quot;,&quot;last_name&quot;:&quot;P. Martin&quot;},{&quot;first_name&quot;:&quot;Benoit&quot;,&quot;last_name&quot;:&quot;Carbain&quot;},{&quot;first_name&quot;:&quot;Bernard&quot;,&quot;last_name&quot;:&quot;T. Golding&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;R. Hardcastle&quot;},{&quot;first_name&quot;:&quot;Lisa&quot;,&quot;last_name&quot;:&quot;K. Harlow&quot;},{&quot;first_name&quot;:&quot;Svitlana&quot;,&quot;last_name&quot;:&quot;Korolchuk&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Matheson&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;R. Newell&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;E. M. Noble&quot;},{&quot;first_name&quot;:&quot;Mangaleswaran&quot;,&quot;last_name&quot;:&quot;Sivaprakasam&quot;},{&quot;first_name&quot;:&quot;Susan&quot;,&quot;last_name&quot;:&quot;J. Tudhope&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;M. Turner&quot;},{&quot;first_name&quot;:&quot;Lan&quot;,&quot;last_name&quot;:&quot;Z. Wang&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;R. Wedge&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Wong&quot;},{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;J. Griffin&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;A. Endicott&quot;},{&quot;first_name&quot;:&quot;Céline&quot;,&quot;last_name&quot;:&quot;Cano&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;14&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;1746-1767&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.6b01254&quot;},&quot;abstract&quot;:&quot;Purines and related heterocycles substituted at C-2 with 4′-sulfamoylanilino and at C-6 with a variety of groups have been synthesized with the aim of achieving selectivity of binding to CDK2 over CDK1. 6-Substituents that favor competitive inhibition at the ATP binding site of CDK2 were identified and typically exhibited 10–80-fold greater inhibition of CDK2 compared to CDK1. Most impressive was 4-((6-([1,1′-biphenyl]-3-yl)-9H-purin-2-yl)amino) benzenesulfonamide (73) that exhibited high potency toward CDK2 (IC50 0.044 μM) but was ∼2000-fold less active toward CDK1 (IC50 86 μM). This compound is therefore a useful tool for studies of cell cycle regulation. Crystal structures of inhibitor–kinase complexes showed that the inhibitor stabilizes a glycine-rich loop conformation that shapes the ATP ribose binding pocket and that is preferred in CDK2 but has not been observed in CDK1. This aspect of the active site may be exploited for the design of inhibitors that distinguish between CDK1 and CDK2.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01254&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01254" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01254&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01254" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.6b01254&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01254" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.6b01254&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.6b01254&amp;href=/doi/10.1021/acs.jmedchem.6b01254" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.6b01254" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.6b01254" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.6b01254%26sid%3Dliteratum%253Aachs%26pmid%3D28005359%26genre%3Darticle%26aulast%3DCoxon%26date%3D2017%26atitle%3DCyclin-Dependent%2BKinase%2B%2528CDK%2529%2BInhibitors%253A%2BStructure%25E2%2580%2593Activity%2BRelationships%2Band%2BInsights%2Binto%2Bthe%2BCDK-2%2BSelectivity%2Bof%2B6-Substituted%2B2-Arylaminopurines%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D5%26spage%3D1746%26epage%3D1767%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291074" title="Purification">Purification</a>,</li><li><a href="/action/doSearch?ConceptID=290860" title="Solution chemistry">Solution chemistry</a>,</li><li><a href="/action/doSearch?ConceptID=292553" title="Ethanol">Ethanol</a>,</li><li><a href="/action/doSearch?ConceptID=291594" title="Silica">Silica</a>,</li><li><a href="/action/doSearch?ConceptID=292234" title="Chromatography">Chromatography</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/jmcmar.2017.60.issue-5/20170309/jmcmar.2017.60.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Purines and related heterocycles substituted at C-2 with 4′-sulfamoylanilino and at C-6 with a variety of groups have been synthesized with the aim of achieving selectivity of binding to CDK2 over CDK1. 6-Substituents that favor competitive inhibition at the ATP binding site of CDK2 were identified and typically exhibited 10–80-fold greater inhibition of CDK2 compared to CDK1. Most impressive was 4-((6-([1,1′-biphenyl]-3-yl)-9<i>H</i>-purin-2-yl)amino) benzenesulfonamide (<b>73</b>) that exhibited high potency toward CDK2 (IC<sub>50</sub> 0.044 μM) but was ∼2000-fold less active toward CDK1 (IC<sub>50</sub> 86 μM). This compound is therefore a useful tool for studies of cell cycle regulation. Crystal structures of inhibitor–kinase complexes showed that the inhibitor stabilizes a glycine-rich loop conformation that shapes the ATP ribose binding pocket and that is preferred in CDK2 but has not been observed in CDK1. This aspect of the active site may be exploited for the design of inhibitors that distinguish between CDK1 and CDK2.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The cyclin-dependent kinase (CDK) family of serine/threonine kinases plays an integral role in the regulation of the eukaryotic cell cycle as well as having key functions in apoptosis, transcription, differentiation, and neuronal function.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Deregulation of the cell cycle, a hallmark of human cancer, is frequently associated with aberrant CDK activity through mechanisms that may include mutation/overexpression of CDKs or mutations to genes encoding proteins that directly or indirectly modulate CDK activity.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3-5)</a> CDK2 activation entails association with partner cyclins A and E, whereas the endogenous proteins p21<sup>Cip1</sup> and p27<sup>Kip1</sup> are inhibitory. Cyclin E overexpression and/or p27<sup>Kip1</sup> suppression are a common feature of many human tumors.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a></div><div class="NLM_p">Pharmacological inhibition of CDK family members is a potential therapeutic approach for the treatment of cancer. In this context, a large number of ATP-competitive inhibitors have been evaluated.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8 ref9">(5-9)</a> The clinical development of CDK inhibitors as antitumor agents was originally hampered by poor kinase selectivity, particularly within the CDK family, and uncertainty as to which CDK constitutes the most appropriate therapeutic target.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> However, an appreciation of the roles played by specific CDKs in sustaining signaling through dysregulated pathways that drive particular cancers is leading to more stringent patient selection and correspondingly improved efficacy. For example, the highly selective CDK4/6 inhibitor palbociclib has been approved for the treatment of ER-positive, HER2-negative breast cancer, while abemaciclib, palbociclib, and ribociclib are in phase III clinical trials to treat advanced breast cancer in which signaling through the CDK4/6-retinoblastoma axis is critical.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Similarly, agents that target a subset of CDKs are being evaluated in a range of other clinically defined segments.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">The validity of CDK2 as a cancer therapeutic target was originally called into question both by CDK2 knockdown experiments in which loss of CDK2 failed to induce cell cycle arrest in a number of tumor cell lines<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and by mouse knockout experiments where the animals were viable.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> However, applying the rationale outlined above, CDK2 inhibitors are also expected to have utility in settings in which the cancer is addicted to enhanced CDK2 activity or where synthetic lethalities can be identified. Recent studies employing a chemical genetic approach in which CDK2 expression was maintained, but kinase activity was inhibited, provides compelling evidence that CDK2 is a valid cancer target. In a panel of human cancer cells transformed with various oncogenes, highly selective small-molecule CDK2 inhibition resulted in marked growth inhibition.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> CDK2-selective inhibitors may also have applications in combination therapies in appropriate clinical settings. For example, a recent study demonstrated that a combination of phosphatidylinositol-3-kinase and CDK2 inhibitors induced apoptosis in malignant glioma xenografts via a synthetic–lethal interaction.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Accumulating evidence also implicates CDK2 as a prospective therapeutic target in BRCA-deficient cancers,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> neuroblastoma,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> and ovarian cancer.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> These observations, taken together with supportive clinical data,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> have led to a resurgence of interest in CDK2 inhibitors as cancer therapeutic agents.<a onclick="showRef(event, 'ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref21 ref22">(21, 22)</a> Ideally, such an inhibitor would discriminate between CDK2 and CDK1 to avoid cell toxicity as a result of inhibiting CDK1, which is an essential member of the CDK family.<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0012.gif" alt="" id="fx1" /></img></div><div class="NLM_p">Our previous studies employing a structure-lead approach resulted in the development of selective ATP-competitive CDK2 inhibitors based on 2-amino-6-alkoxy- (<b>1</b>; NU2058) and 2-arylamino-6-alkoxy- (<b>2</b>) purine derivatives.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> These efforts were rewarded by the identification of potent purine-based inhibitors, exemplified by 6-cyclohexylmethoxy-2-(4′-sulfamoylanilino)purine (<b>3</b>; NU6102, CDK2 IC<sub>50</sub> = 5.0 nM)<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> as well as alkoxypyrimidine inhibitors (e.g., <b>4</b>, CDK2 IC<sub>50</sub> = 0.8 nM).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Importantly, <b>3</b> exhibits selectivity for CDK2 over other CDK-family members, proving some 50-fold selective for CDK2 over CDK1 (IC<sub>50</sub> = 250 nM), a kinase with close structural homology to CDK2. In addition, <b>3</b> is only weakly active against CDK7 and CDK9 (IC<sub>50</sub> = 4.4 and 1.1 μM, respectively). These CDKs play a key role in transcriptional regulation through phosphorylation of RNA polymerase II.<a onclick="showRef(event, 'ref2 ref27'); return false;" href="javascript:void(0);" class="ref ref2 ref27">(2, 27)</a> Modulation of protein synthesis by off-target inhibition of CDK7/CDK9 has obfuscated previous studies to elucidate the pharmacological effects of clinically evaluated compounds initially identified as selective CDK2 inhibitors such as seliciclib (<b>5</b>), dinaciclib (<b>6</b>), and SNS-032 (<b>7</b>).<a onclick="showRef(event, 'ref3 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref3 ref28 ref29">(3, 28, 29)</a><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0013.gif" alt="" id="fx2" /></img></div><div class="NLM_p">Crystal structures of purines <b>1</b>–<b>3</b> in complex with T160-phosphorylated CDK2-cyclin A (CDK2-cyclin A) provided valuable details of inhibitor interactions within the ATP-binding site.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a> The purine heterocycle anchored the inhibitor through a triplet of hydrogen bonds between <i>N</i>-9, <i>N</i>-3, and the 2-amino group, and the backbone carbonyl moiety of Glu81 and amide and carbonyl moieties of Leu83, respectively, located in the hinge region of the kinase (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The greater potency and selectivity of <b>3</b> compared with <b>2</b> and the parent 2-amino-6-cyclohexylmethoxypurine <b>1</b>, has been attributed, at least in part, to additional interactions of the 2-sulfanilyl substituent of <b>3</b> with the specificity surface of CDK2.<a onclick="showRef(event, 'ref24 ref30'); return false;" href="javascript:void(0);" class="ref ref24 ref30">(24, 30)</a> Notably, two hydrogen bond interactions between the sulfonamide group of <b>3</b> and Asp86 facilitate optimal hydrophobic packing of the arylamino ring.</div><div class="NLM_p">Extensive structure–activity relationship studies (SARs) at the purine 2-position of <b>3</b> have further established the importance of these inhibitor–kinase interactions.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> By contrast, although the 6-cyclohexylmethyl group of <b>3</b> occupies the ribose-binding pocket, the precise nature of the interactions made by substituents at the purine 6-position with the CDK2 active site remains uncertain, notwithstanding that a large number of derivatives have previously been evaluated empirically.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p last">In this paper, we report the results of studies to characterize interactions between substituents at the purine 6-position and the CDK2 ATP-binding site. The effect upon biological activity of modifying the core purine heterocycle of <b>3</b> is also reported. These studies have resulted in the identification of 4-((6-([1,1′-biphenyl]-3-yl)-9<i>H</i>-purin-2-yl)amino) benzenesulfonamide <b>73</b> as a potent and selective CDK2 inhibitor (IC<sub>50</sub> = 44 nM), exhibiting some 2000-fold-selectivity over CDK1 (IC<sub>50</sub> = 86 μM).</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84645" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84645" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With a view to establishing the overall contribution of the 6-cyclohexylmethoxy substituent of <b>1</b> and <b>3</b> to inhibitor binding, the simple 6-unsubstituted purines <b>8</b>, <b>12</b>, and <b>13</b> were required. 2-Aminopurine (<b>8</b>) was commercially available, while the 2-phenylaminopurine (<b>12</b>) and 2-sulfanilylpurine (<b>13</b>) derivatives were synthesized as outlined in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Thus, selective reductive dehalogenation of 6-chloro-2-fluoropurine (<b>10</b>), prepared from 2-amino-6-chloropurine (<b>9</b>) following a literature procedure,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> afforded 2-fluoropurine (<b>11</b>). Treatment of <b>11</b> with aniline or 4-aminobenzenesulfonamide (sulfanilamide) in 2,2,2-trifluoroethanol (TFE) with catalysis by trifluoroacetic acid (TFA) as described previously<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> gave the respective 2-arylaminopurines <b>12</b> and <b>13</b> in good yield. The required 2-arylaminoguanine derivatives <b>15</b> and <b>16</b> were also readily accessible from commercially available 2-bromohypoxanthine (<b>14</b>) under similar conditions. The 6-alkoxypurine derivatives (<b>30</b>–<b>35</b>) were synthesized by utilizing previously optimized methodology.<a onclick="showRef(event, 'ref23 ref25 ref31'); return false;" href="javascript:void(0);" class="ref ref23 ref25 ref31">(23, 25, 31)</a> Briefly, introduction of the 6-alkoxy substituent was achieved either by direct reaction of the appropriate sodium alkoxide with 2-amino-6-chloropurine (<b>9</b>) by employing the corresponding alcohol as solvent or, where necessary, following conversion into the “DABCO-purine” intermediate (<b>17</b>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Elaboration of the 6-alkoxy-2-aminopurines (<b>18</b>–<b>23</b>) into the corresponding 2-fluoropurines (<b>24</b>–<b>29</b>) under Balz–Schiemann conditions enabled subsequent introduction of the 2-(4-aminobenzenesulfonamide) group using the TFA-TFE procedure to furnish the target purines (<b>30</b>–<b>35</b>) in good overall yields (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0003.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) aq HBF<sub>4</sub>, NaNO<sub>2</sub>, −15 to 0 °C; (ii) Pd(OH)<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, MeOH, reflux; (iii) ArNH<sub>2</sub>, TFA, TFE, 90 °C; (iv) POCl<sub>3</sub>, PhNMe<sub>2</sub>, reflux; (v) 3,4-2<i>H</i>-dihydropyran, (<i>rac</i>)-camphorsulfonic acid, EtOAc, 75 °C; (vi) R-CCH, PdCl<sub>2</sub>(MeCN)<sub>2</sub>, dicyclohexyl-(2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)phosphine, Cs<sub>2</sub>CO<sub>3</sub>, MeCN; (vii) TFA, <i>i</i>-PrOH, H<sub>2</sub>O, reflux; (viii) DABCO, DMSO, 25 °C. (ix) For <b>18</b>, <b>19</b>, <b>22</b>: ROH, Na, reflux. For <b>20</b>, <b>21</b>, <b>23</b>: ROH, NaH, DMSO, 25 °C. For definition of R groups, see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></p></figure><div class="NLM_p">The 6-ethynylpurine derivatives (<b>41</b> and <b>42</b>) were synthesized from the THP-protected 6-chloro-2-fluoropurine (<b>36</b>)<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> via a Sonogashira alkynylation approach (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Coupling of triisopropylacetylene with <b>36</b>, employing Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>/CuI, afforded the protected 6-ethynylpurine (<b>37</b>) in excellent yield, and removal of the <i>N</i><sup>9</sup>-THP group to give <b>38</b> and introduction of the 2-arylamino substituent proceeded in the manner described above to give <b>39</b> and <b>40</b>. Removal of the TIPS group to furnish the target 2-arylamino-6-ethynylpurines <b>41</b> and <b>42</b> was achieved under standard conditions. The 6-propynyl- and 6-phenylethynyl-purine derivatives <b>48</b> and <b>49</b> were accessible from the guanine derivative <b>15</b> by sequential chlorination at the purine 6-position (<b>44</b>), THP protection (<b>45</b>), introduction of the appropriately substituted ethynyl group under Sonogashira conditions (<b>46</b>, <b>47</b>), and final <i>N</i><sup>9</sup>-deprotection to furnish the target purines <b>48</b> and <b>49</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The 6-ethylpurine derivative (<b>52</b>) was readily obtained by reduction of the 6-ethynyl group of the THP derivative <b>43</b> with Lindlar’s catalyst-quinoline to afford <b>50</b>, with <i>N</i><sup>9</sup>-deprotection (<b>51</b>) and final introduction of the 2-(4-aminobenzenesulfonamide) group, giving <b>52</b> in modest overall yield.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0004.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 3,4-2<i>H</i>-dihydropyran, (<i>rac</i>)-camphorsulfonic acid, EtOAc, 75 °C; (ii) (<i>i</i>-Pr)<sub>3</sub>SiCCH, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, THF, 25 °C; (iii) TFA, <i>i</i>-PrOH, H<sub>2</sub>O, reflux; (iv) PhNH<sub>2</sub> or 4-NH<sub>2</sub>C<sub>6</sub>H<sub>4</sub>SO<sub>2</sub>NH<sub>2</sub>, TFA, TFE, 90 °C; (v) (<i>n</i>-Bu)<sub>4</sub>NF, THF, 25 °C; (vi) Lindlar’s catalyst, quinoline, H<sub>2</sub>, EtOAc, RT, 2 h; (vii) RB(OH)<sub>2</sub> or RBF<sub>3</sub>K, Pd(OAc)<sub>2</sub>, dicyclohexyl(2′,6′-dimethoxybiphenyl-2-yl)phosphine, K<sub>3</sub>PO<sub>4</sub>, PhMe, H<sub>2</sub>O, 100 °C. For definition of R groups, see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></p></figure><div class="NLM_p">Efforts to synthesize the 6-cyclopropylpurine (<b>55</b>) employing Suzuki–Miyaura conditions were unsuccessful, likely due to competing protodeboronation of the cyclopropylboronic acid under the reaction conditions employed. This problem was successfully addressed as reported in the literature by converting the cyclopropylboronic acid into the corresponding potassium trifluoroborate,<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> whereby coupling to the THP-protected 6-chloro-2-fluoropurine (<b>36</b>) occurred to furnish <b>53</b> in acceptable yield. Subsequent transformation into the target 6-cyclopropylpurine (<b>55</b>) was achieved readily. The introduction of aryl substituents at the purine 6-position was achieved using Suzuki–Miyaura cross-coupling chemistry with 6-chloro-2-fluoropurine derivative <b>36</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Optimization of the reagents and reaction conditions employed for the cross-coupling step enabled the preparation of a defined series of 2-fluoro-6-arylpurine derivatives (<b>56</b>–<b>62</b>) in excellent yields, and conversion into the requisite 6-aryl-2-(4-sulfonamidophenyl)aminopurines (<b>70</b>–<b>76</b>) proceeded smoothly under the previously described conditions.<a onclick="showRef(event, 'ref25 ref33'); return false;" href="javascript:void(0);" class="ref ref25 ref33">(25, 33)</a></div><div class="NLM_p">The synthesis of prospective CDK2 inhibitors encompassing alternative heterocyclic systems was undertaken as summarized in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. In each case, the parent chloroheterocycles (<b>77</b>, <b>84</b>, <b>85</b>, <b>92</b>, <b>99</b>) were synthesized by adapting literature procedures<a onclick="showRef(event, 'ref37 ref38 ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref37 ref38 ref39 ref40 ref41">(37-41)</a> and the cyclohexylmethyl substituent introduced by treatment with the corresponding alkoxide, with <i>N</i><sup>9</sup> protected where necessary, as described previously. Iodination (<b>81</b>)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> or chlorination (<b>88</b>, <b>89</b>, <b>96</b>) of the respective 2-aminoheterocycles under Sandmeyer conditions facilitated introduction of the 2-arylamino group under the standard TFA-TFE conditions (<b>88</b>, <b>89</b>) or employing a Buchwald amination procedure (<b>81</b>, <b>96</b>), followed by deprotection as necessary to afford the target compounds <b>83</b>, <b>90</b>, <b>91</b>, and <b>98</b>. The imidazo[1,2-<i>a</i>]pyrimidine derivatives (<b>101</b>, <b>102</b>) were prepared from 5,7-dichloroimidazo[1,2-<i>a</i>]pyrimidine (<b>99</b>)<a onclick="showRef(event, 'ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref43 ref44">(43, 44)</a> by regioselective 5-alkoxylation to give <b>100</b>, followed by final introduction of the arylamino group at the 7-position under TFA-TFE conditions. Given the possibility of alkoxide attack at the 7-position of <b>99</b> to furnish the alternative regioisomer, the structure of <b>102</b> was unambiguously confirmed by X-ray crystallography (<a class="ref internalNav" href="#notes-5" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0005.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) PMB-Cl, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (ii) NaH, cyclohexylmethanol, DMSO, 25 °C; (iii) TFA, 80 °C; (iv) CH<sub>2</sub>I<sub>2</sub>, <i>iso</i>-amyl nitrite, CuI, THF, 80 °C; (v) sulfanilamide, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C; (vi) LiCl, <i>iso</i>-amyl nitrite, SOCl<sub>2</sub>, DMA or THF, 0–25 °C; (vii) ArNH<sub>2</sub>, TFA, TFE, 90 °C; (viii) SEM-Cl, NaH, MeCN, 0 °C; (ix) TBAF, THF, 25 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87044" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87044" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The chemical structures, CDK inhibitory activity, and in vitro antitumor activity for the purine derivatives and alternative heterocycles are summarized in <a class="ref internalNav" href="#tbl1" aria-label="Tables 1">Tables 1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, with the values for compounds <b>1</b>–<b>3</b> included for comparative purposes.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Chemical Structures and CDK2-Inhibitory Activity of Purine Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0006.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0007.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were determined in accordance with previously described methods.<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20, 23)</a></p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Data shown are the mean of at least two independent experiments ± standard deviation.</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Percent inhibition values are in brackets.</p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">The oxo-tautomers predominate.</p></div></div><div></div></div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Structure–Activity Relationships</h3><div class="NLM_p">The importance of a substituent at the purine 6-position was reaffirmed by the simple 2-amino- and 2-phenylamino-purines (<b>8</b> and <b>12</b>), where a dramatic reduction in potency was observed compared with the parent 6-cyclohexylmethoxy derivatives <b>1</b> and <b>2</b>, respectively. A similar effect was also evident for the sulfanilylpurine <b>13</b>, which was some 300-fold less active than <b>3</b>. These results are consistent with the putative interaction of this inhibitor class with the ATP-binding site of CDK2, which requires that the 6-substituent occupies a lipophilic pocket close to the ribose binding site, thereby orienting the purine to make the triplet of hydrogen bonds with the hinge region.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The low-micromolar potency of the 2-sulfanilyl derivative <b>13</b> likely reflects the contribution to binding arising through additional interactions between the arylsulfonamide group of <b>13</b> with the CDK2 surface adjacent to the ATP binding site on the C-terminal lobe (termed the “specificity surface”) despite the absence of a 6-substituent. Perhaps not surprisingly, the guanine derivatives <b>15</b> and <b>16</b> were only weakly active, attributable to unfavorable interactions between the 6-oxo functionality and the ribose-binding pocket. These derivatives also exhibited the very poor aqueous solubility characteristic of many guanine derivatives.</div><div class="NLM_p">Replacement of the 6-cyclohexylmethoxy group of <b>3</b> by smaller alkoxy substituents proved informative and was broadly consistent with our earlier investigations with derivatives of <b>1</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In that study, 2-amino-6-methoxypurine (<i>O</i><sup>6</sup>-methylguanine) demonstrated negligible activity (CDK2; IC<sub>50</sub> > 100 μM), and the relatively poor chemical stability of this purine militated against preparing the corresponding 2-sulfanilyl analogue. The 6-ethoxypurine <b>30</b> exhibited high CDK2 inhibitory activity (IC<sub>50</sub> = 26 nM), with an approximately 3-fold increase in potency being observed for the <i>n</i>-propoxy- (<b>31</b>; IC<sub>50</sub> = 8 nM) and <i>iso</i>-propoxy- (<b>32</b>; IC<sub>50</sub> = 10 nM) derivatives. Potency was improved further by increasing the size of the 6-alkoxy group, as demonstrated by the activity of the isomeric butoxy analogues <b>33</b> and <b>34</b> with IC<sub>50</sub> values of 3 and 1 nM, respectively. The relationship between the bulk of the 6-alkoxy group and the CDK2-inhibitory activity generally parallels that previously observed for the corresponding 2-amino-6-alkoxypurines, albeit that the sulfanilylpurines <b>30</b>–<b>34</b> are several orders of magnitude more potent. For example, <b>34</b> (IC<sub>50</sub> = 1 nM) is approximately 50000-fold more potent than the corresponding 2-amino-6-<i>sec</i>-butoxypurine (CDK2; IC<sub>50</sub> = 49 ± 7 μM),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> again corroborating the crucial binding contribution made by the arylsulfonamide function. A propargyloxy group at the purine <i>O</i><sup>6</sup>-position conferred activity comparable to the ethoxy derivative (compare <b>35</b> and <b>30</b>), in keeping with the trend reported previously for the 2-amino-6-alkoxypurine series.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">The introduction of an ethyl substituent at the purine 6-position (<b>52</b>) reduced CDK2-inhibitory activity some 10-fold compared with the 6-ethoxypurine (<b>30</b>), and very modest potency was also observed for the 6-ethynyl derivatives <b>41</b> and <b>42</b>. Although 6-alkoxy and 6-alkyl groups differ with regard to both their electronic and steric character, as well as lipophilicity, the high potency of the 6-triisopropylsilyethynylpurine (<b>40</b>; IC<sub>50</sub> = 17 nM) shows that steric bulk, as well as electronic factors, is an important feature for binding in the ribose pocket of CDK2. The modest improvement in potency observed for the prop-1-ynyl (<b>48</b>) and phenylethynyl (<b>49</b>) derivatives compared with the parent 6-ethynylpurine <b>41</b> also suggests that the overall shape of the 6-substituent is an important factor for occupancy of the ribose-binding pocket, supported by the activity of the 6-cyclopropylpurine <b>55</b> (IC<sub>50</sub> = 19 nM). These data also suggest that the oxygen atom of the 6-alkoxypurines, which would act as a weak hydrogen bond acceptor, does not make a significant contribution to binding affinity.</div><div class="NLM_p">The potency of the 6-phenylpurine (<b>70</b>; IC<sub>50</sub> = 24 nM) prompted further elaboration, with comparable activity residing in the 3-methoxyphenyl (<b>71</b>), 4-methoxyphenyl (<b>72</b>), and 6-(3-phenylphenyl)purine (<b>73</b>) derivatives. By contrast, the piperonyl derivative (<b>74</b>) was some 20-fold less potent than <b>70</b>, and the introduction of still larger groups was detrimental, as evident from the very weak CDK2 inhibitory activity of the dibenzofuran-1-yl (<b>75</b>) and thianthren-1-yl (<b>76</b>) analogues. The bulkier bicyclic and tricyclic heteroaromatic rings of these purines are presumably poorly accommodated within the ribose-binding pocket. It is of interest to note that the CDK2 inhibitory activity of the 6-unsubstituted derivative <b>13</b> is equipotent with <b>75</b> and superior to that of <b>76</b>, implying that the 6-substituents of these purines make a negligible binding contribution.</div><div class="NLM_p">With a view to assessing selectivity for CDK2, selected purine derivatives were evaluated against a panel of CDKs (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). As expected, removal of the 6-cyclohexylmethyl substituent of <b>3</b>, which makes a number of interactions with the conserved ATP ribose binding site to furnish <b>13</b> compromised potency against all the CDKs evaluated, although the effect was less pronounced against CDK2.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. CDK Selectivity and Cellular Activity for Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0008.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0009.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were determined in accordance with previously described methods.<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20, 23)</a></p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Data shown are the mean of at least two independent experiments ± standard deviation.</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">Percent inhibition values are in brackets.</p></div></div><div></div></div><div class="NLM_p">The 6-alkoxypurines <b>34</b> and <b>35</b> exhibited good selectivity for CDK2 over the closely related CDK1 (80-fold and 50-fold, respectively), with <b>34</b> retaining selectivity over CDKs 4, 7, and 9 comparable with <b>3</b>. A similar profile was observed for the 6-phenylpurine <b>70</b>, which was some 30-fold selective for CDK2 over CDK1. By contrast, the 6-([1,1′-biphenyl]-3-yl)purine derivative <b>73</b> exhibited a very interesting CDK selectivity profile, proving some 2000-fold selective for CDK2 over CDK1 while exhibiting only weak inhibitory activity against CDKs 4, 7, and 9. To the best of our knowledge, this level of selectivity for CDK2 over CDK1 is unprecedented.</div><div class="NLM_p">Modification of the core purine heterocycle of <b>1</b> and <b>3</b> afforded further interesting results (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). A comparison of 2-amino-6-cyclohexylmethylpurine <b>1</b> with the alternative heterocycles <b>86</b>, <b>87</b>, and <b>93</b> revealed that although these compounds exhibited comparable potency against CDK2, activity against other CDK family members was markedly attenuated. The very weak activity of the imidazopyrimidine derivatives <b>101</b> and <b>102</b> is not surprising given the absence of the requisite donor–acceptor–donor motif and presumably reflects the combined influence arising from the absence of the <i>N</i><sup>1</sup> and <i>N</i><sup>7</sup> functions found in the corresponding purine derivatives <b>1</b> and <b>3</b>. The modest CDK inhibition profile of imidazopyridine <b>83</b> indicates that removal of the <i>N</i><sup>1</sup> nitrogen is detrimental to CDK inhibitory activity. However, with the exception of the imidazopyridine (<b>83</b>) and imidazopyrimidine (<b>102</b>) derivatives, modification of the core purine heterocycle of <b>3</b> was generally tolerated without a marked loss of CDK2 inhibitory activity. Thus, triazolopyrimidine (<b>90</b>) analogue is 2.5-fold more potent than <b>3</b>, while pyrazolopyrimidine (<b>91</b>) and pyrrolopyrimidine (<b>98</b>) analogues proved only some 4–5-fold less potent than <b>3</b> against CDK2 and retained good selectivity over all other CDK family members examined. Notably, derivatives <b>91</b> and <b>98</b> were approximately 100-fold selective for CDK2 over CDK1.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Chemical Structures and CDK Inhibitory Activity of Other Heterocyclic Derivatives</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0010.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> values were determined in accordance with previously described methods.<a onclick="showRef(event, 'ref20 ref23'); return false;" href="javascript:void(0);" class="ref ref20 ref23">(20, 23)</a></p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Data shown are the mean of at least two independent experiments ± standard deviation.</p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Percent inhibition values are in brackets.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Value determined at 100 μM.</p></div></div><div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cellular Studies</h3><div class="NLM_p">The ability of compounds to inhibit cellular proliferation was examined in a 5-day growth assay using five histologically distinct retinoblastoma protein (Rb)-proficient human tumor lines (A375 melanoma, Calu-6 lung carcinoma, MDA-MB-231 breast adenocarcinoma, SJSA1 osteosarcoma, and SKUT-1B uterine corpus leiomyosarcoma). While compound <b>73</b> demonstrated appreciable nanomolar potency versus CDK2 in isolated kinase assays, the maximal concentration tested in cellular assays (30 μM) had no or limited effects on the growth of cells, thereby preventing the concentration that induced a 50% growth inhibitory (GI<sub>50</sub>) effect to be determined (data not shown). In contrast, compounds <b>91</b> and <b>98</b>, which were only 2.4- and 1.7-fold more potent respectively in CDK2 kinase assays, dose-dependently inhibited the growth of each tumor cell line with GI<sub>50</sub> values ranging from 1–22 μM. The cellular activity of these compounds compared favorably to that of compound <b>3</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0001.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Activity of compounds <b>3</b>, <b>91</b>, and <b>98</b> against tumor cell growth.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Rb-proficient human tumor cell lines were incubated for 120 h with compounds and cellular protein determined by SRB assay. Dose–response curves and GI<sub>50</sub> bar charts represent the mean ± SEM from three or four independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Structure Determination</h3><div class="NLM_p">Compounds within this series show greater activity toward CDK2 than CDK1, generally varying between 10- and 80-fold (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). However, <b>73</b> exhibits exceptional discrimination being a ca. 2000-fold more potent inhibitor of CDK2. To confirm the binding mode and to identify potential interactions that might explain the selectivity of <b>73</b> for CDK2 over CDK1, <b>73</b> and <b>3</b> were cocrystallized with CDK2-cyclin A and CDK1-cyclin B-cyclin-dependent kinases regulatory subunit 2 (CKS2), respectively. The poor potency of <b>73</b> toward CDK1 appears to preclude determination of a CDK1-cyclin B-CKS2–<b>73</b> cocomplex structure, as despite repeated attempts we were unable to visualize the compound in the active site. The statistics for the data sets and for the crystallographic refinements are presented in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>. Compound <b>73</b> emulates the interactions made by <b>3</b> within the CDK2 active site (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Indeed, the purine and aniline rings of each inhibitor superimpose very well. The purine rings occupy the CDK2 ATP binding site, and each makes a triplet of hydrogen bonds with the backbone carbonyl of Glu81 and the amide NH and carbonyl moieties of Leu83 within the hinge sequence (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). The respective anilino rings project out of the CDK2 catalytic site so that the sulfonamide NH<sub>2</sub> group and one of the oxygens in each make hydrogen bonds with the side chain and backbone nitrogen of Asp86, respectively.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. X-ray Data Collection and Refinement Statistics</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">CDK2-cyclin A–<b>73</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CDK1-cyclin B-CKS2–<b>3</b><a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Data Collection</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">space group</td><td class="colsep0 rowsep0" align="left"><i>P</i>2<sub>1</sub>2<sub>1</sub>2<sub>1</sub></td><td class="colsep0 rowsep0" align="left"><i>P</i>1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unit cell (Å)</td><td class="colsep0 rowsep0" align="left"><i>a</i> = 73.5, <i>b</i> = 132.1, <i>c</i> = 149.2</td><td class="colsep0 rowsep0" align="left"><i>a</i> = 65.0, <i>b</i> = 67.8, <i>c</i> = 85.1, α = 103.9, β = 90.9, γ = 90.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">resolution (Å)</td><td class="colsep0 rowsep0" align="left">66.03–2.97</td><td class="colsep0 rowsep0" align="left">65.76–2.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">(highest resolution shell)</td><td class="colsep0 rowsep0" align="left">(3.13–2.97)</td><td class="colsep0 rowsep0" align="left">(2.10–2.06)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total observations</td><td class="colsep0 rowsep0" align="left">226370 (7244)</td><td class="colsep0 rowsep0" align="left">169709 (8389)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">unique</td><td class="colsep0 rowsep0" align="left">30773 (1098)</td><td class="colsep0 rowsep0" align="left">84841 (4161)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>merge</sub><sup>a</sup></td><td class="colsep0 rowsep0" align="left">0.086</td><td class="colsep0 rowsep0" align="left">0.092</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mean <i>I</i>/σ(<i>I</i>)</td><td class="colsep0 rowsep0" align="left">6.7 (1.6)</td><td class="colsep0 rowsep0" align="left">6.2 (1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">completeness %</td><td class="colsep0 rowsep0" align="left">100 (99.7)</td><td class="colsep0 rowsep0" align="left">97.3 (95.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="left">Refinement</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">total number of atoms</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">protein</td><td class="colsep0 rowsep0" align="left">8927</td><td class="colsep0 rowsep0" align="left">20449</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">other</td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">waters</td><td class="colsep0 rowsep0" align="left">18</td><td class="colsep0 rowsep0" align="left">291</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i> (highest resolution shell)</td><td class="colsep0 rowsep0" align="left">0.213</td><td class="colsep0 rowsep0" align="left">0.198</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>R</i><sub>free</sub> (highest resolution shell)</td><td class="colsep0 rowsep0" align="left">0.266</td><td class="colsep0 rowsep0" align="left">0.254</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd bonds (Å)</td><td class="colsep0 rowsep0" align="left">0.0122</td><td class="colsep0 rowsep0" align="left">0.0217</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rmsd angles (deg)</td><td class="colsep0 rowsep0" align="left">1.770</td><td class="colsep0 rowsep0" align="left">2.233</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">The structures have been deposited in the PDB with accession codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQE">5LQE</a> (CDK2-cyclin A–<b>73</b>) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQF">5LQF</a> (CDK1-cyclin B-CKS2–<b>3</b>).</p></div></div></div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of CDK2-cyclin A–<b>73</b> and CDK1-cyclin B-CKS2–<b>3</b>. (A) Surface representation of CDK2 (ice-blue) bound to cyclin A (coral) in complex with <b>73</b> (yellow). The inset shows the interactions of <b>73</b> within the ATP site of CDK2-cyclin A. (B) Surface representation of CDK1 (dark-cyan) bound to cyclin B (pale-crimson) and CKS2 (lemon) in complex with <b>3</b> (green). The inset shows the interactions of <b>3</b> within the ATP site of CDK1-cyclin B-CKS2. In (A) and (B), the protein backbone is rendered in ribbon representation and selected CDK2 and CDK1 residues are drawn respectively with carbon atoms colored ice-blue and dark-cyan. The hydrogen bonds are shown as black dotted lines. (C) The structural conformations of the CDK2-cyclin A and CDK1-cyclin B-CKS2 glycine-rich loops to illustrate the alternative poses of catalytic residue Tyr15. The left-hand side panel compares CDK2-cyclin A in complex with <b>73</b> (ice-blue) to other inhibitor bound CDK2-cyclin A complexes (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EOS">4EOS</a> (green), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TNW">3TNW</a> (coral), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MY5">3MY5</a> (lilac)). The right-hand panel overlays CDK1-cyclin B-CKS2 bound to <b>3</b> (ice-blue) with apo CDK1-cyclin B-CKS2 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YC3">4YC3</a>, lilac) and CDK1-cyclin B-CKS2 in complex with compound <b>23</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HQ0">5HQ0</a>, green). The conformations of the loop when CDK1 is bound to <b>3</b> or compound <b>23</b> cannot be distinguished. Gly-rich loop, glycine-rich loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structures of <b>73</b> and <b>3</b> differ in the substitution present at the purine C-6 position. The <i>O</i><sup>6</sup>-cyclohexylmethyl substituent of <b>3</b> occupies the ATP ribose binding pocket and is complementary in shape and forms favorable hydrophobic interactions with an apolar pocket created by the conformation of the CDK2 glycine-rich loop (residues 9–19).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This loop adopts an identical backbone structure when bound to <b>73</b> so that the purine-proximal phenyl ring emulates the position of the cyclohexylmethyl substitutent of <b>3</b>. The distal phenyl ring substituted at the <i>meta</i> position can then be comfortably accommodated as it twists toward the aniline moiety (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>A). In contrast, <i>para</i> substitutions of the purine-proximal phenyl ring exemplified by <b>72</b>, <b>74</b>, <b>75</b>, and <b>76</b> (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>) would be directed out of the CDK2 active site toward the tip of the glycine-rich loop. Smaller substitutions, for example a methoxy in <b>72</b> can be accommodated but larger ring systems as exemplified by <b>74</b> and <b>76</b> lead to considerable drops in potency, suggesting they may sterically clash with the CDK2 structure in this region (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>).</div><div class="NLM_p">To probe further the binding mode of the series, CDK1-cyclin B-CKS2 was cocrystallized with <b>3</b> (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>B). This structure shows that the purine backbone emulates the interactions made by this inhibitor within the CDK2 binding site and that the <i>O</i><sup>6</sup>-cyclohexylmethyl substituent occupies the ribose binding pocket. As previously reported,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> inhibitor binding within the ATP binding site is accompanied by minor remodelling of the CDK1-cyclin B into a conformation compatible with catalysis.</div><div class="NLM_p last">All of the side chains contacted by <b>73</b> in the co-complex with CDK2-cyclin A are conserved in CDK1 so that selectivity must derive from indirect readout of remote sequence differences. One mechanism by which such differences can impact inhibitor binding is where they shape the conformational energy landscape, permitting conformations in one kinase that are precluded in another. As described above, the glycine-rich loop makes a significant contribution to the catalytic cleft, shaping the binding site that accommodates the purine C-6 substituents. We note that the glycine-rich loop in the CDK2-cyclin A–<b>73</b> structure adopts a conformation in which Tyr15 is folded into the active site, contacting residues of the C-helix (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). This position for the side chain of Tyr15 is seen in a number of other CDK2-cyclin A–inhibitor complexes, suggesting that it reflects a preferred conformation of CDK2. However, in available structures of apo CDK1-cyclin B, and CDK1-cyclin bound to compound <b>23</b><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> or <b>3</b> (this paper), a comparable location for the side chain of Tyr15 has not been observed (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>C). We speculate, therefore, that <b>73</b> binds more tightly to CDK2 than to CDK1 because in doing so, it stabilizes a glycine-rich loop conformation that is preferred in CDK2 but not in CDK1.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06237" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06237" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Novel 6-substituted 2-(4′-sulfamoylanilino)purines have been designed as competitive inhibitors acting at the ATP binding site of CDK2 with particular attention being given to abrogating activity against CDK1. A variety of substituents were explored, either attached directly to C-6 or via an oxygen link, in the context of their possible interaction with a lipophilic pocket close to the ATP ribose binding site. The relationship between the size of a 6-alkoxy group and CDK2-inhibitory activity was found to parallel that previously observed for the corresponding 2-amino-6-alkoxypurines. In general, the new compounds were significantly less potent (typically 10–80×) against CDK1 than CDK2. Most impressive was 4-((6-([1,1′-biphenyl]-3-yl)-9<i>H</i>-purin-2-yl)amino) benzenesulfonamide that was ∼2000-fold less active toward CDK1 (IC<sub>50</sub> 86 μM), while retaining high potency against CDK2 (0.044 μM). Compounds substituted with relatively large conformationally constrained groups, e.g. bicyclic and tricyclic aromatic systems, showed greatly reduced inhibitory activity, indicating poorly accommodation of these substituents in the lipophilic binding site. Analogues of 6-cyclohexylmethoxy-2-(4′-sulfamoylanilino)purine, in which the purine ring was replaced by a triazolopyrimidine, pyrazolopyrimidine or pyrrolopyrimidine were only marginally less active against CDK2 than the parent purine. However, replacement with an imidazopyridine or imidazopyrimidine gave much less potent derivatives. Co-crystal structures of inhibitors bound to CDK2 and CDK1 revealed that the binding mode of the purine-based inhibitor series is conserved. We show that inhibitor binding to CDK2 stabilizes a glycine-rich loop conformation that shapes the ATP ribose binding pocket, resulting in effective inhibition of CDK2. We propose that this region of the active site might be the basis of the design of further inhibitors differentiating between CDK1 and CDK2.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04008" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04008" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> General Synthetic Procedures</h3><div class="NLM_p">Chemicals and solvents were obtained from standard suppliers. Solvents were either dried by standard techniques or purchased as anhydrous. Reactions needing microwave irradiation were carried out in an Initiator Sixty Biotage apparatus. Petrol refers to petroleum ether (bp 40–60 °C, reagent grade, Fisher Scientific). All reactions that required inert or dry atmosphere were carried out under a blanket of nitrogen, which was dried by passage through a column of phosphorus pentoxide. Glassware was dried in an oven prior to use. Column chromatography was carried out using 40–60 μm mesh silica in glass columns under medium pressure or with a Biotage SP4 flash purification system using KP-Si. Thin layer chromatography (TLC) was performed on 20 mm precoated plates of silica gel (Merck, silica gel 60F254); visualization was achieved using ultraviolet light (254 nm). NMR spectra were recorded on a Bruker Spectrospin AC 300E (300 MHz) NMR Spectrometer or Bruker BioSpin UltraShield Plus 500 MHz using deuterated solvent as a lock. IR spectra were recorded on a Bio-Rad FTS 3000MX diamond ATR, and UV analysis was performed using a Hitachi U-2000 spectrophotometer. LC-MS analysis was carried out on a Micromass Platform instrument operating in positive and negative ion electrospray mode, employing a 50 mm × 4.6 mm C18 column (Supelco Discovery or Waters Symmetry) and a 15 min gradient elution of 0.05% formic acid and methanol (10–90%). HRMS were measured using a Finnigan MAT 95 XP or a Finnigan MAT 900 XLT by the EPSRC National Mass Spectrometry Service Centre (Swansea). The purity of final compounds was assessed by reversed-phase HPLC; all tested compounds were >95% purity. HPLC instrument, Agilent 1200 equipped with a photodiode array detector (190–400 nm). Sample temperature, ambient; injection volume, 5 μL; flow rate, 1 mL/min. 5–100% MeCN gradient over 9 min and an isocratic hold at 100% MeCN for 2.5 min, before returning to initial conditions. Mobile phase A = 0.1% ammonia in water or 0.1% formic acid in water, mobile phase B = MeCN. Column: Waters XSELECT CSH C18, 3.5 μm, 4.6 mm × 150 mm or Waters XTerra RP18, 5 μm, 4.6 mm × 150 mm. Column maintained at ambient temperature.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> General Procedure A</h4><div class="NLM_p">To a stirred suspension of the appropriate haloheterocycle (1.0 mol equiv) and 4-aminobenzenesulfonamide (2.0 mol equiv) in TFE (25 mL/g of haloheterocycle) was added TFA (2.5 mL/g of haloheterocycle) dropwise. The resulting solution was heated under reflux for 12–48 h under a nitrogen atmosphere. The solvent was removed in vacuo, and the residue was redissolved in EtOAc (10–20 mL). The solution was washed with saturated aqueous sodium bicarbonate solution (3 × 10 mL), and the aqueous extracts were combined and washed with EtOAc (2 × 15 mL). The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent removed under reduced pressure to give a residue that was purified in the manner indicated.</div><div id="sec5_1_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i15" class="anchor-spacer"></div><h5 class="article-section__title" id="_i15"> 6-Chloro-2-fluoro-9<i>H</i>-purine (<b>10</b>).<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></h5><div class="NLM_p last">To a stirred solution of HBF<sub>4</sub> (48% aqueous, 120 mL) at 0 °C was added 2-amino-6-chloropurine (<b>9</b>) (6.0 g, 35.0 mmol). Over 20 min, a solution of NaNO<sub>2</sub> (4.9 g, 70.0 mmol) in water (200 mL) was added dropwise, ensuring the temperature remained close to 0 °C. The pale-yellow solution was raised to room temperature and stirred for 18 h. The resulting solution was neutralized to pH 7 in an ice bath at 0 °C by addition of Na<sub>2</sub>CO<sub>3</sub> (6.00 g) in water (200 mL). Solvents were removed in vacuo, and the residual solid was redissolved in MeOH (100 mL) and adsorbed onto silica (250 mL). The crude material was purified by chromatography (silica; 10% MeOH:DCM) to afford <b>10</b> as a white crystalline solid (4.52 g, 75%); mp 171–173 °C (lit.,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> mp 174 °C); UV λ<sub>max</sub> (EtOH) 393 nm. IR (cm<sup>–1</sup>) 2964, 2785, 1735, 1581. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (1H, s, H-8), 13.9 (1H, s, N<i>H</i>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 172.6 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> 2-Fluoro-9<i>H</i>-purine (<b>11</b>)<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a></h5><div class="NLM_p last">To a stirred suspension of 6-chloro-2-fluoropurine (<b>10</b>) (0.30 g, 1.74 mmol) and palladium hydroxide on carbon (20% w/w, 0.30 g) in methanol (15 mL) was added ammonium formate (0.34 g, 5.35 mmol). The suspension was heated under reflux for 1 h before filtering through a pad of Celite, eluting with methanol (20 mL). Removal of volatiles under reduced pressure afforded <b>11</b> as a white solid (240 mg, 100%); mp 219 °C (dec.) (lit.,<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> decomposed at 216 °C). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (1H, s, H-8), 9.01 (1H, s, H-6), 13.9 (1H, s, N<i>H</i>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 139.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Phenyl-(9<i>H</i>-purin-2-yl)amine (<b>12</b>)</h5><div class="NLM_p last">Prepared from aniline (0.18 mL, 2 mmol) and 2-fluoro-9<i>H</i>-purine (<b>11</b>, 0.138 g, 1.0 mmol) in accordance with general procedure A. The reaction mixture was stirred under reflux for overnight. After removal of the solvent in vacuo, the residue was dissolved in EtOAc (10–30 mL), washed with saturated aqueous NaHCO<sub>3</sub> (3 × 30 mL), and dried (MgSO<sub>4</sub>). The crude material was purified by chromatography (silica; 0–20% MeOH:DCM), followed by recrystallization from DCM to afford <b>12</b> as an off-white solid (65 mg, 31%); <i>R</i><sub>f</sub> 0.20 (5% MeOH:DCM); mp 200–201 °C; UV λ<sub>max</sub> (EtOH) 328, 270, 239, 206 nm. IR (cm<sup>–1</sup>) 3234, 3103, 2804, 1624, 1602, 1539, 1402, 1292, 1217. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.91 (1H, t, <i>J</i> = 7.5 Hz, H-4′), 7.28 (2H, t, <i>J</i> = 7.5 Hz, H-3′ and H-5′), 7.83 (2H, d, <i>J</i> = 9.0 Hz, H-2′ and H-6′), 8.82 (1H, s, H-6), 8.24 (1H, s, H-8), 9.53 (1H, s, N<i>H</i>), 12.9 (1H, s, N<i>H</i>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 212.0 [M + H]<sup>+</sup>. HRMS calcd for C<sub>11</sub>H<sub>10</sub>N<sub>5</sub> [M + H]<sup>+</sup> 212.0931, found 212.0933.</div></div><div id="sec5_1_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i18" class="anchor-spacer"></div><h5 class="article-section__title" id="_i18"> 4-(9<i>H</i>-Purin-2-ylamino)benzenesulfonamide (<b>13</b>)</h5><div class="NLM_p last">Prepared following general procedure A from 2-fluoro-9<i>H</i>-purine (<b>11</b>, 0.10 g, 0.725 mmol). Recrystallization from MeOH:H<sub>2</sub>O gave <b>13</b> as a pale-white solid (74 mg, 35%); <i>R</i><sub>f</sub> 0.40 (20% MeOH:DCM); mp >320 °C (dec); UV λ<sub>max</sub> (EtOH) 287, 213 nm. IR (cm<sup>–1</sup>) 3223, 1585, 1481, 1307, 1251, 1148, 1091. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.17 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.73 (2H, d, <i>J</i> = 9.0 Hz, H-3′ and H-5′), 7.99 (2H, d, <i>J</i> = 9.0 Hz, H-2′ and H-6′), 8.33 (1H, s, H-6), 8.00 (1H, s, H-8), 10.00 (1H, s, N<i>H</i>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 291.0 [M + H]<sup>+</sup>. HRMS calcd for C<sub>11</sub>H<sub>11</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 291.0659, found 291.0659.</div></div><div id="sec5_1_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i19" class="anchor-spacer"></div><h5 class="article-section__title" id="_i19"> <i>N</i><sup>2</sup>-Phenylguanine 2,2,2-trifluoroacetate (<b>15</b>)</h5><div class="NLM_p last">The title compound was prepared following general procedure A using 2-bromohypoxanthine (<b>14</b>, 1.00 g, 4.7 mmol) and aniline (0.9 mL, 9.40 mmol) to yield <b>15</b> as a white solid (1.17 g, 73%). The isolated compound was pure by analytical HPLC without the need for further purification; mp 229–231 °C; UV λ<sub>max</sub> (EtOH) 273 nm. IR (cm<sup>–1</sup>) 3332, 3128, 2943, 2756, 2555, 2387, 1678, 1572. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.07 (1H, t, <i>J</i> = 7.5 Hz, H-4′), 7.36 (2H, dd, <i>J</i> = 7.5, 8.0 Hz, H-3′ and H-5′), 7.62 (2 H, d, <i>J</i> = 8.0 Hz, H-2′ and H-6′), 7.94 (1H, s, H-8), 8.46 (1H, br s, N<i>H</i>), 9.00 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 113, 120, 123, 129, 138, 139, 150, 152, 155. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 228.3 [M + H]<sup>+</sup>. HRMS calcd for C<sub>11</sub>H<sub>10</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 228.0881, found 228.0880.</div></div><div id="sec5_1_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> 6-Oxo-2-((4-sulfamoylphenyl)amino)-6,9-dihydro-1<i>H</i>-purine 2,2,2-trifluoroacetate (<b>16</b>)</h5><div class="NLM_p last">Synthesized in accordance with general procedure A from 2-bromohypoxanthine (<b>14</b>, 0.10 g, 0.47 mmol) to yield <b>16</b> as an amorphous white solid (60 mg, 42%); mp >300 °C; UV λ<sub>max</sub> (EtOH) 275 nm. IR (cm<sup>–1</sup>) 3348, 3113, 2990, 2877, 2792, 2333, 1672, 1575, 1365, 1153. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.28 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.79 (4H, m, H-2′, H-3′, H-5′ and H-6′), 8.31 (1H, s, H-8), 9.25 (1H, br s, N<i>H</i>), 10.84 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 113, 120, 123, 127, 138, 139, 150, 152, 156. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 307.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_1_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> 1-(2-Amino-9<i>H</i>-purin-6-yl)-4-aza-1-azoniabicyclo[2.2.2]octane (<b>17</b>).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></h5><div class="NLM_p last">1,4-Diazabicyclo[2.2.2]octane (9.90 g, 88.4 mmol) was added to a solution of 2-amino-6-chloropurine <b>9</b> (5.00 g, 29.5 mmol) in DMSO (100 mL) over 1 h, and the mixture was stirred at room temperature for 24 h. The resulting white precipitate was filtered and washed with diethyl ether. The solid was suspended in DCM (200 mL) and stirred for 1 h. After filtration and washing with DCM several times, <b>9</b> was obtained as a white solid, which was dried in vacuo (7.95 g, 96%) and used without further purification; mp 230 °C (dec) (lit.,<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> decomposed at 230 °C). <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 3.31 (6H, t, <i>J</i> = 7.5 Hz, (N(CH<sub>2</sub>)<sub>3</sub>), 4.07 (6H, t, <i>J</i> = 7.5 Hz, (N<sup>+</sup>(CH<sub>2</sub>)<sub>3</sub>), 8.13 (1H, s, H-8). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 38.7, 53.4, 116.0, 143.7, 151.3, 158.4.</div></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> General Procedure B</h4><div class="NLM_p last">2-Amino-6-chloropurine (<b>9</b>, 1.0 mol equiv) was added to a solution prepared from metallic sodium (5.0 mol equiv) dissolved in the appropriate alcohol (3.4 mL/mmol). The mixture was stirred at reflux until LCMS analysis indicated the absence of starting materials (3–24 h). After cooling, the reaction mixture was neutralized with glacial AcOH and the volatile material was removed in vacuo. Unless otherwise indicated, purification was achieved either by recrystallization from H<sub>2</sub>O or by adding H<sub>2</sub>O to the reaction mixture and extracting the product into EtOAc (3 × 100 mL), followed by drying (MgSO<sub>4</sub>) and removal of the solvent in vacuo.</div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> General Procedure C</h4><div class="NLM_p last">The appropriate alcohol (4.0 mol equiv) was added dropwise to a stirred suspension of NaH (3.0 mol equiv) in DMSO (2.5–3.0 mL/mmol), and the resulting mixture was stirred for 1–2 h. To this was added DABCO-purine (17, 1.0 mol equiv) or the appropriate haloheterocycle (1.0 mol equiv), and the mixture was stirred for 24 h with heating as specified. Water (20–200 mL) was added, and the basic emulsion was neutralized with glacial acetic acid. The aqueous phase was extracted with EtOAc (3 × 50–100 mL), and the organic layers were washed with saturated aqueous NaCl (100 mL). The combined organic layers were dried (MgSO<sub>4</sub>) and concentrated in vacuo to yield the crude product, which was purified by chromatography on silica and/or recrystallization from an appropriate solvent.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure D</h4><div class="NLM_p last">To a stirred solution of hydrofluoroboric acid (50%, aq, 20.0 mol equiv) cooled below −20 °C was added the appropriate 2-amino-6-alkoxypurine (1.0 mol equiv). While maintaining the temperature at −15 °C, a solution of NaNO<sub>2</sub> (2.0 mol equiv) in H<sub>2</sub>O (1–3 mL/mmol NaNO<sub>2</sub>) was added dropwise over 10 min. The mixture was stirred at room temperature for 3 h and neutralized at −15 °C by the dropwise addition of 15% (w/v) aqueous Na<sub>2</sub>CO<sub>3</sub> solution, and the precipitated solid was collected by filtration and washed with H<sub>2</sub>O. The residual solid was triturated with EtOAc (3 × 100 mL) and filtered. The combined filtrates were concentrated under reduced pressure to furnish the product, which was purified as indicated.</div></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> General Procedure E</h4><div class="NLM_p last">The appropriate 9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (1.0 mol equiv) was dissolved in 2-propanol (60 mL/g) and deionized water (20 mL/g). Trifluoroacetic acid (10.0 mol equiv) was added, and the reaction mixture was stirred at 100 °C for 2 h and cooled to room temperature, and the solution was adjusted to pH 8 by addition of conc aqueous ammonia solution. The volume of solvent was reduced by 50% under reduced pressure; if a precipitate resulted, this was collected and washed with 2-propanol (2 × 10 mL). If precipitation was not observed following neutralization, the reaction mixture was partitioned between EtOAc (20 mL) and saturated aqueous NaCl solution (20 mL) The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated under reduced pressure, and the product was purified by chromatography as specified.</div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> General Procedure F</h4><div class="NLM_p last">Tetrabutylammonium fluoride solution (1.0 M in THF, 1.5 mol equiv) was added dropwise to a stirred solution of the appropriate 6-triisopropylsilylethynylpurine (1.0 mol equiv) in anhydrous THF (10–20 mL), and the mixture was stirred for 5–15 min at ambient temperature under N<sub>2</sub>. Volatiles were evaporated under reduced pressure, and the residue was redissolved in EtOAc (100 mL/g) and washed with saturated aqueous NaCl (100 mL/g), and the organic fraction was removed in vacuo. The product was purified as described.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure G</h4><div class="NLM_p last">An oxygen-free solution of the required boronic acid or potassium trifluoroborate salt (1.09 mmol), the appropriately 2-substituted 6-chloro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (0.78 mmol), dicyclohexyl(2′,6′-dimethoxybiphenyl-2-yl)phosphine (SPhos) (2.5 mol %), and palladium acetate (1.0 mol %) in toluene (4 mL) was degassed by bubbling nitrogen through the solution in a sealed vial for 5 min. To the pale-yellow solution was added K<sub>3</sub>PO<sub>4</sub> (1.56 mmol) and water (approximately 50 μL). The solution was again degassed for 15 min and subsequently heated to 100 °C for 18 h. The black-brown suspension was filtered through Celite, eluting with MeOH (3 × 10 mL), and the product was isolated by chromatography as indicated.</div></div><div id="sec5_1_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 2-Amino-6-ethoxypurine (<b>18</b>)<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a></h4><div class="NLM_p last">Treatment of EtOH (100 mL) with Na (3.38 g, 147.5 mmol), followed by addition of 2-amino-6-chloropurine <b>9</b> (5.0 g, 29.5 mmol) according to general procedure B, afforded the crude product. Recrystallization from H<sub>2</sub>O gave <b>18</b> as a white powder (4.75 g, 90%); <i>R</i><sub>f</sub> 0.26 (10% MeOH:DCM), mp 247 °C (dec) (lit.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> mp 230 °C (dec), lit.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> mp 293 °C (dec)). IR (cm<sup>–1</sup>) 3321, 2981, 2363, 2143, 1619, 1584, 1508, 1458, 1427, 1396, 1375, 1342, 1285, 1223, 1161, 1118 cm<sup>–1</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.35 (3H, t, <i>J</i> = 7.1 Hz, C<i>H</i><sub>3</sub>), 4.44 (2H, q, <i>J</i> = 7.1 Hz, C<i>H</i><sub>2</sub>), 6.21 (2H, s, N<i>H</i><sub>2</sub>), 7.81 (1H, s, H-8). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.9, 61.6, 160.1. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 180.3 [M + H]<sup>+</sup>. Anal. Found: C, 47.11; H, 4.97; N, 38.97. C<sub>7</sub>H<sub>9</sub>N<sub>5</sub>O requires: C, 46.92; H, 5.06; N, 39.09.</div></div><div id="sec5_1_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 2-Amino-6-<i>n</i>-propoxypurine (<b>19</b>)<a onclick="showRef(event, 'ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref50 ref51">(50, 51)</a></h4><div class="NLM_p last">Treatment of 1-propanol (20 mL) with Na (0.68 g, 29.5 mmol), followed by addition of 2-amino-6-chloropurine <b>9</b> (1.0 g, 5.9 mmol) according to general procedure B, gave the crude product. Recrystallization from H<sub>2</sub>O afforded <b>19</b> (1.06 g, 93%) as a yellow solid, <i>R</i><sub>f</sub> 0.21 (10% MeOH:DCM), mp 196–198 °C (lit.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> mp 199–201 °C, lit.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> mp 208 °C). IR (cm<sup>–</sup>1) 3484, 3389, 3318, 3203, 2965, 2935, 2882, 2522, 2361, 2338, 1578, 1507, 1449, 1398, 1362, 1331, 1276, 1225, 1165, 1119. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.97 (3H, t, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>) 1.76 (2H, tq, <i>J</i> = 7.2, 7.2 Hz, CH<sub>3</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O), 4.34 (2H, t, <i>J</i> = 6.8 Hz, OC<i>H</i><sub>2</sub>), 6.20 (2H, s, N<i>H</i><sub>2</sub>), 7.82 (1H, s, H-8), 12.37 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.7, 22.2, 67.3, 138.5, 160.1, 160.3, 162.2. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 194.17 [M + H]<sup>+</sup>. Anal. Found: C, 46.81; H, 5.95; N, 33.78. C<sub>8</sub>H<sub>11</sub>N<sub>5</sub>O·0.7H<sub>2</sub>O requires: C, 46.69; H, 6.07; N, 34.03.</div></div><div id="sec5_1_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 2-Amino-6-isopropoxypurine (<b>20</b>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></h4><div class="NLM_p last">Treatment of 2-propanol (0.85 mL, 14.2 mmol) with NaH (0.26 mg, 10.7 mmol) in DMSO (10 mL), followed by addition of <b>17</b> (1.0 g, 3.6 mmol) was performed according to general procedure C, to afford the crude product. Purification by chromatography (silica; 5–10% MeOH:DCM) afforded <b>20</b> as a yellow oil. Trituration of the oil with diethyl ether afforded <b>20</b> (0.38 g, 55%) as an off-white solid; <i>R</i><sub>f</sub> 0.28 (10% MeOH:DCM), mp 205–207 °C (lit.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> mp 209–210 °C). IR (cm<sup>–1</sup>) 3491, 3331, 3195, 2976, 2773, 1618, 1580, 1504, 1445, 1391, 1372, 1321, 1272, 1224, 1180, 1144. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.33 (6H, d, <i>J</i> = 6.2 Hz, 2 × C<i>H</i><sub>3</sub>), 5.47 (1H, septet, <i>J</i> = 6.2 Hz, OC<i>H</i>), 6.17 (2H, s, N<i>H</i><sub>2</sub>), 7.81 (1H, s, H-8), 12.39 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.3, 68.2, 160.1. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 194.15 [M + H]<sup>+</sup>. Anal. Found: C, 49.48; H, 5.64; N, 35.71. C<sub>8</sub>H<sub>11</sub>N<sub>5</sub>O·0.1H<sub>2</sub>O requires: C, 49.27; H, 5.79; N, 35.91</div></div><div id="sec5_1_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 2-Amino-6-(2-methyl-1-propoxy)purine (<b>21</b>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></h4><div class="NLM_p last">2-Methyl-1-propanol (1.31 mL, 14.2 mmol) was added to NaH (0.25 mg, 10.7 mmol) in DMSO (10 mL), followed by addition of <b>17</b> (1.0 g, 3.6 mmol) according to general procedure C, to afford the crude product. Trituration of the residual yellow oil with petrol furnished a cream solid. Purification by chromatography (silica; 5–10% MeOH:DCM) gave <b>21</b> (0.42 g, 57%) as pale-yellow crystals; <i>R</i><sub>f</sub> 0.41 (10% MeOH/DCM), mp 180–182 °C (lit.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> mp 89–92 °C). IR (cm<sup>–1</sup>) 3512, 3473, 3359, 2958, 2875, 1620, 1575, 1507, 1451, 1386, 1363, 1332, 1272, 1223, 1159, 1121. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.98 (6H, d, <i>J</i> = 6.7 Hz, 2 × C<i>H</i><sub>3</sub>), 2.07 (1H, septet, <i>J</i> = 6.7 Hz, OCH<sub>2</sub>C<i>H</i>), 4.17 (2H, d, <i>J</i> = 6.8 Hz, OC<i>H</i><sub>2</sub>), 6.21 (2H, s, N<i>H</i><sub>2</sub>), 7.82 (1H, s, H-8). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.4, 27.8, 71.9, 160.1, 162.2. LRMS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 206.81 [M – H]<sup>−</sup>.</div></div><div id="sec5_1_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-Amino-6-(1-methylpropoxy)purine (<b>22</b>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></h4><div class="NLM_p last">Treatment of 2-butanol (20 mL) with Na (0.68 g, 29.5 mmol), followed by addition of 2-amino-6-chloropurine <b>9</b> (1.0 g, 5.9 mmol) was performed according to general procedure B, to give a pale-yellow solid. H<sub>2</sub>O was added, and the product was extracted into EtOAc (3 × 100 mL), dried (MgSO<sub>4</sub>), and the solvent removed in vacuo to yield <b>22</b> (0.90 g, 74%) as off-white crystals, <i>R</i><sub>f</sub> 0.3 (10% MeOH:DCM); mp 77 °C (dec) (lit.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> mp 88–90 °C). IR (cm<sup>–1</sup>) 3322, 3190, 2971, 2936, 2876, 2772, 1616, 1575, 1504, 1451, 1393, 1375, 1326, 1273, 1222. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.91 (3H, t, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>CHCH<sub>3</sub>), 1.29 (3H, d, <i>J</i> = 6.2 Hz, CH<sub>3</sub>CH<sub>2</sub>CHC<i>H</i><sub>3</sub>), 1.57–1.79 (2H, m, CH<sub>3</sub>C<i>H</i><sub>2</sub>CHCH<sub>3</sub>), 5.27–5.38 (1H, m, CH<sub>3</sub>CH<sub>2</sub>C<i>H</i>CH<sub>3</sub>), 6.19 (2H, s, N<i>H</i><sub>2</sub>), 7.79 (1H, s, H-8). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.0, 19.8, 28.9, 72.7, 137.7, 160.1. LRMS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 206.08 [M – H]<sup>−</sup>. Anal. Found: C, 51.52; H, 6.43; N, 32.64. C<sub>9</sub>H<sub>13</sub>N<sub>5</sub>O·0.25H<sub>2</sub>O requires: C, 51.05; H, 6.43; N, 33.08.</div></div><div id="sec5_1_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 2-Amino-6-(prop-2-ynyloxy)purine (<b>23</b>).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a></h4><div class="NLM_p last">Treatment of propargyl alcohol (0.83 mL, 14.2 mmol) with NaH (0.25 mg, 10.7 mmol) in DMSO (10 mL), followed by addition of <b>17</b> (1.0 g, 3.6 mmol) was performed according to general procedure C, affording the product <b>23</b> (0.54 g, 80%) as a beige solid, <i>R</i><sub>f</sub> 0.26 (10% MeOH:DCM); mp 181 °C (dec) (lit.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> mp 230 °C (dec)). IR (cm<sup>–1</sup>) 3319, 3190, 2777, 2126, 1651, 1621, 1589, 1510, 1460, 1438, 1400, 1339, 1277, 1221, 1184, 1142. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.58 (1H, t, <i>J</i> = 2.4 Hz, OCH<sub>2</sub>CC<i>H</i>), 5.10 (2H, d, <i>J</i> = 2.4 Hz, OC<i>H</i><sub>2</sub>CCH), 6.35 (2H, s, N<i>H</i><sub>2</sub>), 7.85 (1H, s, H-8). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 53.0, 78.0, 79.6, 113.7, 138.5, 155.7, 159.1, 159.9. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 190.00 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 2-Fluoro-6-ethoxypurine (<b>24</b>)</h4><div class="NLM_p last">Prepared following general procedure D from <b>18</b> (1.0 g, 5.6 mmol) to give <b>24</b> as a white solid (0.22 g, 22%); <i>R</i><sub>f</sub> 0.39 (10% MeOH/DCM); mp 225–227 °C. IR (cm<sup>–1</sup>) 3117, 2997, 2740, 2669, 2506, 2363, 2339, 1836, 1760, 1605, 1487, 1425, 1373, 1343, 1281, 1219, 1151, 1111, 1038, 1007. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.41 (3H, t, <i>J</i> = 7.1 Hz, C<i>H</i><sub>3</sub>), 4.57 (2H, q, <i>J</i> = 7.1 Hz, C<i>H</i><sub>2</sub>), 8.39 (1H, s, H-8), 13.55 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.6 (CH<sub>3</sub>), 64.0 (CH<sub>2</sub>), 144.0 (C<sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 183.1 [M + H]<sup>+</sup>. Anal. Found: C, 44.80; H, 3.67; N, 29.48. C<sub>7</sub>H<sub>7</sub>N<sub>4</sub>OF·0.3H<sub>2</sub>O requires: C, 44.83; H, 4.08; N, 29.87.</div></div><div id="sec5_1_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 2-Fluoro-6-<i>n</i>-propoxypurine (<b>25</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure D from <b>19</b> (1.0 g, 5.2 mmol) to yield <b>25</b> (0.58 g, 57%) as a white solid; <i>R</i><sub>f</sub> 0.18 (70% EtOAc:petrol); mp 197–199 °C. IR (cm<sup>–1</sup>) 3105, 2973, 2944, 2886, 2741, 2680, 2523, 2362, 2338, 1772, 1607, 1422, 1368, 1347, 1269, 1213, 1149, 1038. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.00 (3H, t, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>) 1.82 (2H, tq, <i>J</i> = 7.1, 7.1 Hz, CH<sub>3</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O), 4.47 (2H, t, <i>J</i> = 6.7 Hz, CH<sub>3</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 8.39 (1H, s, H-8), 13.55 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.5 (CH<sub>3</sub>), 22.0 (CH<sub>3</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>O), 69.4 (<i>O</i><sup>6</sup>CH<sub>2</sub>), 144.0 (Ar-C), 156.0 (<i>C</i><sup>8</sup>), 158.8 (Ar-C). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 154.0 [M – C<sub>3</sub>H<sub>7</sub>]<sup>+</sup>. HRMS calcd for C<sub>8</sub>H<sub>9</sub>FN<sub>4</sub>O [M<sup>+</sup>] 196.0760, found 196.0757.</div></div><div id="sec5_1_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Fluoro-6-isopropoxypurine (<b>26</b>)</h4><div class="NLM_p last">Synthesized by general prodecure D from <b>20</b> (0.30 g, 1.6 mmol) to yield <b>26</b> as a white solid (0.16 g, 53%); <i>R</i><sub>f</sub> 0.22 (70% EtOAc:petrol); mp 184 °C (dec). IR (cm<sup>–1</sup>) 2990, 2536, 1605, 1472, 1424, 1371, 1275, 1034, 1017. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.40 (6H, d, <i>J</i> = 6.2 Hz, 2 × C<i>H</i><sub>3</sub>), 5.49 (1H, septet, <i>J</i> = 6.2 Hz, OC<i>H</i>), 8.37 (1H, s, H-8), 13.52 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.0 (CH<sub>3</sub>), 71.5 (<i>O</i><sup>6</sup>CH), 162.2 (<i>C</i><sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 154.0 [M – C<sub>3</sub>H<sub>7</sub>]<sup>+</sup>. HRMS calcd for C<sub>8</sub>H<sub>9</sub>FN<sub>4</sub>O [M<sup>+</sup>] 196.0760, found 196.0760.</div></div><div id="sec5_1_7_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 2-Fluoro-6-(2-methyl-1-propoxy)purine (<b>27</b>)</h4><div class="NLM_p last">From <b>21</b> (0.40 g, 1.9 mmol) in accordance with general procedure D to yield <b>27</b> (0.25 g, 62%) as a white solid; <i>R</i><sub>f</sub> 0.25 (70% EtOAc:petrol); mp 202–204 °C. IR (cm<sup>–1</sup>) 3130, 3059, 2968, 2937, 2884, 2804, 2693, 2528, 1760, 1700, 1603, 1476, 1451, 1418, 1364, 1341, 1267, 1211, 1140, 1113, 1040. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.01 (6H, d, <i>J</i> = 6.7 Hz, 2 × C<i>H</i><sub>3</sub>), 2.13 (1H, septet, <i>J</i> = 6.7 Hz, OCH<sub>2</sub>C<i>H</i>), 4.30 (2H, d, <i>J</i> = 6.7 Hz, OC<i>H</i><sub>2</sub>), 8.40 (1H, s, H-8), 13.55 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.2 (CH<sub>3</sub>), 27.7 (<i>O</i><sup>6</sup>CH<sub>2</sub><i>C</i>H), 73.7 (<i>O</i><sup>6</sup>CH<sub>2</sub>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 154.0 [M – C<sub>3</sub>H<sub>7</sub>]<sup>+</sup>. HRMS calcd for C<sub>9</sub>H<sub>11</sub>FN<sub>4</sub>O [M<sup>+</sup>] 210.0917, found 210.0922.</div></div><div id="sec5_1_7_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-Fluoro-6-(1-methylpropoxy)purine (<b>28</b>)</h4><div class="NLM_p last">Prepared according to general procedure D from <b>22</b> (0.66 g, 3.2 mmol) as a white solid (0.29 g, 43%); <i>R</i><sub>f</sub> 0.21 (70% EtOAc:petrol); mp 187–189 °C. IR (cm<sup>–1</sup>) 2975, 2940, 1604, 1468, 1421, 1372, 1344, 1277, 1211, 1148, 1038. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.93 (3H, t, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>CHCH<sub>3</sub>), 1.36 (3H, d, <i>J</i> = 6.2 Hz, CH<sub>3</sub>CH<sub>2</sub>CHC<i>H</i><sub>3</sub>), 1.66–1.83 (2H, m, CH<sub>3</sub>C<i>H</i><sub>2</sub>CHCH<sub>3</sub>), 5.29–5.37 (1H, m, CH<sub>3</sub>CH<sub>2</sub>C<i>H</i>CH<sub>3</sub>), 8.37 (1H, s, H-8), 13.55 (1H, s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.8 (<i>C</i>H<sub>3</sub>CH<sub>2</sub>CHCH<sub>3</sub>), 19.5 (CH<sub>3</sub>CH<sub>2</sub>CH<i>C</i>H<sub>3</sub>), 28.6 (CH<sub>3</sub><i>C</i>H<sub>2</sub>CHCH<sub>3</sub>), 75.9 (CH<sub>3</sub>CH<sub>2</sub><i>C</i>HCH<sub>3</sub>), 158.8 (C<sup>8</sup>). LRMS (ES<sup>–</sup>) <i>m</i>/<i>z</i> 209.1 [M – H]<sup>−</sup>. Anal. Found: C, 51.71; H, 5.27; N, 26.33. C<sub>9</sub>H<sub>11</sub>N<sub>4</sub>OF requires: C, 51.42; H, 5.27; N, 26.65.</div></div><div id="sec5_1_7_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-Fluoro-6-(prop-2-ynyloxy)purine (<b>29</b>)</h4><div class="NLM_p last">Synthesized from <b>23</b> (0.28 g, 1.5 mmol) in accordance with general procedure D as a pale-yellow solid (77 mg, 27%); <i>R</i><sub>f</sub> 0.18 (70% EtOAc:petrol); mp 201 °C (dec). IR (cm<sup>–1</sup>) 3261, 3123, 2970, 2864, 2803, 2363, 2336, 2140, 1651, 1607, 1460, 1379, 1341, 1275, 1217, 1142, 1107, 1048. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.70 (1H, t, <i>J</i> = 2.4 Hz, OCH<sub>2</sub>CC<i>H</i>), 5.23 (2H, d, <i>J</i> = 2.2 Hz, OC<i>H</i><sub>2</sub>CCH), 8.45 (1H, s, H-8). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 55.4 (<i>O</i><sup>6</sup>CH<sub>2</sub>C<i>C</i>H), 78.5 (<i>O</i><sup>6</sup><i>C</i>H<sub>2</sub>CCH), 79.1 (<i>O</i><sup>6</sup>CH<sub>2</sub><i>C</i>CH), 162.2 (C<sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 192.0 [M<sup>+</sup>]. HRMS calcd for C<sub>8</sub>H<sub>5</sub>FN<sub>4</sub>O [M<sup>+</sup>] 192.0447, found 192.0448.</div></div><div id="sec5_1_7_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Sulfanilyl-6-ethoxypurine (<b>30</b>)</h4><div class="NLM_p last">Prepared from <b>24</b> (0.20 g, 1.1 mmol) following general procedure A. Purification by chromatography (silica; 5–20% MeOH:DCM) afforded <b>30</b> (39 mg, 11%) as an off-white solid; <i>R</i><sub>f</sub> 0.20 (10% MeOH:DCM); mp 265 °C (dec); UV λ<sub>max</sub> (EtOH) 257, 241 nm. IR (cm<sup>–1</sup>) 3473, 3317, 3223, 2984, 2787, 2363, 2338, 1628, 1578, 1540, 1499, 1442, 1376, 1312, 1254, 1142, 1013. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.43 (3H, t, <i>J</i> = 7.1 Hz, C<i>H</i><sub>3</sub>), 4.59 (2H, q, <i>J</i> = 7.1 Hz, C<i>H</i><sub>2</sub>), 7.16 (2H, s, N<i>H</i><sub>2</sub>), 7.71 (2H, d, <i>J</i> = 8.9 Hz, H-3′ and H-5′), 7.97 (2H, d, <i>J</i> = 8.9 Hz, H-2′ and H-6′), 8.08 (1H, s, H-8), 9.76 (1H, s, N<i>H</i>), 12.69 (1H, s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 14.9 (CH<sub>3</sub>), 62.6 (CH<sub>2</sub>), 117.6 (Ar-C), 126.8 (Ar-C), 155.1 (C<sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 335.0 [M + H]<sup>+</sup>. HRMS calcd for C<sub>13</sub>H<sub>14</sub>N<sub>6</sub>O<sub>3</sub>S [M<sup>+</sup>] 334.0848, found 334.0835.</div></div><div id="sec5_1_7_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-Sulfanilyl-6-propoxypurine (<b>31</b>)</h4><div class="NLM_p last">Prepared from <b>25</b> (0.25 g, 1.3 mmol) according to general procedure A. Purification by chromatography (silica; 50–100% EtOAc:petrol followed by 0–10% MeOH:DCM), afforded <b>31</b> (0.25 g, 56%) as a beige solid; <i>R</i><sub>f</sub> 0.10 (70% EtOAc:petrol); mp 207 °C (dec); UV λ<sub>max</sub> (EtOH) 310 nm. IR (cm<sup>–1</sup>) 3251, 3115, 2971, 2934, 2878, 2361, 2340, 1700, 1596, 1580, 1528, 1498, 1453, 1389, 1321, 1306, 1243, 1146, 1094. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.03 (3H, t, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>) 1.85 (2H, tq, <i>J</i> = 6.9, 6.9 Hz, CH<sub>3</sub>C<i>H</i><sub>2</sub>CH<sub>2</sub>O), 4.50 (2H, t, <i>J</i> = 6.8 Hz, CH<sub>3</sub>CH<sub>2</sub>C<i>H</i><sub>2</sub>O), 7.17 (2H, s, N<i>H</i><sub>2</sub>), 7.72 (2H, d, <i>J</i> = 8.8 Hz, H-2′ and H-6′), 7.97 (2H, d, <i>J</i> = 8.8 Hz, H-3′ and H-5′), 8.09 (1H, s, H-8), 9.77 (1H, s, NH), 12.96 (1H, br s, NH). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.7 (CH<sub>3</sub>), 22.2 (CH<sub>3</sub><i>C</i>H<sub>2</sub>CH<sub>2</sub>O), 68.2 (<i>O</i><sup>6</sup>CH<sub>2</sub>), 117.6 (<i>C</i>HCNH), 126.8 (<i>C</i>HCSO<sub>2</sub>NH<sub>2</sub>), 135.7 (Ar-CNH), 144.6 (CSO<sub>2</sub>NH<sub>2</sub>), 155.1 (C<sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 349.8 [M + H]<sup>+</sup>. HRMS calcd for C<sub>14</sub>H<sub>16</sub>N<sub>6</sub>O<sub>3</sub>S [M<sup>+</sup>] 348.1005, found 348.0994; Anal. Found: C 45.41; H 4.75; N 22.40. C<sub>14</sub>H<sub>16</sub>N<sub>6</sub>O<sub>3</sub>S·0.3CF<sub>3</sub>CO<sub>2</sub>H requires: C, 45.83; H, 4.29; N, 21.97.</div></div><div id="sec5_1_7_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 2-Sulfanilyl-6-isopropoxypurine (<b>32</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure A from <b>26</b> (0.07 g, 0.4 mmol). Purification by chromatography (silica; 50–100% EtOAc:petrol followed by 0–10% MeOH:DCM), afforded <b>32</b> (38 mg, 31%) as a beige solid; <i>R</i><sub>f</sub> 0.03 (70% EtOAc:petrol); mp 177 °C (dec); UV λ<sub>max</sub> (EtOH) 307 nm. IR (cm<sup>–1</sup>) 3472, 3312, 3210, 3117, 2982, 2793, 2691, 2643, 2362, 2342, 1715, 1685, 1617, 1597, 1578, 1538, 1500, 1440, 1381, 1306, 1255, 1140, 1117, 1096. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.42 (6H, d, <i>J</i> = 6.2 Hz, 2 × C<i>H</i><sub>3</sub>), 5.59 (1H, septet, <i>J</i> = 6.2 Hz, OC<i>H</i>), 7.16 (2H, s, N<i>H</i><sub>2</sub>), 7.72 (2H, d, <i>J</i> = 8.8 Hz, H-2′ and H-6′), 7.96 (2H, d, <i>J</i> = 8.8 Hz, 2 × H-3′ and H-5′), 8.07 (1H, s, H-8), 9.74 (1H, s, N<i>H</i>), 12.91 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 21.9 (CH<sub>3</sub>), 69.0 (<i>O</i><sup>6</sup>CH), 117.1 (<i>C</i>HCNH), 126.5 (<i>C</i>HCSO<sub>2</sub>NH<sub>2</sub>), 135.2 (Ar-CNH), 144.3 (CSO<sub>2</sub>NH<sub>2</sub>), 154.7 (C<sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 349.8 [M + H]<sup>+</sup>. HRMS calcd for C<sub>14</sub>H<sub>16</sub>N<sub>6</sub>O<sub>3</sub>S [M<sup>+</sup>] 348.1005, found 348.1007.</div></div><div id="sec5_1_7_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 2-Sulfanilyl-6-(2-methyl-1-propoxy)purine (<b>33</b>)</h4><div class="NLM_p last">Prepared following general procedure A from <b>27</b> (0.12 g, 0.6 mmol). Purification by chromatography (silica, 50–100% EtOAc:petrol followed by 0–10% MeOH:DCM), afforded <b>33</b> (0.11 g, 53%) as a light-brown solid; <i>R</i><sub>f</sub> 0.21 (70% EtOAc:petrol); mp 133 °C (dec); UV λ<sub>max</sub> (EtOH) 308 nm. IR (cm<sup>–1</sup>) 3285, 3108, 2962, 2360, 2337, 1595, 1576, 1543, 1499, 1438, 1396, 1321, 1249, 1221, 1144, 1096, 1016. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.03 (6H, d, <i>J</i> = 6.7 Hz, 2 × C<i>H</i><sub>3</sub>), 2.16 (1H, septet, <i>J</i> = 6.7 Hz, OCH<sub>2</sub>C<i>H</i>), 4.33 (2H, d, <i>J</i> = 6.8 Hz, OC<i>H</i><sub>2</sub>CH), 7.17 (2H, s, N<i>H</i><sub>2</sub>), 7.71 (2H, d, <i>J</i> = 8.9 Hz, H-2′ and H-6′), 7.97 (2H, d, <i>J</i> = 8.9 Hz, H-3′ and H-5′), 8.09 (1H, s, H-8), 9.77 (1H, s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 19.4 (CH<sub>3</sub>), 27.9 (<i>O</i><sup>6</sup>CH<sub>2</sub><i>C</i>H), 72.7 (<i>O</i><sup>6</sup>CH<sub>2</sub>), 117.6 (<i>C</i>HCNH), 126.8 (<i>C</i>HCSO<sub>2</sub>NH<sub>2</sub>), 135.7 (Ar-CNH), 144.6 (CSO<sub>2</sub>NH<sub>2</sub>), 155.1 (C<sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 363.8 [M + H]<sup>+</sup>. HRMS calcd for C<sub>15</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub>S [M<sup>+</sup>] 362.1161, found 362.1145.</div></div><div id="sec5_1_7_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> (<i>R</i>/<i>S</i>)-6-(1-Methylpropoxy)-2-sulfanilylpurine (<b>34</b>)</h4><div class="NLM_p last">Synthesized from <b>28</b> (0.1 g, 0.5 mmol) following general procedure A. Purification by chromatography (silica; 50–100% EtOAc:petrol followed by 0–10% MeOH:DCM), afforded <b>34</b> (41 mg, 24%) as a light-brown solid; <i>R</i><sub>f</sub> 0.10 (70% EtOAc:petrol); mp 162 °C (dec); UV (EtOH) λ<sub>max</sub> 308 nm. IR (cm<sup>–1</sup>) 3649, 3317, 3219, 3106, 2972, 2938, 2874, 2363, 2340, 1701, 1596, 1579, 1528, 1498, 1453, 1389, 1306, 1243, 1145, 1094. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.97 (3H, t, <i>J</i> = 7.4 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>CHCH<sub>3</sub>), 1.39 (3H, d, <i>J</i> = 6.2 Hz, CH<sub>3</sub>CH<sub>2</sub>CHC<i>H</i><sub>3</sub>), 1.68–1.87 (2H, m, CH<sub>3</sub>C<i>H</i><sub>2</sub>CHCH<sub>3</sub>), 5.40–5.46 (1H, m, CH<sub>3</sub>CH<sub>2</sub>C<i>H</i>CH<sub>3</sub>), 7.17 (2H, s, N<i>H</i><sub>2</sub>), 7.72 (2H, d, <i>J</i> = 8.8 Hz, H-2′ and H-6′), 7.96 (2H, d, <i>J</i> = 8.9 Hz, H-3′ and H-5′), 8.13 (1H, s, H-8), 9.76 (1H, s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.0 (<i>C</i>H<sub>3</sub>CH<sub>2</sub>CHCH<sub>3</sub>), 19.7 (CH<sub>3</sub>CH<sub>2</sub>CH<i>C</i>H<sub>3</sub>), 28.8 (CH<sub>3</sub><i>C</i>H<sub>2</sub>CHCH<sub>3</sub>), 74.2 (CH<sub>3</sub>CH<sub>2</sub><i>C</i>HCH<sub>3</sub>), 117.6 (<i>C</i>HCNH), 126.8 (<i>C</i>HCSO<sub>2</sub>NH<sub>2</sub>), 135.8 (Ar-CNH), 144.6 (CSO<sub>2</sub>NH<sub>2</sub>), 155.2 (C<sup>8</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 363.8 [M + H]<sup>+</sup>. HRMS calcd for C<sub>15</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub>S [M<sup>+</sup>] 362.1161, found 362.1166. Anal. Found: C, 48.32; H, 5.15; N, 22.08. C<sub>15</sub>H<sub>18</sub>N<sub>6</sub>O<sub>3</sub>S·0.2CF<sub>3</sub>CO<sub>2</sub>H requires: C, 48.02; H, 4.76; N, 21.82.</div></div><div id="sec5_1_7_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 2-Sulfanilyl-6-(prop-2-ynyloxy)purine (<b>35</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure A from <b>29</b> (0.045 g, 0.2 mmol). Purification by chromatography (silica; 50–100% EtOAc:petrol followed by 0–10% MeOH:DCM), yielded <b>35</b> (27 mg, 34%) as a beige solid; <i>R</i><sub>f</sub> 0.1 (70% EtOAc:petrol); mp 161 °C (dec); UV (EtOH) λ<sub>max</sub> 307 nm. IR (cm<sup>–1</sup>) 3370, 3245, 2971, 2795, 2361, 2340, 1715, 1699, 1619, 1585, 1575, 1540, 1499, 1472, 1454, 1443, 1396, 1321, 1307, 1271, 1143, 1095. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.68 (1H, t, <i>J</i> = 2.3 Hz, OCH<sub>2</sub>CC<i>H</i>), 5.24 (2H, d, <i>J</i> = 2.3 Hz, OC<i>H</i><sub>2</sub>CCH), 7.18 (2H, s, N<i>H</i><sub>2</sub>), 7.72 (2H, d, <i>J</i> = 8.8 Hz, H-2′ and H-6′), 7.98 (2H, d, <i>J</i> = 8.8 Hz, H-3′ and H-5′), 8.13 (1H, s, H-8), 9.87 (1H, s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 53.6 (<i>O</i><sup>6</sup>CH<sub>2</sub>C<i>C</i>H), 78.0 (<i>O</i><sup>6</sup><i>C</i>H<sub>2</sub>CCH), 79.1 (<i>O</i><sup>6</sup>CH<sub>2</sub><i>C</i>CH), 115.1 (Ar-C), 117.5 (<i>C</i>HCNH), 126.5 (<i>C</i>HCSO<sub>2</sub>NH<sub>2</sub>), 135.5 (Ar-CNH), 139.9 (<i>C</i><sup>2</sup>NH), 143.9 (CSO<sub>2</sub>NH<sub>2</sub>), 154.3 (C<sup>8</sup>), 158.6 (Ar-C). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 345.8 [M + H]<sup>+</sup>. HRMS calcd for C<sub>14</sub>H<sub>12</sub>N<sub>6</sub>O<sub>3</sub>S [M<sup>+</sup>] 344.0692, found 344.0700.</div></div><div id="sec5_1_7_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 6-Chloro-2-fluoro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>36</b>)</h4><div class="NLM_p last">3,4-Dihydropyran (60 μL, 0.58 mmol) was added dropwise over 10 min to a vigorously stirred solution of <b>10</b> (0.10 g, 0.58 mmol) and (<i>rac</i>)-camphorsulfonic acid (5 mg, 0.02 mmol) in EtOAc (50 mL) at 65 °C. The temperature was maintained at 65 °C for 18 h. The resulting bright-yellow solution was neutralized to pH 7 by careful addition of aqueous NH<sub>3</sub> solution until a cloudy suspension persisted. The crude mixture was washed with brine (2 × 30 mL) and the aqueous phase was re-extracted with EtOAc (2 × 30 mL). The combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and purified by chromatography (silica; 30% EtOAc:petrol) to afford <b>36</b> as a pale-yellow oil which became a white waxy solid on refrigeration (110 mg, 75%); mp 92–94 °C; UV λ<sub>max</sub> (EtOH) 269 nm. IR (cm<sup>–1</sup>) 3132, 2955, 2876, 1574. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57–1.64 (2H, m, C<i>H</i><sub>2</sub>), 1.70–1.80 (1H, m, C<i>H</i>), 1.94–2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.23–2.32 (1H, m, C<i>H</i>), 3.70–3.77 (1H, m, C<i>H</i>), 4.00–4.06 (1H, m, C<i>H</i>), 5.71 (1H, dd, <i>J</i> = 2.3, 10.9 Hz, NC<i>H</i>), 8.92 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.0 (<i>N</i><sup>9</sup>-CH<i>C</i>H<sub>2</sub>CH<sub>2</sub>), 24.3 (<i>N</i><sup>9</sup>-CHOCH<sub>2</sub><i>C</i>H<sub>2</sub>), 29.6 (<i>N</i><sup>9</sup>-CHCH<sub>2</sub><i>C</i>H<sub>2</sub>), 67.7 (<i>N</i><sup>9</sup>-CHO<i>C</i>H<sub>2</sub>CH<sub>2</sub>), 81.7 (<i>N</i><sup>9</sup>-<i>C</i>H), 130.1 (d, <i>J</i><sub>CF</sub> = 4.8 Hz, Ar-C), 146.4 (d, <i>J</i><sub>CF</sub> = 2.8 Hz, Ar-C), 150.6 (d, <i>J</i><sub>CF</sub> = 18.5 Hz, Ar-C), 153.2 (d, <i>J</i><sub>CF</sub> = 17.6 Hz, Ar-C), 156.2 (d, <i>J</i><sub>CF</sub> = 213.7 Hz, Ar-C<sup>2</sup>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 257.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 2-Fluoro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-6-((triisopropylsilyl)ethynyl)-9<i>H</i>-purine (<b>37</b>)</h4><div class="NLM_p last">An oxygen-free solution of <b>36</b> (0.050 g, 1.95 mmol), bis(triphenylphosphine)palladium(II) chloride (41 mg, 3.0 mol %) and copper iodide (7 mg, 2.0 mol %) in THF (10 mL) was degassed by bubbling nitrogen through the solution in a sealed vial for 5 min. Triisopropylsilylacetylene (0.50 mL, 2.2 mmol) and triethylamine (0.70 mL, 4.9 mmol) were added to the mixture, which was again degassed for 15 min. After stirring at room temperature for 18 h, the black-brown suspension was filtered through Celite, eluting with MeOH (3 × 20 mL). Purification by chromatography (silica; 10% EtOAc:petrol) furnished <b>37</b> as a viscous yellow oil (78 mg, 99%); <i>R</i><sub>f</sub> 0.30 (10% EtOAc:petrol); UV λ<sub>max</sub> (EtOH) 303 nm. IR (cm<sup>–1</sup>) 3433, 2946, 2866, 2706, 2361, 1703. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.12–1.25 (21H, m, Si(C<i>H</i>(C<i>H</i><sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 1.56–1.63 (2H, m, C<i>H</i><sub>2</sub>), 1.71–1.80 (1H, m, CH), 1.94–2.03 (2H, m, C<i>H</i><sub>2</sub>), 2.20–2.30 (1H, m, C<i>H</i>), 3.70–3.78 (1H, m, CH), 4.01–4.07 (1H, m, C<i>H</i>), 5.70 (1H, dd, <i>J</i> = 2.2, 10.8 Hz, NC<i>H</i>), 8.89 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.5 (Si(<i>C</i>H(CH<sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 18.4 (Si(CH(<i>C</i>H<sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 22.0 (<i>N</i><sup>9</sup>-CH<i>C</i>H<sub>2</sub>CH<sub>2</sub>), 24.4 (<i>N</i><sup>9</sup>-CHOCH<sub>2</sub><i>C</i>H<sub>2</sub>), 29.7 (<i>N</i><sup>9</sup>-CHCH<sub>2</sub><i>C</i>H<sub>2</sub>), 67.7 (<i>N</i><sup>9</sup>-CHO<i>C</i>H<sub>2</sub>CH<sub>2</sub>), 81.4 (<i>N</i><sup>9</sup>-<i>C</i>H), 100.2 (C≡C), 102.8 (C≡C), 133.9 (d, <i>J</i><sub>CF</sub> = 4.6 Hz, Ar-C), 140.8 (d, <i>J</i><sub>CF</sub> = 17.9 Hz, Ar-C), 146.6 (d, <i>J</i><sub>CF</sub> = 2.8 Hz, Ar-C), 153.8 (d, <i>J</i><sub>CF</sub> = 17.8 Hz, Ar-C), 157.4 (d, <i>J</i><sub>CF</sub> = 210.6 Hz, Ar-C<sup>2</sup>). HRMS calcd for C<sub>21</sub>H<sub>32</sub>FN<sub>4</sub>OSi [M + H]<sup>+</sup> 403.2324, found 403.2324.</div></div><div id="sec5_1_7_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-Fluoro-6-((triisopropylsilyl)ethynyl)-9<i>H</i>-purine (<b>38</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure E from <b>37</b> (0.29 g, 0.72 mmol). Purification by chromatography (silica; 30% EtOAc:petrol) gave <b>38</b> as a pale-yellow oil (22 mg, 96%); <i>R</i><sub>f</sub> 0.25 (30% EtOAc:petrol); UV λ<sub>max</sub> (EtOH) 302 nm. IR (cm<sup>–1</sup>) 2945, 2866, 2361, 2000, 1584. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.12–1.21 (21H, m, Si(C<i>H</i>(C<i>H</i><sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 8.68 (1H, s, H-8), 13.89 (1H, br, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 11.1 (Si(<i>C</i>H(CH<sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 18.5 (Si(CH(<i>C</i>H<sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 99.5 (C≡C), 106.1 (C≡C), 131.2 (m, Ar-C), 141.6 (m, Ar-C), 145.3 (m, Ar-C), 156.6 (m, Ar-C), 158.6 (d, <i>J</i><sub>CF</sub> = 217.4 Hz, Ar-C<sup>2</sup>). HRMS calcd for C<sub>16</sub>H<sub>24</sub>FN<sub>4</sub>Si [M + H]<sup>+</sup> 319.1749, found 319.1752.</div></div><div id="sec5_1_7_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-(2-(Triisopropylsilyl)ethynyl)-<i>N</i>-phenyl-9<i>H</i>-purin-2-amine (<b>39</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure A from <b>38</b> (0.455 g, 1.43 mmol). Purified by chromatography (silica; 5% MeOH:DCM) to give the title compound as a yellow gum (0.39 g, 1.00 mmol, 70%); <i>R</i><sub>f</sub> 0.39 (5% MeOH:DCM); UV λ<sub>max</sub> (EtOH) 276 nm. IR (cm<sup>–1</sup>) 3389, 2361, 2021. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.09–1.22 (21H, m, Si(C<i>H</i>(C<i>H</i><sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 7.00–7.04 (1H, m, H-4′), 7.22 (1H, s, N<i>H</i>), 7.29 (2H, dd, <i>J</i> = 7.7, 8.1 Hz, H-3′ and H-5′), 7.46 (1H, s, H-8), 7.52 (2H, dd, <i>J</i> = 1.7, 7.7 Hz, H-2′ and H-6′), 10.42 (1H, s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 11.3 (Si(<i>C</i>H(CH<sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 18.7 (Si(CH(<i>C</i>H<sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 100.8 (C≡C), 101.8 (C≡C), 120.7 (Ar-C), 123.7 (Ar-C), 129.4 (Ar-C), 139.2 (Ar-C), 141.0 (Ar-C), 142.6 (Ar-C), 153.4 (Ar-C), 156.5 (Ar-C). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 392.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-(6-((Triisopropylsilyl)ethynyl)-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>40</b>)</h4><div class="NLM_p last">Following general procedure A employing <b>38</b> (0.156 g, 0.49 mmol). Purification by reversed phase column chromatography (C18 silica; 25–95% MeCN/water + 0.1% HCOOH), afforded <b>40</b> as a yellow solid (70 mg, 30%); mp 163–165 °C; UV λ<sub>max</sub> (EtOH) 361 nm. IR (cm<sup>–1</sup>) 3327, 2944, 2867, 1569, 1531, 1368, 1149. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.15 (21H, m, Si(C<i>H</i>(C<i>H</i><sub>3</sub>)<sub>2</sub>)<sub>3</sub>), 7.17 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.70 (2H, d, <i>J</i> = 9.0 Hz, H-2′ and H-6′), 7.95 (2H, d, <i>J</i> = 9.0 Hz, H-3′ and H-5′), 8.33 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.6, 18.4, 90.6, 98.4, 117.1, 123.4, 126.5, 135.6, 144.0, 155.5, 165.0, 166.3, 166.5, 291.0, 286.5, 215.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 471.4 [M + H]<sup>+</sup>. HRMS calcd for C<sub>22</sub>H<sub>30</sub>N<sub>6</sub>O<sub>2</sub>SSi [M + H]<sup>+</sup> 471.1987, found 471.1942.</div></div><div id="sec5_1_7_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-Ethynyl-<i>N</i>-phenyl-9<i>H</i>-purin-2-amine (<b>41</b>)</h4><div class="NLM_p last">Treatment of <b>39</b> (0.330 g, 0.84 mmol) according to general procedure F, followed by purification by chromatography (silica; EtOAc), yielded <b>41</b> as a yellow solid (201 mg, 100%); <i>R</i><sub>f</sub> 0.27 (100% EtOAc); mp 140–160 °C (dec); UV λ<sub>max</sub> (EtOH) 243 nm. IR (cm<sup>–1</sup>) 3414, 3111, 3072, 2920, 2110, 1704. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.86 (1H, s, C≡C<i>H</i>), 6.91–6.96 (1H, m, H-4′), 7.29 (2H, dd, <i>J</i> = 7.6, 8.0 Hz, H-3′ and H-5′), 7.80 (2H, dd, <i>J</i> = 2.0, 8.0 Hz, H-2′ and H-6′), 8.30 (1H, s, H-8), 9.70 (1H, s, N<i>H</i>), 13.17 (1H, br, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 87.0 (C≡<i>C</i>H), 118.3 (Ar-C), 120.0 (Ar-C), 128.4 (Ar-C), 140.8 (Ar-C), 156.2 (Ar-C). HRMS calcd for C<sub>13</sub>H<sub>10</sub>N<sub>5</sub> [M + H]<sup>+</sup> 236.0931, found 236.0934.</div></div><div id="sec5_1_7_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-(6-Ethynyl-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>42</b>)</h4><div class="NLM_p last">Deprotection of <b>40</b> (0.050 g, 0.11 mmol) in accordance with general procedure F, followed by purification by chromatography (silica; 10% MeOH:DCM), afforded <b>42</b> as a beige solid (18 mg, 50%); mp 156–158 °C. IR (cm<sup>–1</sup>) 3347, 3255, 2920, 2848, 2118, 1568, 1529, 1477, 1128. UV λ<sub>max</sub> (EtOH) 356, 292, 215 nm. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 4.90 (1H, s, C≡C<i>H</i>), 7.16 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.17 (2H, d, <i>J</i> = 9.0 Hz, H-2′ and H-6′), 7.93 (2H, d, <i>J</i> = 9.0 Hz, H-3′ and H-5′), 8.36 (1H, s, H-8). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 315.1 [M + H]<sup>+</sup>. HRMS calcd for C<sub>13</sub>H<sub>10</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 315.0664, found 315.0687. Note: Insufficient material for <sup>13</sup>C NMR analysis.</div></div><div id="sec5_1_7_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 6-Ethynyl-2-fluoro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>43</b>)</h4><div class="NLM_p last">Deprotection of <b>37</b> (68 mg, 0.169 mmol) in accordance with general procedure F, but using 1.2 mol equiv of TBAF, followed by purification by chromatography (silica; 15–100% EtOAc:petrol), afforded <b>43</b> as an off-white solid (41 mg, 100%); <i>R</i><sub>f</sub> 0.32 (50% EtOAc:petrol). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.58–1.63 (1H, m, C<i>H</i>), 1.63–1.78 (2H, m, C<i>H</i><sub>2</sub>), 1.90–1.99 (1H, m, C<i>H</i>), 1.99–2.06 (1H, m, C<i>H</i>), 2.07–2.12 (1H, m, C<i>H</i>), 3.68–3.74 (1H, m, C<i>H</i>), 3.71 (1H, s, C≡C<i>H</i>), 4.09–4.14 (1H, m, C<i>H</i>), 5.65 (1H, dd, <i>J</i> = 2.6, 10.8 Hz, NC<i>H</i>), 8.26 (1H, s, H-8). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 247.0 [M + H]<sup>+</sup>. Note: Insufficient material for <sup>13</sup>C NMR analysis.</div></div><div id="sec5_1_7_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-Chloro-<i>N</i>-phenyl-9<i>H</i>-purin-2-amine (<b>44</b>)</h4><div class="NLM_p last">A mixture of <i>N</i><sup>2</sup>-phenylguanine trifluoroacetate (<b>15</b>) (2.00 g, 5.87 mmol) and <i>N</i>,<i>N</i>-diethylaniline (1.9 mL, 11.73 mmol) in POCl<sub>3</sub> (30 mL) was heated at 115 °C for 60 min. The resultant yellow solution was carefully added dropwise to crushed ice–water with stirring, and the aqueous solution was neutralized by cautious addition of aqueous NaOH solution (1.0 M). The aqueous mixture was extracted with EtOAc (2 × 20 mL), and the combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>) and evaporated under reduced pressure. Purification by chromatography (silica; 50% EtOAc:petrol) gave <b>44</b> as a white powder (670 mg, 46%); mp 172–174 °C; UV λ<sub>max</sub> (EtOH) 329, 272 nm. IR (cm<sup>–1</sup>) 3399, 3289, 1627, 1601, 1571, 1540. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.89–6.92 (1H, t, <i>J</i> = 7.5 Hz, H-4′), 7.23–7.26 (2H, dd, <i>J</i> = 7.4, 7.5 Hz, H-3′ and H-5′), 7.71–7.73 (2H, d, <i>J</i> = 7.4 Hz, H-2′ and H-6′), 8.20 (1H, s, H-8), 9.81 (1H, br s, N<i>H</i>), 13.20 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 118.6, 121.5, 128.5, 140.3, 142.4, 155.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 246.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 6-Chloro-<i>N</i>-phenyl-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purin-2-amine (<b>45</b>)</h4><div class="NLM_p last">To a solution of <b>44</b> (0.2 g, 0.82 mmol) and CSA (0.01 g, 0.041 mmol) in EtOAc (25 mL) was added DHP (83 μL, 0.90 mmol), and the mixture was heated at 75 °C for 17 h. After cooling, the pH was adjusted to 8–9 with concentrated aqueous ammonia, and the volatiles were removed in vacuo. Purification by chromatography (silica; 1/2 to 2/1 EtOAc:petrol) furnished <b>45</b> as a waxy solid (194 mg, 72%); mp 194–196 °C; UV λ<sub>max</sub> (EtOH) 330, 275 nm. IR (cm<sup>–1</sup>) 3274, 3106, 2934, 2849, 1579, 1573, 1535. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.38–1.39 (2H, m, C<i>H</i><sub>2</sub>), 1.49–1.54 (1H, m, C<i>H</i>), 1.76–1.80 (2H, m, C<i>H</i><sub>2</sub>), 2.09–2.17 (1H, m, C<i>H</i>), 3.43–3.48 (1H, m, C<i>H</i>), 3.81–3.83 (1H, m, C<i>H</i>), 5.38–5.40 (1H, dd, <i>J</i> = 2.0, 11.0 Hz, NC<i>H</i>), 6.74–6.77 (1H, t, <i>J</i> = 8.5 Hz, H-4′), 7.07–7.11 (2H, dd, <i>J</i> = 7.5, 8.5 Hz, H-3′ and H-5′), 7.56–7.58 (2H, d, <i>J</i> = 7.5 Hz, H-2′ and H-6′), 8.26 (1H, s, H-8), 9.79 (1H, br s, N<i>H</i>), 13.21 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 24.5, 29.4, 54.9, 67.7, 81.6, 118.7, 121.7, 124.7, 128.6, 140.1, 142.4, 149.3, 152.7, 155.3. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 329.7 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-Phenyl-6-(prop-1-yn-1-yl)-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purin-2-amine (<b>46</b>)</h4><div class="NLM_p last">A suspension of <b>45</b> (0.1 g, 0.30 mmol), PdCl<sub>2</sub>(CH<sub>3</sub>CN)<sub>2</sub> (0.8 mg, 0.003 mmol), dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (4.3 mg, 0.009 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.26 g, 0.79 mmol) in acetonitrile (1 mL) was degassed for 10 min under a nitrogen atmosphere at room temperature. While degassing, an excess of methylacetylene was condensed and added to the reaction mixture via a cannula, and the reaction mixture was heated and stirred at 40 °C for 2.5 h. After cooling to room temperature, water (5 mL) was added and the mixture was extracted with EtOAc (3 × 15 mL). The combined organic extracts were washed with brine (10 mL), dried (MgSO<sub>4</sub>), and the solvent was evaporated under reduced pressure. Purification by chromatography (silica; 30%–80% EtOAc:petrol) gave <b>46</b> as a colorless glassy compound (78 mg, 77%); <i>R</i><sub>f</sub> 0.27 (30% EtOAc:petrol). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.62–1.85 (3H, m, C<i>H</i><sub>2</sub> and C<i>H</i>), 2.06–2.15 (3H, m, C<i>H</i><sub>2</sub> and C<i>H</i>), 2.23 (3H, s, C≡CC<i>H</i><sub>3</sub>), 3.74–3.81 (1H, m, C<i>H</i>), 4.15–4.21 (1H, m, C<i>H</i>), 5.60–5.67 (1H, m, C<i>H</i>), 7.04 (1H, dd, <i>J</i> = 7.4, 7.3 Hz, H-4′), 7.34 (2H, dd, <i>J</i> = 8.5, 7.4 Hz, H-2′ and H-6′), 7.47 (1H, s, N<i>H</i>), 7.34 (2H, dd, <i>J</i> = 8.6, 0.9 Hz, H-3′ and H-5′), 8.03 (1H, s, H-8). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 334.0 [M + H]<sup>+</sup>. Note: Insufficient material for <sup>13</sup>C NMR analysis.</div></div><div id="sec5_1_7_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-Phenyl-6-(phenylethynyl)-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purin-2-amine (<b>47</b>)</h4><div class="NLM_p last">To a degassed suspension of <b>45</b> (0.1 g, 0.30 mmol), PdCl<sub>2</sub>(CH<sub>3</sub>CN)<sub>2</sub> (0.8 mg, 0.003 mmol), dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl (4.3 mg, 0.009 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (0.26 g, 0.79 mmol) in anhydrous acetonitrile (1 mL) was added an excess of phenylacetylene, and the mixture was heated at 80 °C for 2 h. After cooling, water (5 mL) was added and the suspension was extracted with EtOAc (3 × 15 mL). The combined organic extract was washed with brine (10 mL) and dried (MgSO<sub>4</sub>), and the solvent was removed in vacuo. Purification by chromatography (silica; 0–80% EtOAc:petrol) gave <b>47</b> as a colorless glassy compound (94 mg, 78%); <i>R</i><sub>f</sub> 0.53 (65% EtOAc:petrol). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.64–1.88 (3H, m, C<i>H</i><sub>2</sub> and C<i>H</i>), 2.07–2.19 (3H, m, C<i>H</i><sub>2</sub> and C<i>H</i>), 3.74–3.84 (1H, m, C<i>H</i>), 4.16–4.24 (1H, m, C<i>H</i>), 5.63–5.71 (1H, m, C<i>H</i>), 7.03–7.08 (1H, m, H-4′), 7.32–7.46 (5H, m, phenyl), 7.50 (1H, s, N<i>H</i>), 7.70 (2H, d, <i>J</i> = 8.3 Hz, H-2′ and H-6′), 7.72–7.75 (2H, m, H-3′ and H-5′), 8.08 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 22.9, 25.0, 31.5, 68.8, 82.2, 84.1, 97.6, 118.9, 121.5, 122.5, 128.5, 129.0, 129.4, 130.0, 132.9, 139.8, 141.0, 142.3, 152.5, 156.2. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 396.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> <i>N</i>-Phenyl-6-(prop-1-yn-1-yl)-9<i>H</i>-purin-2-amine (<b>48</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure E from <b>46</b> (0.061 g, 0.18 mmol). Recrystallization from EtOAc-petrol gave <b>48</b> as a pale-yellow solid (18 mg, 40%); mp 155–158 °C (dec); UV λ<sub>max</sub> (EtOH) 272 nm. IR (cm<sup>–1</sup>) 1529, 1577, 2236, 2919. <sup>1</sup>H NMR (500 MHz, MeOD-<i>d</i><sub>4</sub>) δ 2.12 (3H, s, C≡CC<i>H</i><sub>3</sub>), 6.87 (1H, t, <i>J</i> = 7.3 Hz, H-4′), 7.18 (2H, t, <i>J</i> = 7.8 Hz, H-2′ and H-6′), 7.63 (2H, d, <i>J</i> = 7.9 Hz, H-3′ and H-5′), 8.04 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, MeOD-<i>d</i><sub>4</sub>) δ 4.3, 116.9, 119.2, 120.1, 122.9, 129.6, 163.2, 163.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 250.1 [M + H]<sup>+</sup>. HRMS calcd for C<sub>14</sub>H<sub>12</sub>N<sub>5</sub> [M + H]<sup>+</sup> 250.1087, found 250.1085.</div></div><div id="sec5_1_7_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-Phenyl-6-(phenylethynyl)-9<i>H</i>-purin-2-amine (<b>49</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure E from <b>47</b> (0.055 g, 0.14 mmol). Recrystallization from EtOAc–petrol gave <b>49</b> as a yellow solid (22 mg, 51%); mp 206–208 °C (dec); UV λ<sub>max</sub> (EtOH) 281 nm. IR (cm<sup>–1</sup>) 1532, 1574, 2208, 3226. <sup>1</sup>H NMR (500 MHz, MeOD-<i>d</i><sub>4</sub>) δ 6.79 (1H, t, <i>J</i> = 7.3 Hz, H-4′), 7.11 (2H, dd, <i>J</i> = 7.8, 8.1 Hz, H-2′ and H-6′), 7.23–7.32 (3H, m, H-3′, H-5′ and Ar-H), 7.54–7.58 (4H, m, 4 × ArH), 8.02 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, MeOD-<i>d</i><sub>4</sub>) δ 97.3, 120.2, 122.8, 122.9, 129.6, 129.8, 131.2, 133.5, 141.8, 158.6. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 312.2 [M + H]<sup>+</sup>. HRMS calculated for C<sub>19</sub>H<sub>14</sub>N<sub>5</sub> [M + H]<sup>+</sup> 312.1244, found 312.1242.</div></div><div id="sec5_1_7_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 6-Ethyl-2-fluoro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>50</b>)</h4><div class="NLM_p last">To a solution of <b>43</b> (0.05 g, 0.20 mmol) and quinoline (20 μL) in EtOAc (5 mL) was added Lindlar’s catalyst (10 mg, 20% w/w), and the mixture was stirred for 2 h under an atmosphere of H<sub>2</sub>. The suspension was filtered through Celite, eluting with methanol (30 mL), and volatiles were removed in vacuo. Purification by chromatography (silica; 50% EtOAc:petrol) yielded <b>50</b> as a colorless oil (50 mg, 99%); UV λ<sub>max</sub> (EtOH) 264 nm. IR (cm<sup>–1</sup>) 2946, 2860, 2364, 2338, 1604. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.35 (3H, t, <i>J</i> = 7.5 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 1.59 (2H, m, C<i>H</i><sub>2</sub>), 1.97 (1H, m, C<i>H</i>), 1.99 (2H, d, <i>J</i> = 10.5 Hz, C<i>H</i><sub>2</sub>), 2.50 (1H, m, C<i>H</i>), 3.01 (2H, q, <i>J</i> = 7.5 Hz, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 3.73 (1H, m, C<i>H</i>), 4.04 (1H, d, <i>J</i> = 10.5 Hz, C<i>H</i>), 5.69 (1H, d, <i>J</i> = 10.5 Hz, C<i>H</i>), 8.74 (1H, s, H-8). <sup>13</sup>C NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.3, 22.7, 24.8, 26.5, 31.8, 68.9, 82.1, 142.1, 157.9, 159.6, 167.4, 167.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 251.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 6-Ethyl-2-fluoro-9<i>H</i>-purine (<b>51</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure E from <b>50</b> (0.18 g, 0.72 mmol). Purification by chromatography (silica; 25% EtOAc:petrol) yielded <b>51</b> as a white solid (0.117 g, 98%); mp 146–148 °C; UV λ<sub>max</sub> (EtOH) 269 nm. IR (cm<sup>–1</sup>) 1676, 1616, 1573. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.30 (3H, t, <i>J</i> = 7.5 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 3.00 (2H, q, <i>J</i> = 7.5 Hz, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 8.17 (1 H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.7, 25.9, 68.3, 116.0, 118.4, 146.4, 158.0 (d, <i>J</i><sub>C–F</sub> = 206.0 Hz), 158.3 (d, <i>J</i><sub>C–F</sub> = 31.5 Hz). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 167.7 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 4-(6-Ethyl-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>52</b>)</h4><div class="NLM_p last">Prepared by general procedure A from <b>51</b> (0.081 g, 0.49 mmol), following purification by chromatography (silica; 50% EtOAc:petrol), as a white solid (33 mg, 21%); mp 291–293 °C; UV λ<sub>max</sub> (EtOH) 318, 287, 212 nm. IR (cm<sup>–1</sup>) 3377, 3060, 2852, 1388, 1158. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.35 (3H, t, <i>J</i> = 6.0 Hz, C<i>H</i><sub>3</sub>CH<sub>2</sub>), 3.00 (2H, q, <i>J</i> = 6.0 Hz, CH<sub>3</sub>C<i>H</i><sub>2</sub>), 7.14 (2H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.69 (2H, d, <i>J</i> = 7.5 Hz, H-2′ and H-6′), 7.99 (2H, d, <i>J</i> = 7.5 Hz, H-3′ and H-5′), 8.17 (1H, s, H-8), 9.89 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.3, 26.0, 117.0, 118.9, 125.4, 126.4, 135.2, 141.2, 144.4, 154.0, 155.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 318.6 [M + H]<sup>+</sup>. HRMS calcd for C<sub>13</sub>H<sub>14</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 319.097076, found 319.09788.</div></div><div id="sec5_1_7_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6-Cyclopropyl-2-fluoro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>53</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>36</b> (0.04 g, 0.27 mmol) and potassium cyclopropyltrifluoroborate (50 mg, 0.19 mmol) following general procedure G. Purification by chromatography (silica; 50% EtOAc:petrol) afforded <b>53</b> as a colorless oil (21 mg, 42%); UV λ<sub>max</sub> (EtOH) 211, 325, 391 nm. IR (cm<sup>–1</sup>) 2986. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.25 (4H, d, <i>J</i> = 6.5 Hz, cyclopropyl 2 × C<i>H</i><sub>2</sub>), 1.55 (2H, m, C<i>H</i><sub>2</sub>), 1.72 (1H, m, C<i>H</i>), 1.95 (2H, d, <i>J</i> = 10.5 Hz, C<i>H</i><sub>2</sub>), 2.27 (1H, m, C<i>H</i>), 2.67 (1H, m, cyclopropyl C<i>H</i>), 3.70 (1H, m, C<i>H</i>), 3.99 (1H, d, <i>J</i> = 10.5 Hz, C<i>H</i>), 5.63 (1H, d, <i>J</i> = 10.5 Hz, C<i>H</i>), 8.70 (1H, s, H-8). <sup>13</sup>C NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.9, 13.2, 22.2, 24.4, 29.7, 67.7, 81.3, 130.9, 144.1, 151.8, 157.6, 159.8, 176.9. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 262.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 6-Cyclopropyl-2-fluoro-9<i>H</i>-purine (<b>54</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>53</b> (0.19 g, 0.72 mmol) employing general procedure E. Purification by chromatography (silica; EtOAc) afforded <b>54</b> as a white solid (0.12 g, 95%); mp 137–139 °C; UV λ<sub>max</sub> (EtOH) 323, 213 nm. IR (cm<sup>–1</sup>) 3062. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.11 (4H, d, <i>J</i> = 6.5 Hz, cyclopropyl 2 × C<i>H</i><sub>2</sub>), 2.51 (1H, m, cyclopropyl C<i>H</i>), 8.40 (1H, s, H-8). <sup>13</sup>C NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.6, 13.1, 131.2, 144.2, 151.8, 157.6, 159.8. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 179.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 4-(6-Cyclopropyl-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>55</b>)</h4><div class="NLM_p last">Synthesized following general procedure A from <b>54</b> (0.086 g, 0.49 mmol). Purification by chromatography (silica; EtOAc) afforded <b>55</b> as a pale-yellow solid (24 mg, 15%); mp 291–293 °C; UV λ<sub>max</sub> (EtOH) 315.5, 289, 213 nm. IR (cm<sup>–1</sup>) 3389, 3062, 2921, 2851, 1727, 1604, 1579, 1531, 1379, 1149. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.23 (4H, d, <i>J</i> = 6.5 Hz, cyclopropyl 2 × C<i>H</i><sub>2</sub>), 1.35 (1H, m, cyclopropyl C<i>H</i>), 7.18 (2H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.74 (2H, d, <i>J</i> = 8.0 Hz, H-2′ and H-6′), 7.99 (2H, d, <i>J</i> = 8.0 Hz, H-3′ and H-5′), 8.22 (1H, s, H-8), 9.75 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.5, 13.0, 117.1, 126.4, 126.6, 141.1, 144.4, 151.8, 155.5, 162.9. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 331.1 [M + H]<sup>+</sup>. HRMS calcd for C<sub>14</sub>H<sub>15</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 331.0977, found 331.0980.</div></div><div id="sec5_1_7_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 2-Fluoro-6-phenyl-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>56</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure G from <b>36</b> (0.20 g, 0.78 mmol) and phenylboronic acid (0.133 g, 1.09 mmol). Purification by chromatography (silica; 20% EtOAc:petrol) gave <b>56</b> as a white solid (0.30 g, 95%); mp 138–140 °C; UV λ<sub>max</sub> (EtOH) 306, 269, 203 nm. IR (cm<sup>–1</sup>) 3117, 2956, 2858, 1586. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60 (2H, m, C<i>H</i><sub>2</sub>), 1.76 (1H, m, C<i>H</i>), 2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.29 (1H, s, C<i>H</i>), 3.77 (1H, t, <i>J</i> = 12.0 Hz, C<i>H</i>), 4.04 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 5.74 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 7.64, (3H, m, H-3″, H-4″ and H-5″), 8.79 (2H, dd, <i>J</i> = 3.0, 7.5 Hz, H-2″ and H-6″), 8.25 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.2, 24.4, 29.7, 67.7, 81.3, 128.9, 129.3, 129.5, 132.0, 134.0, 145.4, 154.3 (d, <i>J</i><sub>C–F</sub> = 17.5 Hz), 155.5 (d, <i>J</i><sub>C–F</sub> = 144.0 Hz), 157.0, 158.7. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 299.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-Fluoro-6-(3-methoxyphenyl)-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>57</b>)</h4><div class="NLM_p last">Prepared according to general procedure G from <b>36</b> (0.20 g, 0.78 mmol) and 4-methoxyphenylboronic acid (0.16 g, 1.09 mmol). Purification by chromatography (silica; 30% EtOAc:petrol) gave <b>57</b> as a white solid (0.29 g, 80%); mp 133–135 °C; UV λ<sub>max</sub> (EtOH) 306, 271, 204 nm. IR (cm<sup>–1</sup>) 3089, 2938, 2857, 1761, 1586, 1516. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60 (2H, m, C<i>H</i><sub>2</sub>), 1.76 (1H, m, C<i>H</i>), 2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.29 (1H, s, C<i>H</i>), 3.77 (1H, t, <i>J</i> = 12.0 Hz, C<i>H</i>), 3.89 (3H, s, OC<i>H</i><sub>3</sub>), 4.04 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 5.74 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 7.18 (1H, m, H-2″), 7.50–7.55 (1H, m, H-5″), 8.45–8.49 (2H, m, H-4″, H-6″), 8.78 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.2, 24.4, 29.7, 55.3, 67.7, 81.3, 114.4, 117.9, 122.0, 129.4, 130.0, 135.3, 145.4, 154.3 (d, <i>J</i><sub>C–F</sub> = 17.5 Hz), 155.0 (d, <i>J</i><sub>C–F</sub> = 160.0 Hz), 156.9, 158.6, 159.4. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 334.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-Fluoro-6-(4-methoxyphenyl)-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>58</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure G from <b>36</b> (0.20 g, 0.78 mmol) and 4-methoxyphenylboronic acid (0.16 g, 1.09 mmol). Purification by chromatography (silica; 30% EtOAc:petrol) afforded <b>58</b> as a white solid (0.35 g, 98%); mp 131–133 °C; UV λ<sub>max</sub> (EtOH) 306, 271, 204 nm. IR (cm<sup>–1</sup>) 3089, 2938, 2857, 1761, 1586, 1516. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60 (2H, m, C<i>H</i><sub>2</sub>), 1.76 (1H, m, C<i>H</i>), 2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.29 (1H, s, C<i>H</i>), 3.77 (1H, t, <i>J</i> = 12.0 Hz, C<i>H</i>), 3.88 (3H, s, OC<i>H</i><sub>3</sub>), 4.04 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 5.74 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 7.15–7.18 (2H, d, <i>J</i> = 9.0 Hz, H-3″ and H-5″), 8.79–8.81 (2H, d, <i>J</i> = 9.0 Hz, H-2″ and H-6″), 8.85 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.2, 24.4, 29.7, 55.5, 67.7, 81.2, 114.3, 126.5, 128.5, 131.5, 144.7, 153.9 (d, <i>J</i><sub>C–F</sub> = 17.5 Hz), 155.2 (d, <i>J</i><sub>C–F</sub> = 160.0 Hz), 157.0, 158.7, 162.4. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 329.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 6-(3-Biphenyl)-2-fluoro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>59</b>)</h4><div class="NLM_p last">Prepared following general procedure G from <b>36</b> (0.20 g, 0.78 mmol) and 3-biphenylboronic acid (0.22 g, 1.09 mmol). Purification by chromatography (silica; 20% EtOAc:petrol) furnished <b>59</b> as a pale-yellow solid (0.33 g, 80%); mp 221–223 °C; UV λ<sub>max</sub> (EtOH) 346, 274 nm. IR (cm<sup>–1</sup>) 2992, 2844, 2601, 1589. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60 (2H, m, C<i>H</i><sub>2</sub>), 1.76 (1H, m, C<i>H</i>), 2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.29 (1H, s, C<i>H</i>), 3.77 (1H, t, <i>J</i> = 12.0 Hz, C<i>H</i>), 4.04 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 5.79 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 7.45 (1H, d, <i>J</i> = 7.0 Hz, H-6″), 7.56 (1H, dd, <i>J</i> = 7.0, 7.1 Hz, H-5″), 7.78 (5H, m, Ph), 8.40 (1H, s, H-2″), 8.84 (1H, d, <i>J</i> = 7.1 Hz, H-4″), 9.18 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.2, 24.4, 29.7, 67.7, 81.3, 126.8, 127.8, 127.9, 128.4, 129.1, 129.5, 129.6, 130.3, 134.7, 139.6, 140.8, 145.6, 154.4 (d, <i>J</i><sub>C–F</sub> = 17.5 Hz), 155.2 (d, <i>J</i><sub>C–F</sub> = 116.0 Hz), 157.0, 158.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 375.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-Fluoro-6-(3-piperonyl)-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>60</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure G from <b>36</b> (0.20 g, 0.78 mmol) and 3,4-(methylenedioxy)phenylboronic acid (0.18 g, 1.09 mmol). Purification by chromatography (silica; 30% EtOAc:petrol) yielded <b>60</b> as a white solid (0.21 g, 56%); mp 151–153 °C; UV λ<sub>max</sub> (EtOH) 351, 284 nm. IR (cm<sup>–1</sup>) 3011, 2917, 1721, 1616, 1511. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60 (2H, m, C<i>H</i><sub>2</sub>), 1.76 (1H, m, C<i>H</i>), 2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.29 (1H, s, C<i>H</i>), 3.73 (1H, t, <i>J</i> = 12.0 Hz, C<i>H</i>), 4.04 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 5.73 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 6.17 (2H, s, OC<i>H</i><sub>2</sub>O), 7.14–7.17 (1H, d, <i>J</i> = 8.0 Hz, H-5″), 8.28 (1H, s, H-2″), 8.48–8.51 (1H, d, <i>J</i> = 8.0 Hz, H-6″), 8.82 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.2, 24.4, 29.7, 67.7, 81.2, 101.9, 108.6, 125.4, 128.0, 128.6, 144.9, 147.8, 150.6, 154.1, 154.8, 156.9, 158.7. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 343.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 6-(4-Dibenzofuryl)-2-fluoro-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>61</b>)</h4><div class="NLM_p last">Prepared according to general procedure G from <b>36</b> (0.20 g, 0.78 mmol) and 4-dibenzofuranboronic acid (0.23 g, 1.09 mmol). Purification by chromatography (silica; 30% EtOAc:petrol) yielded <b>61</b> as a cream solid (0.39 g, 92%); mp 168–170 °C; UV λ<sub>max</sub> (EtOH) 398, 256, 202 nm. IR (cm<sup>–1</sup>) 3092, 2589, 1579. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60 (2H, m, C<i>H</i><sub>2</sub>), 1.76 (1H, m, C<i>H</i>), 2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.29 (1H, s, C<i>H</i>), 3.77 (1H, t, <i>J</i> = 12 Hz, C<i>H</i>), 4.04 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 5.79 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 7.45–7.47 (1H, dd, <i>J</i> = 7.0, 7.1 Hz, H-2″), 7.52–7.62 (1H, dd, <i>J</i> = 8.0, 8.1 Hz, H-7″), 7.61–7.71 (1H, dd, <i>J</i> = 8.0, 8.1 Hz, H-8″), 7.76–7.79 (1H, d, <i>J</i> = 8.0 Hz, H-9″), 8.25–8.27 (1H, d, <i>J</i> = 7.1 Hz, H-3″), 8.42–8.44 (1H, d, <i>J</i> = 8.0 Hz, H-6″), 8.55–8.58 (1H, d, <i>J</i> = 7.5 Hz, H-1″), 8.93 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.2, 24.5, 29.7, 67.8, 68.3, 81.4, 111.9, 119.3, 121.3, 122.9, 123.1, 123.4, 124.3, 125.2, 128.1, 130.1, 145.6, 153.1, 154.7 (d, <i>J</i><sub>C–F</sub> = 18.0 Hz), 155.7 (d, <i>J</i><sub>C–F</sub> = 160.0 Hz), 156.9, 158.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 389.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-Fluoro-6-(1-thianthrenyl)-9-(tetrahydro-2<i>H</i>-pyran-2-yl)-9<i>H</i>-purine (<b>62</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure G from <b>36</b> (0.20 g, 0.78 mmol) and 1-thianthreneboronic acid (0.28 g, 1.09 mmol). Purification by chromatography (silica; 30% EtOAc:petrol) afforded <b>62</b> as an orange solid (0.43 g, 90%); mp 164–166 °C; UV λ<sub>max</sub> (EtOH) 396, 224 nm. IR (cm<sup>–1</sup>) 3092, 2814, 2589, 1611, 1497. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.60 (2H, m, C<i>H</i><sub>2</sub>), 1.76 (1H, m, C<i>H</i>), 2.02 (2H, m, C<i>H</i><sub>2</sub>), 2.29 (1H, s, C<i>H</i>), 3.77 (1H, t, <i>J</i> = 12.0 Hz, C<i>H</i>), 4.04 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 5.79 (1H, d, <i>J</i> = 12.0 Hz, C<i>H</i>), 7.21–7.30 (1H, dd, <i>J</i> = 7.4, 7.5 Hz, H-3″), 7.31–7.39 (1H, dd, <i>J</i> = 7.5, 7.6 Hz, H-7″), 7.37–7.45 (1H, d, <i>J</i> = 7.5 Hz, H-9″), 7.51–7.58 (1H, dd, <i>J</i> = 7.5, 7.6 Hz, H-8″), 7.59–7.65 (1H, d, <i>J</i> = 7.5 Hz, H-6″), 7.79 (1H, d, <i>J</i> = 7.4 Hz, H-2″), 7.89 (1H, d, <i>J</i> = 7.5 Hz, H-4″), 8.93 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 22.2, 24.4, 29.5, 67.7, 68.3, 81.5 127.5, 128.2, 128.5, 128.7, 128.9, 130.6, 130.9, 131.4, 134.5, 134.7, 135.1, 135.5, 136.4, 146.2, 153.8 (d, <i>J</i><sub>C–F</sub> = 17.5 Hz), 156.2, 155.0 (d, <i>J</i><sub>C–F</sub> = 150.0 Hz), 157.2. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 437.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 2-Fluoro-6-phenyl-9<i>H</i>-purine (<b>63</b>)</h4><div class="NLM_p last">Prepared from <b>56</b> (0.22 g, 0.72 mmol) following general procedure E. Repeated trituration of the precipitated solid with water gave <b>63</b> (0.14 g, 90%); mp 273–275 °C; UV λ<sub>max</sub> (EtOH) 349 nm. IR (cm<sup>–1</sup>) 2820, 1599, 1560. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.62 (3H, m, H-3″, H-4″ and H-5″), 8.68 (1 H, s, H-8), 8.81 (2H, m, H-2″ and H-6″). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 128.8, 129.4, 131.7, 134.4, 145.7, 154.4, 156.0, 157.1, 158.7. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 214.6 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-Fluoro-6-(3-methoxyphenyl)-9<i>H</i>-purine (<b>64</b>)</h4><div class="NLM_p last">Deprotection of <b>57</b> (0.24 g, 0.72 mmol) in accordance with general procedure E afforded the title compound <b>64</b> (0.17 g, 98%) following repeated trituration of the precipitated solid with water; mp 237–238 °C; UV λ<sub>max</sub> (EtOH) 251 nm. IR (cm<sup>–1</sup>) 2837, 1864, 1587, 1565. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.89 (3H, s, OCH<sub>3</sub>), 7.18 (1 H, s, H-2″), 7.50–7.55 (1H, m, H-5″), 8.37 (1H, s, H-8), 8.45–8.49 (2H, m, H-4″, H-6″). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 55.3, 114.2, 117.6, 121.8, 130.0, 135.7, 146.3, 154.3, 157.2, 158.6, 159.4. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 245.5 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 2-Fluoro-6-(4-methoxyphenyl)-9<i>H</i>-purine (<b>65</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure E from <b>58</b> (0.24 g, 0.72 mmol). Trituration of the precipitated solid with water furnished <b>65</b> as a pale-yellow solid (0.17 g, 95%); mp 212–214 °C; UV λ<sub>max</sub> (EtOH) 204 nm. IR (cm<sup>–1</sup>) 2845, 1586. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.88 (3H, s, OC<i>H</i><sub>3</sub>), 7.15–7.18 (2H, d, <i>J</i> = 9.0 Hz, H-3″ and H-5″), 8.60 (1H, s, H-8), 8.79–8.81 (2H, d, <i>J</i> = 9.0 Hz, H-2″ and H-6″). <sup>13</sup>C NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 55.4, 114.1, 114.3, 126.8, 127.5, 131.3, 145.3, 157.1, 158.8, 162.2. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 245.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 6-(Biphenyl-3-yl)-2-fluoro-9<i>H</i>-purine (<b>66</b>)</h4><div class="NLM_p last">The title compound was prepared according to general procedure E from <b>59</b> (0.27 g, 0.72 mmol). Repeated washing of the precipitated solid with water gave <b>66</b> (0.20 g, 97%); mp 245–247 °C; UV λ<sub>max</sub> (EtOH) 349 nm. IR (cm<sup>–1</sup>) 1607, 1568. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.43–7.45 (1H, d, <i>J</i> = 7.0 Hz, H-6″), 7.54–7.58 (1H, dd, <i>J</i> = 6.9, 7.0 Hz, H-5″), 7.74–7.81 (5H, m, Ph), 8.40 (1H, s, H-2″), 8.80–8.85 (1H, d, <i>J</i> = 6.9 Hz, H-4″), 8.91 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 126.8, 127.7, 127.9, 128.2, 129.1, 129.5, 130.0, 135.0, 139.7, 140.7, 146.1 (m, <i>J</i><sub>C–F</sub>), 157.1, 158.7. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 291.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 6-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-2-fluoro-9<i>H</i>-purine (<b>67</b>)</h4><div class="NLM_p last">Deprotection of <b>60</b> (0.25 g, 0.72 mmol) was achieved following general procedure E. Trituration of the white solid that precipitated yielded <b>67</b> (0.16 g, 87%); mp 165–167 °C; UV λ<sub>max</sub> (EtOH) 351, 292 nm. IR (cm<sup>–1</sup>) 2955, 2859, 1601, 1570, 1504. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.17 (2H, s, OC<i>H</i><sub>2</sub>O), 7.18–7.18 (1H, d, <i>J</i> = 8.0 Hz, H-5″), 8.28 (1H, s, H-2″), 8.48–8.51 (1H, d, <i>J</i> = 8.0 Hz, H-6″), 8.63 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 101.9, 108.6, 125.1, 128.4, 145.3, 147.8, 150.3, 153.9 (d, <i>J</i><sub>C–F</sub> = 17.5 Hz), 156.0 (d, <i>J</i><sub>C–F</sub> = 150.0 Hz), 157.0, 158.6. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 259.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 6-(4-Dibenzofuranyl)-2-fluoro-9<i>H</i>-purine (<b>68</b>)</h4><div class="NLM_p last">The title compound was prepared in accordance with general procedure E from <b>61</b> (0.28 g, 0.72 mmol) and purified by repeated washing with water to afford <b>68</b> as an off-white solid (0.20 g, 94%); mp 266–268 °C; UV λ<sub>max</sub> (EtOH) 250 nm. IR (cm<sup>–1</sup>) 3020, 2923, 2832, 1867, 1611, 1568. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.45–7.48 (1H, dd, <i>J</i> = 7.0, 7.1 Hz, H-2″), 7.55–7.63 (1H, dd, <i>J</i> = 7.9, 8.0 Hz, H-7″), 7.61–7.68 (1H, dd, <i>J</i> = 7.9, 8.0 Hz, H-8″), 7.76–7.79 (1H, d, <i>J</i> = 8.0 Hz, H-9″), 8.26–8.29 (1H, d, <i>J</i> = 7.1 Hz, H-3″), 8.43–8.45 (1H, d, <i>J</i> = 8.0 Hz, H-6″), 8.55–8.58 (1H, d, <i>J</i> = 7.0 Hz, H-1″), 8.78 (1H, s, H-8). <sup>13</sup>C NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 112.1, 121.3, 123.0, 123.5, 124.0, 125.0, 128.0, 130.0, 155.7. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 305.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-Fluoro-6-(thianthren-1-yl)-9<i>H</i>-purine (<b>69</b>)</h4><div class="NLM_p last">Synthesized following general procedure E from <b>62</b> (0.32 g, 0.72 mmol) and purified by repeated trituration with water to give <b>69</b> (0.36 g, 93%); mp 166–168 °C; UV λ<sub>max</sub> (EtOH) 250 nm. IR (cm<sup>–1</sup>) 3068, 2817, 2572, 1609, 1511. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.21–7.29 (1H, dd, <i>J</i> = 7.4, 7.5 Hz, H-3″), 7.31–7.38 (1H, dd, <i>J</i> = 7.5, 7.6 Hz, H-7″), 7.39–7.46 (1H, d, <i>J</i> = 7.5 Hz, H-9″), 7.49–7.55 (1H, dd, <i>J</i> = 7.5, 7.6 Hz, H-8″), 7.58–7.64 (1H, d, <i>J</i> = 7.5 Hz, H-6″), 7.79 (1H, d, <i>J</i> = 7.5 Hz, H-2″), 7.88–7.91 (1H, d, <i>J</i> = 7.4 Hz, H-4″), 8.31 (1H, s, H-8). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 124.6, 127.5, 128.2, 128.4, 128.7, 128.9, 130.5, 131.1, 134.7, 134.9, 156.4, 159.9, 160.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 353.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 4-(6-Phenyl-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>70</b>)</h4><div class="NLM_p last">The title compound was synthesized according to general procedure A from <b>63</b> (0.10 g, 0.49 mmol). Purified by chromatography (silica; 50% EtOAc:petrol) to give <b>70</b> as a white solid (80 mg, 45%); mp 153–155 °C; UV λ<sub>max</sub> (EtOH) 349, 294 nm. IR (cm<sup>–1</sup>) 3313, 2922, 2852, 1706, 1589, 1569, 1524, 1373, 1144. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.17 (2 H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.60 (3H, m, H-3″, H-4″ and H-5″), 7.75–7.78 (2H, d, <i>J</i> = 8.5 Hz, H-2′ and H-6′), 8.03–8.06 (2H, d, <i>J</i> = 8.5 Hz, H-3′ and H-5′) 8.37 (1H, s, H-8), 8.94 (2H, m, H-2″ and H-6″), 9.91 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 117.2, 125.4, 126.5, 128.5, 129.3, 130.8, 135.4, 135.8, 142.6, 144.3, 153.0, 154.6, 155.3. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 367.2 [M + H]<sup>+</sup>. HRMS calcd for C<sub>17</sub>H<sub>14</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 367.0972, found 367.0974.</div></div><div id="sec5_1_7_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 4-(6-(3-Methoxyphenyl)-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>71</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure A from <b>64</b> (0.12 g, 0.49 mmol) and purified by chromatography (silica; 50% EtOAc:petrol) to furnish <b>71</b> as a white solid (64 mg, 33%); mp 288–290 °C; UV λ<sub>max</sub> (EtOH) 294 nm. IR (cm<sup>–1</sup>) 3377, 3097, 3020, 2838, 1729, 1597, 1566, 1531, 1365, 1145. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.89 (3H, s, OC<i>H</i><sub>3</sub>), 7.17 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.18 (1H, s, H-2″), 7.50–7.55 (1H, m, H-5″), 7.74–7.77 (2H, d, <i>J</i> = 8.0 Hz, H-2′ and H-6′), 8.03–8.06 (2H, d, <i>J</i> = 8.0 Hz, H-3′ and H-5′), 8.37 (1H, s, H-8), 8.45–8.49 (2H, m, H-4″ and H-6″). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 55.2, 114.2, 116.6, 117.2, 121.8, 126.5, 129.6, 135.4, 137.1, 144.3, 146.3, 155.2, 115.6, 159.3. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 397.3 [M + H]<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>16</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 397.1077, found 397.1071.</div></div><div id="sec5_1_7_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 4-(6-(4-Methoxyphenyl)-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>72</b>)</h4><div class="NLM_p last">Synthesed following general procedure A from <b>65</b> (0.12 g, 0.49 mmol) and isolated by chromatography (silica; 50% EtOAc:petrol) to yield <b>72</b> as a white solid (90 mg, 46%); mp 172–174 °C; UV λ<sub>max</sub> (EtOH) 301, 203 nm. IR (cm<sup>–1</sup>) 3322, 2133, 2005, 1594, 1533, 1514, 1352, 1147. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.88 (3H, s, OC<i>H</i><sub>3</sub>), 7.17 (2H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.18 (2H, d, <i>J</i> = 8.5 Hz, H-3″ and H-5″), 7.74–7.77 (2H, d, <i>J</i> = 8.0 Hz, H-2′ and H-6′), 8.02–8.05 (2H, d, <i>J</i> = 8.0 Hz, H-3′ and H-5′), 8.32 (1H, s, H-8), 8.84–8.87 (2H, d, <i>J</i> = 8.5 Hz, H-2″ and H-6″). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 55.4, 114.0, 117.2, 124.8, 126.5, 128.2, 131.0, 135.3, 142.0, 144.4, 152.8, 154.3, 155.3, 161.5. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 397.3 [M + H]<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>16</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 397.1077, found 397.1071.</div></div><div id="sec5_1_7_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 4-((6-([1,1′-Biphenyl]-3-yl)-9<i>H</i>-purin-2-yl)amino)benzenesulfonamide (<b>73</b>)</h4><div class="NLM_p last">Treatment of <b>66</b> (0.14 g, 0.49 mmol) in accordance with general procedure A with purification by chromatography (silica; EtOAc) afforded <b>73</b> as a white solid (46 mg, 21%); mp 153–155 °C; UV λ<sub>max</sub> (EtOH) 349, 294 nm. IR (cm<sup>–1</sup>) 3313, 2922, 2852, 1706, 1589, 1569, 1524, 1373, 1144. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.18 (1H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.39–7.50 (1H, d, <i>J</i> = 7.0 Hz, H-6″), 7.50–7.62 (1H, dd, <i>J</i> = 7.0, 7.1 Hz, H-5″), 7.66–7.83 (5H, m, Ph), 7.83–7.93 (2H, d, <i>J</i> = 8.0 Hz, H-2′ and H-6′), 8.00–8.13 (2H, d, <i>J</i> = 8.0 Hz, H-3′ and H-5′), 8.35–8.40 (1H, s, H-2″), 8.78–8.93 (1H, d, <i>J</i> = 7.1 Hz, H-4″), 9.18 (1H, s, H-8), 10.00 (1H, br s, N<i>H</i>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 367.2 [M + H]<sup>+</sup>. HRMS calcd for C<sub>23</sub>H<sub>18</sub>N<sub>6</sub>O<sub>2</sub>S [M + H]<sup>+</sup> 367.0972, found 367.0974. HPLC: >96%, XSELECT column, retention time 7.48 min, reverse phase, H<sub>2</sub>O/MeCN/HCOOH gradient run, 1 mL min<sup>–1</sup>.</div></div><div id="sec5_1_7_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 4-(6-(Benzo[<i>d</i>][1,3]dioxol-5-yl)-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>74</b>)</h4><div class="NLM_p last">The title compound was prepared following general procedure A from <b>67</b> (0.13 g, 0.49 mmol). Purification by chromatography (silica; EtOAc) gave <b>74</b> as a pale-yellow solid (30 mg, 15%); mp 284–286 °C; UV λ<sub>max</sub> (EtOH) 352, 295 nm. IR (cm<sup>–1</sup>) 3174, 1573, 1526, 1408, 1350, 1153. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.14 (2H, s, OC<i>H</i><sub>2</sub>O), 7.15 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.73–7.75 (2H, d, <i>J</i> = 8.0, H-2′ and H-6′), 7.98–8.01 (2H, d, <i>J</i> = 8.0 Hz, H-3′ and H-5′), 8.31 (1H, s, H-8), 8.37 (1H, s, H-2″), 8.55 (2H, m, H-5″ and H-6″), 9.89 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 101.6, 108.4, 108.6, 117.2, 124.7, 126.5, 129.9, 133.2, 135.5, 139.8, 142.2, 144.3, 147.6, 149.6, 151.9, 152.4, 154.4, 155.2. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 443.3 [M + H]<sup>+</sup>. HRMS calcd for C<sub>18</sub>H<sub>14</sub>N<sub>6</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 443.1285, found 443.1289.</div></div><div id="sec5_1_7_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 4-(6-(4-Dibenzofuryl)-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>75</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure A from <b>68</b> (0.15 g, 0.49 mmol). Purification by chromatography (silica; 50% EtOAc:petrol) gave <b>75</b> as a white solid (0.10 g, 47%); mp 213-215 °C; UV λ<sub>max</sub> (EtOH) 292, 250 nm. IR (cm<sup>–1</sup>) 3275, 3199, 3104, 2921, 2852, 1714, 1593, 1574, 1535, 1500, 1355, 1146. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.16 (2H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.44–7.53 (1H, dd, <i>J</i> = 6.9, 7.0 Hz, H-2″), 7.54–7.68 (2H, m, H-7″ and H-8″), 7.68–7.74 (1H, d, <i>J</i> = 8.0 Hz, H-9″), 7.69–7.79 (2H, d, <i>J</i> = 8.0 Hz, H-2′ and H-6′), 8.18–8.26 (2H, d, <i>J</i> = 8.0 Hz, H-3′ and H-5′), 8.23–8.32 (1H, d, <i>J</i> = 6.9 Hz, H-3″), 8.38 (1H, s, H-8), 8.38–8.44 (1H, d, <i>J</i> = 7.5 Hz, H-6″), 8.49–8.58 (1H, d, <i>J</i> = 7.0 Hz, H-1″), 10.07 (1H, br s, N<i>H</i>), 13.22 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 111.5, 117.3, 121.0, 121.3, 122.9, 123.1, 123.2, 123.4, 124.9, 126.4, 128.0, 130.0, 135.4, 143.0, 144.4, 152.2, 153.0, 154.4, 155.3, 155.7. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 457.3 [M + H]<sup>+</sup>. HRMS calcd for C<sub>23</sub>H<sub>16</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 457.1077, found 457.1075.</div></div><div id="sec5_1_7_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 6-(4-Thianthren-1-yl)-9<i>H</i>-purin-2-ylamino)benzenesulfonamide (<b>76</b>)</h4><div class="NLM_p last">Synthesized following general procedure A from (<b>69</b>) (0.17 g, 0.49 mmol), and purified by chromatography (silica; 50% EtOAc:petrol) to furnish <b>76</b> as an orange solid (81 mg, 33%); mp 170–172 °C; UV λ<sub>max</sub> (EtOH) 339, 294, 250 nm. IR (cm<sup>–1</sup>) 3317, 2922, 2851, 1706, 1588, 1524, 1371, 1146. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.16 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.21–7.28 (1H, dd, <i>J</i> = 7.4, 7.5 Hz, H-3″), 7.30–7.36 (1H, dd, <i>J</i> = 7.5, 7.6 Hz, H-7″), 7.38–7.43 (1H, d, <i>J</i> = 7.5 Hz, H-9″), 7.48–7.53 (1H, dd, <i>J</i> = 7.5, 7.6 Hz, H-8″), 7.58–7.63 (1H, d, <i>J</i> = 7.5 Hz, H-6″), 7.73 (2H, d, <i>J</i> = 8.5 Hz, H-2′ and H-6′), 7.77–7.80 (1H, d, <i>J</i> = 7.4 Hz, H-2″), 7.88–7.91 (1H, d, <i>J</i> = 7.5 Hz, H-4″), 8.06 (2H, d, <i>J</i> = 8.5 Hz, H-3′ and H-5′), 8.34 (1H, s, H-8). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 505.2 [M + H]<sup>+</sup>. HRMS calcd for C<sub>23</sub>H<sub>16</sub>N<sub>6</sub>O<sub>2</sub>S<sub>3</sub> [M + H]<sup>+</sup> 505.0570, found 505.0573.</div></div><div id="sec5_1_7_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 7-Chloro-3-(4-methoxybenzyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-amine (<b>78</b>)</h4><div class="NLM_p last">To a stirred solution of <b>77</b> (0.04 g, 0.24 mmol) in anhydrous DMF (1 mL) was added anhydrous K<sub>2</sub>CO<sub>3</sub> (36 mg, 0.26 mmol) and 4-methoxybenzyl chloride (34 μL, 0.25 mmol). The reaction mixture was stirred under N<sub>2</sub> at 65 °C for 18 h, and the solvent was removed under reduced pressure. The residual solid was redissolved in EtOAc (30 mL) and washed with brine (3 × 30 mL), and the combined organic fractions were dried (Na<sub>2</sub>SO<sub>4</sub>) and the solvent was removed under reduced pressure. Purification by chromatography (silica; 40% EtOAc:petrol) afforded <b>78</b> as a light-yellow solid (29 mg, 42%); <i>R</i><sub>f</sub> 0.21 (40% EtOAc:petrol); mp 105 °C; UV λ<sub>max</sub> (EtOH) 311 nm. IR (cm<sup>–1</sup>) 3431, 3312, 3198, 3022, 2940, 2798, 1571, 1513. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 3.71 (3H, s, OC<i>H</i><sub>3</sub>), 5.22 (2H, s, C<i>H</i><sub>2</sub>), 6.24 (2H, br s, N<i>H</i><sub>2</sub>), 6.48 (1H, s, H-5), 6.88 (2H, d, <i>J</i> = 8.7 Hz, H-2″ and H-6″), 7.23 (2H, d, <i>J</i> = 8.8 Hz, H-3″ and H-5″), 8.07 (1H, s, H-2). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 45.4 (Ar-CH<sub>2</sub>-Ar), 55.1 (OCH<sub>3</sub>), 103.8 (Ar-C), 114.0 (Ar-C), 124.4 (Ar-C), 128.7 (Ar-C), 129.2 (Ar-C), 133.9 (Ar-C), 140.5 (Ar-C), 146.6 (Ar-C), 157.4 (Ar-C), 158.7 (Ar-C). HRMS calcd for C<sub>14</sub>H<sub>14</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup> 289.0851, found 289.0855.</div></div><div id="sec5_1_7_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 7-(Cyclohexylmethoxy)-3-(4-methoxybenzyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-amine (<b>79</b>)</h4><div class="NLM_p last">Synthesized following general method C from <b>78</b> (0.172 g, 0.60 mmol). The product was isolated by chromatography (silica; 80% EtOAc:petrol) to furnish <b>79</b> as a colorless oil (0.16 g, 0.45 mmol, 75%); <i>R</i><sub>f</sub> 0.47 (20% EtOAc:petrol); UV λ<sub>max</sub> (EtOH) 271 nm. IR (cm<sup>–1</sup>) 3311, 2954, 2899, 2163, 1672, 1598, 1516. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.90–1.87 (11H, m, cyclohexyl), 3.71 (3H, s, OC<i>H</i><sub>3</sub>), 4.00 (2H, d, <i>J</i> = 6.7 Hz, OC<i>H</i><sub>2</sub>), 5.17 (2H, br s, N<i>H</i><sub>2</sub>), 5.24 (2H, s, C<i>H</i><sub>2</sub>), 5.90 (1H, s, H-5), 6.87 (2H, d, <i>J</i> = 8.7 Hz, H-2″ and H-6″), 7.20 (2H, d, <i>J</i> = 8.8 Hz, H-3″ and H-5″), 7.82 (1H, s, H-2). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.2 (CH<sub>2</sub>), 26.0 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 37.0 (CH), 45.0 (Ar-CH<sub>2</sub>), 55.1 (CH<sub>3</sub>), 73.3 (CH<sub>2</sub>), 87.5 (Ar-C), 113.9 (Ar-C), 118.2 (Ar-C), 128.7 (Ar-C), 129.7 (Ar-C), 137.9 (Ar-C), 147.4 (Ar-C), 157.8 (Ar-C), 158.5 (Ar-C), 158.6 (Ar-C). HRMS calcd for C<sub>21</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup> 367.2129, found 367.2132.</div></div><div id="sec5_1_7_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 7-(Cyclohexylmethoxy)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-amine (<b>80</b>)</h4><div class="NLM_p last">A solution of <b>79</b> (0.035 g, 0.10 mmol) in TFA (1 mL) was heated under reflux for 2 h, and the cooled solution was neutralized with saturated aqueous NaHCO<sub>3</sub> (25 mL). The reaction mixture was extracted with EtOAc (3 × 30 mL), and the combined organic fraction was dried (MgSO<sub>4</sub>) and evaporated under reduced pressure. Purification by chromatography (silica; 10% MeOH:DCM) to furnish <b>80</b> as a white solid (16.5 mg, 70%); mp 99–102 °C; UV λ<sub>max</sub> (EtOH) 293, 244 nm. IR (cm<sup>–1</sup>) 3447, 3323, 3187, 2923, 2850, 2795, 2026, 1591, 1527. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.03–2.00 (11H, m, cyclohexyl), 4.03 (2H, d, <i>J</i> = 6.1 Hz, OC<i>H</i><sub>2</sub>), 4.37 (2H, br s, N<i>H</i><sub>2</sub>), 5.91 (1H, s, H-5), 7.77 (1H, s, H-2), 9.89 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 25.7, 26.4, 29.8, 37.5, 74.4, 88.1, 157.3. HRMS calcd for C<sub>13</sub>H<sub>19</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 247.1553, found 247.1556.</div></div><div id="sec5_1_7_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 7-(Cyclohexylmethoxy)-5-iodo-3-(4-methoxybenzyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridine (<b>81</b>)</h4><div class="NLM_p last">A solution of <b>79</b> (0.112 g, 0.31 mmol) in THF (4 mL) containing diiodomethane (123 μL, 1.50 mmol), CuI (59 mg, 0.31 mmol), and isoamyl nitrite (187 μL, 0.92 mmol) was heated to reflux for 4 h, and the dark-brown solution was filtered (Celite) and extracted with EtOAc (2 × 20 mL). The combined organic fraction was washed sequentially with aqueous sodium thiosulfate solution (10%, 2 × 40 mL) and brine (40 mL) and dried (MgSO<sub>4</sub>), and the solvent was removed in vacuo. Purification by chromatography (silica; 30% EtOAc:petrol) afforded <b>81</b> as a yellow oil (64 mg, 44%); <i>R</i><sub>f</sub> 0.19 (30% EtOAc:petrol); UV λ<sub>max</sub> (EtOH) 262 nm. IR (cm<sup>–1</sup>) 3333, 2951, 2891, 2122, 1672, 1584, 1521. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.98–1.89 (11H, m, cyclohexyl), 3.71 (3H, s, OC<i>H</i><sub>3</sub>), 4.19 (2H, d, <i>J</i> = 6.5 Hz, OC<i>H</i><sub>2</sub>), 5.17 (2H, s, C<i>H</i><sub>2</sub>), 6.90 (2H, d, <i>J</i> = 8.7 Hz, H-2″ and H-6″), 7.18 (1H, s, H-5), 7.26 (2H, d, <i>J</i> = 8.8 Hz, H-3″ and H-5″), 8.31 (1H, s, H-2). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.1 (CH<sub>2</sub>), 25.9 (CH<sub>2</sub>), 28.9 (CH<sub>2</sub>), 37.0 (CH), 45.8 (Ar-CH<sub>2</sub>), 55.1 (CH<sub>3</sub>), 74.4 (CH<sub>2</sub>), 112.0 (Ar-C), 112.7 (Ar-C), 114.1 (Ar-C), 124.6 (Ar-C), 128.8 (Ar-C), 129.0 (Ar-C), 142.6 (Ar-C), 148.5 (Ar-C), 157.0 (Ar-C), 158.8 (Ar-C). HRMS calcd for C<sub>21</sub>H<sub>25</sub>IN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup> 478.0986, found 478.0980.</div></div><div id="sec5_1_7_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 4-((7-(Cyclohexylmethoxy)-3-(4-methoxybenzyl)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-yl) amino)benzenesulfonamide (<b>82</b>)</h4><div class="NLM_p last">To a solution of <b>81</b> (0.048 g, 0.10 mmol) in anhydrous MeCN (2 mL) was added sulfanilamide (19 mg, 0.11 mmol), anhydrous K<sub>2</sub>CO<sub>3</sub> (28 mg, 0.20 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (2.3 mg, 0.004 mmol), and XPhos (1.9 mg, 0.004 mmol). The reaction mixture was degassed under N<sub>2</sub> for 30 min and stirred at 80 °C for 2 h. The cooled solution was filtered (Celite) extracted with EtOAc (2 × 20 mL), and the combined organic extract was washed sequentially with aqueous HCl (1 M, 20 mL), saturated aqeuous NaHCO<sub>3</sub> (20 mL), and brine (30 mL), and dried (Na<sub>2</sub>SO<sub>4</sub>), and the volatiles were evaporated in vacuo. Purification by chromatography (silica; 70% EtOAc:petrol) yielded <b>82</b> as a white solid (23 mg, 43%); <i>R</i><sub>f</sub> 0.59 (70% EtOAc:petrol); mp 142 °C; UV λ<sub>max</sub> (EtOH) 257 nm. IR (cm<sup>–1</sup>) 3329, 2933, 2874, 2158, 1662, 1588, 1501. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 1.00–1.97 (11H, m, cyclohexyl), 3.79 (3H, s, OC<i>H</i><sub>3</sub>), 4.01 (2H, d, <i>J</i> = 6.1 Hz, OC<i>H</i><sub>2</sub>), 4.76 (2H, br s, N<i>H</i><sub>2</sub>), 5.28 (2H, s, C<i>H</i><sub>2</sub>), 6.17 (1H, s, H-5), 6.79 (1H, br s, N<i>H</i>), 6.88 (2H, d, <i>J</i> = 8.8 Hz, H-2″ and H-6″), 7.24 (2H, d, <i>J</i> = 8.7 Hz, H-3″ and H-5″), 7.61 (2H, <i>J</i> = 8.8 Hz, H-2′ and H-6′), 7.81 (2H, <i>J</i> = 8.8 Hz, H-3′ and H-5′), 8.11 (1H, s, H-2). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 25.7 (CH<sub>2</sub>), 26.4 (CH<sub>2</sub>), 29.8 (CH<sub>2</sub>), 37.6 (CH<sub>2</sub>), 46.9 (CH), 55.4 (CH<sub>2</sub>), 74.8 (OCH<sub>3</sub>), 90.7 (OCH<sub>2</sub>), 114.3 (Ar-C), 117.1 (Ar-C), 128.0 (Ar-C), 129.1 (Ar-C), 139.7 (Ar-C), 145.5 (Ar-C), 152.1 (Ar-C). HRMS calcd for C<sub>27</sub>H<sub>32</sub>N<sub>5</sub>O<sub>4</sub>S [M + H]<sup>+</sup> 522.2170, found 522.2166.</div></div><div id="sec5_1_7_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 4-((7-(Cyclohexylmethoxy)-3<i>H</i>-imidazo[4,5-<i>b</i>]pyridin-5-yl)amino) benzenesulfonamide (<b>83</b>)</h4><div class="NLM_p last">A solution of <b>82</b> (0.022 g, 0.042 mmol) in TFA (1 mL) was heated under reflux for 2 h, and the cooled solution was neutralized with saturated aqueous NaHCO<sub>3</sub> (25 mL). The reaction mixture was extracted with EtOAc (3 × 30 mL), and the combined organic fraction was dried (MgSO<sub>4</sub>) and evaporated under reduced pressure. The title compound was purified by preparative TLC on silica, using 5% MeOH:DCM as eluent, to afford <b>83</b> as a white solid (16.7 mg, 99%); <i>R</i><sub>f</sub> 0.25 (5% MeOH:DCM); mp 165–166 °C; UV λ<sub>max</sub> (EtOH) 324, 274 nm. IR (cm<sup>–1</sup>) 3332, 2925, 2852, 2164, 1677, 1583, 1500. <sup>1</sup>H NMR (500 MHz, MeOD-<i>d</i><sub>4</sub>) δ 1.07–2.05 (11H, m, cyclohexyl), 4.03 (2H, d, <i>J</i> = 6.2 Hz, OC<i>H</i><sub>2</sub>), 6.33 (1H, s, H-5), 7.77 (2H, d, <i>J</i> = 8.9 Hz, H-2′ and H-6′), 7.92 (2H, d, <i>J</i> = 8.8 Hz, H-3′ and H-5′), 7.96 (1H, s, H-2). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 26.9 (CH<sub>2</sub>), 27.6 (CH<sub>2</sub>), 30.8 (CH<sub>2</sub>), 38.9 (CH), 74.9 (CH<sub>2</sub>O), 90.9 (Ar-C), 117.9 (Ar-C), 128.2 (Ar-C). HRMS calcd for C<sub>19</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 522.2170, found 522.2166. HPLC: >98%, XSELECT column, retention time 5.47 min, reverse phase, H<sub>2</sub>O/MeCN/HCOOH gradient run, 1 mL min<sup>–1</sup>.</div></div><div id="sec5_1_7_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> 7-(Cyclohexylmethoxy)-3<i>H</i>-[1,2,3]triazolo[4,5-<i>d</i>]pyrimidin-5-amine (<b>86</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure C from <b>84</b> (1.50 g, 8.82 mmol). Precipitation from aqueous AcOH, and repeated washing with water gave <b>86</b> a pale-orange solid (1.52 g, 70%); mp 214–216 °C; UV λ<sub>max</sub> (EtOH) 285 nm. IR (cm<sup>–1</sup>) 3494, 3378, 2925, 2780, 2651, 2362, 2329, 2115, 2085, 2013, 1906, 1628, 1608, 1578, 1488. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.03–1.89 (11H, m, cyclohexyl), 4.30 (2H, d, <i>J</i> = 6.5 Hz, OC<i>H</i><sub>2</sub>), 6.91 (2H, br s, N<i>H</i><sub>2</sub>), 15.28 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.1 (CH<sub>2</sub>), 25.9 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 36.6 (CH), 71.2 (CH<sub>2</sub>), 162.2 (Ar-C). HRMS calcd for C<sub>11</sub>H<sub>17</sub>N<sub>6</sub>O [M + H]<sup>+</sup> 249.1458, found 249.1461.</div></div><div id="sec5_1_7_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 4-(Cyclohexylmethoxy)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-amine (<b>87</b>)</h4><div class="NLM_p last">Prepared according to the general procedure C from <b>85</b> (0.125 g, 0.74 mmol). Purification by chromatography (silica; 10% MeOH:DCM) gave <b>87</b> as an off white crystalline solid (68 mg, 37%); <i>R</i><sub>f</sub> 0.70 (10% MeOH:DCM), mp 193–195 °C; UV λ<sub>max</sub> (EtOH) 275 nm. IR (cm<sup>–1</sup>) 3498, 3353, 3232, 3121, 2960, 2921, 2851, 2750, 2667, 2158, 2038, 1902, 1794, 1633, 1578, 1497, 1469, 1441. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.98–1.82 (11H, m, cyclohexyl), 4.21 (2H, d, <i>J</i> = 6.5 Hz, OC<i>H</i><sub>2</sub>), 6.55 (2H, br s, N<i>H</i><sub>2</sub>), 7.77 (1H, s, CH), 12.78 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.2 (CH<sub>2</sub>), 26.0 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 36.7 (CH), 70.5 (CH<sub>2</sub>), 95.4 (Ar-C), 131.6 (Ar-C), 158.9 (Ar-C), 162.0 (Ar-C), 163.4 (Ar-C). HRMS calcd for C<sub>12</sub>H<sub>18</sub>N<sub>5</sub>O [M + H]<sup>+</sup> 248.1506, found 248.1508.</div></div><div id="sec5_1_7_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 5-Chloro-7-(cyclohexylmethoxy)-3<i>H</i>-[1,2,3]triazolo[4,5-<i>d</i>]pyrimidine (<b>88</b>)</h4><div class="NLM_p last">To a solution of LiCl (34 mg, 0.80 mmol) in DMA (0.5 mL) at 0 °C was added <b>86</b> (0.05 g, 0.20 mmol), followed by isoamyl nitrite (61 μL, 0.30 mmol) and SOCl<sub>2</sub> (16 μL, 0.22 mmol). The reaction mixture was stirred for 1 h and allowed to warm to ambient temperature over 18 h. After addition of saturated aqueous NaHCO<sub>3</sub> (15 mL), the reaction mixture was extracted with EtOAc (3 × 15 mL), and the combined organic layers were washed with brine (2 × 30 mL) and dried (Na<sub>2</sub>SO<sub>4</sub>). Evaporation of the solvent under reduced pressure furnished <b>88</b> as a brown oil (54 mg, > 99%), which was used directly without further purification.</div></div><div id="sec5_1_7_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 6-Chloro-4-(cyclohexylmethoxy)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine (<b>89</b>)</h4><div class="NLM_p last">To a solution of LiCl (69 mg,1.62 mmol) in DMA (1 mL) at 0 °C was added <b>87</b> (0.100 g, 0.40 mmol), followed by isoamyl nitrite (123 μL, 0.61 mmol) and SOCl<sub>2</sub> (32 μL, 0.45 mmol). The reaction mixture was stirred at room temperature for 18 h, cooled, and EtOAc (45 mL) was added. The resultant solution was washed sequentially with aqueous saturated NaHCO<sub>3</sub> solution (45 mL) and brine (2 × 45 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and the volatiles were evaporated under reduced pressure. The product was purified by chromatography (silica; 5% MeOH:DCM) to give <b>89</b> as a yellow solid (65 mg, 60%); <i>R</i><sub>f</sub> 0.32 (5% MeOH:DCM), mp 152–153 °C; UV λ<sub>max</sub> (EtOH) 252 nm. IR (cm<sup>–1</sup>) 3148, 2922, 2851, 1677, 1579, 1443. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 0.96–1.95 (11H, m, cyclohexyl), 4.39 (2H, d, <i>J</i> = 6.0 Hz, OC<i>H</i><sub>2</sub>), 8.09 (1H, s, C<i>H</i>), 11.19 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.2 (CH<sub>2</sub>), 26.0 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 36.7 (CH), 70.5 (CH<sub>2</sub>O), 95.4 (Ar-C), 131.6 (C<sup>1</sup>-H), 158.9 (Ar-C), 162.0 (Ar-C), 163.4 (Ar-C). HRMS calcd for C<sub>12</sub>H<sub>16</sub>ClN<sub>4</sub>O [M + H]<sup>+</sup> 267.1007, found 267.1012.</div></div><div id="sec5_1_7_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 4-((7-(Cyclohexylmethoxy)-3<i>H</i>-[1,2,3]triazolo[4,5-<i>d</i>]pyrimidin-5-yl)amino) benzenesulfonamide (<b>90</b>)</h4><div class="NLM_p last">The title compound was prepared following general procedure A from <b>88</b> (0.054 g, 0.20 mmol) and isolated by chromatography (silica; 30% EtOAc:petrol) to give the title compound <b>90</b> as a white solid (28 mg, 35%); <i>R</i><sub>f</sub> 0.18 (70% EtOAc:petrol); mp 217–219 °C; UV λ<sub>max</sub> (EtOH) 310 nm. IR (cm<sup>–1</sup>) 3254, 3121, 2924, 2851, 2363, 2342, 2199, 2140, 1992, 19118, 1700, 1582, 1534, 1492, 1447. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.04–1.92 (11H, m, cyclohexyl), 4.36 (2H, d, <i>J</i> = 6.8 Hz, OC<i>H</i><sub>2</sub>), 7.18 (2H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.72 (2H, d, <i>J</i> = 8.8 Hz, H-2′ and H-6′), 7.99 (2H, d, <i>J</i> = 9.0 Hz, H-3′ and H-5′), 9.92 (1H, br s, N<i>H</i>) 13.34 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.1 (CH<sub>2</sub>), 29.1 (CH<sub>2</sub>), 35.9 (CH), 118.0 (Ar-C), 126.4 (Ar-C). HRMS calcd for C<sub>17</sub>H<sub>22</sub>N<sub>7</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 404.1499, found 404.1500. HPLC: >99.5%, XTerra column, retention time 11.64 min, reverse phase, H<sub>2</sub>O/MeCN/HCOOH gradient run, 1 mL min<sup>–1</sup>.</div></div><div id="sec5_1_7_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 4-((4-(Cyclohexylmethoxy)-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)amino)benzenesulfonamide (<b>91</b>)</h4><div class="NLM_p last">The title compound was prepared by general procedure A from <b>89</b> (0.042 g, 0.18 mmol). Chromatography (silica; 70% EtOAc:petrol) afforded <b>91</b> as a white solid (20 mg, 28%); <i>R</i><sub>f</sub> 0.21 (70% EtOAc:petrol), mp 268–269 °C; UV λ<sub>max</sub> (EtOH) 304 nm. IR (cm<sup>–1</sup>) 3367, 3333, 3269, 2922, 2853, 2162, 2012, 1691, 1658, 1624, 1583, 1551, 1524. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.04–1.92 (11H, m, cyclohexyl), 4.36 (2H, d, <i>J</i> = 6.8 Hz, OC<i>H</i><sub>2</sub>), 7.18 (2H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.72 (2H, d, <i>J</i> = 8.8 Hz, H-2′ and H-6′), 7.98 (1H, br s, C<i>H</i>), 7.99 (2H, d, <i>J</i> = 9.0 Hz, H-3′ and H-5′), 9.92 (1H, br s, N<i>H</i>) 13.34 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.4 (CH<sub>2</sub>), 26.5 (CH<sub>2</sub>), 29.5 (CH<sub>2</sub>), 37.1 (CH), 71.5 (CH<sub>2</sub>) 118.6 (Ar-C), 136.6 (Ar-C), 144.0 (Ar-C). HRMS calcd for C<sub>18</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 403.1547, found 403.1547. HPLC: >98.5%, XTerra column, retention time 11.92 min, reverse phase, H<sub>2</sub>O/MeCN/HCOOH gradient run, 1 mL min<sup>–1</sup>.</div></div><div id="sec5_1_7_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 4-(Cyclohexylmethoxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>93</b>)</h4><div class="NLM_p last">Prepared in accordance with general method C from <b>92</b> (0.15 g, 0.89 mmol), with heating under microwave irradiation (170 °C, 5 h). The product was isolated by chromatography (silica; 10% MeOH:DCM) to yield <b>93</b> as a white crystalline solid (37 mg, 17%); <i>R</i><sub>f</sub> 0.55 (10% MeOH:DCM); mp 216.3-217.3 °C; UV λ<sub>max</sub> (EtOH) 221 nm. IR (cm<sup>–1</sup>) 3494, 3362, 3117, 2922, 2851, 2164, 2045, 1968, 1617, 1585, 1499, 1478. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.98–1.83 (11H, m, cyclohexyl), 4.15 (2H, d, <i>J</i> = 6.5, OC<i>H</i><sub>2</sub>), 5.91 (2H, br s, N<i>H</i><sub>2</sub>), 6.17 (1H, dd, <i>J</i> = 1.9 and 3.5, C<i>H</i>), 6.79 (1H, dd, <i>J</i> = 2.2 and 3.5, HNC<i>H</i>), 10.97 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.2 (CH<sub>2</sub>), 26.0 (CH<sub>2</sub>), 29.3 (CH<sub>2</sub>), 36.8 (CH), 69.9 (CH<sub>2</sub>O), 96.9 (C<sup>1</sup>-H), 97.9 (Ar-C), 119.1 (C<sup>2</sup>-H), 155.0 (Ar-C), 159.3 (Ar-C), 162.7 (Ar-C). HRMS calcd for C<sub>13</sub>H<sub>19</sub>N<sub>4</sub>O [M + H]<sup>+</sup> 247.1553, found 247.1556.</div></div><div id="sec5_1_7_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 4-Chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>94</b>)</h4><div class="NLM_p last">NaH (60% in mineral oil, 26 mg, 0.65 mmol) was added dropwise to a solution of <b>92</b> (0.10 g, 0.59 mmol) in anhydrous MeCN (3 mL) at −30 °C, and the reaction mixture was stirred for 45 min. 2-(Trimethylsilyl)ethoxymethyl chloride (90%, 122 μL, 0.62 mmol) was added dropwise, and the reaction mixture was stirred for a further 3 h at room temperature. After cooling and addition of water (20 mL), the resultant solution was extracted with EtOAc (20 mL), and the combined organic fractions were washed with brine (3 × 20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and the solvent was removed in vacuo. Purification by chromatography (silica; 15% EtOAc:petrol) gave <b>94</b> as a yellow solid (130 mg, 74%); <i>R</i><sub>f</sub> 0.41 (15% EtOAc:petrol); mp 63–64 °C; UV λ<sub>max</sub> (EtOH) 317, 234 nm. IR (cm<sup>–1</sup>) 3423, 3318, 3212, 3096, 2952, 1631, 1608, 1546, 1493. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ −0.04 (9H, s, (C<i>H</i><sub>3</sub>)<sub>3</sub>), 0.91 (2H, t, <i>J</i> = 8.0 Hz, OCH<sub>2</sub>C<i>H</i><sub>2</sub>Si), 3.81 (2H, t, <i>J</i> = 8.3 Hz, OC<i>H</i><sub>2</sub>CH<sub>2</sub>Si), 4.96 (2H, br s, N<i>H</i><sub>2</sub>), 5.44 (2H, s, C<i>H</i><sub>2</sub>), 6.43 (1H, d, <i>J</i> = 3.7 Hz, C<i>H</i>), 6.99 (1H, d, <i>J</i> = 3.7 Hz, NC<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.0 (Si(CH<sub>3</sub>)<sub>3</sub>), 19.2 (CH<sub>2</sub><i>C</i>H<sub>2</sub>Si), 67.7 (O<i>C</i>H<sub>2</sub>CH<sub>2</sub>), 74.3 (NCH<sub>2</sub>O), 102.2 (C<sup>5</sup>H), 112.2 (Ar-C), 127.0 (C<sup>6</sup>H), 154.2 (Ar-C), 155.6 (Ar-C), 160.2 (Ar-C). HRMS calcd for C<sub>12</sub>H<sub>20</sub>ClN<sub>4</sub>OSi [M + H]<sup>+</sup> 299.1089, found 299.1090.</div></div><div id="sec5_1_7_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 4-(Cyclohexylmethoxy)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-amine (<b>95</b>)</h4><div class="NLM_p last">Synthesized following general procedure C from <b>94</b> (0.30 g, 1.01 mmol), except using THF as solvent. The title compound was isolated by chromatography (silica; 15% EtOAc:petrol) to furnish <b>95</b> as a yellow solid (296 mg, 78%); <i>R</i><sub>f</sub> 0.17 (15% EtOAc:petrol); mp 88–90 °C; UV λ<sub>max</sub> (EtOH) 286, 260, 223 nm. IR (cm<sup>–1</sup>) 3346, 3222, 2926, 2852, 1647, 1602. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ −0.05 (9H, s, (C<i>H</i><sub>3</sub>)<sub>3</sub>), 0.91 (2H, t, <i>J</i> = 8.3 Hz, OCH<sub>2</sub>C<i>H</i><sub>2</sub>Si), 1.01–1.91 (11H, m cyclohexyl), 3.51 (2H, t, <i>J</i> = 8.3 Hz, OC<i>H</i><sub>2</sub>CH<sub>2</sub>Si), 4.21 (2H, d, <i>J</i> = 6.5 Hz, OC<i>H</i><sub>2</sub>), 4.68 (2H, br s, N<i>H</i><sub>2</sub>), 5.41 (2H, s, C<i>H</i><sub>2</sub>), 6.40 (1H, d, <i>J</i> = 3.7 Hz, C<i>H</i>), 6.82 (1H, d, <i>J</i> = 3.7 Hz, NC<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.0 (Si(CH<sub>3</sub>)<sub>3</sub>), 19.2 (CH<sub>2</sub><i>C</i>H<sub>2</sub>Si), 27.2 (CH<sub>2</sub>), 28.0 (CH<sub>2</sub>), 31.3 (CH<sub>2</sub>), 38.8 (CH), 67.4 (O<i>C</i>H<sub>2</sub>CH<sub>2</sub>), 72.6 (CH<sub>2</sub>), 74.1 (NCH<sub>2</sub>O), 101.2 (C<sup>5</sup>H), 123.6 (C<sup>6</sup>H), 160.6 (Ar-C), 165.4 (Ar-C). HRMS calcd for C<sub>19</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub>Si [M + H]<sup>+</sup> 377.2367, found 377.2367.</div></div><div id="sec5_1_7_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 2-Chloro-4-(cyclohexylmethoxy)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>96</b>)</h4><div class="NLM_p last">To a solution of LiCl in THF (0.5 M, 2.13 mL, 1.1 mmol) was added <b>95</b> (0.10 g, 0.27 mmol), and the reaction mixture was cooled to 0 °C. Isoamyl nitrite (81 μL, 0.40 mmol) and SOCl<sub>2</sub> (21.3 μL, 0.29 mmol) were added, and the solution was stirred at room temperature for 5 h. The reaction mixture was added to a solution of aqueous NH<sub>4</sub>Cl (2 M, 30 mL), extracted with EtOAc (2 × 30 mL), and the combined organic layers were washed with water (3 × 30 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and evaporated in vacuo. Purification by chromatography (silica; 15% EtOAc:petrol) gave <b>96</b> as a clear oil (60 mg, 56%); <i>R</i><sub>f</sub> 0.45 (15% EtOAc:petrol); UV λ<sub>max</sub> (EtOH) 270 nm. IR (cm<sup>–1</sup>) 2924, 2852, 1750, 1661, 1588, 1558, 1506. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ −0.09 (9H, s, (CH<sub>3</sub>)<sub>3</sub>), 0.82 (2H, t, <i>J</i> = 8.1 Hz, OCH<sub>2</sub>C<i>H</i><sub>2</sub>Si), 0.95–1.89 (11H, m cyclohexyl), 3.50 (2H, t, <i>J</i> = 8.1 Hz, OC<i>H</i><sub>2</sub>CH<sub>2</sub>Si), 4.28 (2H, d, <i>J</i> = 6.0 Hz, OC<i>H</i><sub>2</sub>), 5.52 (2H, s, CH<sub>2</sub>), 6.61 (1H, d, <i>J</i> = 3.6 Hz, C<i>H</i>), 7.55 (1H, d, <i>J</i> = 3.5 Hz, NC<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 0.0 (Si(CH<sub>3</sub>)<sub>3</sub>), 18.5 (CH<sub>2</sub><i>C</i>H<sub>2</sub>Si), 26.6 (CH<sub>2</sub>), 30.5 (CH<sub>2</sub>) 31.8 (CH<sub>2</sub>), 38.8 (CH), 67.1 (O<i>C</i>H<sub>2</sub>CH<sub>2</sub>), 73.3 (CH<sub>2</sub>), 74.2 (NCH<sub>2</sub>O), 100.4 (C<sup>5</sup>H), 126.4 (C<sup>6</sup>H), 129.7 (Ar-C). HRMS calcd for C<sub>19</sub>H<sub>31</sub>ClN<sub>3</sub>O<sub>2</sub>Si [M + H]<sup>+</sup> 396.1869, found 396.1872.</div></div><div id="sec5_1_7_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> 4-((4-(Cyclohexylmethoxy)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)benzenesulfonamide (<b>97</b>)</h4><div class="NLM_p last">To a degassed solution of <b>96</b> (0.050 g, 0.13 mmol) in MeCN (2 mL) was added sulfanilamide (24 mg, 0.14 mmol), anhydrous K<sub>2</sub>CO<sub>3</sub> (35 mg, 0.25 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (3 mg, 5.0 × 10<sup>–3</sup> mmol), and XPhos (2.4 mg, 5.0 × 10<sup>–3</sup> mmol), and the reaction mixture was stirred under N<sub>2</sub> at 80 °C for 2 h. The cooled mixture was filtered (Celite), diluted with EtOAc (20 mL), and washed sequentially with aqueous HCl solution (1 M, 20 mL), saturated aqueous NaHCO<sub>3</sub> solution (20 mL), and brine (30 mL). After drying (Na<sub>2</sub>SO<sub>4</sub>), volatiles were removed under reduced pressure and the product was isolated by chromatography (silica; 50% EtOAc:petrol) to give <b>97</b> as a yellow oil (33 mg, 49%); <i>R</i><sub>f</sub> 0.63 (50% EtOAc:petrol); UV λ<sub>max</sub> (EtOH) 269 nm. IR (cm<sup>–1</sup>) 3644, 3342, 2924, 2853, 1586, 1528, 1488. <sup>1</sup>H NMR (500 MHz,CDCl<sub>3</sub>) δ −0.08 (9H, s, Si(CH<sub>3</sub>)<sub>3</sub>), 0.88–0.95 (2H, t, <i>J</i> = 8.36 Hz, OCH<sub>2</sub>C<i>H</i><sub>2</sub>Si) 1.04–1.93 (11H, m, cyclohexyl), 3.56 (2H, t, <i>J</i> = 3.4 Hz, OC<i>H</i><sub>2</sub>CH<sub>2</sub>Si) 4.29 (2H, d, <i>J</i> = 6.5 Hz, OC<i>H</i><sub>2</sub>), 4.72 (2H, br s, N<i>H</i><sub>2</sub>), 5.52 (2H, s, C<i>H</i><sub>2</sub>), 6.49 (1H, d, <i>J</i> = 3.5 Hz, C<i>H</i>), 6.96 (1H, d, <i>J</i> = 3.6 Hz, NC<i>H</i>), 7.20 (1H, br s, NH), 7.87 (4H, ap s, H-2′, H-3′, H-5′ and H-6′). <sup>13</sup>C NMR (125 MHz, CDCl<sub>3</sub>) δ 0.0 (SiCH<sub>3</sub>), 15.6 (CH<sub>2</sub>Si), 27.2 (CH<sub>2</sub>), 27.9 (CH<sub>2</sub>), 31.3 (CH<sub>2</sub>), 38.8 (CH), 67.8 (CH<sub>2</sub>), 73.2 (CH<sub>2</sub>), 74.5 (CH<sub>2</sub>), 101.5 (Ar-C), 101.9 (Ar-C), 118.8 (Ar-C), 125.0 (Ar-C), 129.3 (Ar-C), 146.2 (Ar-C). HRMS calcd for C<sub>25</sub>H<sub>38</sub>N<sub>5</sub>O<sub>4</sub>SSi [M + H]<sup>+</sup> 532.2408, found 532.2406. Note: Not all carbons are visible.</div></div><div id="sec5_1_7_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> 4-((4-(Cyclohexylmethoxy)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-2-yl)amino)benzenesulfonamide (<b>98</b>)</h4><div class="NLM_p last">A solution of <b>97</b> (0.040 g, 7.5 × 10<sup>–2</sup> mmol) in TFA (1.5 mL) was heated under reflux for 10 min, and the cooled solution was neutralized with saturated aqueous NaHCO<sub>3</sub> solution. The aqueous solution was extracted with EtOAc (2 × 30 mL), and the solvent was evaporated under reduced pressure. The residual yellow solid was redissolved in MeCN:H<sub>2</sub>O (1:1, 8 mL), the pH of the solution was adjusted to 10 with dilute aqueous ammonia (28%), and the solution was stirred for 1 h at room temperature and evaporated in vacuo. Isolation by chromatography (silica; 70% EtOAc:petrol) to give <b>98</b> as a white solid (12 mg, 40%); <i>R</i><sub>f</sub> 0.39 (70% EtOAc:petrol); mp 251.2–252.0 °C; UV λ<sub>max</sub> (EtOH) 312 nm. IR (cm<sup>–1</sup>) 3374, 3322, 2058, 2924, 2856, 2012, 1615, 1595, 1579. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.07–1.95 (11H, m, cyclohexyl), 4.31 (2H, d, <i>J</i> = 6.3 Hz, OC<i>H</i><sub>2</sub>), 6.34 (1H, dd, <i>J</i> = 2.1 and 2.1 Hz, C<i>H</i>), 7.05 (1H, dd, <i>J</i> = 2.2 and 2.2 Hz, HNC<i>H</i>), 7.13 (2H, br s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.68 (2H, d, <i>J</i> = 8.9 Hz, H-2′ and H-6′) 7.99 (2H, d, <i>J</i> = 8.8 Hz, H-3′ and H-5′), 9.57 (1H, br s, N<i>H</i>), 11.54 (1H, br s, N<i>H</i>). <sup>13</sup>C NMR (125 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.2 (CH<sub>2</sub>), 26.0 (CH<sub>2</sub>), 29.3 (CH<sub>2</sub>), 36.8 (CH), 70.6 (CH<sub>2</sub>), 98.2 (C<sup>5</sup>H), 116.9 (Ar-C), 126.4 (C<sup>6</sup>H), 134.9 (Ar-C), 144.6 (Ar-C), 146.4 (Ar-C), 153.6 (Ar-C), 154.4 (Ar-C), 162.4 (Ar-C). HRMS calcd for C<sub>19</sub>H<sub>24</sub>N<sub>5</sub>O<sub>3</sub>S [M + H]<sup>+</sup> 402.1594, found 402.1596. HPLC: >99.5%, XSELECT column, retention time 8.45 min, reverse phase, H<sub>2</sub>O/MeCN/HCOOH gradient run, 1 mL min<sup>–1</sup>.</div></div><div id="sec5_1_7_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> 7-Chloro-5-cyclohexylmethoxyimidazo[1,2-<i>a</i>]pyrimidine (<b>100</b>)</h4><div class="NLM_p last">Synthesized in accordance with general procedure C from <b>99</b> (1.0 g, 5.4 mmol). The product was purified by precipitation with glacial acetic acid, and repeated washing with water, to afford <b>100</b> as a pale-orange powder (1.16 g, 81%); <i>R</i><sub>f</sub> 0.23 (60% EtOAc:petrol). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05–1.95 (11H, m, cyclohexyl), 4.30 (2H, d, <i>J</i> = 6.1 Hz, OC<i>H</i><sub>2</sub>), 6.63 (1H, s, H-6), 7.63 (2H, d, <i>J</i> = 1.2 Hz, H-3), 7.81 (2H, d, <i>J</i> = 1.3 Hz, H-2). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.4, 26.2, 29.0, 36.9, 76.3, 88.8, 107.6, 134.2, 148.1, 152.1, 155.6. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 266.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_1_7_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 5-Cyclohexylmethoxy-7-anilinoimidazo[1,2-<i>a</i>]pyrimidine (<b>101</b>)</h4><div class="NLM_p last">The title compound was synthesized according to general procedure A from <b>100</b> (0.075 mg, 0.28 mmol). Purification by chromatography (silica; EtOAc), followed by crystallization from MeOH, gave <b>101</b> (31 mg, 34%); <i>R</i><sub>f</sub> 0.11 (100% EtOAc); mp 252–253 °C; UV λ<sub>max</sub> (EtOH) 305, 257, 212 nm. IR (cm<sup>–1</sup>) 3153, 2926, 2847, 2161, 1627, 1595, 1568, 1531, 1489, 1291, 1259, 1122. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.05–1.85 (11H, m, cyclohexyl), 4.35 (2H, d, <i>J</i> = 6.2 Hz, OC<i>H</i><sub>2</sub>), 5.98 (1H, s, H-6), 6.99 (1H, t, <i>J</i> = 7.3 Hz, Ph<i>H</i>), 7.26 (1H, d, <i>J</i> = 1.6 Hz, H-3), 7.33 (2H, dd, <i>J</i> = 7.6, 8.2 Hz, 2 × Ph<i>H</i>), 7.44 (1H, d, <i>J</i> = 1.6 Hz, H-2), 7.83 (2H, d, <i>J</i> = 7.7 Hz, 2 × Ph<i>H</i>), 9.45 (1H, s, N<i>H</i>). LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 323.0 [M + H]<sup>+</sup>. Anal. Found: C, 70.41; H, 6.59; N, 17.40. C<sub>19</sub>H<sub>22</sub>N<sub>4</sub>O requires C, 70.78; H, 6.88; N, 17.38%.</div></div><div id="sec5_1_7_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> 5-Cyclohexylmethoxy-7-(4′-sulfamoylanilino)imidazo[1,2-<i>a</i>]pyrimidine (<b>102</b>)</h4><div class="NLM_p last">Prepared in accordance with general procedure A from <b>100</b> (0.25 g, 0.94 mmol), and purified by chromatography (silica; 5% MeOH:EtOAc) to give <b>102</b> as a colorless solid (28 mg, 7%); <i>R</i><sub>f</sub> 0.47 (10% MeOH:EtOAc); mp 228–229 °C. IR (cm<sup>–1</sup>) 3348, 3292, 2926, 2847, 1653, 1617, 1591, 1536, 1429, 1310, 1155. UV λ<sub>max</sub> (EtOH) 315, 266, 216 nm. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.15–1.90 (11H, m, cyclohexyl), 4.16 (2H, d, <i>J</i> = 6.1 Hz, OC<i>H</i><sub>2</sub>), 6.03 (1H, s, H-6), 7.24 (2H, s, SO<sub>2</sub>N<i>H</i><sub>2</sub>), 7.32 (1H, d, <i>J</i> = 1.6 Hz, H-3), 7.51 (1H, d, <i>J</i> = 1.6 Hz, H-2), 7.78 (2H, d, <i>J</i> = 8.9 Hz, H-2′ and H-6′), 7.99 (2H, d, <i>J</i> = 8.9 Hz, H-3′ and H-5′), 9.85 (1H, s, N<i>H</i>). <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ 25.45, 26.19, 29.16, 36.85, 75.00, 78.91, 105.83, 118.42, 127.05, 131.95, 137.03, 144.01, 154.73, 155.68. LRMS (ES<sup>+</sup>) <i>m</i>/<i>z</i> 402.0 [M + H]<sup>+</sup>; Anal. Found: C, 57.06; H, 5.53; N, 17.09. C<sub>19</sub>H<sub>23</sub>N<sub>5</sub>O<sub>3</sub>S requires: C, 56.84; H, 5.77; N, 17.44%.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Protein Kinase Assays</h3><div class="NLM_p last">Human CDK1/B was purchased from New England Biolabs or prepared as described,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> CDK2/A2 was prepared as described,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> CDK4/D was provided by AstraZeneca, and CDK7/H and CDK9/T were purchased from Upstate. IC<sub>50</sub> values for CDK1/B, CDK2/A, and CDK4/D were determined as described.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> IC<sub>50</sub> values for CDK7/H and CDK9/H were determined according to the supplier’s instructions (Upstate). CDK1/B, CDK2/A, and CDK4/D were assayed at an ATP concentration of 12.5 μM, CDK7/H and CDK9/T at an ATP concentration of 100 μM. Published <i>K</i><sub>m</sub>(ATP) values for CDK1-cyclin B, CDK2-cyclin A, CDK4-cyclin D2, CDK7-cyclin H-MAT, and CDK9-cyclin T are 0.8, 0.58, 3.8, 4.1, and 0.7 μM, respectively (<a href="http://www.proqinase.com" class="extLink">www.proqinase.com</a>).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Growth Inhibition Assays</h3><div class="NLM_p last">The ability of selected compounds to inhibit cell growth was assessed in a panel of human cancer cell lines using an SRB assay.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Briefly, cells in 96-well plates were exposed to inhibitor (0.1–30 μM, three replicates per drug concentration) or 0.5% (v/v) DMSO (for compound <b>73</b> treatments) or 0.1% (v/v) DMSO (for all other inhibitors) for 120 h, stained with sulforhodamine B and the absorbance at 570 nm measured (SpectraMax250; Molecular Devices, Wokingham, UK). At least three independent experiments were performed. Growth inhibitory GI<sub>50</sub> values were calculated using GraphPad Prism software (GraphPad Software, Inc., San Diego, CA).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> Crystallization and Structure Determination</h3><div class="NLM_p">Crystals of CDK2-cyclin A bound to <b>73</b> and CDK1-cyclin B-CKS2 bound to <b>3</b> were grown as previously described.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Briefly, the inhibitors were added in 2-fold molar excess (which was also a 10-fold higher concentration than the inhibitor IC<sub>50</sub>) to a low concentration solution of the appropriate protein complex and then the samples were concentrated to 10–12 mg mL<sup>–1</sup> for crystallization. CDK2-cyclin A–<b>73</b> crystals were grown from a well solution containing 0.6–0.8 M KCl, 0.9–1.2 M (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub>, and 100 mM HEPES (pH 7.0). CDK1-cyclin B-CKS2 was cocrystallized with <b>3</b> from a screen covering the conditions 0.1 M MES/imidazole buffer (pH 6.7), 6.5% MPD, 5% PEG4K, 10% PEG1K. Before data collection, crystals were cryoprotected by brief immersion in either 8 M sodium formate (CDK2-cyclin A) or 25% ethylene glycol (CDK1-cyclin B-CKS2).</div><div class="NLM_p last">Data processing was carried out using XDS, MOSFLM, POINTLESS/AIMLESS,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and other programs of the CCP4 suite,<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> run through the CCP4i2 GUI.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The structures of the different complexes were solved by molecular replacement using Phaser,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and search models drawn from PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QMZ">1QMZ</a> (cyclin A-bound CDK2) and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y72">4Y72</a> (CDK1-cyclin B-CKS2). Models of <b>73</b> and <b>3</b> and ligand restraints were generated using ACEDRG within the CCP4i2 suite,<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and built into the electron density using Coot.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Structures were refined using REFMAC,<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> interspersed with manual rebuilding in Coot, including TLS refinement.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i111"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01254">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.6b01254" class="ext-link">10.1021/acs.jmedchem.6b01254</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Structure of compound <b>102</b> and associated crystal data and refinement statistics; <sup>1</sup>H NMR spectra for compounds <b>70</b>, <b>73</b>, <b>83</b>, <b>90</b>, <b>91</b>, and <b>98</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_001.pdf">jm6b01254_si_001.pdf (3.61 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_002.csv">jm6b01254_si_002.csv (5.4 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">CDK2-cyclin A in complex with compound <b>73</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQE">5LQE</a>), and CDK1-cyclin B-CKS2 in complex with compound <b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQF">5LQF</a>) have been deposited with the PDB and the atomic coordinates and experimental data will be released upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.6b01254" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27273" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27273" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane A. Endicott</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, U.K.</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f99398979cd79c979d909a968d8db9979a95d7989ad78c92"><span class="__cf_email__" data-cfemail="a5cfc4cbc08bc0cbc1ccc6cad1d1e5cbc6c98bc4c68bd0ce">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Céline Cano</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2032-2272" title="Orcid link">http://orcid.org/0000-0002-2032-2272</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#553630393c3b307b36343b3a153b36397b34367b203e"><span class="__cf_email__" data-cfemail="395a5c5550575c175a58575679575a5517585a174c52">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher R. Coxon</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth Anscombe</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzannah J. Harnor</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1646-593X" title="Orcid link">http://orcid.org/0000-0003-1646-593X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathew P. Martin</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, Newcastle University Medical School, Paul O’Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benoit Carbain</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bernard T. Golding</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian R. Hardcastle</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lisa K. Harlow</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Svitlana Korolchuk</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, Newcastle University Medical School, Paul O’Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Matheson</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David R. Newell</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, Newcastle University Medical School, Paul O’Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin E. M. Noble</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, University of Oxford, South Parks Road, Oxford, OX1 3QU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mangaleswaran Sivaprakasam</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Susan J. Tudhope</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, Newcastle University Medical School, Paul O’Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David M. Turner</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lan Z. Wang</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, Newcastle University Medical School, Paul O’Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen R. Wedge</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, Newcastle University Medical School, Paul O’Gorman Building, Framlington Place, Newcastle upon Tyne, NE2 4HH, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Wong</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger J. Griffin</span> - <span class="hlFld-Affiliation affiliation">Newcastle
Cancer Centre, Northern Institute for Cancer Research, School of Chemistry, Newcastle University, Bedson Building, Newcastle
upon Tyne NE1 7RU, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.R.C. and E.A. contributed equally to the work described in this paper. C.R.C., synthesis and characterization of compounds; E.A., protein expression, crytallization, and structure determination; S.J.H., synthesis and characterization of compounds and manuscript preparation; M.P.M., protein structure determination and interpretation; Benoit Carbain, synthesis and characterization of compounds; I.R.H., experimental design and interpretation; L.K.H., synthesis and characterization of compounds; S.K., protein expression and crystallization; C.J.M., synthesis and characterization of compounds; M.E.M.N., protein structure determination, data analysis and interpretation, and manuscript preparation; D.R.N., project conception, experimental design and interpretation; D.M.T., synthesis and characterization of compounds; M.S., synthesis and characterization of compounds; S.J.T., design, conduct, and interpretation of the cellular studies; L.Z.W., design, conduct, and interpretation of CDK2 inhibition experiments; C.W., synthesis and characterization of compounds; S.R.W., experimental design and interpretation and manuscript preparation; B.T.G., project conception, experimental design and interpretation, data analysis, and manuscript preparation; R.J.G., project conception, experimental design and interpretation, data analysis, and manuscript preparation; J.A.E., experimental design and interpretation and manuscript preparation; C.C., project conception, experimental design and interpretation, data analysis, and manuscript preparation.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><sup>#</sup>R.J.G.: Deceased 24 September 2014.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e11779-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i117">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54324" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54324" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Cancer Research UK (grant no. C2115/A21421) and the Medical Research Council (grant no. G0901526) for financial support. The use of the EPSRC Mass Spectrometry Service at the University of Wales (Swansea) is also gratefully acknowledged. We also thank beamline staff at The Diamond Light Source who provided excellent facilities for data collection, E. Lowe and A. Basle for assistance with data collection and management, N. Brown for advice, and I. Taylor for technical support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i118" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i118"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i119" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i119"> Abbreviations Used</h2><tr><td class="NLM_term">CDK</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase</p></td></tr><tr><td class="NLM_term">CKS</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase subunit</p></td></tr><tr><td class="NLM_term">GI50</td><td class="NLM_def"><p class="first last">half-maximum growth inhibition</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid</p></td></tr><tr><td class="NLM_term">MES</td><td class="NLM_def"><p class="first last">2-morpholin-4-ylethanesulfonic acid</p></td></tr><tr><td class="NLM_term">MPD</td><td class="NLM_def"><p class="first last">2-methyl-2,4-pentanediol</p></td></tr><tr><td class="NLM_term">SRB</td><td class="NLM_def"><p class="first last">sulforhodamine B</p></td></tr><tr><td class="NLM_term">TFE</td><td class="NLM_def"><p class="first last">2,2,2-trifluoroethanol</p></td></tr><tr><td class="NLM_term">TLS</td><td class="NLM_def"><p class="first last">translation, libration, and screw-rotation</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i120">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdks, Cyclins and CKIs: Roles Beyond Cell Cycle Regulation</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">3079</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span><span class="refDoi"> DOI: 10.1242/dev.091744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1242%2Fdev.091744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=23861057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGktL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=3079-3093&author=S.+Limauthor=P.+Kaldis&title=Cdks%2C+Cyclins+and+CKIs%3A+Roles+Beyond+Cell+Cycle+Regulation&doi=10.1242%2Fdev.091744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cdks, cyclins and CKIs: roles beyond cell cycle regulation</span></div><div class="casAuthors">Lim, Shuhui; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3079-3093</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (Cdks) are serine/threonine kinases and their catalytic activities are modulated by interactions with cyclins and Cdk inhibitors (CKIs).  Close cooperation between this trio is necessary for ensuring orderly progression through the cell cycle.  In addn. to their well-established function in cell cycle control, it is becoming increasingly apparent that mammalian Cdks, cyclins and CKIs play indispensable roles in processes such as transcription, epigenetic regulation, metab., stem cell self-renewal, neuronal functions and spermatogenesis.  Even more remarkably, they can accomplish some of these tasks individually, without the need for Cdk/cyclin complex formation or kinase activity.  In this Review, we discuss the latest revelations about Cdks, cyclins and CKIs with the goal of showcasing their functional diversity beyond cell cycle regulation and their impact on development and disease in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp5LNcD6NywLVg90H21EOLACvtfcHk0lhauXtwc6VdsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGktL%252FF&md5=8095fc798a0e7efeab60d36ee414596f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1242%2Fdev.091744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.091744%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdks%252C%2520Cyclins%2520and%2520CKIs%253A%2520Roles%2520Beyond%2520Cell%2520Cycle%2520Regulation%26jtitle%3DDevelopment%26date%3D2013%26volume%3D140%26spage%3D3079%26epage%3D3093%26doi%3D10.1242%2Fdev.091744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Malumbres, M.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinases</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1186/gb4184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1186%2Fgb4184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25180339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FnsVehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=122-132&author=M.+Malumbres&title=Cyclin-Dependent+Kinases&doi=10.1186%2Fgb4184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases</span></div><div class="casAuthors">Malumbres Marcos</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">122</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are protein kinases characterized by needing a separate subunit - a cyclin - that provides domains essential for enzymatic activity.  CDKs play important roles in the control of cell division and modulate transcription in response to several extra- and intracellular cues.  The evolutionary expansion of the CDK family in mammals led to the division of CDKs into three cell-cycle-related subfamilies (Cdk1, Cdk4 and Cdk5) and five transcriptional subfamilies (Cdk7, Cdk8, Cdk9, Cdk11 and Cdk20).  Unlike the prototypical Cdc28 kinase of budding yeast, most of these CDKs bind one or a few cyclins, consistent with functional specialization during evolution.  This review summarizes how, although CDKs are traditionally separated into cell-cycle or transcriptional CDKs, these activities are frequently combined in many family members.  Not surprisingly, deregulation of this family of proteins is a hallmark of several diseases, including cancer, and drug-targeted inhibition of specific members has generated very encouraging results in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQodaug4zJdjgHqQV89nF-2fW6udTcc2eZBiZsBZWWxRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FnsVehsg%253D%253D&md5=9fd79ec8f495f712bada681b0a0b5afe</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Fgb4184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb4184%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DCyclin-Dependent%2520Kinases%26jtitle%3DGenome%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D122%26epage%3D132%26doi%3D10.1186%2Fgb4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell Cycle, CDKs and Cancer: A Changing Paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1038/nrc2602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+Cycle%2C+CDKs+and+Cancer%3A+A+Changing+Paradigm&doi=10.1038%2Fnrc2602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0ljUtAQiDr53dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520Cycle%252C%2520CDKs%2520and%2520Cancer%253A%2520A%2520Changing%2520Paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166%26doi%3D10.1038%2Fnrc2602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Casimiro, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco-Velazquez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre-Alvarado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestell, R. G.</span><span> </span><span class="NLM_article-title">Overview of Cyclins D1 Function in Cancer and the CDK Inhibitor Landscape: Past and Present</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1517/13543784.2014.867017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543784.2014.867017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=24387133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=295-304&author=M.+C.+Casimiroauthor=M.+Velasco-Velazquezauthor=C.+Aguirre-Alvaradoauthor=R.+G.+Pestell&title=Overview+of+Cyclins+D1+Function+in+Cancer+and+the+CDK+Inhibitor+Landscape%3A+Past+and+Present&doi=10.1517%2F13543784.2014.867017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present</span></div><div class="casAuthors">Casimiro, Mathew C.; Velasco-Velazquez, Marco; Aguirre-Alvarado, Charmina; Pestell, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-304</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Intensive efforts, over the last decade, have been made to inhibit the kinase activity of cyclins that act as mediators during cell-cycle progression.  Activation of the cyclin D1 oncogene, often by amplification or rearrangement, is a major driver of multiple types of human tumors including breast and squamous cell cancers, B-cell lymphoma, myeloma and parathyroid adenoma.  Areas covered: In this review, the authors summarize the activity of cyclins and cyclin-dependent kinases in cell-cycle progression and transcription.  They focus on cyclin D1/CDK4/CDK6, a central mediator in the transition from G1 to S phase.  Furthermore, the authors discuss the first generation of pan-cyclin-dependent kinase inhibitors that failed to meet expectation and discuss, in detail, the second generation of highly specific cyclin D1/CDK4/CDK6 inhibitors that are proving to be more efficacious.  Expert opinion: The mechanism by which cyclin D1 drives tumorigenesis may be dependent on kinase and kinase-independent functions.  Further evidence is necessary to delineate the roles of cyclin D1 in early pre-neoplastic lesions where its overexpression may promote genomic instability in a kinase-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdqXSkoQhAO7Vg90H21EOLACvtfcHk0ljUtAQiDr53dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFymurg%253D&md5=f4dd99c04d0a5162fc14777d4f1ec7d3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.867017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.867017%26sid%3Dliteratum%253Aachs%26aulast%3DCasimiro%26aufirst%3DM.%2BC.%26aulast%3DVelasco-Velazquez%26aufirst%3DM.%26aulast%3DAguirre-Alvarado%26aufirst%3DC.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26atitle%3DOverview%2520of%2520Cyclins%2520D1%2520Function%2520in%2520Cancer%2520and%2520the%2520CDK%2520Inhibitor%2520Landscape%253A%2520Past%2520and%2520Present%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D295%26epage%3D304%26doi%3D10.1517%2F13543784.2014.867017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Targeting CDK4 and CDK6: From Discovery to Therapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-0894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1158%2F2159-8290.CD-15-0894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=26658964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslaqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=353-367&author=C.+J.+Sherrauthor=D.+Beachauthor=G.+I.+Shapiro&title=Targeting+CDK4+and+CDK6%3A+From+Discovery+to+Therapy&doi=10.1158%2F2159-8290.CD-15-0894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CDK4 and CDK6: From Discovery to Therapy</span></div><div class="casAuthors">Sherr, Charles J.; Beach, David; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-367</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Biochem. and genetic characterization of D-type cyclins, their cyclin D-dependent kinases (CDK4 and CDK6), and the polypeptide CDK4/6 inhibitor p16INK4 over two decades ago revealed how mammalian cells regulate entry into the DNA synthetic (S) phase of the cell-division cycle in a retinoblastoma protein-dependent manner.  These investigations provided proof-of-principle that CDK4/6 inhibitors, particularly when combined with coinhibition of allied mitogen-dependent signal transduction pathways, might prove valuable in cancer therapy.  FDA approval of the CDK4/6 inhibitor palbociclib used with the aromatase inhibitor letrozole for breast cancer treatment highlights long-sought success.  The newest findings herald clin. trials targeting other cancers.  Significance: Rapidly emerging data with selective inhibitors of CDK4/6 have validated these cell-cycle kinases as anticancer drug targets, corroborating longstanding preclin. predictions.  This review addresses the discovery of these CDKs and their regulators, as well as translation of CDK4/6 biol. to pos. clin. outcomes and development of rational combinatorial therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNk2UjFylJJ7Vg90H21EOLACvtfcHk0ljUtAQiDr53dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslaqu70%253D&md5=f4b1670d4771ca2079fb1eb7ebaef2b2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-0894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-0894%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DBeach%26aufirst%3DD.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DTargeting%2520CDK4%2520and%2520CDK6%253A%2520From%2520Discovery%2520to%2520Therapy%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26spage%3D353%26epage%3D367%26doi%3D10.1158%2F2159-8290.CD-15-0894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Bruyere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Targeting Cyclin-Dependent Kinases in Anti-Neoplastic Therapy</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">772</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span><span class="refDoi"> DOI: 10.1016/j.ceb.2013.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.ceb.2013.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=24011867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWjurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=772-779&author=C.+Bruyereauthor=L.+Meijer&title=Targeting+Cyclin-Dependent+Kinases+in+Anti-Neoplastic+Therapy&doi=10.1016%2Fj.ceb.2013.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cyclin-dependent kinases in anti-neoplastic therapy</span></div><div class="casAuthors">Bruyere, Celine; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772-779</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cell cycle progression is controlled by sequential activation of cyclin-dependent kinases (CDKs), which are often deregulated in cancer.  Consequently numerous pharmacol. inhibitors of CDKs have been developed with the aim of treating cancers.  The article briefly reviews CDK inhibitors and their use to treat cancers, with specific focus on the use of biomarkers and drugs combination to improve their therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJcNl85MPhErVg90H21EOLACvtfcHk0ljUtAQiDr53dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWjurvM&md5=a4371b2c5996863f19e89416e8f8361b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2013.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2013.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DBruyere%26aufirst%3DC.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DTargeting%2520Cyclin-Dependent%2520Kinases%2520in%2520Anti-Neoplastic%2520Therapy%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2013%26volume%3D25%26spage%3D772%26epage%3D779%26doi%3D10.1016%2Fj.ceb.2013.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Asghar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkiewicz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, E. S.</span><span> </span><span class="NLM_article-title">The History and Future of Targeting Cyclin-Dependent Kinases in Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1038/nrd4504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrd4504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25633797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvVCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=130-146&author=U.+Asgharauthor=A.+K.+Witkiewiczauthor=N.+C.+Turnerauthor=E.+S.+Knudsen&title=The+History+and+Future+of+Targeting+Cyclin-Dependent+Kinases+in+Cancer+Therapy&doi=10.1038%2Fnrd4504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The history and future of targeting cyclin-dependent kinases in cancer therapy</span></div><div class="casAuthors">Asghar, Uzma; Witkiewicz, Agnieszka K.; Turner, Nicholas C.; Knudsen, Erik S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-146</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer represents a pathol. manifestation of uncontrolled cell division; therefore, it has long been anticipated that our understanding of the basic principles of cell cycle control would result in effective cancer therapies.  In particular, cyclin-dependent kinases (CDKs) that promote transition through the cell cycle were expected to be key therapeutic targets because many tumorigenic events ultimately drive proliferation by impinging on CDK4 or CDK6 complexes in the G1 phase of the cell cycle.  Moreover, perturbations in chromosomal stability and aspects of S phase and G2/M control mediated by CDK2 and CDK1 are pivotal tumorigenic events.  Translating this knowledge into successful clin. development of CDK inhibitors has historically been challenging, and numerous CDK inhibitors have demonstrated disappointing results in clin. trials.  Here, we review the biol. of CDKs, the rationale for therapeutically targeting discrete kinase complexes and historical clin. results of CDK inhibitors.  We also discuss how CDK inhibitors with high selectivity (particularly for both CDK4 and CDK6), in combination with patient stratification, have resulted in more substantial clin. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_utd-yiEZLVg90H21EOLACvtfcHk0lhQBqWux20Rdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvVCrtLc%253D&md5=113bcd2e99a8267119d180670d3c7761</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd4504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4504%26sid%3Dliteratum%253Aachs%26aulast%3DAsghar%26aufirst%3DU.%26aulast%3DWitkiewicz%26aufirst%3DA.%2BK.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DKnudsen%26aufirst%3DE.%2BS.%26atitle%3DThe%2520History%2520and%2520Future%2520of%2520Targeting%2520Cyclin-Dependent%2520Kinases%2520in%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D130%26epage%3D146%26doi%3D10.1038%2Fnrd4504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase Inhibitor Therapy for Hematologic Malignancies</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span><span class="refDoi"> DOI: 10.1517/13543784.2013.789859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543784.2013.789859" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=723-738&author=P.+Boseauthor=G.+L.+Simmonsauthor=S.+Grant&title=Cyclin-Dependent+Kinase+Inhibitor+Therapy+for+Hematologic+Malignancies&doi=10.1517%2F13543784.2013.789859"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.789859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.789859%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DSimmons%26aufirst%3DG.%2BL.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DCyclin-Dependent%2520Kinase%2520Inhibitor%2520Therapy%2520for%2520Hematologic%2520Malignancies%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D723%26epage%3D738%26doi%3D10.1517%2F13543784.2013.789859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arceci, R. J.</span><span> </span><span class="NLM_article-title">Targeting Cell Cycle Regulators in Hematologic Malignancies</span> <span class="citation_source-journal">Front. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.3389/fcell.2015.00016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.3389%2Ffcell.2015.00016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25914884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A280%3ADC%252BC2MjnvFGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=16-37&author=E.+Aleemauthor=R.+J.+Arceci&title=Targeting+Cell+Cycle+Regulators+in+Hematologic+Malignancies&doi=10.3389%2Ffcell.2015.00016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cell cycle regulators in hematologic malignancies</span></div><div class="casAuthors">Aleem Eiman; Arceci Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cell and developmental biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hematologic malignancies represent the fourth most frequently diagnosed cancer in economically developed countries.  In hematologic malignancies normal hematopoiesis is interrupted by uncontrolled growth of a genetically altered stem or progenitor cell (HSPC) that maintains its ability of self-renewal.  Cyclin-dependent kinases (CDKs) not only regulate the mammalian cell cycle, but also influence other vital cellular processes, such as stem cell renewal, differentiation, transcription, epigenetic regulation, apoptosis, and DNA repair.  Chromosomal translocations, amplification, overexpression and altered CDK activities have been described in different types of human cancer, which have made them attractive targets for pharmacological inhibition.  Mouse models deficient for one or more CDKs have significantly contributed to our current understanding of the physiological functions of CDKs, as well as their roles in human cancer.  The present review focuses on selected cell cycle kinases with recent emerging key functions in hematopoiesis and in hematopoietic malignancies, such as CDK6 and its role in MLL-rearranged leukemia and acute lymphocytic leukemia, CDK1 and its regulator WEE-1 in acute myeloid leukemia (AML), and cyclin C/CDK8/CDK19 complexes in T-cell acute lymphocytic leukemia.  The knowledge gained from gene knockout experiments in mice of these kinases is also summarized.  An overview of compounds targeting these kinases, which are currently in clinical development in various solid tumors and hematopoietic malignances, is presented.  These include the CDK4/CDK6 inhibitors (palbociclib, LEE011, LY2835219), pan-CDK inhibitors that target CDK1 (dinaciclib, flavopiridol, AT7519, TG02, P276-00, terampeprocol and RGB 286638) as well as the WEE-1 kinase inhibitor, MK-1775.  The advantage of combination therapy of cell cycle inhibitors with conventional chemotherapeutic agents used in the treatment of AML, such as cytarabine, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7iirrp56VY9y3lHz94U-GfW6udTcc2eZecQnWj-QmC7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjnvFGisw%253D%253D&md5=a6eb7c941baaff78abc39b3a1cb4c293</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffcell.2015.00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcell.2015.00016%26sid%3Dliteratum%253Aachs%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DArceci%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520Cell%2520Cycle%2520Regulators%2520in%2520Hematologic%2520Malignancies%26jtitle%3DFront.%2520Cell%2520Dev.%2520Biol.%26date%3D2015%26volume%3D3%26spage%3D16%26epage%3D37%26doi%3D10.3389%2Ffcell.2015.00016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">O’Leary, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span> </span><span class="NLM_article-title">Treating Cancer with Selective CDK4/6 Inhibitors</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span><span class="refDoi"> DOI: 10.1038/nrclinonc.2016.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrclinonc.2016.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=27030077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2iurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=417-430&author=B.+O%E2%80%99Learyauthor=R.+S.+Finnauthor=N.+C.+Turner&title=Treating+Cancer+with+Selective+CDK4%2F6+Inhibitors&doi=10.1038%2Fnrclinonc.2016.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Treating cancer with selective CDK4/6 inhibitors</span></div><div class="casAuthors">O'Leary, Ben; Finn, Richard S.; Turner, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">417-430</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Uncontrolled cellular proliferation, mediated by dysregulation of the cell-cycle machinery and activation of cyclin-dependent kinases (CDKs) to promote cell-cycle progression, lies at the heart of cancer as a pathol. process.  Clin. implementation of first-generation, nonselective CDK inhibitors, designed to inhibit this proliferation, was originally hampered by the high risk of toxicity and lack of efficacy noted with these agents.  The emergence of a new generation of selective CDK4/6 inhibitors, including ribociclib, abemaciclib and palbociclib, has enabled tumor types in which CDK4/6 has a pivotal role in the G1-to-S-phase cell-cycle transition to be targeted with improved effectiveness, and fewer adverse effects.  Results of pivotal phase III trials investigating palbociclib in patients with advanced-stage estrogen receptor (ER)-pos. breast cancer have demonstrated a substantial improvement in progression-free survival, with a well-tolerated toxicity profile.  Mechanisms of acquired resistance to CDK4/6 inhibitors are beginning to emerge that, although unwelcome, might enable rational post-CDK4/6 inhibitor therapeutic strategies to be identified.  Extending the use of CDK4/6 inhibitors beyond ER-pos. breast cancer is challenging, and will likely require biomarkers that are predictive of a response, and the use of combination therapies in order to optimize CDK4/6 targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGNYw6CRUf17Vg90H21EOLACvtfcHk0lgO0xNv0xDdTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2iurc%253D&md5=6641dc6ab3cbd70edac46319ce4e6f45</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.26%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DR.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26atitle%3DTreating%2520Cancer%2520with%2520Selective%2520CDK4%252F6%2520Inhibitors%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D13%26spage%3D417%26epage%3D430%26doi%3D10.1038%2Fnrclinonc.2016.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sánchez-Martínez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallena, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Dios, A.</span><span> </span><span class="NLM_article-title">Cyclin Dependent Kinase (CDK) Inhibitors as Anticancer Drugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3420</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.bmcl.2015.05.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=26115571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3420-3435&author=C.+S%C3%A1nchez-Mart%C3%ADnezauthor=L.+M.+Gelbertauthor=M.+J.+Lallenaauthor=A.+de+Dios&title=Cyclin+Dependent+Kinase+%28CDK%29+Inhibitors+as+Anticancer+Drugs&doi=10.1016%2Fj.bmcl.2015.05.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin dependent kinase (CDK) inhibitors as anticancer drugs</span></div><div class="casAuthors">Sanchez-Martinez, Concepcion; Gelbert, Lawrence M.; Lallena, Maria Jose; de Dios, Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3420-3435</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sustained proliferative capacity is a hallmark of cancer.  In mammalian cells proliferation is controlled by the cell cycle, where cyclin-dependent kinases (CDKs) regulate crit. checkpoints.  CDK4 and CDK6 are considered highly validated anticancer drug targets due to their essential role regulating cell cycle progression at the G1 restriction point.  This review provides an overview of recent advances on cyclin dependent kinase inhibitors in general with special emphasis on CDK4 and CDK6 inhibitors and compds. under clin. evaluation.  Chem. structures, structure activity relationships, and relevant preclin. properties will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwE7MEzEetPbVg90H21EOLACvtfcHk0lgO0xNv0xDdTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fN&md5=d4451fdbfd0ef0b08165105b9c8a38dc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.100%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Mart%25C3%25ADnez%26aufirst%3DC.%26aulast%3DGelbert%26aufirst%3DL.%2BM.%26aulast%3DLallena%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BDios%26aufirst%3DA.%26atitle%3DCyclin%2520Dependent%2520Kinase%2520%2528CDK%2529%2520Inhibitors%2520as%2520Anticancer%2520Drugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3420%26epage%3D3435%26doi%3D10.1016%2Fj.bmcl.2015.05.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of Cancer Cells Despite CDK2 Inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/S1535-6108(03)00053-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2FS1535-6108%2803%2900053-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=12676582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+Cancer+Cells+Despite+CDK2+Inhibition&doi=10.1016%2FS1535-6108%2803%2900053-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Proliferation of cancer cells despite CDK2 inhibition</span></div><div class="casAuthors">Tetsu, Osamu; McCormick, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-245</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The authors have investigated the contribution of CDK4 and CDK2 inhibition to G1 arrest in colon cancers following inhibition of the MEK/MAP kinase pathway.  CDK4 inhibition is sufficient to cause arrest, but inhibition of CDK2 by p27 Kip1 redistribution or ectopic expression has no effect on proliferation.  Likewise, inhibition of CDK2 through expression of dominant-neg. (DN) CDK2 or antisense oligonucleotides did not prevent cell proliferation in these cells.  The authors therefore tested whether CDK2 activity is dispensable in other cells.  Surprisingly, osteosarcomas and Rb-neg. cervical cancers continued to proliferate after depletion of CDK2 through antisense oligonucleotides or small interfering (si) RNA.  Here the authors report sustained cell proliferation in the absence of CDK2, and the authors suggest that CDK2 is not a suitable target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUlrtla8E307Vg90H21EOLACvtfcHk0lgO0xNv0xDdTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOrtb0%253D&md5=a4c67cbe660ff486912ab5113cfe53bb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900053-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900053-9%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520Cancer%2520Cells%2520Despite%2520CDK2%2520Inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245%26doi%3D10.1016%2FS1535-6108%2803%2900053-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odajima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase 2 is Essential for Meiosis but not for Mitotic Cell Division in Mice</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1038/ng1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fng1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=12923533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=25-31&author=S.+Ortegaauthor=I.+Prietoauthor=J.+Odajimaauthor=A.+Martinauthor=P.+Dubusauthor=R.+Sotilloauthor=J.+L.+Barberoauthor=M.+Malumbresauthor=M.+Barbacid&title=Cyclin-Dependent+Kinase+2+is+Essential+for+Meiosis+but+not+for+Mitotic+Cell+Division+in+Mice&doi=10.1038%2Fng1232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice</span></div><div class="casAuthors">Ortega, Sagrario; Prieto, Ignacio; Odajima, Junko; Martin, Alberto; Dubus, Pierre; Sotillo, Rocio; Barbero, Jose Luis; Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We targeted the locus encoding the cyclin-dependent kinase 2 (CDK2) by homologous recombination in mouse embryonic stem (ES) cells.  Embryonic fibroblasts lacking CDK2 proliferate normally and become immortal after continuous passage in culture.  Elimination of a conditional Cdk2 allele in immortal cells does not have a significant effect on proliferation.  Cdk2-/- mice are viable and survive for up to two years, indicating that CDK2 is also dispensable for proliferation and survival of most cell types.  But CDK2 is essential for completion of prophase I during meiotic cell division in male and female germ cells, an unforeseen role for this cell cycle kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5r24x7syf9bVg90H21EOLACvtfcHk0lgO0xNv0xDdTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D&md5=7f2898209c25b5b663626897ec956a2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fng1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1232%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DPrieto%26aufirst%3DI.%26aulast%3DOdajima%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DBarbero%26aufirst%3DJ.%2BL.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCyclin-Dependent%2520Kinase%25202%2520is%2520Essential%2520for%2520Meiosis%2520but%2520not%2520for%2520Mitotic%2520Cell%2520Division%2520in%2520Mice%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D35%26spage%3D25%26epage%3D31%26doi%3D10.1038%2Fng1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Berthet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessarollo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdk2 Knockout Mice are Viable</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1785</span><span class="refDoi"> DOI: 10.1016/j.cub.2003.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.cub.2003.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=14561402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1775-1785&author=C.+Berthetauthor=E.+Aleemauthor=V.+Coppolaauthor=L.+Tessarolloauthor=P.+Kaldis&title=Cdk2+Knockout+Mice+are+Viable&doi=10.1016%2Fj.cub.2003.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk2 Knockout Mice Are Viable</span></div><div class="casAuthors">Berthet, Cyril; Aleem, Eiman; Coppola, Vincenzo; Tessarollo, Lino; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1775-1785</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Background: Cyclin-dependent kinases (Cdks) and their cyclin regulatory subunits control cell growth and division.  Cdk2/cyclin E complexes are thought to be required because they phosphorylate the retinoblastoma protein and drive cells through the G1/S transition into the S phase of the cell cycle.  In addn., Cdk2 assocs. with cyclin A, which itself is essential for cell proliferation during early embryonic development.  Results: In order to study the functions of Cdk2 in vivo, we generated Cdk2 knockout mice.  Surprisingly, these mice are viable, and therefore Cdk2 is not an essential gene in the mouse.  However, Cdk2 is required for germ cell development; both male and female Cdk2-/- mice are sterile.  Immunoppts. of cyclin E1 complexes from Cdk2-/- spleen exts. displayed no activity toward histone H1.  Cyclin A2 complexes were active in primary mouse embryonic fibroblasts (MEFs), embryo exts. and in spleen exts. from young animals.  In contrast, there was little cyclin A2 kinase activity in immortalized MEFs and spleen exts. from adult animals.  Cdk2-/- MEFs proliferate but enter delayed into S phase.  Ectopic expression of Cdk2 in Cdk2-/- MEFs rescued the delayed entry into S phase.  Conclusions: Although Cdk2 is not an essential gene in the mouse, it is required for germ cell development and meiosis.  Loss of Cdk2 affects the timing of S phase, suggesting that Cdk2 is involved in regulating progression through the mitotic cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0o-n-kcfSW7Vg90H21EOLACvtfcHk0lhbuksKqEzaVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D&md5=8bb2c819e566952895434253f667454c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2003.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2003.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DBerthet%26aufirst%3DC.%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DCoppola%26aufirst%3DV.%26aulast%3DTessarollo%26aufirst%3DL.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdk2%2520Knockout%2520Mice%2520are%2520Viable%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D1775%26epage%3D1785%26doi%3D10.1016%2Fj.cub.2003.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Horiuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusdra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlbold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrick, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span> </span><span class="NLM_article-title">Chemical-Genetic Analysis of Cyclin Dependent Kinase 2 Function Reveals an Important Role in Cellular Transformation by Multiple Oncogenic Pathways</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">E1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">E1027</span><span class="refDoi"> DOI: 10.1073/pnas.1111317109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1073%2Fpnas.1111317109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=22474407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslGmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E1019-E1027&author=D.+Horiuchiauthor=N.+E.+Huskeyauthor=L.+Kusdraauthor=L.+Wohlboldauthor=K.+A.+Merrickauthor=C.+Zhangauthor=K.+J.+Creasmanauthor=K.+M.+Shokatauthor=R.+P.+Fisherauthor=A.+Goga&title=Chemical-Genetic+Analysis+of+Cyclin+Dependent+Kinase+2+Function+Reveals+an+Important+Role+in+Cellular+Transformation+by+Multiple+Oncogenic+Pathways&doi=10.1073%2Fpnas.1111317109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways</span></div><div class="casAuthors">Horiuchi, Dai; Huskey, Noelle E.; Kusdra, Leonard; Wohlbold, Lara; Merrick, Karl A.; Zhang, Chao; Creasman, Katelyn J.; Shokat, Kevan M.; Fisher, Robert P.; Goga, Andrei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">E1019-E1027, SE1019/1-SE1019/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A family of conserved serine/threonine kinases known as cyclin-dependent kinases (CDKs) drives orderly cell cycle progression in mammalian cells.  Prior studies have suggested that CDK2 regulates S-phase entry and progression, and frequently shows increased activity in a wide spectrum of human tumors.  Genetic KO/knockdown approaches, however, have suggested that lack of CDK2 protein does not prevent cellular proliferation, both during somatic development in mice as well as in human cancer cell lines.  Here, we use an alternative, chem.-genetic approach to achieve specific inhibition of CDK2 kinase activity in cells.  We directly compare small-mol. inhibition of CDK2 kinase activity with siRNA knockdown and show that small-mol. inhibition results in marked defects in proliferation of nontransformed cells, whereas siRNA knockdown does not, highlighting the differences between these two approaches.  In addn., CDK2 inhibition drastically diminishes anchorage-independent growth of human cancer cells and cells transformed with various oncogenes.  Our results establish that CDK2 activity is necessary for normal mammalian cell cycle progression and suggest that it might be a useful therapeutic target for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr38-RTvuFoa7Vg90H21EOLACvtfcHk0lhbuksKqEzaVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslGmtLk%253D&md5=dcb463a6fc2696712617034313e8960a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1111317109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1111317109%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DD.%26aulast%3DHuskey%26aufirst%3DN.%2BE.%26aulast%3DKusdra%26aufirst%3DL.%26aulast%3DWohlbold%26aufirst%3DL.%26aulast%3DMerrick%26aufirst%3DK.%2BA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCreasman%26aufirst%3DK.%2BJ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DFisher%26aufirst%3DR.%2BP.%26aulast%3DGoga%26aufirst%3DA.%26atitle%3DChemical-Genetic%2520Analysis%2520of%2520Cyclin%2520Dependent%2520Kinase%25202%2520Function%2520Reveals%2520an%2520Important%2520Role%2520in%2520Cellular%2520Transformation%2520by%2520Multiple%2520Oncogenic%2520Pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE1019%26epage%3DE1027%26doi%3D10.1073%2Fpnas.1111317109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Cheng, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charron, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Q. W.</span><span> </span><span class="NLM_article-title">Dual Blockade of Lipid and Cyclin-Dependent Kinases Induces Synthetic Lethality in Malignant Glioma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">12722</span><span class="NLM_x">–</span> <span class="NLM_lpage">12727</span><span class="refDoi"> DOI: 10.1073/pnas.1202492109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1073%2Fpnas.1202492109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=12722-12727&author=C.+K.+Chengauthor=W.+C.+Gustafsonauthor=E.+Charronauthor=B.+T.+Housemanauthor=E.+Zunderauthor=A.+Gogaauthor=N.+S.+Grayauthor=B.+Pollokauthor=S.+A.+Oakesauthor=C.+D.+Jamesauthor=K.+M.+Shokatauthor=W.+A.+Weissauthor=Q.+W.+Fan&title=Dual+Blockade+of+Lipid+and+Cyclin-Dependent+Kinases+Induces+Synthetic+Lethality+in+Malignant+Glioma&doi=10.1073%2Fpnas.1202492109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202492109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202492109%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%2BK.%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DCharron%26aufirst%3DE.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DZunder%26aufirst%3DE.%26aulast%3DGoga%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DPollok%26aufirst%3DB.%26aulast%3DOakes%26aufirst%3DS.%2BA.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DFan%26aufirst%3DQ.%2BW.%26atitle%3DDual%2520Blockade%2520of%2520Lipid%2520and%2520Cyclin-Dependent%2520Kinases%2520Induces%2520Synthetic%2520Lethality%2520in%2520Malignant%2520Glioma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D12722%26epage%3D12727%26doi%3D10.1073%2Fpnas.1202492109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Deans, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNees, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heierhorst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase 2 Functions in Normal DNA Repair and is a Therapeutic Target in BRCA1-Deficient Cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8219</span><span class="NLM_x">–</span> <span class="NLM_lpage">8226</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-3945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1158%2F0008-5472.CAN-05-3945" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8219-8226&author=A.+J.+Deansauthor=K.+K.+Khannaauthor=C.+J.+McNeesauthor=C.+Mercurioauthor=J.+Heierhorstauthor=G.+A.+McArthur&title=Cyclin-Dependent+Kinase+2+Functions+in+Normal+DNA+Repair+and+is+a+Therapeutic+Target+in+BRCA1-Deficient+Cancers&doi=10.1158%2F0008-5472.CAN-05-3945"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3945%26sid%3Dliteratum%253Aachs%26aulast%3DDeans%26aufirst%3DA.%2BJ.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DMcNees%26aufirst%3DC.%2BJ.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DHeierhorst%26aufirst%3DJ.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26atitle%3DCyclin-Dependent%2520Kinase%25202%2520Functions%2520in%2520Normal%2520DNA%2520Repair%2520and%2520is%2520a%2520Therapeutic%2520Target%2520in%2520BRCA1-Deficient%2520Cancers%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8219%26epage%3D8226%26doi%3D10.1158%2F0008-5472.CAN-05-3945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Molenaar, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebus, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentijn, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerhout, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versteeg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, H. N.</span><span> </span><span class="NLM_article-title">Inactivation of CDK2 is Synthetically Lethal to MYCN Over-Expressing Cancer Cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">12968</span><span class="NLM_x">–</span> <span class="NLM_lpage">12973</span><span class="refDoi"> DOI: 10.1073/pnas.0901418106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1073%2Fpnas.0901418106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=19525400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=12968-12973&author=J.+J.+Molenaarauthor=M.+E.+Ebusauthor=D.+Geertsauthor=J.+Kosterauthor=F.+Lamersauthor=L.+J.+Valentijnauthor=E.+M.+Westerhoutauthor=R.+Versteegauthor=H.+N.+Caron&title=Inactivation+of+CDK2+is+Synthetically+Lethal+to+MYCN+Over-Expressing+Cancer+Cells&doi=10.1073%2Fpnas.0901418106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells</span></div><div class="casAuthors">Molenaar, Jan J.; Ebus, Marli E.; Geerts, Dirk; Koster, Jan; Lamers, Fieke; Valentijn, Linda J.; Westerhout, Ellen M.; Versteeg, Rogier; Caron, Huib N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12968-12973</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Two genes have a synthetically lethal relationship when the silencing or inhibiting of 1 gene is only lethal in the context of a mutation or activation of the second gene.  This situation offers an attractive therapeutic strategy, as inhibition of such a gene will only trigger cell death in tumor cells with an activated second oncogene but spare normal cells without activation of the second oncogene.  Here we present evidence that CDK2 is synthetically lethal to neuroblastoma cells with MYCN amplification and over-expression.  Neuroblastomas are childhood tumors with an often lethal outcome.  Twenty percent of the tumors have MYCN amplification, and these tumors are ultimately refractory to any therapy.  Targeted silencing of CDK2 by 3 RNA interference techniques induced apoptosis in MYCN-amplified neuroblastoma cell lines, but not in MYCN single copy cells.  Silencing of MYCN abrogated this apoptotic response in MYCN-amplified cells.  Inversely, silencing of CDK2 in MYCN single copy cells did not trigger apoptosis, unless a MYCN transgene was activated.  The MYCN induced apoptosis after CDK2 silencing was accompanied by nuclear stabilization of P53, and mRNA profiling showed up-regulation of P53 target genes.  Silencing of P53 rescued the cells from MYCN-driven apoptosis.  The synthetic lethality of CDK2 silencing in MYCN activated neuroblastoma cells can also be triggered by inhibition of CDK2 with a small mol. drug.  Treatment of neuroblastoma cells with roscovitine, a CDK inhibitor, at clin. achievable concns. induced MYCN-dependent apoptosis.  The synthetically lethal relationship between CDK2 and MYCN indicates CDK2 inhibitors as potential MYCN-selective cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48u4K0MeszLVg90H21EOLACvtfcHk0lj60NPeXLvtJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKru77P&md5=016ebf4ccc1f5c6e3b965e999cca58c7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0901418106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0901418106%26sid%3Dliteratum%253Aachs%26aulast%3DMolenaar%26aufirst%3DJ.%2BJ.%26aulast%3DEbus%26aufirst%3DM.%2BE.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DKoster%26aufirst%3DJ.%26aulast%3DLamers%26aufirst%3DF.%26aulast%3DValentijn%26aufirst%3DL.%2BJ.%26aulast%3DWesterhout%26aufirst%3DE.%2BM.%26aulast%3DVersteeg%26aufirst%3DR.%26aulast%3DCaron%26aufirst%3DH.%2BN.%26atitle%3DInactivation%2520of%2520CDK2%2520is%2520Synthetically%2520Lethal%2520to%2520MYCN%2520Over-Expressing%2520Cancer%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D12968%26epage%3D12973%26doi%3D10.1073%2Fpnas.0901418106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase 2 is an Ideal Target for Ovary Tumors with Elevated Cyclin E1 Expression</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">20801</span><span class="NLM_x">–</span> <span class="NLM_lpage">20812</span><span class="refDoi"> DOI: 10.18632/oncotarget.4600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.18632%2Foncotarget.4600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=20801-20812&author=L.+Yangauthor=D.+Fangauthor=H.+Chenauthor=Y.+Luauthor=Z.+Dongauthor=H.+F.+Dingauthor=Q.+Jingauthor=S.+B.+Suauthor=S.+Huang&title=Cyclin-Dependent+Kinase+2+is+an+Ideal+Target+for+Ovary+Tumors+with+Elevated+Cyclin+E1+Expression&doi=10.18632%2Foncotarget.4600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4600%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DH.%2BF.%26aulast%3DJing%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DS.%2BB.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DCyclin-Dependent%2520Kinase%25202%2520is%2520an%2520Ideal%2520Target%2520for%2520Ovary%2520Tumors%2520with%2520Elevated%2520Cyclin%2520E1%2520Expression%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D20801%26epage%3D20812%26doi%3D10.18632%2Foncotarget.4600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Guha, M.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase Inhibitors Move into Phase III</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1038/nrd3908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrd3908" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=892-894&author=M.+Guha&title=Cyclin-Dependent+Kinase+Inhibitors+Move+into+Phase+III&doi=10.1038%2Fnrd3908"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd3908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3908%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DM.%26atitle%3DCyclin-Dependent%2520Kinase%2520Inhibitors%2520Move%2520into%2520Phase%2520III%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D892%26epage%3D894%26doi%3D10.1038%2Fnrd3908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oumata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloulou, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase Inhibitors Closer to Market Launch?</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">963</span><span class="refDoi"> DOI: 10.1517/13543776.2013.789861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543776.2013.789861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=23600454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=945-963&author=H.+Galonsauthor=N.+Oumataauthor=O.+Gloulouauthor=L.+Meijer&title=Cyclin-Dependent+Kinase+Inhibitors+Closer+to+Market+Launch%3F&doi=10.1517%2F13543776.2013.789861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase inhibitors closer to market launch?</span></div><div class="casAuthors">Galons, Herve; Oumata, Nassima; Gloulou, Olfa; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">945-963</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Interest in cyclin-dependent kinase (CDK) inhibitors was stimulated by the demonstration that their pharmacol. activities could lead to therapies for numerous diseases.  Until now, despite the clin. introduction of a dozen compds. belonging to other classes of kinase inhibitors, no CDK inhibitor has reached the marketplace.  Areas covered: This review covers CDK inhibitor patents published between 2009 and Sept. 2012.  It presents compds. currently undergoing clin. development, along with our earlier (2010) review of the same topic, as well as descriptions of recently published compds. not disclosed in the patent literature.  It provides the reader with an update of all chem. structures of current interest in the CDK inhibitor field.  Expert opinion: Though cancer remains the most obvious application for CDK inhibition, other indications, such as HIV infection, could potentially be treated with CDK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO3flHndUPMrVg90H21EOLACvtfcHk0lj60NPeXLvtJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3K&md5=6bd4f5033c6dc3627d4baf1f9ddf214c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.789861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.789861%26sid%3Dliteratum%253Aachs%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DOumata%26aufirst%3DN.%26aulast%3DGloulou%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DCyclin-Dependent%2520Kinase%2520Inhibitors%2520Closer%2520to%2520Market%2520Launch%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D945%26epage%3D963%26doi%3D10.1517%2F13543776.2013.789861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Santo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span> </span><span class="NLM_article-title">Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1053/j.seminoncol.2015.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1053%2Fj.seminoncol.2015.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=26615126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=788-800&author=L.+Santoauthor=K.+T.+Siuauthor=N.+Raje&title=Targeting+Cyclin-Dependent+Kinases+and+Cell+Cycle+Progression+in+Human+Cancers&doi=10.1053%2Fj.seminoncol.2015.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers</span></div><div class="casAuthors">Santo, Loredana; Siu, Ka Tat; Raje, Noopur</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-800</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Uncontrolled cell division is a defining characteristic of cancer cells.  Cyclin-dependent kinases (Cdks) are crit. regulators of cell cycle progression.  Deregulated Cdk activities as a result of gene amplification, translocation, or point mutations of Cdks or cyclins, have been reported in a majority of human cancers.  These kinases, therefore, represent potential therapeutic targets for the treatment of cancer.  In this review, we offer an overview of Cdk functions in driving cell cycle progression and transcriptional regulation, a highlight of the DNA damage checkpoints, and an outline of the most relevant Cdk inhibitors currently in clin. trials with an emphasis on the Cdk inhibitors used for treatment of multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBLbVHqlZ2OrVg90H21EOLACvtfcHk0lj60NPeXLvtJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksL7J&md5=ee57a7c9b080ae0ad3860a4d8b2dd691</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2015.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2015.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DSiu%26aufirst%3DK.%2BT.%26aulast%3DRaje%26aufirst%3DN.%26atitle%3DTargeting%2520Cyclin-Dependent%2520Kinases%2520and%2520Cell%2520Cycle%2520Progression%2520in%2520Human%2520Cancers%26jtitle%3DSemin.%2520Oncol.%26date%3D2015%26volume%3D42%26spage%3D788%26epage%3D800%26doi%3D10.1053%2Fj.seminoncol.2015.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span> </span><span class="NLM_article-title">Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2804</span><span class="refDoi"> DOI: 10.1021/jm990628o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990628o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2797-2804&author=C.+E.+Arrisauthor=F.+T.+Boyleauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=E.+F.+Garmanauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=A.+M.+Lawrieauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=E.+A.+Sausvilleauthor=R.+Schultzauthor=W.+Yu&title=Identification+of+Novel+Purine+and+Pyrimidine+Cyclin-Dependent+Kinase+Inhibitors+with+Distinct+Molecular+Interactions+and+Tumor+Cell+Growth+Inhibition+Profiles&doi=10.1021%2Fjm990628o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm990628o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990628o%26sid%3Dliteratum%253Aachs%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGarman%26aufirst%3DE.%2BF.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLawrie%26aufirst%3DA.%2BM.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DSchultz%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520Novel%2520Purine%2520and%2520Pyrimidine%2520Cyclin-Dependent%2520Kinase%2520Inhibitors%2520with%2520Distinct%2520Molecular%2520Interactions%2520and%2520Tumor%2520Cell%2520Growth%2520Inhibition%2520Profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2797%26epage%3D2804%26doi%3D10.1021%2Fjm990628o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Davies, T.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M.-E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H.-J.</span><span> </span><span class="NLM_article-title">Structure-Based Design of a Potent Purine-Based Cyclin-Dependent Kinase Inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1038/nsb842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnsb842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=745-749&author=T.-G.+Daviesauthor=J.+Bentleyauthor=C.-E.+Arrisauthor=F.+T.+Boyleauthor=N.-J.+Curtinauthor=J.-A.+Endicottauthor=A.-E.+Gibsonauthor=B.-T.+Goldingauthor=R.-J.+Griffinauthor=I.-R.+Hardcastleauthor=P.+Jewsburyauthor=L.-N.+Johnsonauthor=V.+Mesguicheauthor=D.-R.+Newellauthor=M.-E.+M.+Nobleauthor=J.-A.+Tuckerauthor=L.+Wangauthor=H.-J.+Whitfield&title=Structure-Based+Design+of+a+Potent+Purine-Based+Cyclin-Dependent+Kinase+Inhibitor&doi=10.1038%2Fnsb842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnsb842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb842%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.-G.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DArris%26aufirst%3DC.-E.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.-J.%26aulast%3DEndicott%26aufirst%3DJ.-A.%26aulast%3DGibson%26aufirst%3DA.-E.%26aulast%3DGolding%26aufirst%3DB.-T.%26aulast%3DGriffin%26aufirst%3DR.-J.%26aulast%3DHardcastle%26aufirst%3DI.-R.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.-N.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.-R.%26aulast%3DNoble%26aufirst%3DM.-E.%2BM.%26aulast%3DTucker%26aufirst%3DJ.-A.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhitfield%26aufirst%3DH.-J.%26atitle%3DStructure-Based%2520Design%2520of%2520a%2520Potent%2520Purine-Based%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D745%26epage%3D749%26doi%3D10.1038%2Fnsb842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyerol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">N2-Substituted O6-Cyclohexylmethylguanine Derivatives: Potent Inhibitors of Cyclin-Dependent Kinases 1 and 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3710</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span><span class="refDoi"> DOI: 10.1021/jm0311442</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0311442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3710-3722&author=I.+R.+Hardcastleauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=Y.+Chenauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=J.+Menyerolauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=D.+J.+Prattauthor=L.+Z.+Wangauthor=H.+J.+Whitfield&title=N2-Substituted+O6-Cyclohexylmethylguanine+Derivatives%3A+Potent+Inhibitors+of+Cyclin-Dependent+Kinases+1+and+2&doi=10.1021%2Fjm0311442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N2-Substituted O6-Cyclohexylmethylguanine Derivatives: Potent Inhibitors of Cyclin-Dependent Kinases 1 and 2</span></div><div class="casAuthors">Hardcastle, Ian R.; Arris, Christine E.; Bentley, Johanne; Boyle, F. Thomas; Chen, Yuzhu; Curtin, Nicola J.; Endicott, Jane A.; Gibson, Ashleigh E.; Golding, Bernard T.; Griffin, Roger J.; Jewsbury, Philip; Menyerol, Jerome; Mesguiche, Veronique; Newell, David R.; Noble, Martin E. M.; Pratt, David J.; Wang, Lan-Zhen; Whitfield, Hayley J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3710-3722</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ATP competitive cyclin-dependent kinase inhibitor O6-cyclohexylmethylguanine (NU2058, 1) has been employed as the lead in a structure-based drug discovery program resulting in the discovery of the potent CDK1 and -2 inhibitor NU6102 (3, IC50 = 9.5 nM and 5.4 nM vs CDK1/cyclin B and CDK2/cyclin A3, resp.).  The SAR for this series have been explored further by the synthesis and evaluation of 45 N2-substituted analogs of NU2058.  These studies have confirmed the requirement for the hydrogen bonding N2-NH group and the requirement for an arom. N2-substituent to confer potency in the series.  Addnl. potency is conferred by the presence of a group capable of donating a hydrogen bond at the 4'-position, for example, the 4'-hydroxy deriv. (25, IC50 = 94 nM and 69 nM vs. CDK1/cyclinB and CDK2/cyclin A3, resp.), 4'-monomethylsulfonamide deriv. (28, IC50 = 9 nM and 7.0 nM vs. CDK1/cyclinB and CDK2/cyclin A3, resp.), and 4'-carboxamide deriv. (34, IC50 = 67 nM and 64 nM vs. CDK1/cyclinB and CDK2/cyclin A3, resp.).  X-ray crystal structures have been obtained for key compds. and have been used to explain the obsd. trends in activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDB9D6YHzKLVg90H21EOLACvtfcHk0lhPrN0rVxJ3sg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gisbg%253D&md5=305eef50961c3f1ffad033cf9ab18c3f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0311442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0311442%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DMenyerol%26aufirst%3DJ.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DN2-Substituted%2520O6-Cyclohexylmethylguanine%2520Derivatives%253A%2520Potent%2520Inhibitors%2520of%2520Cyclin-Dependent%2520Kinases%25201%2520and%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3710%26epage%3D3722%26doi%3D10.1021%2Fjm0311442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Marchetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggerty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 5-Substituted O4-Alkylpyrimidines as CDK2 Inhibitors</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">–</span> <span class="NLM_lpage">2407</span><span class="refDoi"> DOI: 10.1039/b925481a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1039%2Fb925481a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=2397-2407&author=F.+Marchettiauthor=C.+Canoauthor=N.+J.+Curtinauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=K.+Haggertyauthor=D.+R.+Newellauthor=R.+J.+Parsonsauthor=S.+L.+Payneauthor=L.+Z.+Wangauthor=I.+R.+Hardcastle&title=Synthesis+and+Biological+Evaluation+of+5-Substituted+O4-Alkylpyrimidines+as+CDK2+Inhibitors&doi=10.1039%2Fb925481a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fb925481a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb925481a%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DCano%26aufirst%3DC.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHaggerty%26aufirst%3DK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DParsons%26aufirst%3DR.%2BJ.%26aulast%3DPayne%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25205-Substituted%2520O4-Alkylpyrimidines%2520as%2520CDK2%2520Inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D2397%26epage%3D2407%26doi%3D10.1039%2Fb925481a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Jonkers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, J. T.</span><span> </span><span class="NLM_article-title">Getting up to Speed with Transcription Elongation by RNA Polymerase II</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1038/nrm3953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrm3953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25693130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=167-177&author=I.+Jonkersauthor=J.+T.+Lis&title=Getting+up+to+Speed+with+Transcription+Elongation+by+RNA+Polymerase+II&doi=10.1038%2Fnrm3953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Getting up to speed with transcription elongation by RNA polymerase II</span></div><div class="casAuthors">Jonkers, Iris; Lis, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-177</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent advances in sequencing techniques that measure nascent transcripts and that reveal the positioning of RNA polymerase II (Pol II) have shown that the pausing of Pol II in promoter-proximal regions and its release to initiate a phase of productive elongation are key steps in transcription regulation.  Moreover, after the release of Pol II from the promoter-proximal region, elongation rates are highly dynamic throughout the transcription of a gene, and vary on a gene-by-gene basis.  Interestingly, Pol II elongation rates affect co-transcriptional processes such as splicing, termination and genome stability.  Increasing nos. of factors and regulatory mechanisms have been assocd. with the steps of transcription elongation by Pol II, revealing that elongation is a highly complex process.  Elongation is thus now recognized as a key phase in the regulation of transcription by Pol II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoGYHNxHU1bVg90H21EOLACvtfcHk0lh5D8fx2q0Pgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFemsrw%253D&md5=6b8aa1cef47c37a0fd26a83f60cbab49</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrm3953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3953%26sid%3Dliteratum%253Aachs%26aulast%3DJonkers%26aufirst%3DI.%26aulast%3DLis%26aufirst%3DJ.%2BT.%26atitle%3DGetting%2520up%2520to%2520Speed%2520with%2520Transcription%2520Elongation%2520by%2520RNA%2520Polymerase%2520II%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D167%26epage%3D177%26doi%3D10.1038%2Fnrm3953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianella-Borradori, A.</span><span> </span><span class="NLM_article-title">Recent Progress in the Discovery and Development of Cyclin-Dependent Kinase Inhibitors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1517/13543784.14.4.457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543784.14.4.457" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=457-477&author=P.+M.+Fischerauthor=A.+Gianella-Borradori&title=Recent+Progress+in+the+Discovery+and+Development+of+Cyclin-Dependent+Kinase+Inhibitors&doi=10.1517%2F13543784.14.4.457"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.4.457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.4.457%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DGianella-Borradori%26aufirst%3DA.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Cyclin-Dependent%2520Kinase%2520Inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D457%26epage%3D477%26doi%3D10.1517%2F13543784.14.4.457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Parry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhavalkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oft, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, E. M.</span><span> </span><span class="NLM_article-title">Dinaciclib (SCH 727965), A Novel and Potent Cyclin-Dependent Kinase Inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1158%2F1535-7163.MCT-10-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=20663931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=2344-2353&author=D.+Parryauthor=T.+Guziauthor=F.+Shanahanauthor=N.+Davisauthor=D.+Prabhavalkarauthor=D.+Wiswellauthor=W.+Seghezziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=R.+Dollauthor=A.+Nomeirauthor=W.+Windsorauthor=T.+Fischmannauthor=Y.+Wangauthor=M.+Oftauthor=T.+Chenauthor=P.+Kirschmeierauthor=E.+M.+Lees&title=Dinaciclib+%28SCH+727965%29%2C+A+Novel+and+Potent+Cyclin-Dependent+Kinase+Inhibitor&doi=10.1158%2F1535-7163.MCT-10-0324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor</span></div><div class="casAuthors">Parry, David; Guzi, Timothy; Shanahan, Frances; Davis, Nicole; Prabhavalkar, Deepa; Wiswell, Derek; Seghezzi, Wolfgang; Paruch, Kamil; Dwyer, Michael P.; Doll, Ronald; Nomeir, Amin; Windsor, William; Fischmann, Thierry; Wang, Yaolin; Oft, Martin; Chen, Taiying; Kirschmeier, Paul; Lees, Emma M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2353</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDK) are key pos. regulators of cell cycle progression and attractive targets in oncol.  SCH 727965 inhibits CDK2, CDK5, CDK1, and CDK9 activity in vitro with IC50 values of 1, 1, 3, and 4 nmol/L, resp.  SCH 727965 was selected as a clin. candidate using a functional screen in vivo that integrated both efficacy and safety parameters.  Compared with flavopiridol, SCH 727965 exhibits superior activity with an improved therapeutic index.  In cell-based assays, SCH 727965 completely suppressed retinoblastoma phosphorylation, which correlated with apoptosis onset and total inhibition of bromodeoxyuridine incorporation in >100 tumor cell lines of diverse origin and background.  Moreover, short exposures to SCH 727965 were sufficient for long-lasting cellular effects.  SCH 727965 induced regression of established solid tumors in a range of mouse models following intermittent scheduling of doses below the maximally tolerated level.  This was assocd. with modulation of pharmacodynamic biomarkers in skin punch biopsies and rapidly reversible, mechanism-based effects on hematol. parameters.  These results suggest that SCH 727965 is a potent and selective CDK inhibitor and a novel cytotoxic agent.  Mol Cancer Ther; 9(8); 2344-53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxn1NtmEAh7LVg90H21EOLACvtfcHk0lh5D8fx2q0Pgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D&md5=bd2d30fdfdca0f2bceb3f5c0b44b8630</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0324%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26aulast%3DGuzi%26aufirst%3DT.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DPrabhavalkar%26aufirst%3DD.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DDoll%26aufirst%3DR.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DWindsor%26aufirst%3DW.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOft%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKirschmeier%26aufirst%3DP.%26aulast%3DLees%26aufirst%3DE.%2BM.%26atitle%3DDinaciclib%2520%2528SCH%2520727965%2529%252C%2520A%2520Novel%2520and%2520Potent%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D2344%26epage%3D2353%26doi%3D10.1158%2F1535-7163.MCT-10-0324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span> </span><span class="NLM_article-title">Dissecting the Determinants of Cyclin-Dependent Kinase 2 and Cyclin-Dependent Kinase 4 Inhibitor Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5470</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span><span class="refDoi"> DOI: 10.1021/jm060216x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060216x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFOqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5470-5477&author=D.+J.+Prattauthor=J.+Bentleyauthor=P.+Jewsburyauthor=F.+T.+Boyleauthor=J.+A.+Endicottauthor=M.+E.+Noble&title=Dissecting+the+Determinants+of+Cyclin-Dependent+Kinase+2+and+Cyclin-Dependent+Kinase+4+Inhibitor+Selectivity&doi=10.1021%2Fjm060216x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the Determinants of Cyclin-Dependent Kinase 2 and Cyclin-Dependent Kinase 4 Inhibitor Selectivity</span></div><div class="casAuthors">Pratt, David J.; Bentley, Jo; Jewsbury, Philip; Boyle, F. Tom; Endicott, Jane A.; Noble, Martin E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5470-5477</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin dependent kinases are a key family of kinases involved in cell cycle regulation and are an attractive target for cancer chemotherapy.  The roles of four residues of the cyclin-dependent kinase active site in inhibitor selectivity were investigated by producing cyclin-dependent kinase 2 mutants bearing equiv. cyclin-dependent kinase 4 residues, namely F82H, L83V, H84D, and K89T.  Assay of the mutants with a cyclin-dependent kinase 4-selective bisanilinopyrimidine shows that the K89T mutation is primarily responsible for the selectivity of this compd.  Use of the cyclin-dependent kinase 2-selective 6-cyclohexylmethoxy-2-(4'-sulfamoylanilino)purine (NU6102) shows that K89T has no role in the selectivity, while the remaining three mutations have a cumulative influence.  The results indicate that certain residues that are not frequently considered in structure-aided kinase inhibitor design have an important role to play.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYKIfTcMWw2LVg90H21EOLACvtfcHk0lgQglNrH7QwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFOqs7g%253D&md5=9c34770c007482e690fa7414974f9279</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060216x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060216x%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26atitle%3DDissecting%2520the%2520Determinants%2520of%2520Cyclin-Dependent%2520Kinase%25202%2520and%2520Cyclin-Dependent%2520Kinase%25204%2520Inhibitor%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5470%26epage%3D5477%26doi%3D10.1021%2Fjm060216x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">Probing the ATP Ribose-Binding Domain of Cyclin-Dependent Kinases 1 and 2 with O(6)-Substituted Guanine Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3381</span><span class="NLM_x">–</span> <span class="NLM_lpage">3393</span><span class="refDoi"> DOI: 10.1021/jm020056z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020056z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3381-3393&author=A.+E.+Gibsonauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=N.+J.+Curtinauthor=T.+G.+Daviesauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=J.+A.+Tuckerauthor=H.+J.+Whitfield&title=Probing+the+ATP+Ribose-Binding+Domain+of+Cyclin-Dependent+Kinases+1+and+2+with+O%286%29-Substituted+Guanine+Derivatives&doi=10.1021%2Fjm020056z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm020056z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020056z%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DProbing%2520the%2520ATP%2520Ribose-Binding%2520Domain%2520of%2520Cyclin-Dependent%2520Kinases%25201%2520and%25202%2520with%2520O%25286%2529-Substituted%2520Guanine%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3381%26epage%3D3393%26doi%3D10.1021%2Fjm020056z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Montgomery, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewson, K.</span><span> </span><span class="NLM_article-title">Synthesis of Potential Anticancer Agents XX. 2-Fluoropurines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1021/ja01487a055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01487a055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1960&pages=463-468&author=J.+A.+Montgomeryauthor=K.+Hewson&title=Synthesis+of+Potential+Anticancer+Agents+XX.+2-Fluoropurines&doi=10.1021%2Fja01487a055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja01487a055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01487a055%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DHewson%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520Potential%2520Anticancer%2520Agents%2520XX.%25202-Fluoropurines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1960%26volume%3D82%26spage%3D463%26epage%3D468%26doi%3D10.1021%2Fja01487a055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Carbain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebraud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meschini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Trifluoroacetic Acid in 2,2,2-Trifluoroethanol Facilitates S<sub>N</sub>Ar Reactions of Heterocycles with Arylamines</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2317</span><span class="refDoi"> DOI: 10.1002/chem.201304336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fchem.201304336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=24458729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12jurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=2311-2317&author=B.+Carbainauthor=C.+R.+Coxonauthor=H.+Lebraudauthor=K.+J.+Elliottauthor=C.+J.+Mathesonauthor=E.+Meschiniauthor=A.+R.+Robertsauthor=D.+M.+Turnerauthor=C.+Wongauthor=C.+Canoauthor=R.+J.+Griffinauthor=I.+R.+Hardcastleauthor=B.+T.+Golding&title=Trifluoroacetic+Acid+in+2%2C2%2C2-Trifluoroethanol+Facilitates+SNAr+Reactions+of+Heterocycles+with+Arylamines&doi=10.1002%2Fchem.201304336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroacetic Acid in 2,2,2-Trifluoroethanol Facilitates SNAr Reactions of Heterocycles with Arylamines</span></div><div class="casAuthors">Carbain, Benoit; Coxon, Christopher R.; Lebraud, Honorine; Elliott, Kristopher J.; Matheson, Christopher J.; Meschini, Elisa; Roberts, Amy R.; Turner, David M.; Wong, Christopher; Cano, Celine; Griffin, Roger J.; Hardcastle, Ian R.; Golding, Bernard T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2311-2317</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Small-mol. drug discovery requires reliable synthetic methods for attaching amino compds. to heterocyclic scaffolds.  Trifluoroacetic acid-2,2,2-trifluoroethanol (TFA-TFE) is as an effective combination for achieving SNAr reactions between anilines and heterocycles (e.g., purines and pyrimidines) substituted with a leaving group (fluoro-, chloro-, bromo- or alkylsulfonyl).  This method provides a variety of compds. contg. a "kinase-privileged fragment" assocd. with potent inhibition of kinases.  TFE is an advantageous solvent because of its low nucleophilicity, ease of removal and ability to solubilize polar substrates.  Furthermore, TFE may assist the breakdown of the Meisenheimer-Jackson intermediate by solvating the leaving group.  TFA is a necessary and effective acidic catalyst, which activates the heterocycle by N-protonation without deactivating the aniline by conversion into an anilinium species.  The TFA-TFE methodol. is compatible with a variety of functional groups and complements organometallic alternatives, which are often disadvantageous because of the expense of reagents, the frequent need to explore diverse sets of reaction conditions, and problems with product purifn.  In contrast, product isolation from TFA-TFE reactions is straightforward: evapn. of the reaction mixt., basification and chromatog. affords anal. pure material.  A total of 45 examples, e.g., I, are described with seven discrete heterocyclic scaffolds and 2-, 3- and 4-substituted anilines giving product yields that are normally in the range 50-90 %.  Reactions can be performed with either conventional heating or microwave irradn., with the latter often giving improved yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaJWXELf9ezbVg90H21EOLACvtfcHk0lgQglNrH7QwRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12jurk%253D&md5=9340e85c3e81fe52595359a90c6bcbe2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fchem.201304336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201304336%26sid%3Dliteratum%253Aachs%26aulast%3DCarbain%26aufirst%3DB.%26aulast%3DCoxon%26aufirst%3DC.%2BR.%26aulast%3DLebraud%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DK.%2BJ.%26aulast%3DMatheson%26aufirst%3DC.%2BJ.%26aulast%3DMeschini%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DA.%2BR.%26aulast%3DTurner%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DCano%26aufirst%3DC.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DTrifluoroacetic%2520Acid%2520in%25202%252C2%252C2-Trifluoroethanol%2520Facilitates%2520SNAr%2520Reactions%2520of%2520Heterocycles%2520with%2520Arylamines%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D2311%26epage%3D2317%26doi%3D10.1002%2Fchem.201304336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Lembicz, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Facilitation of Displacements at the 6-Position of Purines by the Use of 1,4-Diazabicyclo[2.2.2.]octane as Leaving Group</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1039/a608207f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1039%2Fa608207f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=185-186&author=N.+K.+Lembiczauthor=S.+Grantauthor=W.+Cleggauthor=R.+J.+Griffinauthor=S.+L.+Heathauthor=B.+T.+Golding&title=Facilitation+of+Displacements+at+the+6-Position+of+Purines+by+the+Use+of+1%2C4-Diazabicyclo%5B2.2.2.%5Doctane+as+Leaving+Group&doi=10.1039%2Fa608207f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fa608207f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa608207f%26sid%3Dliteratum%253Aachs%26aulast%3DLembicz%26aufirst%3DN.%2BK.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DClegg%26aufirst%3DW.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHeath%26aufirst%3DS.%2BL.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DFacilitation%2520of%2520Displacements%2520at%2520the%25206-Position%2520of%2520Purines%2520by%2520the%2520Use%2520of%25201%252C4-Diazabicyclo%255B2.2.2.%255Doctane%2520as%2520Leaving%2520Group%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1997%26spage%3D185%26epage%3D186%26doi%3D10.1039%2Fa608207f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Roch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursulaya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">Gene Expression Signatures and Small-Molecule Compounds Link a Protein Kinase to Plasmodium Falciparum Motility</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1038/nchembio.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnchembio.87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=18454143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=347-356&author=N.+Katoauthor=T.+Sakataauthor=G.+Bretonauthor=K.+G.+Le+Rochauthor=A.+Nagleauthor=C.+Andersenauthor=B.+Bursulayaauthor=K.+Hensonauthor=J.+Johnsonauthor=K.+A.+Kumarauthor=F.+Marrauthor=D.+Masonauthor=C.+McNamaraauthor=D.+Plouffeauthor=V.+Ramachandranauthor=M.+Spoonerauthor=T.+Tuntlandauthor=Y.+Zhouauthor=E.+C.+Petersauthor=A.+Chatterjeeauthor=P.+G.+Schultzauthor=G.+E.+Wardauthor=N.+Grayauthor=J.+Harperauthor=E.+A.+Winzeler&title=Gene+Expression+Signatures+and+Small-Molecule+Compounds+Link+a+Protein+Kinase+to+Plasmodium+Falciparum+Motility&doi=10.1038%2Fnchembio.87"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility</span></div><div class="casAuthors">Kato, Nobutaka; Sakata, Tomoyo; Breton, Ghislain; Le Roch, Karine G.; Nagle, Advait; Andersen, Carsten; Bursulaya, Badry; Henson, Kerstin; Johnson, Jeffrey; Kumar, Kota Arun; Marr, Felix; Mason, Daniel; McNamara, Case; Plouffe, David; Ramachandran, Vandana; Spooner, Muriel; Tuntland, Tove; Zhou, Yingyao; Peters, Eric C.; Chatterjee, Arnab; Schultz, Peter G.; Ward, Gary E.; Gray, Nathanael; Harper, Jeffrey; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-dependent protein kinases play a crucial role in intracellular calcium signaling in plants, some algae and protozoa.  In Plasmodium falciparum, calcium-dependent protein kinase 1 (PfCDPK1) is expressed during schizogony in the erythrocytic stage as well as in the sporozoite stage.  It is coexpressed with genes that encode the parasite motor complex, a cellular component required for parasite invasion of host cells, parasite motility and potentially cytokinesis.  A targeted gene-disruption approach demonstrated that pfcdpk1 seems to be essential for parasite viability.  An in vitro biochem. screen using recombinant PfCDPK1 against a library of 20,000 compds. resulted in the identification of a series of structurally related 2,6,9-trisubstituted purines.  Compd. treatment caused sudden developmental arrest at the late schizont stage in P. falciparum and a large redn. in intracellular parasites in Toxoplasma gondii, which suggests a possible role for PfCDPK1 in regulation of parasite motility during egress and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtzj1uwvk0LVg90H21EOLACvtfcHk0lh1eU_IR25e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFOisro%253D&md5=79c632fdd4cc704b366e2fcd44c242c4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.87%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DN.%26aulast%3DSakata%26aufirst%3DT.%26aulast%3DBreton%26aufirst%3DG.%26aulast%3DLe%2BRoch%26aufirst%3DK.%2BG.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DC.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DHenson%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%2BA.%26aulast%3DMarr%26aufirst%3DF.%26aulast%3DMason%26aufirst%3DD.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DSpooner%26aufirst%3DM.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWard%26aufirst%3DG.%2BE.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DHarper%26aufirst%3DJ.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DGene%2520Expression%2520Signatures%2520and%2520Small-Molecule%2520Compounds%2520Link%2520a%2520Protein%2520Kinase%2520to%2520Plasmodium%2520Falciparum%2520Motility%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D347%26epage%3D356%26doi%3D10.1038%2Fnchembio.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormisky, P. E.</span><span> </span><span class="NLM_article-title">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">7481</span><span class="NLM_x">–</span> <span class="NLM_lpage">7485</span><span class="refDoi"> DOI: 10.1021/jo801269m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801269m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=7481-7485&author=G.+A.+Molanderauthor=P.+E.+Gormisky&title=Cross-Coupling+of+Cyclopropyl-+and+Cyclobutyltrifluoroborates+with+Aryl+and+Heteroaryl+Chlorides&doi=10.1021%2Fjo801269m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span></div><div class="casAuthors">Molander, Gary A.; Gormisky, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7481-7485</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Suitable conditions were found for the Suzuki-Miyaura cross-coupling reaction of potassium cyclopropyl- and cyclobutyltrifluoroborates with aryl chlorides.  Both of these secondary alkyl trifluoroborates coupled in moderate to excellent yield with electron-rich, electron-poor, and hindered aryl chlorides to give a variety of substituted aryl cyclopropanes and cyclobutanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6VymYqSga5rVg90H21EOLACvtfcHk0lh1eU_IR25e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF&md5=575a47623b0f8fd598563f41b81e3564</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo801269m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801269m%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DGormisky%26aufirst%3DP.%2BE.%26atitle%3DCross-Coupling%2520of%2520Cyclopropyl-%2520and%2520Cyclobutyltrifluoroborates%2520with%2520Aryl%2520and%2520Heteroaryl%2520Chlorides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D7481%26epage%3D7485%26doi%3D10.1021%2Fjo801269m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Temple, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">Preparation of 2,5-Diamino-4,6-dichloropyrimidine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3141</span><span class="NLM_x">–</span> <span class="NLM_lpage">3142</span><span class="refDoi"> DOI: 10.1021/jo00909a030</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00909a030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=3141-3142&author=C.+Templeauthor=B.+H.+Smithauthor=J.+A.+Montgomery&title=Preparation+of+2%2C5-Diamino-4%2C6-dichloropyrimidine&doi=10.1021%2Fjo00909a030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo00909a030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00909a030%26sid%3Dliteratum%253Aachs%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DPreparation%2520of%25202%252C5-Diamino-4%252C6-dichloropyrimidine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D3141%26epage%3D3142%26doi%3D10.1021%2Fjo00909a030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Shealy, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">v-Triazolo[4,5-d]pyramidines. II. O-Substituted Derivatives of 8-Azaguanine and 8-Azahypoxanthine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4518</span><span class="NLM_x">–</span> <span class="NLM_lpage">4523</span><span class="refDoi"> DOI: 10.1021/jo01059a096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01059a096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1962&pages=4518-4523&author=Y.+F.+Shealyauthor=J.+D.+Claytonauthor=C.+A.+O%E2%80%99Dellauthor=J.+A.+Montgomery&title=v-Triazolo%5B4%2C5-d%5Dpyramidines.+II.+O-Substituted+Derivatives+of+8-Azaguanine+and+8-Azahypoxanthine&doi=10.1021%2Fjo01059a096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo01059a096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01059a096%26sid%3Dliteratum%253Aachs%26aulast%3DShealy%26aufirst%3DY.%2BF.%26aulast%3DClayton%26aufirst%3DJ.%2BD.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DC.%2BA.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3Dv-Triazolo%255B4%252C5-d%255Dpyramidines.%2520II.%2520O-Substituted%2520Derivatives%2520of%25208-Azaguanine%2520and%25208-Azahypoxanthine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1962%26volume%3D27%26spage%3D4518%26epage%3D4523%26doi%3D10.1021%2Fjo01059a096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Seela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steker, H.</span><span> </span><span class="NLM_article-title">Synthesis of 2′-Deoxyribofuranosides of 8-Aza-7-deazaguanine and Related Pyrazolo[3,4-d]pyrimidines</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1613</span><span class="refDoi"> DOI: 10.1002/hlca.19860690714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fhlca.19860690714" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1986&pages=1602-1613&author=F.+Seelaauthor=H.+Steker&title=Synthesis+of+2%E2%80%B2-Deoxyribofuranosides+of+8-Aza-7-deazaguanine+and+Related+Pyrazolo%5B3%2C4-d%5Dpyrimidines&doi=10.1002%2Fhlca.19860690714"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19860690714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19860690714%26sid%3Dliteratum%253Aachs%26aulast%3DSeela%26aufirst%3DF.%26aulast%3DSteker%26aufirst%3DH.%26atitle%3DSynthesis%2520of%25202%25E2%2580%25B2-Deoxyribofuranosides%2520of%25208-Aza-7-deazaguanine%2520and%2520Related%2520Pyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1986%26volume%3D69%26spage%3D1602%26epage%3D1613%26doi%3D10.1002%2Fhlca.19860690714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Brückl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knochel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carell, T.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of Deazaguanosine-Derived tRNA Nucleosides PreQ0, PreQ1, and Archaeosine Using the Turbo-Grignard Method</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">6517</span><span class="NLM_x">–</span> <span class="NLM_lpage">6519</span><span class="refDoi"> DOI: 10.1002/ejoc.201000987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fejoc.201000987" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=6517-6519&author=T.+Br%C3%BCcklauthor=I.+Thomaauthor=A.+J.+Wagnerauthor=P.+Knochelauthor=T.+Carell&title=Efficient+Synthesis+of+Deazaguanosine-Derived+tRNA+Nucleosides+PreQ0%2C+PreQ1%2C+and+Archaeosine+Using+the+Turbo-Grignard+Method&doi=10.1002%2Fejoc.201000987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201000987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201000987%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCckl%26aufirst%3DT.%26aulast%3DThoma%26aufirst%3DI.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DKnochel%26aufirst%3DP.%26aulast%3DCarell%26aufirst%3DT.%26atitle%3DEfficient%2520Synthesis%2520of%2520Deazaguanosine-Derived%2520tRNA%2520Nucleosides%2520PreQ0%252C%2520PreQ1%252C%2520and%2520Archaeosine%2520Using%2520the%2520Turbo-Grignard%2520Method%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2010%26volume%3D2010%26spage%3D6517%26epage%3D6519%26doi%3D10.1002%2Fejoc.201000987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Revankar, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Synthesis and Antimicrobial Activity of Certain Imidazo[1,2-a]pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1255</span><span class="refDoi"> DOI: 10.1021/jm00246a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00246a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADyaE28XisFOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=1253-1255&author=G.+R.+Revankarauthor=T.+R.+Matthewsauthor=R.+K.+Robins&title=Synthesis+and+Antimicrobial+Activity+of+Certain+Imidazo%5B1%2C2-a%5Dpyrimidines&doi=10.1021%2Fjm00246a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimicrobial activity of certain imidazo[1,2-a]pyrimidines</span></div><div class="casAuthors">Revankar, Ganapathi R.; Matthews, Thomas R.; Robins, Roland K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1253-5</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 5-substituted and 5,7-disubstituted imidazo[1,2-a]pyrimidines (I) were prepd. and the in vitro antimicrobial activity of these compds. against a variety of microorganisms tested.  5-N-octylaminoimidazo[1,2-a]pyrimidine [57473-44-6] exhibited significant activity against all the microorganisms tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkZLt9kjhi87Vg90H21EOLACvtfcHk0lgzYG62OFUDoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XisFOltQ%253D%253D&md5=74622577085276ae6061326835a19a2e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00246a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00246a018%26sid%3Dliteratum%253Aachs%26aulast%3DRevankar%26aufirst%3DG.%2BR.%26aulast%3DMatthews%26aufirst%3DT.%2BR.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520and%2520Antimicrobial%2520Activity%2520of%2520Certain%2520Imidazo%255B1%252C2-a%255Dpyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D1253%26epage%3D1255%26doi%3D10.1021%2Fjm00246a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsukura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niijima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horizoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span> </span><span class="NLM_article-title">2-Alkynyl-8-aryl-9-methyladenines as Novel Adenosine Receptor Antagonists: Their Synthesis and Structure-Activity Relationships Toward Hepatic Glucose Production Induced Via Agonism of the A(2B) Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1021/jm990499b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990499b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=170-179&author=H.+Haradaauthor=O.+Asanoauthor=Y.+Hoshinoauthor=S.+Yoshikawaauthor=M.+Matsukuraauthor=Y.+Kabasawaauthor=J.+Niijimaauthor=Y.+Kotakeauthor=N.+Watanabeauthor=T.+Kawataauthor=T.+Inoueauthor=T.+Horizoeauthor=N.+Yasudaauthor=H.+Minamiauthor=K.+Nagataauthor=M.+Murakamiauthor=J.+Nagaokaauthor=S.+Kobayashiauthor=I.+Tanakaauthor=S.+Abe&title=2-Alkynyl-8-aryl-9-methyladenines+as+Novel+Adenosine+Receptor+Antagonists%3A+Their+Synthesis+and+Structure-Activity+Relationships+Toward+Hepatic+Glucose+Production+Induced+Via+Agonism+of+the+A%282B%29+Receptor&doi=10.1021%2Fjm990499b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm990499b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990499b%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DO.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DMatsukura%26aufirst%3DM.%26aulast%3DKabasawa%26aufirst%3DY.%26aulast%3DNiijima%26aufirst%3DJ.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHorizoe%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DN.%26aulast%3DMinami%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DNagaoka%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DI.%26aulast%3DAbe%26aufirst%3DS.%26atitle%3D2-Alkynyl-8-aryl-9-methyladenines%2520as%2520Novel%2520Adenosine%2520Receptor%2520Antagonists%253A%2520Their%2520Synthesis%2520and%2520Structure-Activity%2520Relationships%2520Toward%2520Hepatic%2520Glucose%2520Production%2520Induced%2520Via%2520Agonism%2520of%2520the%2520A%25282B%2529%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D170%26epage%3D179%26doi%3D10.1021%2Fjm990499b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Rao, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D. E.</span><span> </span><span class="NLM_article-title">The Synthesis of Certain 5,7-Dihydroxyimidazo[1,2-α] pyrimidines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.1002/jhet.5570100626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fjhet.5570100626" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1973&pages=1021-1023&author=R.+P.+Raoauthor=R.+K.+Robinsauthor=D.+E.+O%E2%80%99Brien&title=The+Synthesis+of+Certain+5%2C7-Dihydroxyimidazo%5B1%2C2-%CE%B1%5D+pyrimidines&doi=10.1002%2Fjhet.5570100626"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570100626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570100626%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%2BP.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Synthesis%2520of%2520Certain%25205%252C7-Dihydroxyimidazo%255B1%252C2-%25CE%25B1%255D%2520pyrimidines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1973%26volume%3D10%26spage%3D1021%26epage%3D1023%26doi%3D10.1002%2Fjhet.5570100626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Revankar, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of some Nucleosides Resembling Guanosine: Imidazo[1,2-a]pyrimidine Nucleosides</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.1975.tb29221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1111%2Fj.1749-6632.1975.tb29221.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1975&pages=166-172&author=R.+R.+Revankarauthor=R.+K.+Robins&title=Synthesis+and+Biological+Activity+of+some+Nucleosides+Resembling+Guanosine%3A+Imidazo%5B1%2C2-a%5Dpyrimidine+Nucleosides&doi=10.1111%2Fj.1749-6632.1975.tb29221.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1975.tb29221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1975.tb29221.x%26sid%3Dliteratum%253Aachs%26aulast%3DRevankar%26aufirst%3DR.%2BR.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%2520some%2520Nucleosides%2520Resembling%2520Guanosine%253A%2520Imidazo%255B1%252C2-a%255Dpyrimidine%2520Nucleosides%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1975%26volume%3D255%26spage%3D166%26epage%3D172%26doi%3D10.1111%2Fj.1749-6632.1975.tb29221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span> </span><span class="NLM_article-title">Preclinical In Vitro and In Vivo Evaluation of the Potent and Specific Cyclin-Dependent Kinase 2 Inhibitor NU6102 and a Water Soluble Prodrug NU6301</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2052</span><span class="NLM_x">–</span> <span class="NLM_lpage">2059</span><span class="refDoi"> DOI: 10.1016/j.ejca.2011.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.ejca.2011.04.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2052-2059&author=H.+D.+Thomasauthor=L.-Z.+Wangauthor=C.+Rocheauthor=J.+Bentleyauthor=Y.+Chengauthor=I.+R.+Hardcastleauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=N.+J.+Curtinauthor=D.+R.+Newell&title=Preclinical+In+Vitro+and+In+Vivo+Evaluation+of+the+Potent+and+Specific+Cyclin-Dependent+Kinase+2+Inhibitor+NU6102+and+a+Water+Soluble+Prodrug+NU6301&doi=10.1016%2Fj.ejca.2011.04.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2011.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2011.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DWang%26aufirst%3DL.-Z.%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26atitle%3DPreclinical%2520In%2520Vitro%2520and%2520In%2520Vivo%2520Evaluation%2520of%2520the%2520Potent%2520and%2520Specific%2520Cyclin-Dependent%2520Kinase%25202%2520Inhibitor%2520NU6102%2520and%2520a%2520Water%2520Soluble%2520Prodrug%2520NU6301%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D2052%26epage%3D2059%26doi%3D10.1016%2Fj.ejca.2011.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Brown, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korolchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moukhametzianov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span> </span><span class="NLM_article-title">CDK1 Structures Reveal Conserved and Unique Features of the Essential Cell Cycle CDK</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6769</span><span class="NLM_x">–</span> <span class="NLM_lpage">6780</span><span class="refDoi"> DOI: 10.1038/ncomms7769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fncomms7769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25864384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2itLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6769-6780&author=N.+R.+Brownauthor=S.+Korolchukauthor=M.+P.+Martinauthor=W.+A.+Stanleyauthor=R.+Moukhametzianovauthor=M.+E.+M.+Nobleauthor=J.+A.+Endicott&title=CDK1+Structures+Reveal+Conserved+and+Unique+Features+of+the+Essential+Cell+Cycle+CDK&doi=10.1038%2Fncomms7769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">CDK1 structures reveal conserved and unique features of the essential cell cycle CDK</span></div><div class="casAuthors">Brown, Nicholas R.; Korolchuk, Svitlana; Martin, Mathew P.; Stanley, Will A.; Moukhametzianov, Rouslan; Noble, Martin E. M.; Endicott, Jane A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6769</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CDK1 is the only essential cell cycle CDK in human cells and is required for successful completion of M-phase.  It is the founding member of the CDK family and is conserved across all eukaryotes.  Here we report the crystal structures of complexes of CDK1-Cks1 and CDK1-cyclin B-Cks2.  These structures confirm the conserved nature of the inactive monomeric CDK fold and its ability to be remodelled by cyclin binding.  Relative to CDK2-cyclin A, CDK1-cyclin B is less thermally stable, has a smaller interfacial surface, is more susceptible to activation segment dephosphorylation and shows differences in the substrate sequence features that det. activity.  Both CDK1 and CDK2 are potential cancer targets for which selective compds. are required.  We also describe the first structure of CDK1 bound to a potent ATP-competitive inhibitor and identify aspects of CDK1 structure and plasticity that might be exploited to develop CDK1-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojjBjB0sd2dLVg90H21EOLACvtfcHk0lhKmgj6S2khgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2itLvM&md5=af77d3ad7127139a492cb631362712a5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fncomms7769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7769%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BR.%26aulast%3DKorolchuk%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DStanley%26aufirst%3DW.%2BA.%26aulast%3DMoukhametzianov%26aufirst%3DR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26atitle%3DCDK1%2520Structures%2520Reveal%2520Conserved%2520and%2520Unique%2520Features%2520of%2520the%2520Essential%2520Cell%2520Cycle%2520CDK%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6769%26epage%3D6780%26doi%3D10.1038%2Fncomms7769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Beach, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nampalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. K.</span><span> </span><span class="NLM_article-title">A Highly Stereoselective Synthesis of Anti-HIV 2′,3′-Dideoxy- and 2′,3′-Didehydro-2′,3′-dideoxynucleosides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3887</span><span class="NLM_x">–</span> <span class="NLM_lpage">3894</span><span class="refDoi"> DOI: 10.1021/jo00040a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00040a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1Ojsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=3887-3894&author=J.+W.+Beachauthor=H.+O.+Kimauthor=L.+S.+Jeongauthor=S.+Nampalliauthor=Q.+Islamauthor=S.+K.+Ahnauthor=J.+R.+Babuauthor=C.+K.+Chu&title=A+Highly+Stereoselective+Synthesis+of+Anti-HIV+2%E2%80%B2%2C3%E2%80%B2-Dideoxy-+and+2%E2%80%B2%2C3%E2%80%B2-Didehydro-2%E2%80%B2%2C3%E2%80%B2-dideoxynucleosides&doi=10.1021%2Fjo00040a031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A highly stereoselective synthesis of anti-HIV 2',3'-dideoxy- and 2',3'-didehydro-2',3'-dideoxynucleosides</span></div><div class="casAuthors">Beach, J. Warren; Kim, Hea O.; Jeong, Lak S.; Nampalli, Satyanarayana; Islam, Qamrul; Ahn, Soon K.; Babu, J. Ramesh; Chu, Chung K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3887-94</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A general total synthetic method for the stereocontrolled synthesis of 2',3'-dideoxy- and 2',3'-didehydro-2',3'-dideoxynucleosides, is presented.  Introduction of an α-phenylselenenyl group at the 2-position of 2,3-dideoxyribosyl acetate directs the glycosyl bond formation to give ≥95% β-isomer.  This 2'-phenylselenenyl nucleoside may be converted to either the 2',3'-dideoxynucleoside by treatment with n-Bu3SnH and Et3B at room temp. or to the unsatd. deriv. by treatment with H2O2/cat. pyridine.  The application of this method to the syntheses of pyrimidines (ddU, ddT, ddC), 6-substituted purines (ddA, ddT, 6-chloro-ddP, N6-Me-ddA), and 2,6-disubstituted pruines(2-F-ddA, 6-chloro-2-amino-ddP) as well as selected 2',3'-didehydro-2',3'-dideoxy derivs., is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWpyT9XTv7X7Vg90H21EOLACvtfcHk0lhKmgj6S2khgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1Ojsbg%253D&md5=c757042948e3dfc3fdc661b3774c545f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo00040a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00040a031%26sid%3Dliteratum%253Aachs%26aulast%3DBeach%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DNampalli%26aufirst%3DS.%26aulast%3DIslam%26aufirst%3DQ.%26aulast%3DAhn%26aufirst%3DS.%2BK.%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DChu%26aufirst%3DC.%2BK.%26atitle%3DA%2520Highly%2520Stereoselective%2520Synthesis%2520of%2520Anti-HIV%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Dideoxy-%2520and%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Didehydro-2%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxynucleosides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D3887%26epage%3D3894%26doi%3D10.1021%2Fjo00040a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Baumgarten, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. M.</span><span> </span><span class="NLM_article-title">Reactions of Amines. V. Synthesis of α-Amino Ketones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1021/ja01487a054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01487a054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1960&pages=459-463&author=H.+E.+Baumgartenauthor=J.+M.+Petersen&title=Reactions+of+Amines.+V.+Synthesis+of+%CE%B1-Amino+Ketones&doi=10.1021%2Fja01487a054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja01487a054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01487a054%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgarten%26aufirst%3DH.%2BE.%26aulast%3DPetersen%26aufirst%3DJ.%2BM.%26atitle%3DReactions%2520of%2520Amines.%2520V.%2520Synthesis%2520of%2520%25CE%25B1-Amino%2520Ketones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1960%26volume%3D82%26spage%3D459%26epage%3D463%26doi%3D10.1021%2Fja01487a054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Kos, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongejan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Plas, H. C.</span><span> </span><span class="NLM_article-title">Deamination, Involving Ring Opening, in Reactions of 1-Aminopurinium Mesitylenesulfonates with Methanolic Ammonia</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4841</span><span class="NLM_x">–</span> <span class="NLM_lpage">4848</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)87667-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2FS0040-4020%2801%2987667-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=4841-4848&author=N.+J.+Kosauthor=H.+Jongejanauthor=H.+C.+Van+Der+Plas&title=Deamination%2C+Involving+Ring+Opening%2C+in+Reactions+of+1-Aminopurinium+Mesitylenesulfonates+with+Methanolic+Ammonia&doi=10.1016%2FS0040-4020%2801%2987667-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2987667-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252987667-5%26sid%3Dliteratum%253Aachs%26aulast%3DKos%26aufirst%3DN.%2BJ.%26aulast%3DJongejan%26aufirst%3DH.%26aulast%3DVan%2BDer%2BPlas%26aufirst%3DH.%2BC.%26atitle%3DDeamination%252C%2520Involving%2520Ring%2520Opening%252C%2520in%2520Reactions%2520of%25201-Aminopurinium%2520Mesitylenesulfonates%2520with%2520Methanolic%2520Ammonia%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D4841%26epage%3D4848%26doi%3D10.1016%2FS0040-4020%2801%2987667-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Balsiger, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">Synthesis of Potential Anticancer Agents. XXV. Preparation of 6-Alkoxy-2-aminopurines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1573</span><span class="NLM_x">–</span> <span class="NLM_lpage">1575</span><span class="refDoi"> DOI: 10.1021/jo01079a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01079a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1960&pages=1573-1575&author=R.+W.+Balsigerauthor=J.+A.+Montgomery&title=Synthesis+of+Potential+Anticancer+Agents.+XXV.+Preparation+of+6-Alkoxy-2-aminopurines&doi=10.1021%2Fjo01079a026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo01079a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01079a026%26sid%3Dliteratum%253Aachs%26aulast%3DBalsiger%26aufirst%3DR.%2BW.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520of%2520Potential%2520Anticancer%2520Agents.%2520XXV.%2520Preparation%2520of%25206-Alkoxy-2-aminopurines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1960%26volume%3D25%26spage%3D1573%26epage%3D1575%26doi%3D10.1021%2Fjo01079a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasdale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanugula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lembicz, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Resistance-Modifying Agents. 8. Inhibition of O(6)-Alkylguanine-DNA Alkyltransferase by O(6)-Alkenyl-, O(6)-Cycloalkenyl-, and O(6)-(2-Oxoalkyl)guanines and Potentiation of Temozolomide Cytotoxicity In Vitro by O(6)-(1-Cyclopentenylmethyl)guanine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4071</span><span class="NLM_x">–</span> <span class="NLM_lpage">4083</span><span class="refDoi"> DOI: 10.1021/jm000961o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000961o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4071-4083&author=R.+J.+Griffinauthor=C.+E.+Arrisauthor=C.+Bleasdaleauthor=F.+T.+Boyleauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=C.+Dalbyauthor=S.+Kanugulaauthor=N.+K.+Lembiczauthor=D.+R.+Newellauthor=A.+E.+Peggauthor=B.+T.+Golding&title=Resistance-Modifying+Agents.+8.+Inhibition+of+O%286%29-Alkylguanine-DNA+Alkyltransferase+by+O%286%29-Alkenyl-%2C+O%286%29-Cycloalkenyl-%2C+and+O%286%29-%282-Oxoalkyl%29guanines+and+Potentiation+of+Temozolomide+Cytotoxicity+In+Vitro+by+O%286%29-%281-Cyclopentenylmethyl%29guanine&doi=10.1021%2Fjm000961o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm000961o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000961o%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBleasdale%26aufirst%3DC.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DDalby%26aufirst%3DC.%26aulast%3DKanugula%26aufirst%3DS.%26aulast%3DLembicz%26aufirst%3DN.%2BK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DResistance-Modifying%2520Agents.%25208.%2520Inhibition%2520of%2520O%25286%2529-Alkylguanine-DNA%2520Alkyltransferase%2520by%2520O%25286%2529-Alkenyl-%252C%2520O%25286%2529-Cycloalkenyl-%252C%2520and%2520O%25286%2529-%25282-Oxoalkyl%2529guanines%2520and%2520Potentiation%2520of%2520Temozolomide%2520Cytotoxicity%2520In%2520Vitro%2520by%2520O%25286%2529-%25281-Cyclopentenylmethyl%2529guanine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4071%26epage%3D4083%26doi%3D10.1021%2Fjm000961o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Evans, P. R.</span><span> </span><span class="NLM_article-title">An Introduction to Data Reduction: Space-Group Determination, Scaling and Intensity Statistics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1107/S090744491003982X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS090744491003982X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=282-292&author=P.+R.+Evans&title=An+Introduction+to+Data+Reduction%3A+Space-Group+Determination%2C+Scaling+and+Intensity+Statistics&doi=10.1107%2FS090744491003982X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">An introduction to data reduction: Space-group determination, scaling and intensity statistics</span></div><div class="casAuthors">Evans, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">282-292</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  This paper presents an overview of how to run the CCP4 programs for data redn. (SCALA, POINTLESS and CTRUNCATE) through the CCP4 graphical interface ccp4i and points out some issues that need to be considered, together with a few examples.  It covers detn. of the point-group symmetry of the diffraction data (the Laue group), which is required for the subsequent scaling step, examn. of systematic absences, which in many cases will allow inference of the space group, putting multiple data sets on a common indexing system when there are alternatives, the scaling step itself, which produces a large set of data-quality indicators, estn. of |F| from intensity and finally examn. of intensity statistics to detect crystal pathologies such as twinning.  An appendix outlines the scoring schemes used by the program POINTLESS to assign probabilities to possible Laue and space groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEq8RhfQOW8LVg90H21EOLACvtfcHk0ljsJK1eg8ElRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D&md5=f425388a87744d721d324118d50e4f9a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS090744491003982X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491003982X%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26atitle%3DAn%2520Introduction%2520to%2520Data%2520Reduction%253A%2520Space-Group%2520Determination%252C%2520Scaling%2520and%2520Intensity%2520Statistics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D282%26epage%3D292%26doi%3D10.1107%2FS090744491003982X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+J.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0ljsJK1eg8ElRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Potterton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkenburg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E.</span><span> </span><span class="NLM_article-title">A Graphical User Interface to the CCP4 Program Suite</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">D59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span><span class="refDoi"> DOI: 10.1107/S0907444903008126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444903008126" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D59&publication_year=2003&pages=1131-1137&author=E.+Pottertonauthor=P.+Briggsauthor=M.+Turkenburgauthor=E.+Dodson&title=A+Graphical+User+Interface+to+the+CCP4+Program+Suite&doi=10.1107%2FS0907444903008126"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0907444903008126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444903008126%26sid%3Dliteratum%253Aachs%26aulast%3DPotterton%26aufirst%3DE.%26aulast%3DBriggs%26aufirst%3DP.%26aulast%3DTurkenburg%26aufirst%3DM.%26aulast%3DDodson%26aufirst%3DE.%26atitle%3DA%2520Graphical%2520User%2520Interface%2520to%2520the%2520CCP4%2520Program%2520Suite%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2003%26volume%3DD59%26spage%3D1131%26epage%3D1137%26doi%3D10.1107%2FS0907444903008126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser Crystallographic Software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+Crystallographic+Software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0ljUKTsRS4tRbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520Crystallographic%2520Software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljUKTsRS4tRbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Liklihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Liklihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Liklihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 45 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Phani Ghanakota, Pieter H. Bos, Kyle D. Konze, Joshua Staker, Gabriel Marques, Kyle Marshall, Karl Leswing, Robert Abel, <span class="NLM_string-name hlFld-ContribAuthor">Sathesh Bhat</span>. </span><span class="cited-content_cbyCitation_article-title">Combining Cloud-Based Free-Energy Calculations, Synthetically Aware Enumerations, and Goal-Directed Generative Machine Learning for Rapid Large-Scale Chemical Exploration and Optimization. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (9)
                                     , 4311-4325. <a href="https://doi.org/10.1021/acs.jcim.0c00120" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c00120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c00120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c00120%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DCombining%252BCloud-Based%252BFree-Energy%252BCalculations%25252C%252BSynthetically%252BAware%252BEnumerations%25252C%252Band%252BGoal-Directed%252BGenerative%252BMachine%252BLearning%252Bfor%252BRapid%252BLarge-Scale%252BChemical%252BExploration%252Band%252BOptimization%26aulast%3DGhanakota%26aufirst%3DPhani%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D31012020%26date%3D19062020%26date%3D02062020%26volume%3D60%26issue%3D9%26spage%3D4311%26epage%3D4325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yang Wang, Xing Chen, Yaoyao Yan, Xiaochen Zhu, Mingming Liu, <span class="NLM_string-name hlFld-ContribAuthor">Xinhua Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SARs of 5-Chloro-N4-phenyl-N2-(pyridin-2-yl)pyrimidine-2,4-diamine Derivatives as Oral Available and Dual CDK 6 and 9 Inhibitors with Potent Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 3327-3347. <a href="https://doi.org/10.1021/acs.jmedchem.9b02121" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b02121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b02121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b02121%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BSARs%252Bof%252B5-Chloro-N4-phenyl-N2-%252528pyridin-2-yl%252529pyrimidine-2%25252C4-diamine%252BDerivatives%252Bas%252BOral%252BAvailable%252Band%252BDual%252BCDK%252B6%252Band%252B9%252BInhibitors%252Bwith%252BPotent%252BAntitumor%252BActivity%26aulast%3DWang%26aufirst%3DYang%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D20122019%26date%3D12032020%26date%3D04032020%26volume%3D63%26issue%3D6%26spage%3D3327%26epage%3D3347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Joseph Katigbak, Haotian Li, David Rooklin, <span class="NLM_string-name hlFld-ContribAuthor">Yingkai Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">AlphaSpace 2.0: Representing Concave Biomolecular Surfaces Using β-Clusters. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (3)
                                     , 1494-1508. <a href="https://doi.org/10.1021/acs.jcim.9b00652" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00652</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00652&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00652%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAlphaSpace%252B2.0%25253A%252BRepresenting%252BConcave%252BBiomolecular%252BSurfaces%252BUsing%252B%2525CE%2525B2-Clusters%26aulast%3DKatigbak%26aufirst%3DJoseph%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D04082019%26date%3D11022020%26date%3D29012020%26volume%3D60%26issue%3D3%26spage%3D1494%26epage%3D1508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Piotr Leonczak, Puneet Srivastava, Omprakash Bande, Guy Schepers, Eveline Lescrinier, <span class="NLM_string-name hlFld-ContribAuthor">Piet Herdewijn</span>. </span><span class="cited-content_cbyCitation_article-title">N8-Glycosylated 8-Azapurine and Methylated Purine Nucleobases: Synthesis and Study of Base Pairing Properties. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (21)
                                     , 13394-13409. <a href="https://doi.org/10.1021/acs.joc.9b01576" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01576</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01576&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01576%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DN8-Glycosylated%252B8-Azapurine%252Band%252BMethylated%252BPurine%252BNucleobases%25253A%252BSynthesis%252Band%252BStudy%252Bof%252BBase%252BPairing%252BProperties%26aulast%3DLeonczak%26aufirst%3DPiotr%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13062019%26date%3D16102019%26volume%3D84%26issue%3D21%26spage%3D13394%26epage%3D13409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kyle D. Konze, Pieter H. Bos, Markus K. Dahlgren, Karl Leswing, Ivan Tubert-Brohman, Andrea Bortolato, Braxton Robbason, Robert Abel, <span class="NLM_string-name hlFld-ContribAuthor">Sathesh Bhat</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction-Based Enumeration, Active Learning, and Free Energy Calculations To Rapidly Explore Synthetically Tractable Chemical Space and Optimize Potency of Cyclin-Dependent Kinase 2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (9)
                                     , 3782-3793. <a href="https://doi.org/10.1021/acs.jcim.9b00367" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00367</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00367&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00367%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DReaction-Based%252BEnumeration%25252C%252BActive%252BLearning%25252C%252Band%252BFree%252BEnergy%252BCalculations%252BTo%252BRapidly%252BExplore%252BSynthetically%252BTractable%252BChemical%252BSpace%252Band%252BOptimize%252BPotency%252Bof%252BCyclin-Dependent%252BKinase%252B2%252BInhibitors%26aulast%3DKonze%26aufirst%3DKyle%2BD.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30042019%26date%3D22082019%26date%3D12082019%26volume%3D59%26issue%3D9%26spage%3D3782%26epage%3D3793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Solomon Tadesse, Elizabeth C. Caldon, Wayne Tilley, <span class="NLM_string-name hlFld-ContribAuthor">Shudong Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4233-4251. <a href="https://doi.org/10.1021/acs.jmedchem.8b01469" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01469%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCyclin-Dependent%252BKinase%252B2%252BInhibitors%252Bin%252BCancer%252BTherapy%25253A%252BAn%252BUpdate%26aulast%3DTadesse%26aufirst%3DSolomon%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D20092018%26date%3D20122018%26date%3D13122018%26volume%3D62%26issue%3D9%26spage%3D4233%26epage%3D4251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jianzhong Chen, Xingyu Wang, John Z. H. Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Tong Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of Substituents in Different Positions of Aminothiazole Hinge-Binding Scaffolds on Inhibitor–CDK2 Association Probed by Interaction Entropy Method. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2018,</strong> <em>3 </em>
                                    (12)
                                     , 18052-18064. <a href="https://doi.org/10.1021/acsomega.8b02354" title="DOI URL">https://doi.org/10.1021/acsomega.8b02354</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.8b02354&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.8b02354%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DEffect%252Bof%252BSubstituents%252Bin%252BDifferent%252BPositions%252Bof%252BAminothiazole%252BHinge-Binding%252BScaffolds%252Bon%252BInhibitor%2525E2%252580%252593CDK2%252BAssociation%252BProbed%252Bby%252BInteraction%252BEntropy%252BMethod%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D11092018%26date%3D15112018%26volume%3D3%26issue%3D12%26spage%3D18052%26epage%3D18064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Radek Jorda, Denisa Hendrychová, Jiří Voller, Eva Řezníčková, Tomáš Gucký, <span class="NLM_string-name hlFld-ContribAuthor">Vladimír Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9105-9120. <a href="https://doi.org/10.1021/acs.jmedchem.8b00049" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00049</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00049%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHow%252BSelective%252BAre%252BPharmacological%252BInhibitors%252Bof%252BCell-Cycle-Regulating%252BCyclin-Dependent%252BKinases%25253F%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31012018%26date%3D05102018%26date%3D20092018%26volume%3D61%26issue%3D20%26spage%3D9105%26epage%3D9120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Nashrah
Sharif Khan, Parvez Khan, Mohammad Fawad Ansari, Saurabha Srivastava, Gulam Mustafa Hasan, Mohammad Husain, <span class="NLM_string-name hlFld-ContribAuthor">Md. Imtaiyaz Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Thienopyrimidine–Chalcone Hybrid Molecules Inhibit Fas-Activated Serine/Threonine Kinase: An Approach To Ameliorate Antiproliferation in Human Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2018,</strong> <em>15 </em>
                                    (9)
                                     , 4173-4189. <a href="https://doi.org/10.1021/acs.molpharmaceut.8b00566" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.8b00566</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.8b00566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.8b00566%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DThienopyrimidine%2525E2%252580%252593Chalcone%252BHybrid%252BMolecules%252BInhibit%252BFas-Activated%252BSerine%25252FThreonine%252BKinase%25253A%252BAn%252BApproach%252BTo%252BAmeliorate%252BAntiproliferation%252Bin%252BHuman%252BBreast%252BCancer%252BCells%26aulast%3DKhan%26aufirst%3DNashrah%2BSharif%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D31052018%26date%3D24072018%26date%3D23072018%26date%3D07082018%26date%3D24072018%26volume%3D15%26issue%3D9%26spage%3D4173%26epage%3D4189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.S.  Liang</span>, <span class="hlFld-ContribAuthor ">X.G.  Liu</span>, <span class="hlFld-ContribAuthor ">Y.X.  Cui</span>, <span class="hlFld-ContribAuthor ">S.L.  Zhang</span>, <span class="hlFld-ContribAuthor ">Q.G.  Zhang</span>, <span class="hlFld-ContribAuthor ">J.Z.  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular mechanism concerning conformational changes of CDK2 mediated by binding of inhibitors using molecular dynamics simulations and principal component analysis. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2021,</strong> <em>32 </em>
                                    (7)
                                     , 573-594. <a href="https://doi.org/10.1080/1062936X.2021.1934896" title="DOI URL">https://doi.org/10.1080/1062936X.2021.1934896</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2021.1934896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2021.1934896%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DMolecular%252Bmechanism%252Bconcerning%252Bconformational%252Bchanges%252Bof%252BCDK2%252Bmediated%252Bby%252Bbinding%252Bof%252Binhibitors%252Busing%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Bprincipal%252Bcomponent%252Banalysis%26aulast%3DLiang%26aufirst%3DS.S.%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D7%26spage%3D573%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kimberly A.  Casalvieri</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Matheson</span>, <span class="hlFld-ContribAuthor ">Becka M.  Warfield</span>, <span class="hlFld-ContribAuthor ">Donald S.  Backos</span>, <span class="hlFld-ContribAuthor ">Philip  Reigan</span>. </span><span class="cited-content_cbyCitation_article-title">N-Substituted pyrrolopyrimidines and purines as p90 ribosomal S6 protein kinase-2 (RSK2) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>41 </em>, 116220. <a href="https://doi.org/10.1016/j.bmc.2021.116220" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116220</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116220%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DN-Substituted%252Bpyrrolopyrimidines%252Band%252Bpurines%252Bas%252Bp90%252Bribosomal%252BS6%252Bprotein%252Bkinase-2%252B%252528RSK2%252529%252Binhibitors%26aulast%3DCasalvieri%26aufirst%3DKimberly%2BA.%26date%3D2021%26volume%3D41%26spage%3D116220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Álvaro  Lorente‐Macías</span>, <span class="hlFld-ContribAuthor ">Inmaculada  Iañez</span>, <span class="hlFld-ContribAuthor ">M. Carmen  Jiménez‐López</span>, <span class="hlFld-ContribAuthor ">Manuel  Benítez‐Quesada</span>, <span class="hlFld-ContribAuthor ">Sara  Torres‐Rusillo</span>, <span class="hlFld-ContribAuthor ">Juan J.  Díaz‐Mochón</span>, <span class="hlFld-ContribAuthor ">Ignacio J.  Molina</span>, <span class="hlFld-ContribAuthor ">María J.  Pineda de las Infantas</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and screening of 6‐alkoxy purine analogs as cell type‐selective apoptotic inducers in Jurkat cells. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2021,</strong> <em> </em><a href="https://doi.org/10.1002/ardp.202100095" title="DOI URL">https://doi.org/10.1002/ardp.202100095</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.202100095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.202100095%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252Bscreening%252Bof%252B6%2525E2%252580%252590alkoxy%252Bpurine%252Banalogs%252Bas%252Bcell%252Btype%2525E2%252580%252590selective%252Bapoptotic%252Binducers%252Bin%252BJurkat%252Bcells%26aulast%3DLorente%25E2%2580%2590Mac%25C3%25ADas%26aufirst%3D%25C3%2581lvaro%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Lin</span>, <span class="hlFld-ContribAuthor ">Jiacheng  Li</span>, <span class="hlFld-ContribAuthor ">Liping  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanqing  Li</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Pan  Xu</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Bing  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 4-benzoylamino-1H-pyrazole-3-carboxamide derivatives as potent CDK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>215 </em>, 113281. <a href="https://doi.org/10.1016/j.ejmech.2021.113281" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113281%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B4-benzoylamino-1H-pyrazole-3-carboxamide%252Bderivatives%252Bas%252Bpotent%252BCDK2%252Binhibitors%26aulast%3DLin%26aufirst%3DTingting%26date%3D2021%26volume%3D215%26spage%3D113281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Josef  Jansa</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Jana  Škerlová</span>, <span class="hlFld-ContribAuthor ">Petr  Pachl</span>, <span class="hlFld-ContribAuthor ">Miroslav  Peřina</span>, <span class="hlFld-ContribAuthor ">Eva  Řezníčková</span>, <span class="hlFld-ContribAuthor ">Tomáš  Heger</span>, <span class="hlFld-ContribAuthor ">Tomáš  Gucký</span>, <span class="hlFld-ContribAuthor ">Pavlína  Řezáčová</span>, <span class="hlFld-ContribAuthor ">Antonín  Lyčka</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazo[1,2-c]pyrimidin-5(6H)-one inhibitors of CDK2: Synthesis, kinase inhibition and co-crystal structure. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>216 </em>, 113309. <a href="https://doi.org/10.1016/j.ejmech.2021.113309" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113309%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImidazo%25255B1%25252C2-c%25255Dpyrimidin-5%2525286H%252529-one%252Binhibitors%252Bof%252BCDK2%25253A%252BSynthesis%25252C%252Bkinase%252Binhibition%252Band%252Bco-crystal%252Bstructure%26aulast%3DJansa%26aufirst%3DJosef%26date%3D2021%26volume%3D216%26spage%3D113309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khattab  Al-Khafaji</span>, <span class="hlFld-ContribAuthor ">Tugba  Taskin Tok</span>. </span><span class="cited-content_cbyCitation_article-title">Amygdalin as multi-target anticancer drug against targets of cell division cycle: double docking and molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2021,</strong> <em>39 </em>
                                    (6)
                                     , 1965-1974. <a href="https://doi.org/10.1080/07391102.2020.1742792" title="DOI URL">https://doi.org/10.1080/07391102.2020.1742792</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1742792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1742792%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DAmygdalin%252Bas%252Bmulti-target%252Banticancer%252Bdrug%252Bagainst%252Btargets%252Bof%252Bcell%252Bdivision%252Bcycle%25253A%252Bdouble%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DAl-Khafaji%26aufirst%3DKhattab%26date%3D2021%26date%3D2020%26volume%3D39%26issue%3D6%26spage%3D1965%26epage%3D1974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brilliant N.  Marak</span>, <span class="hlFld-ContribAuthor ">Jayanta  Dowarah</span>, <span class="hlFld-ContribAuthor ">Laldingluaia  Khiangte</span>, <span class="hlFld-ContribAuthor ">Ved Prakash  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">A comprehensive insight on the recent development of Cyclic Dependent Kinase inhibitors as anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112571. <a href="https://doi.org/10.1016/j.ejmech.2020.112571" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112571%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252Bcomprehensive%252Binsight%252Bon%252Bthe%252Brecent%252Bdevelopment%252Bof%252BCyclic%252BDependent%252BKinase%252Binhibitors%252Bas%252Banticancer%252Bagents%26aulast%3DMarak%26aufirst%3DBrilliant%2BN.%26date%3D2020%26volume%3D203%26spage%3D112571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik B  Faber</span>, <span class="hlFld-ContribAuthor ">Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Gunda I  Georg</span>. </span><span class="cited-content_cbyCitation_article-title">Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†. </span><span class="cited-content_cbyCitation_journal-name">Biology of Reproduction</span><span> <strong>2020,</strong> <em>103 </em>
                                    (2)
                                     , 357-367. <a href="https://doi.org/10.1093/biolre/ioaa107" title="DOI URL">https://doi.org/10.1093/biolre/ioaa107</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/biolre/ioaa107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbiolre%2Fioaa107%26sid%3Dliteratum%253Aachs%26jtitle%3DBiology%2520of%2520Reproduction%26atitle%3DReview%252Bof%252Brationale%252Band%252Bprogress%252Btoward%252Btargeting%252Bcyclin-dependent%252Bkinase%252B2%252B%252528CDK2%252529%252Bfor%252Bmale%252Bcontraception%2525E2%252580%2525A0%26aulast%3DFaber%26aufirst%3DErik%2BB%26date%3D2020%26date%3D2020%26volume%3D103%26issue%3D2%26spage%3D357%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Matheson</span>, <span class="hlFld-ContribAuthor ">Christopher R.  Coxon</span>, <span class="hlFld-ContribAuthor ">Richard  Bayliss</span>, <span class="hlFld-ContribAuthor ">Kathy  Boxall</span>, <span class="hlFld-ContribAuthor ">Benoit  Carbain</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Fry</span>, <span class="hlFld-ContribAuthor ">Ian R.  Hardcastle</span>, <span class="hlFld-ContribAuthor ">Suzannah J.  Harnor</span>, <span class="hlFld-ContribAuthor ">Corine  Mas-Droux</span>, <span class="hlFld-ContribAuthor ">David R.  Newell</span>, <span class="hlFld-ContribAuthor ">Mark W.  Richards</span>, <span class="hlFld-ContribAuthor ">Mangaleswaran  Sivaprakasam</span>, <span class="hlFld-ContribAuthor ">David  Turner</span>, <span class="hlFld-ContribAuthor ">Roger J.  Griffin</span>, <span class="hlFld-ContribAuthor ">Bernard T.  Golding</span>, <span class="hlFld-ContribAuthor ">Céline  Cano</span>. </span><span class="cited-content_cbyCitation_article-title">2-Arylamino-6-ethynylpurines are cysteine-targeting irreversible inhibitors of Nek2 kinase. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (6)
                                     , 707-731. <a href="https://doi.org/10.1039/D0MD00074D" title="DOI URL">https://doi.org/10.1039/D0MD00074D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00074D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00074D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3D2-Arylamino-6-ethynylpurines%252Bare%252Bcysteine-targeting%252Birreversible%252Binhibitors%252Bof%252BNek2%252Bkinase%26aulast%3DMatheson%26aufirst%3DChristopher%2BJ.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D6%26spage%3D707%26epage%3D731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Laixue  Pang</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Lifei  Wang</span>, <span class="hlFld-ContribAuthor ">John Z. H.  Zhang</span>, <span class="hlFld-ContribAuthor ">Tong  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Decoding molecular mechanism of inhibitor bindings to CDK2 using molecular dynamics simulations and binding free energy calculations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (4)
                                     , 985-996. <a href="https://doi.org/10.1080/07391102.2019.1591304" title="DOI URL">https://doi.org/10.1080/07391102.2019.1591304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1591304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1591304%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DDecoding%252Bmolecular%252Bmechanism%252Bof%252Binhibitor%252Bbindings%252Bto%252BCDK2%252Busing%252Bmolecular%252Bdynamics%252Bsimulations%252Band%252Bbinding%252Bfree%252Benergy%252Bcalculations%26aulast%3DChen%26aufirst%3DJianzhong%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D4%26spage%3D985%26epage%3D996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed A.  Said</span>, <span class="hlFld-ContribAuthor ">Wagdy M.  Eldehna</span>, <span class="hlFld-ContribAuthor ">Alessio  Nocentini</span>, <span class="hlFld-ContribAuthor ">Samar H.  Fahim</span>, <span class="hlFld-ContribAuthor ">Alessandro  Bonardi</span>, <span class="hlFld-ContribAuthor ">Abdullah A.  Elgazar</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, <span class="hlFld-ContribAuthor ">Dalia H.  Soliman</span>, <span class="hlFld-ContribAuthor ">Hatem A.  Abdel-Aziz</span>, <span class="hlFld-ContribAuthor ">Paola  Gratteri</span>, <span class="hlFld-ContribAuthor ">Sahar M.  Abou-Seri</span>, <span class="hlFld-ContribAuthor ">Claudiu T.  Supuran</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>189 </em>, 112019. <a href="https://doi.org/10.1016/j.ejmech.2019.112019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.112019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.112019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.112019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSulfonamide-based%252Bring-fused%252Banalogues%252Bfor%252BCAN508%252Bas%252Bnovel%252Bcarbonic%252Banhydrase%252Binhibitors%252Bendowed%252Bwith%252Bantitumor%252Bactivity%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Band%252Bin%2525C2%2525A0vitro%252Bbiological%252Bevaluation%26aulast%3DSaid%26aufirst%3DMohamed%2BA.%26date%3D2020%26volume%3D189%26spage%3D112019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Luc  Décout</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems—Purines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14915-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14915-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14915-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14915-7%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%2525E2%252580%252594Purines%26aulast%3DD%25C3%25A9cout%26aufirst%3DJean-Luc%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cristian  O. Salas</span>, <span class="hlFld-ContribAuthor ">Ana Maria  Zarate</span>, <span class="hlFld-ContribAuthor ">Vladimir  Kryštof</span>, <span class="hlFld-ContribAuthor ">Jaime  Mella</span>, <span class="hlFld-ContribAuthor ">Mario  Faundez</span>, <span class="hlFld-ContribAuthor ">Jose  Brea</span>, <span class="hlFld-ContribAuthor ">María Isabel  Loza</span>, <span class="hlFld-ContribAuthor ">Ivan  Brito</span>, <span class="hlFld-ContribAuthor ">Denisa  Hendrychová</span>, <span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Alan R.  Cabrera</span>, <span class="hlFld-ContribAuthor ">Ricardo A.  Tapia</span>, <span class="hlFld-ContribAuthor ">Christian  Espinosa-Bustos</span>. </span><span class="cited-content_cbyCitation_article-title">Promising 2,6,9-Trisubstituted Purine Derivatives for Anticancer Compounds: Synthesis, 3D-QSAR, and Preliminary Biological Assays. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (1)
                                     , 161. <a href="https://doi.org/10.3390/ijms21010161" title="DOI URL">https://doi.org/10.3390/ijms21010161</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21010161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21010161%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DPromising%252B2%25252C6%25252C9-Trisubstituted%252BPurine%252BDerivatives%252Bfor%252BAnticancer%252BCompounds%25253A%252BSynthesis%25252C%252B3D-QSAR%25252C%252Band%252BPreliminary%252BBiological%252BAssays%26aulast%3DO.%2BSalas%26aufirst%3DCristian%26date%3D2020%26date%3D2019%26volume%3D21%26issue%3D1%26spage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruifeng  Wang</span>, <span class="hlFld-ContribAuthor ">Yixuan  Chen</span>, <span class="hlFld-ContribAuthor ">Xiangxin  Zhao</span>, <span class="hlFld-ContribAuthor ">Sijia  Yu</span>, <span class="hlFld-ContribAuthor ">Bowen  Yang</span>, <span class="hlFld-ContribAuthor ">Tianxiao  Wu</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Chenzhou  Hao</span>, <span class="hlFld-ContribAuthor ">Dongmei  Zhao</span>, <span class="hlFld-ContribAuthor ">Maosheng  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>183 </em>, 111716. <a href="https://doi.org/10.1016/j.ejmech.2019.111716" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111716%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252B7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Bderivatives%252Bas%252Bpotential%252BFAK%252Binhibitors%252Band%252Banticancer%252Bagents%26aulast%3DWang%26aufirst%3DRuifeng%26date%3D2019%26volume%3D183%26spage%3D111716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Polishchuk</span>, <span class="hlFld-ContribAuthor ">Alina  Kutlushina</span>, <span class="hlFld-ContribAuthor ">Dayana  Bashirova</span>, <span class="hlFld-ContribAuthor ">Olena  Mokshyna</span>, <span class="hlFld-ContribAuthor ">Timur  Madzhidov</span>. </span><span class="cited-content_cbyCitation_article-title">Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2019,</strong> <em>20 </em>
                                    (23)
                                     , 5834. <a href="https://doi.org/10.3390/ijms20235834" title="DOI URL">https://doi.org/10.3390/ijms20235834</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms20235834&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms20235834%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DVirtual%252BScreening%252BUsing%252BPharmacophore%252BModels%252BRetrieved%252Bfrom%252BMolecular%252BDynamic%252BSimulations%26aulast%3DPolishchuk%26aufirst%3DPavel%26date%3D2019%26date%3D2019%26volume%3D20%26issue%3D23%26spage%3D5834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marina  Bury</span>, <span class="hlFld-ContribAuthor ">Benjamin  Le Calvé</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lessard</span>, <span class="hlFld-ContribAuthor ">Thomas  Dal Maso</span>, <span class="hlFld-ContribAuthor ">James  Saliba</span>, <span class="hlFld-ContribAuthor ">Carine  Michiels</span>, <span class="hlFld-ContribAuthor ">Gerardo  Ferbeyre</span>, <span class="hlFld-ContribAuthor ">Volker  Blank</span>. </span><span class="cited-content_cbyCitation_article-title">NFE2L3 Controls Colon Cancer Cell Growth through Regulation of DUX4, a CDK1 Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>29 </em>
                                    (6)
                                     , 1469-1481.e9. <a href="https://doi.org/10.1016/j.celrep.2019.09.087" title="DOI URL">https://doi.org/10.1016/j.celrep.2019.09.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2019.09.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2019.09.087%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DNFE2L3%252BControls%252BColon%252BCancer%252BCell%252BGrowth%252Bthrough%252BRegulation%252Bof%252BDUX4%25252C%252Ba%252BCDK1%252BInhibitor%26aulast%3DBury%26aufirst%3DMarina%26date%3D2019%26volume%3D29%26issue%3D6%26spage%3D1469%26epage%3D1481.e9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Concepción  Sánchez-Martínez</span>, <span class="hlFld-ContribAuthor ">María José  Lallena</span>, <span class="hlFld-ContribAuthor ">Sonia Gutiérrez  Sanfeliciano</span>, <span class="hlFld-ContribAuthor ">Alfonso  de Dios</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (20)
                                     , 126637. <a href="https://doi.org/10.1016/j.bmcl.2019.126637" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126637</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126637&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126637%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DCyclin%252Bdependent%252Bkinase%252B%252528CDK%252529%252Binhibitors%252Bas%252Banticancer%252Bdrugs%25253A%252BRecent%252Badvances%252B%2525282015%2525E2%252580%2525932019%252529%26aulast%3DS%25C3%25A1nchez-Mart%25C3%25ADnez%26aufirst%3DConcepci%25C3%25B3n%26date%3D2019%26volume%3D29%26issue%3D20%26spage%3D126637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H. T.  Zhu</span>, <span class="hlFld-ContribAuthor ">L. Y.  Qin</span>, <span class="hlFld-ContribAuthor ">T.  Liu</span>, <span class="hlFld-ContribAuthor ">Y.  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">A Convenient Synthesis of N2-Alkylated Guanines. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>55 </em>
                                    (6)
                                     , 874-878. <a href="https://doi.org/10.1134/S1070428019060198" title="DOI URL">https://doi.org/10.1134/S1070428019060198</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428019060198&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428019060198%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252BConvenient%252BSynthesis%252Bof%252BN2-Alkylated%252BGuanines%26aulast%3DZhu%26aufirst%3DH.%2BT.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D6%26spage%3D874%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ranjini  Sankaranarayanan</span>, <span class="hlFld-ContribAuthor ">Chaitanya  Valiveti</span>, <span class="hlFld-ContribAuthor ">D.  Kumar</span>, <span class="hlFld-ContribAuthor ">Severine  Van slambrouck</span>, <span class="hlFld-ContribAuthor ">Siddharth  Kesharwani</span>, <span class="hlFld-ContribAuthor ">Teresa  Seefeldt</span>, <span class="hlFld-ContribAuthor ">Joy  Scaria</span>, <span class="hlFld-ContribAuthor ">Hemachand  Tummala</span>, <span class="hlFld-ContribAuthor ">G.  Bhat</span>. </span><span class="cited-content_cbyCitation_article-title">The Flavonoid Metabolite 2,4,6-Trihydroxybenzoic Acid Is a CDK Inhibitor and an Anti-Proliferative Agent: A Potential Role in Cancer Prevention. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2019,</strong> <em>11 </em>
                                    (3)
                                     , 427. <a href="https://doi.org/10.3390/cancers11030427" title="DOI URL">https://doi.org/10.3390/cancers11030427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers11030427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers11030427%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DThe%252BFlavonoid%252BMetabolite%252B2%25252C4%25252C6-Trihydroxybenzoic%252BAcid%252BIs%252Ba%252BCDK%252BInhibitor%252Band%252Ban%252BAnti-Proliferative%252BAgent%25253A%252BA%252BPotential%252BRole%252Bin%252BCancer%252BPrevention%26aulast%3DSankaranarayanan%26aufirst%3DRanjini%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D3%26spage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiyan  Cheng</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Yang</span>, <span class="hlFld-ContribAuthor ">Suhua  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Han  Wei</span>, <span class="hlFld-ContribAuthor ">Xin  Tian</span>, <span class="hlFld-ContribAuthor ">Quancheng  Kan</span>. </span><span class="cited-content_cbyCitation_article-title">Recent development of CDK inhibitors: An overview of CDK/inhibitor co-crystal structures. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>164 </em>, 615-639. <a href="https://doi.org/10.1016/j.ejmech.2019.01.003" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Bdevelopment%252Bof%252BCDK%252Binhibitors%25253A%252BAn%252Boverview%252Bof%252BCDK%25252Finhibitor%252Bco-crystal%252Bstructures%26aulast%3DCheng%26aufirst%3DWeiyan%26date%3D2019%26volume%3D164%26spage%3D615%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel J.  Wood</span>, <span class="hlFld-ContribAuthor ">Svitlana  Korolchuk</span>, <span class="hlFld-ContribAuthor ">Natalie J.  Tatum</span>, <span class="hlFld-ContribAuthor ">Lan-Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Jane A.  Endicott</span>, <span class="hlFld-ContribAuthor ">Martin E.M.  Noble</span>, <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>. </span><span class="cited-content_cbyCitation_article-title">Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (1)
                                     , 121-130.e5. <a href="https://doi.org/10.1016/j.chembiol.2018.10.015" title="DOI URL">https://doi.org/10.1016/j.chembiol.2018.10.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2018.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2018.10.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DDifferences%252Bin%252Bthe%252BConformational%252BEnergy%252BLandscape%252Bof%252BCDK1%252Band%252BCDK2%252BSuggest%252Ba%252BMechanism%252Bfor%252BAchieving%252BSelective%252BCDK%252BInhibition%26aulast%3DWood%26aufirst%3DDaniel%2BJ.%26date%3D2019%26volume%3D26%26issue%3D1%26spage%3D121%26epage%3D130.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shewei  Guo</span>, <span class="hlFld-ContribAuthor ">Yingwei  Zhen</span>, <span class="hlFld-ContribAuthor ">Mengguo  Guo</span>, <span class="hlFld-ContribAuthor ">Longzhou  Zhang</span>, <span class="hlFld-ContribAuthor ">Guosheng  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and antiproliferative evaluation of novel sulfanilamide-1,2,3-triazole derivatives as tubulin polymerization inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Investigational New Drugs</span><span> <strong>2018,</strong> <em>36 </em>
                                    (6)
                                     , 1147-1157. <a href="https://doi.org/10.1007/s10637-018-0632-7" title="DOI URL">https://doi.org/10.1007/s10637-018-0632-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10637-018-0632-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10637-018-0632-7%26sid%3Dliteratum%253Aachs%26jtitle%3DInvestigational%2520New%2520Drugs%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bantiproliferative%252Bevaluation%252Bof%252Bnovel%252Bsulfanilamide-1%25252C2%25252C3-triazole%252Bderivatives%252Bas%252Btubulin%252Bpolymerization%252Binhibitors%26aulast%3DGuo%26aufirst%3DShewei%26date%3D2018%26date%3D2018%26volume%3D36%26issue%3D6%26spage%3D1147%26epage%3D1157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gaomin  Zhang</span>, <span class="hlFld-ContribAuthor ">Yujie  Ren</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Modeling and Design Studies of Purine Derivatives as Novel CDK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (11)
                                     , 2924. <a href="https://doi.org/10.3390/molecules23112924" title="DOI URL">https://doi.org/10.3390/molecules23112924</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23112924&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23112924%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMolecular%252BModeling%252Band%252BDesign%252BStudies%252Bof%252BPurine%252BDerivatives%252Bas%252BNovel%252BCDK2%252BInhibitors%26aulast%3DZhang%26aufirst%3DGaomin%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D11%26spage%3D2924" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tahir Ali  Chohan</span>, <span class="hlFld-ContribAuthor ">Aisha  Qayyum</span>, <span class="hlFld-ContribAuthor ">Kanwal  Rehman</span>, <span class="hlFld-ContribAuthor ">Muhammad  Tariq</span>, <span class="hlFld-ContribAuthor ">Muhammad Sajid Hamid  Akash</span>. </span><span class="cited-content_cbyCitation_article-title">An insight into the emerging role of cyclin-dependent kinase inhibitors as potential therapeutic agents for the treatment of advanced cancers. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2018,</strong> <em>107 </em>, 1326-1341. <a href="https://doi.org/10.1016/j.biopha.2018.08.116" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.08.116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.08.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.08.116%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DAn%252Binsight%252Binto%252Bthe%252Bemerging%252Brole%252Bof%252Bcyclin-dependent%252Bkinase%252Binhibitors%252Bas%252Bpotential%252Btherapeutic%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Badvanced%252Bcancers%26aulast%3DChohan%26aufirst%3DTahir%2BAli%26date%3D2018%26volume%3D107%26spage%3D1326%26epage%3D1341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mostafa M.  Ghorab</span>, <span class="hlFld-ContribAuthor ">Fatma A.  Ragab</span>, <span class="hlFld-ContribAuthor ">Helmy I.  Heiba</span>, <span class="hlFld-ContribAuthor ">Mohamed S.A.  Elsayed</span>, <span class="hlFld-ContribAuthor ">Walid M.  Ghorab</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and molecular modeling study of certain 4-Methylbenzenesulfonamides with CDK2 inhibitory activity as anticancer and radio-sensitizing agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>80 </em>, 276-287. <a href="https://doi.org/10.1016/j.bioorg.2018.06.010" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.06.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.06.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmolecular%252Bmodeling%252Bstudy%252Bof%252Bcertain%252B4-Methylbenzenesulfonamides%252Bwith%252BCDK2%252Binhibitory%252Bactivity%252Bas%252Banticancer%252Band%252Bradio-sensitizing%252Bagents%26aulast%3DGhorab%26aufirst%3DMostafa%2BM.%26date%3D2018%26volume%3D80%26spage%3D276%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haresh  Ajani</span>, <span class="hlFld-ContribAuthor ">Josef  Jansa</span>, <span class="hlFld-ContribAuthor ">Cemal  Köprülüoğlu</span>, <span class="hlFld-ContribAuthor ">Pavel  Hobza</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>, <span class="hlFld-ContribAuthor ">Antonín  Lyčka</span>, <span class="hlFld-ContribAuthor ">Martin  Lepsik</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazo[1,2-
              c
              ]pyrimidin-5(6
              H
              )-one as a novel core of cyclin-dependent kinase 2 inhibitors: Synthesis, activity measurement, docking, and quantum mechanical scoring. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Recognition</span><span> <strong>2018,</strong> <em>31 </em>
                                    (9)
                                     , e2720. <a href="https://doi.org/10.1002/jmr.2720" title="DOI URL">https://doi.org/10.1002/jmr.2720</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jmr.2720&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjmr.2720%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Recognition%26atitle%3DImidazo%25255B1%25252C2-%252Bc%252B%25255Dpyrimidin-5%2525286%252BH%252B%252529-one%252Bas%252Ba%252Bnovel%252Bcore%252Bof%252Bcyclin-dependent%252Bkinase%252B2%252Binhibitors%25253A%252BSynthesis%25252C%252Bactivity%252Bmeasurement%25252C%252Bdocking%25252C%252Band%252Bquantum%252Bmechanical%252Bscoring%26aulast%3DAjani%26aufirst%3DHaresh%26date%3D2018%26date%3D2018%26volume%3D31%26issue%3D9%26spage%3De2720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy B  Heptinstall</span>, <span class="hlFld-ContribAuthor ">IWS  Adiyasa</span>, <span class="hlFld-ContribAuthor ">Céline  Cano</span>, <span class="hlFld-ContribAuthor ">Ian R  Hardcastle</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in CDK inhibitors for cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (11)
                                     , 1369-1388. <a href="https://doi.org/10.4155/fmc-2017-0246" title="DOI URL">https://doi.org/10.4155/fmc-2017-0246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0246%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bin%252BCDK%252Binhibitors%252Bfor%252Bcancer%252Btherapy%26aulast%3DHeptinstall%26aufirst%3DAmy%2BB%26date%3D2018%26volume%3D10%26issue%3D11%26spage%3D1369%26epage%3D1388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liandong  Jing</span>, <span class="hlFld-ContribAuthor ">Yanbo  Tang</span>, <span class="hlFld-ContribAuthor ">Zhiyan  Xiao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel CDK inhibitors via scaffold hopping from CAN508. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (8)
                                     , 1386-1391. <a href="https://doi.org/10.1016/j.bmcl.2018.02.054" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.02.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.02.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.02.054%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252BCDK%252Binhibitors%252Bvia%252Bscaffold%252Bhopping%252Bfrom%252BCAN508%26aulast%3DJing%26aufirst%3DLiandong%26date%3D2018%26volume%3D28%26issue%3D8%26spage%3D1386%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chao  Tian</span>, <span class="hlFld-ContribAuthor ">Zifei  Han</span>, <span class="hlFld-ContribAuthor ">Yuanxin  Li</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Wang</span>, <span class="hlFld-ContribAuthor ">Zhili  Zhang</span>, <span class="hlFld-ContribAuthor ">Junyi  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine analogues as novel CHK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>151 </em>, 836-848. <a href="https://doi.org/10.1016/j.ejmech.2018.03.075" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2%25252C6-disubstituted-9H-purine%25252C%252B2%25252C4-disubstitued-thieno%25255B3%25252C2-d%25255Dpyrimidine%252Band%252B-7H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidine%252Banalogues%252Bas%252Bnovel%252BCHK1%252Binhibitors%26aulast%3DTian%26aufirst%3DChao%26date%3D2018%26volume%3D151%26spage%3D836%26epage%3D848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Priyank  Patel</span>, <span class="hlFld-ContribAuthor ">Vladislav  Tsiperson</span>, <span class="hlFld-ContribAuthor ">Susan R.S.  Gottesman</span>, <span class="hlFld-ContribAuthor ">Jonathan  Somma</span>, <span class="hlFld-ContribAuthor ">Stacy W.  Blain</span>. </span><span class="cited-content_cbyCitation_article-title">Dual Inhibition of CDK4 and CDK2 via Targeting p27 Tyrosine Phosphorylation Induces a Potent and Durable Response in Breast Cancer Cells. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2018,</strong> <em>16 </em>
                                    (3)
                                     , 361-377. <a href="https://doi.org/10.1158/1541-7786.MCR-17-0602" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-17-0602</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-17-0602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-17-0602%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DDual%252BInhibition%252Bof%252BCDK4%252Band%252BCDK2%252Bvia%252BTargeting%252Bp27%252BTyrosine%252BPhosphorylation%252BInduces%252Ba%252BPotent%252Band%252BDurable%252BResponse%252Bin%252BBreast%252BCancer%252BCells%26aulast%3DPatel%26aufirst%3DPriyank%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D3%26spage%3D361%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Radek  Jorda</span>, <span class="hlFld-ContribAuthor ">Zuzana  Bučková</span>, <span class="hlFld-ContribAuthor ">Eva  Řezníčková</span>, <span class="hlFld-ContribAuthor ">Jan  Bouchal</span>, <span class="hlFld-ContribAuthor ">Vladimír  Kryštof</span>. </span><span class="cited-content_cbyCitation_article-title">Selective inhibition reveals cyclin-dependent kinase 2 as another kinase that phosphorylates the androgen receptor at serine 81. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2018,</strong> <em>1865 </em>
                                    (2)
                                     , 354-363. <a href="https://doi.org/10.1016/j.bbamcr.2017.11.011" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2017.11.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2017.11.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2017.11.011%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3DSelective%252Binhibition%252Breveals%252Bcyclin-dependent%252Bkinase%252B2%252Bas%252Banother%252Bkinase%252Bthat%252Bphosphorylates%252Bthe%252Bandrogen%252Breceptor%252Bat%252Bserine%252B81%26aulast%3DJorda%26aufirst%3DRadek%26date%3D2018%26volume%3D1865%26issue%3D2%26spage%3D354%26epage%3D363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Badr  Jismy</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Hassan  Allouchi</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abarbri</span>. </span><span class="cited-content_cbyCitation_article-title">Concise and Efficient Access to 5,7-Disubstituted Pyrazolo[1,5-
              a
              ]pyrimidines by Pd-Catalyzed Sequential Arylation, Alkynylation and SN
              Ar
              Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (41)
                                     , 6168-6178. <a href="https://doi.org/10.1002/ejoc.201701024" title="DOI URL">https://doi.org/10.1002/ejoc.201701024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201701024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201701024%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConcise%252Band%252BEfficient%252BAccess%252Bto%252B5%25252C7-Disubstituted%252BPyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidines%252Bby%252BPd-Catalyzed%252BSequential%252BArylation%25252C%252BAlkynylation%252Band%252BSN%252BAr%252BReaction%26aulast%3DJismy%26aufirst%3DBadr%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D41%26spage%3D6168%26epage%3D6178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">, , <span class="hlFld-ContribAuthor ">Mathew P.  Martin</span>, <span class="hlFld-ContribAuthor ">Jane A.  Endicott</span>, <span class="hlFld-ContribAuthor ">Martin E.M.  Noble</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of cyclin-dependent protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Essays in Biochemistry</span><span> <strong>2017,</strong> <em>61 </em>
                                    (5)
                                     , 439-452. <a href="https://doi.org/10.1042/EBC20170040" title="DOI URL">https://doi.org/10.1042/EBC20170040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/EBC20170040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FEBC20170040%26sid%3Dliteratum%253Aachs%26jtitle%3DEssays%2520in%2520Biochemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252Bcyclin-dependent%252Bprotein%252Bkinase%252Binhibitors%26aulast%3Dvan%2BMontfort%26aufirst%3DRob%2BL.M.%26date%3D2017%26date%3D2017%26volume%3D61%26issue%3D5%26spage%3D439%26epage%3D452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seketoulie  Keretsu</span>, <span class="hlFld-ContribAuthor ">Pavithra Kuruchi  Balasubramanian</span>, <span class="hlFld-ContribAuthor ">Swapnil Pandurang  Bhujbal</span>, <span class="hlFld-ContribAuthor ">Seung Joo  Cho</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor-guided 3D-Quantitative Structure-Activity Relationship and Docking Studies of 6-Substituted 2-Arylaminopurines as CDK2 Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2017,</strong> <em>38 </em>
                                    (11)
                                     , 1275-1284. <a href="https://doi.org/10.1002/bkcs.11280" title="DOI URL">https://doi.org/10.1002/bkcs.11280</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.11280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.11280%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DReceptor-guided%252B3D-Quantitative%252BStructure-Activity%252BRelationship%252Band%252BDocking%252BStudies%252Bof%252B6-Substituted%252B2-Arylaminopurines%252Bas%252BCDK2%252BKinase%252BInhibitors%26aulast%3DKeretsu%26aufirst%3DSeketoulie%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D11%26spage%3D1275%26epage%3D1284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sun Jun  Park</span>, <span class="hlFld-ContribAuthor ">Eunjin  Kim</span>, <span class="hlFld-ContribAuthor ">Miyoun  Yoo</span>, <span class="hlFld-ContribAuthor ">Joo-Youn  Lee</span>, <span class="hlFld-ContribAuthor ">Chi Hoon  Park</span>, <span class="hlFld-ContribAuthor ">Jong Yeon  Hwang</span>, <span class="hlFld-ContribAuthor ">Jae Du  Ha</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of N9-cis-cyclobutylpurine derivatives for use as cyclin-dependent kinase (CDK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (18)
                                     , 4399-4404. <a href="https://doi.org/10.1016/j.bmcl.2017.08.018" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.08.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.08.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN9-cis-cyclobutylpurine%252Bderivatives%252Bfor%252Buse%252Bas%252Bcyclin-dependent%252Bkinase%252B%252528CDK%252529%252Binhibitors%26aulast%3DPark%26aufirst%3DSun%2BJun%26date%3D2017%26volume%3D27%26issue%3D18%26spage%3D4399%26epage%3D4404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Jun  Fu</span>, <span class="hlFld-ContribAuthor ">Ji-Feng  Liu</span>, <span class="hlFld-ContribAuthor ">Ruo-Han  Zhao</span>, <span class="hlFld-ContribAuthor ">Jia-Huan  Li</span>, <span class="hlFld-ContribAuthor ">Sai-Yang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Bing  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Antiproliferative Evaluation of Novel Sulfanilamide Derivatives as Potential Tubulin Polymerization Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2017,</strong> <em>22 </em>
                                    (9)
                                     , 1470. <a href="https://doi.org/10.3390/molecules22091470" title="DOI URL">https://doi.org/10.3390/molecules22091470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules22091470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules22091470%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%252Band%252BAntiproliferative%252BEvaluation%252Bof%252BNovel%252BSulfanilamide%252BDerivatives%252Bas%252BPotential%252BTubulin%252BPolymerization%252BInhibitors%26aulast%3DFu%26aufirst%3DDong-Jun%26date%3D2017%26date%3D2017%26volume%3D22%26issue%3D9%26spage%3D1470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0003.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) aq HBF<sub>4</sub>, NaNO<sub>2</sub>, −15 to 0 °C; (ii) Pd(OH)<sub>2</sub>, HCO<sub>2</sub>NH<sub>4</sub>, MeOH, reflux; (iii) ArNH<sub>2</sub>, TFA, TFE, 90 °C; (iv) POCl<sub>3</sub>, PhNMe<sub>2</sub>, reflux; (v) 3,4-2<i>H</i>-dihydropyran, (<i>rac</i>)-camphorsulfonic acid, EtOAc, 75 °C; (vi) R-CCH, PdCl<sub>2</sub>(MeCN)<sub>2</sub>, dicyclohexyl-(2′,4′,6′-triisopropyl-[1,1′-biphenyl]-2-yl)phosphine, Cs<sub>2</sub>CO<sub>3</sub>, MeCN; (vii) TFA, <i>i</i>-PrOH, H<sub>2</sub>O, reflux; (viii) DABCO, DMSO, 25 °C. (ix) For <b>18</b>, <b>19</b>, <b>22</b>: ROH, Na, reflux. For <b>20</b>, <b>21</b>, <b>23</b>: ROH, NaH, DMSO, 25 °C. For definition of R groups, see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0004.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 3,4-2<i>H</i>-dihydropyran, (<i>rac</i>)-camphorsulfonic acid, EtOAc, 75 °C; (ii) (<i>i</i>-Pr)<sub>3</sub>SiCCH, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, CuI, Et<sub>3</sub>N, THF, 25 °C; (iii) TFA, <i>i</i>-PrOH, H<sub>2</sub>O, reflux; (iv) PhNH<sub>2</sub> or 4-NH<sub>2</sub>C<sub>6</sub>H<sub>4</sub>SO<sub>2</sub>NH<sub>2</sub>, TFA, TFE, 90 °C; (v) (<i>n</i>-Bu)<sub>4</sub>NF, THF, 25 °C; (vi) Lindlar’s catalyst, quinoline, H<sub>2</sub>, EtOAc, RT, 2 h; (vii) RB(OH)<sub>2</sub> or RBF<sub>3</sub>K, Pd(OAc)<sub>2</sub>, dicyclohexyl(2′,6′-dimethoxybiphenyl-2-yl)phosphine, K<sub>3</sub>PO<sub>4</sub>, PhMe, H<sub>2</sub>O, 100 °C. For definition of R groups, see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0005.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) PMB-Cl, K<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (ii) NaH, cyclohexylmethanol, DMSO, 25 °C; (iii) TFA, 80 °C; (iv) CH<sub>2</sub>I<sub>2</sub>, <i>iso</i>-amyl nitrite, CuI, THF, 80 °C; (v) sulfanilamide, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, K<sub>2</sub>CO<sub>3</sub>, MeCN, 80 °C; (vi) LiCl, <i>iso</i>-amyl nitrite, SOCl<sub>2</sub>, DMA or THF, 0–25 °C; (vii) ArNH<sub>2</sub>, TFA, TFE, 90 °C; (viii) SEM-Cl, NaH, MeCN, 0 °C; (ix) TBAF, THF, 25 °C.</p></p></figure><figure data-id="fig1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0001.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Activity of compounds <b>3</b>, <b>91</b>, and <b>98</b> against tumor cell growth.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Rb-proficient human tumor cell lines were incubated for 120 h with compounds and cellular protein determined by SRB assay. Dose–response curves and GI<sub>50</sub> bar charts represent the mean ± SEM from three or four independent experiments.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/medium/jm-2016-012542_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of CDK2-cyclin A–<b>73</b> and CDK1-cyclin B-CKS2–<b>3</b>. (A) Surface representation of CDK2 (ice-blue) bound to cyclin A (coral) in complex with <b>73</b> (yellow). The inset shows the interactions of <b>73</b> within the ATP site of CDK2-cyclin A. (B) Surface representation of CDK1 (dark-cyan) bound to cyclin B (pale-crimson) and CKS2 (lemon) in complex with <b>3</b> (green). The inset shows the interactions of <b>3</b> within the ATP site of CDK1-cyclin B-CKS2. In (A) and (B), the protein backbone is rendered in ribbon representation and selected CDK2 and CDK1 residues are drawn respectively with carbon atoms colored ice-blue and dark-cyan. The hydrogen bonds are shown as black dotted lines. (C) The structural conformations of the CDK2-cyclin A and CDK1-cyclin B-CKS2 glycine-rich loops to illustrate the alternative poses of catalytic residue Tyr15. The left-hand side panel compares CDK2-cyclin A in complex with <b>73</b> (ice-blue) to other inhibitor bound CDK2-cyclin A complexes (PDB entries <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EOS">4EOS</a> (green), <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TNW">3TNW</a> (coral), and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MY5">3MY5</a> (lilac)). The right-hand panel overlays CDK1-cyclin B-CKS2 bound to <b>3</b> (ice-blue) with apo CDK1-cyclin B-CKS2 (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YC3">4YC3</a>, lilac) and CDK1-cyclin B-CKS2 in complex with compound <b>23</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HQ0">5HQ0</a>, green). The conformations of the loop when CDK1 is bound to <b>3</b> or compound <b>23</b> cannot be distinguished. Gly-rich loop, glycine-rich loop.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-5/acs.jmedchem.6b01254/20170303/images/large/jm-2016-012542_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.6b01254&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i120">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75724" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75724" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lim, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdks, Cyclins and CKIs: Roles Beyond Cell Cycle Regulation</span> <span class="citation_source-journal">Development</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">3079</span><span class="NLM_x">–</span> <span class="NLM_lpage">3093</span><span class="refDoi"> DOI: 10.1242/dev.091744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1242%2Fdev.091744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=23861057" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFGktL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2013&pages=3079-3093&author=S.+Limauthor=P.+Kaldis&title=Cdks%2C+Cyclins+and+CKIs%3A+Roles+Beyond+Cell+Cycle+Regulation&doi=10.1242%2Fdev.091744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cdks, cyclins and CKIs: roles beyond cell cycle regulation</span></div><div class="casAuthors">Lim, Shuhui; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Development (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3079-3093</span>CODEN:
                <span class="NLM_cas:coden">DEVPED</span>;
        ISSN:<span class="NLM_cas:issn">0950-1991</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">A review.  Cyclin-dependent kinases (Cdks) are serine/threonine kinases and their catalytic activities are modulated by interactions with cyclins and Cdk inhibitors (CKIs).  Close cooperation between this trio is necessary for ensuring orderly progression through the cell cycle.  In addn. to their well-established function in cell cycle control, it is becoming increasingly apparent that mammalian Cdks, cyclins and CKIs play indispensable roles in processes such as transcription, epigenetic regulation, metab., stem cell self-renewal, neuronal functions and spermatogenesis.  Even more remarkably, they can accomplish some of these tasks individually, without the need for Cdk/cyclin complex formation or kinase activity.  In this Review, we discuss the latest revelations about Cdks, cyclins and CKIs with the goal of showcasing their functional diversity beyond cell cycle regulation and their impact on development and disease in mammals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp5LNcD6NywLVg90H21EOLACvtfcHk0li8v8L_cBwGrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFGktL%252FF&md5=8095fc798a0e7efeab60d36ee414596f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1242%2Fdev.091744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1242%252Fdev.091744%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DS.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdks%252C%2520Cyclins%2520and%2520CKIs%253A%2520Roles%2520Beyond%2520Cell%2520Cycle%2520Regulation%26jtitle%3DDevelopment%26date%3D2013%26volume%3D140%26spage%3D3079%26epage%3D3093%26doi%3D10.1242%2Fdev.091744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Malumbres, M.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinases</span> <span class="citation_source-journal">Genome Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">122</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span><span class="refDoi"> DOI: 10.1186/gb4184</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1186%2Fgb4184" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25180339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A280%3ADC%252BC2M%252FnsVehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2014&pages=122-132&author=M.+Malumbres&title=Cyclin-Dependent+Kinases&doi=10.1186%2Fgb4184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinases</span></div><div class="casAuthors">Malumbres Marcos</div><div class="citationInfo"><span class="NLM_cas:title">Genome biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">122</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cyclin-dependent kinases (CDKs) are protein kinases characterized by needing a separate subunit - a cyclin - that provides domains essential for enzymatic activity.  CDKs play important roles in the control of cell division and modulate transcription in response to several extra- and intracellular cues.  The evolutionary expansion of the CDK family in mammals led to the division of CDKs into three cell-cycle-related subfamilies (Cdk1, Cdk4 and Cdk5) and five transcriptional subfamilies (Cdk7, Cdk8, Cdk9, Cdk11 and Cdk20).  Unlike the prototypical Cdc28 kinase of budding yeast, most of these CDKs bind one or a few cyclins, consistent with functional specialization during evolution.  This review summarizes how, although CDKs are traditionally separated into cell-cycle or transcriptional CDKs, these activities are frequently combined in many family members.  Not surprisingly, deregulation of this family of proteins is a hallmark of several diseases, including cancer, and drug-targeted inhibition of specific members has generated very encouraging results in clinical trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQodaug4zJdjgHqQV89nF-2fW6udTcc2eaERbo8sEPC-bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M%252FnsVehsg%253D%253D&md5=9fd79ec8f495f712bada681b0a0b5afe</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1186%2Fgb4184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fgb4184%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26atitle%3DCyclin-Dependent%2520Kinases%26jtitle%3DGenome%2520Biol.%26date%3D2014%26volume%3D15%26spage%3D122%26epage%3D132%26doi%3D10.1186%2Fgb4184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cell Cycle, CDKs and Cancer: A Changing Paradigm</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">153</span><span class="NLM_x">–</span> <span class="NLM_lpage">166</span><span class="refDoi"> DOI: 10.1038/nrc2602</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrc2602" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=19238148" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=153-166&author=M.+Malumbresauthor=M.+Barbacid&title=Cell+Cycle%2C+CDKs+and+Cancer%3A+A+Changing+Paradigm&doi=10.1038%2Fnrc2602"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell cycle, CDKs and cancer: a changing paradigm</span></div><div class="casAuthors">Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">153-166</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Tumor-assocd. cell cycle defects are often mediated by alterations in cyclin-dependent kinase (CDK) activity.  Misregulated CDKs induce unscheduled proliferation as well as genomic and chromosomal instability.  According to current models, mammalian CDKs are essential for driving each cell cycle phase, so therapeutic strategies that block CDK activity are unlikely to selectively target tumor cells.  However, recent genetic evidence has revealed that, whereas CDK1 is required for the cell cycle, interphase CDKs are only essential for proliferation of specialized cells.  Emerging evidence suggests that tumor cells may also require specific interphase CDKs for proliferation.  Thus, selective CDK inhibition may provide therapeutic benefit against certain human neoplasias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzlIKlbCPWnLVg90H21EOLACvtfcHk0lj_BJqoOMpF3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1ans78%253D&md5=2a7eb34b2381e288b3f43ec1bffc0aec</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnrc2602&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2602%26sid%3Dliteratum%253Aachs%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCell%2520Cycle%252C%2520CDKs%2520and%2520Cancer%253A%2520A%2520Changing%2520Paradigm%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2009%26volume%3D9%26spage%3D153%26epage%3D166%26doi%3D10.1038%2Fnrc2602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Casimiro, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Velasco-Velazquez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aguirre-Alvarado, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pestell, R. G.</span><span> </span><span class="NLM_article-title">Overview of Cyclins D1 Function in Cancer and the CDK Inhibitor Landscape: Past and Present</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">304</span><span class="refDoi"> DOI: 10.1517/13543784.2014.867017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543784.2014.867017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=24387133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFymurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=295-304&author=M.+C.+Casimiroauthor=M.+Velasco-Velazquezauthor=C.+Aguirre-Alvaradoauthor=R.+G.+Pestell&title=Overview+of+Cyclins+D1+Function+in+Cancer+and+the+CDK+Inhibitor+Landscape%3A+Past+and+Present&doi=10.1517%2F13543784.2014.867017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: past and present</span></div><div class="casAuthors">Casimiro, Mathew C.; Velasco-Velazquez, Marco; Aguirre-Alvarado, Charmina; Pestell, Richard G.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">295-304</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Intensive efforts, over the last decade, have been made to inhibit the kinase activity of cyclins that act as mediators during cell-cycle progression.  Activation of the cyclin D1 oncogene, often by amplification or rearrangement, is a major driver of multiple types of human tumors including breast and squamous cell cancers, B-cell lymphoma, myeloma and parathyroid adenoma.  Areas covered: In this review, the authors summarize the activity of cyclins and cyclin-dependent kinases in cell-cycle progression and transcription.  They focus on cyclin D1/CDK4/CDK6, a central mediator in the transition from G1 to S phase.  Furthermore, the authors discuss the first generation of pan-cyclin-dependent kinase inhibitors that failed to meet expectation and discuss, in detail, the second generation of highly specific cyclin D1/CDK4/CDK6 inhibitors that are proving to be more efficacious.  Expert opinion: The mechanism by which cyclin D1 drives tumorigenesis may be dependent on kinase and kinase-independent functions.  Further evidence is necessary to delineate the roles of cyclin D1 in early pre-neoplastic lesions where its overexpression may promote genomic instability in a kinase-independent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdqXSkoQhAO7Vg90H21EOLACvtfcHk0lj_BJqoOMpF3Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFymurg%253D&md5=f4dd99c04d0a5162fc14777d4f1ec7d3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.867017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.867017%26sid%3Dliteratum%253Aachs%26aulast%3DCasimiro%26aufirst%3DM.%2BC.%26aulast%3DVelasco-Velazquez%26aufirst%3DM.%26aulast%3DAguirre-Alvarado%26aufirst%3DC.%26aulast%3DPestell%26aufirst%3DR.%2BG.%26atitle%3DOverview%2520of%2520Cyclins%2520D1%2520Function%2520in%2520Cancer%2520and%2520the%2520CDK%2520Inhibitor%2520Landscape%253A%2520Past%2520and%2520Present%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D295%26epage%3D304%26doi%3D10.1517%2F13543784.2014.867017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sherr, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shapiro, G. I.</span><span> </span><span class="NLM_article-title">Targeting CDK4 and CDK6: From Discovery to Therapy</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">367</span><span class="refDoi"> DOI: 10.1158/2159-8290.CD-15-0894</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1158%2F2159-8290.CD-15-0894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=26658964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC28Xlslaqu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=353-367&author=C.+J.+Sherrauthor=D.+Beachauthor=G.+I.+Shapiro&title=Targeting+CDK4+and+CDK6%3A+From+Discovery+to+Therapy&doi=10.1158%2F2159-8290.CD-15-0894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting CDK4 and CDK6: From Discovery to Therapy</span></div><div class="casAuthors">Sherr, Charles J.; Beach, David; Shapiro, Geoffrey I.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-367</span>CODEN:
                <span class="NLM_cas:coden">CDAIB2</span>;
        ISSN:<span class="NLM_cas:issn">2159-8274</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Biochem. and genetic characterization of D-type cyclins, their cyclin D-dependent kinases (CDK4 and CDK6), and the polypeptide CDK4/6 inhibitor p16INK4 over two decades ago revealed how mammalian cells regulate entry into the DNA synthetic (S) phase of the cell-division cycle in a retinoblastoma protein-dependent manner.  These investigations provided proof-of-principle that CDK4/6 inhibitors, particularly when combined with coinhibition of allied mitogen-dependent signal transduction pathways, might prove valuable in cancer therapy.  FDA approval of the CDK4/6 inhibitor palbociclib used with the aromatase inhibitor letrozole for breast cancer treatment highlights long-sought success.  The newest findings herald clin. trials targeting other cancers.  Significance: Rapidly emerging data with selective inhibitors of CDK4/6 have validated these cell-cycle kinases as anticancer drug targets, corroborating longstanding preclin. predictions.  This review addresses the discovery of these CDKs and their regulators, as well as translation of CDK4/6 biol. to pos. clin. outcomes and development of rational combinatorial therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNk2UjFylJJ7Vg90H21EOLACvtfcHk0lgUI0OEDMs34g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xlslaqu70%253D&md5=f4b1670d4771ca2079fb1eb7ebaef2b2</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1158%2F2159-8290.CD-15-0894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F2159-8290.CD-15-0894%26sid%3Dliteratum%253Aachs%26aulast%3DSherr%26aufirst%3DC.%2BJ.%26aulast%3DBeach%26aufirst%3DD.%26aulast%3DShapiro%26aufirst%3DG.%2BI.%26atitle%3DTargeting%2520CDK4%2520and%2520CDK6%253A%2520From%2520Discovery%2520to%2520Therapy%26jtitle%3DCancer%2520Discovery%26date%3D2016%26volume%3D6%26spage%3D353%26epage%3D367%26doi%3D10.1158%2F2159-8290.CD-15-0894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Bruyere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Targeting Cyclin-Dependent Kinases in Anti-Neoplastic Therapy</span> <span class="citation_source-journal">Curr. Opin. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">772</span><span class="NLM_x">–</span> <span class="NLM_lpage">779</span><span class="refDoi"> DOI: 10.1016/j.ceb.2013.08.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.ceb.2013.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=24011867" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVWjurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2013&pages=772-779&author=C.+Bruyereauthor=L.+Meijer&title=Targeting+Cyclin-Dependent+Kinases+in+Anti-Neoplastic+Therapy&doi=10.1016%2Fj.ceb.2013.08.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cyclin-dependent kinases in anti-neoplastic therapy</span></div><div class="casAuthors">Bruyere, Celine; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Cell Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">772-779</span>CODEN:
                <span class="NLM_cas:coden">COCBE3</span>;
        ISSN:<span class="NLM_cas:issn">0955-0674</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Cell cycle progression is controlled by sequential activation of cyclin-dependent kinases (CDKs), which are often deregulated in cancer.  Consequently numerous pharmacol. inhibitors of CDKs have been developed with the aim of treating cancers.  The article briefly reviews CDK inhibitors and their use to treat cancers, with specific focus on the use of biomarkers and drugs combination to improve their therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJcNl85MPhErVg90H21EOLACvtfcHk0lgUI0OEDMs34g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVWjurvM&md5=a4371b2c5996863f19e89416e8f8361b</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ceb.2013.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ceb.2013.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DBruyere%26aufirst%3DC.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DTargeting%2520Cyclin-Dependent%2520Kinases%2520in%2520Anti-Neoplastic%2520Therapy%26jtitle%3DCurr.%2520Opin.%2520Cell%2520Biol.%26date%3D2013%26volume%3D25%26spage%3D772%26epage%3D779%26doi%3D10.1016%2Fj.ceb.2013.08.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Asghar, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Witkiewicz, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, E. S.</span><span> </span><span class="NLM_article-title">The History and Future of Targeting Cyclin-Dependent Kinases in Cancer Therapy</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">146</span><span class="refDoi"> DOI: 10.1038/nrd4504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrd4504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25633797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjvVCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=130-146&author=U.+Asgharauthor=A.+K.+Witkiewiczauthor=N.+C.+Turnerauthor=E.+S.+Knudsen&title=The+History+and+Future+of+Targeting+Cyclin-Dependent+Kinases+in+Cancer+Therapy&doi=10.1038%2Fnrd4504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The history and future of targeting cyclin-dependent kinases in cancer therapy</span></div><div class="casAuthors">Asghar, Uzma; Witkiewicz, Agnieszka K.; Turner, Nicholas C.; Knudsen, Erik S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-146</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cancer represents a pathol. manifestation of uncontrolled cell division; therefore, it has long been anticipated that our understanding of the basic principles of cell cycle control would result in effective cancer therapies.  In particular, cyclin-dependent kinases (CDKs) that promote transition through the cell cycle were expected to be key therapeutic targets because many tumorigenic events ultimately drive proliferation by impinging on CDK4 or CDK6 complexes in the G1 phase of the cell cycle.  Moreover, perturbations in chromosomal stability and aspects of S phase and G2/M control mediated by CDK2 and CDK1 are pivotal tumorigenic events.  Translating this knowledge into successful clin. development of CDK inhibitors has historically been challenging, and numerous CDK inhibitors have demonstrated disappointing results in clin. trials.  Here, we review the biol. of CDKs, the rationale for therapeutically targeting discrete kinase complexes and historical clin. results of CDK inhibitors.  We also discuss how CDK inhibitors with high selectivity (particularly for both CDK4 and CDK6), in combination with patient stratification, have resulted in more substantial clin. activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ_utd-yiEZLVg90H21EOLACvtfcHk0lgUI0OEDMs34g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjvVCrtLc%253D&md5=113bcd2e99a8267119d180670d3c7761</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1038%2Fnrd4504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4504%26sid%3Dliteratum%253Aachs%26aulast%3DAsghar%26aufirst%3DU.%26aulast%3DWitkiewicz%26aufirst%3DA.%2BK.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DKnudsen%26aufirst%3DE.%2BS.%26atitle%3DThe%2520History%2520and%2520Future%2520of%2520Targeting%2520Cyclin-Dependent%2520Kinases%2520in%2520Cancer%2520Therapy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D130%26epage%3D146%26doi%3D10.1038%2Fnrd4504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Bose, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase Inhibitor Therapy for Hematologic Malignancies</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">723</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span><span class="refDoi"> DOI: 10.1517/13543784.2013.789859</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543784.2013.789859" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2013&pages=723-738&author=P.+Boseauthor=G.+L.+Simmonsauthor=S.+Grant&title=Cyclin-Dependent+Kinase+Inhibitor+Therapy+for+Hematologic+Malignancies&doi=10.1517%2F13543784.2013.789859"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1517%2F13543784.2013.789859&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2013.789859%26sid%3Dliteratum%253Aachs%26aulast%3DBose%26aufirst%3DP.%26aulast%3DSimmons%26aufirst%3DG.%2BL.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DCyclin-Dependent%2520Kinase%2520Inhibitor%2520Therapy%2520for%2520Hematologic%2520Malignancies%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2013%26volume%3D22%26spage%3D723%26epage%3D738%26doi%3D10.1517%2F13543784.2013.789859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arceci, R. J.</span><span> </span><span class="NLM_article-title">Targeting Cell Cycle Regulators in Hematologic Malignancies</span> <span class="citation_source-journal">Front. Cell Dev. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span><span class="refDoi"> DOI: 10.3389/fcell.2015.00016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.3389%2Ffcell.2015.00016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25914884" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A280%3ADC%252BC2MjnvFGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=16-37&author=E.+Aleemauthor=R.+J.+Arceci&title=Targeting+Cell+Cycle+Regulators+in+Hematologic+Malignancies&doi=10.3389%2Ffcell.2015.00016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cell cycle regulators in hematologic malignancies</span></div><div class="casAuthors">Aleem Eiman; Arceci Robert J</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in cell and developmental biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hematologic malignancies represent the fourth most frequently diagnosed cancer in economically developed countries.  In hematologic malignancies normal hematopoiesis is interrupted by uncontrolled growth of a genetically altered stem or progenitor cell (HSPC) that maintains its ability of self-renewal.  Cyclin-dependent kinases (CDKs) not only regulate the mammalian cell cycle, but also influence other vital cellular processes, such as stem cell renewal, differentiation, transcription, epigenetic regulation, apoptosis, and DNA repair.  Chromosomal translocations, amplification, overexpression and altered CDK activities have been described in different types of human cancer, which have made them attractive targets for pharmacological inhibition.  Mouse models deficient for one or more CDKs have significantly contributed to our current understanding of the physiological functions of CDKs, as well as their roles in human cancer.  The present review focuses on selected cell cycle kinases with recent emerging key functions in hematopoiesis and in hematopoietic malignancies, such as CDK6 and its role in MLL-rearranged leukemia and acute lymphocytic leukemia, CDK1 and its regulator WEE-1 in acute myeloid leukemia (AML), and cyclin C/CDK8/CDK19 complexes in T-cell acute lymphocytic leukemia.  The knowledge gained from gene knockout experiments in mice of these kinases is also summarized.  An overview of compounds targeting these kinases, which are currently in clinical development in various solid tumors and hematopoietic malignances, is presented.  These include the CDK4/CDK6 inhibitors (palbociclib, LEE011, LY2835219), pan-CDK inhibitors that target CDK1 (dinaciclib, flavopiridol, AT7519, TG02, P276-00, terampeprocol and RGB 286638) as well as the WEE-1 kinase inhibitor, MK-1775.  The advantage of combination therapy of cell cycle inhibitors with conventional chemotherapeutic agents used in the treatment of AML, such as cytarabine, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7iirrp56VY9y3lHz94U-GfW6udTcc2eZaETZ9umwZYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MjnvFGisw%253D%253D&md5=a6eb7c941baaff78abc39b3a1cb4c293</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffcell.2015.00016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffcell.2015.00016%26sid%3Dliteratum%253Aachs%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DArceci%26aufirst%3DR.%2BJ.%26atitle%3DTargeting%2520Cell%2520Cycle%2520Regulators%2520in%2520Hematologic%2520Malignancies%26jtitle%3DFront.%2520Cell%2520Dev.%2520Biol.%26date%3D2015%26volume%3D3%26spage%3D16%26epage%3D37%26doi%3D10.3389%2Ffcell.2015.00016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">O’Leary, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finn, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span> </span><span class="NLM_article-title">Treating Cancer with Selective CDK4/6 Inhibitors</span> <span class="citation_source-journal">Nat. Rev. Clin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">417</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span><span class="refDoi"> DOI: 10.1038/nrclinonc.2016.26</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrclinonc.2016.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=27030077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC28XlsF2iurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=417-430&author=B.+O%E2%80%99Learyauthor=R.+S.+Finnauthor=N.+C.+Turner&title=Treating+Cancer+with+Selective+CDK4%2F6+Inhibitors&doi=10.1038%2Fnrclinonc.2016.26"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Treating cancer with selective CDK4/6 inhibitors</span></div><div class="casAuthors">O'Leary, Ben; Finn, Richard S.; Turner, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Clinical Oncology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">417-430</span>CODEN:
                <span class="NLM_cas:coden">NRCOAA</span>;
        ISSN:<span class="NLM_cas:issn">1759-4774</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Uncontrolled cellular proliferation, mediated by dysregulation of the cell-cycle machinery and activation of cyclin-dependent kinases (CDKs) to promote cell-cycle progression, lies at the heart of cancer as a pathol. process.  Clin. implementation of first-generation, nonselective CDK inhibitors, designed to inhibit this proliferation, was originally hampered by the high risk of toxicity and lack of efficacy noted with these agents.  The emergence of a new generation of selective CDK4/6 inhibitors, including ribociclib, abemaciclib and palbociclib, has enabled tumor types in which CDK4/6 has a pivotal role in the G1-to-S-phase cell-cycle transition to be targeted with improved effectiveness, and fewer adverse effects.  Results of pivotal phase III trials investigating palbociclib in patients with advanced-stage estrogen receptor (ER)-pos. breast cancer have demonstrated a substantial improvement in progression-free survival, with a well-tolerated toxicity profile.  Mechanisms of acquired resistance to CDK4/6 inhibitors are beginning to emerge that, although unwelcome, might enable rational post-CDK4/6 inhibitor therapeutic strategies to be identified.  Extending the use of CDK4/6 inhibitors beyond ER-pos. breast cancer is challenging, and will likely require biomarkers that are predictive of a response, and the use of combination therapies in order to optimize CDK4/6 targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGNYw6CRUf17Vg90H21EOLACvtfcHk0li8qYZlo27j9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XlsF2iurc%253D&md5=6641dc6ab3cbd70edac46319ce4e6f45</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnrclinonc.2016.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrclinonc.2016.26%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DB.%26aulast%3DFinn%26aufirst%3DR.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26atitle%3DTreating%2520Cancer%2520with%2520Selective%2520CDK4%252F6%2520Inhibitors%26jtitle%3DNat.%2520Rev.%2520Clin.%2520Oncol.%26date%3D2016%26volume%3D13%26spage%3D417%26epage%3D430%26doi%3D10.1038%2Fnrclinonc.2016.26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sánchez-Martínez, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gelbert, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lallena, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Dios, A.</span><span> </span><span class="NLM_article-title">Cyclin Dependent Kinase (CDK) Inhibitors as Anticancer Drugs</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">3420</span><span class="NLM_x">–</span> <span class="NLM_lpage">3435</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.bmcl.2015.05.100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=26115571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3420-3435&author=C.+S%C3%A1nchez-Mart%C3%ADnezauthor=L.+M.+Gelbertauthor=M.+J.+Lallenaauthor=A.+de+Dios&title=Cyclin+Dependent+Kinase+%28CDK%29+Inhibitors+as+Anticancer+Drugs&doi=10.1016%2Fj.bmcl.2015.05.100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin dependent kinase (CDK) inhibitors as anticancer drugs</span></div><div class="casAuthors">Sanchez-Martinez, Concepcion; Gelbert, Lawrence M.; Lallena, Maria Jose; de Dios, Alfonso</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3420-3435</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Sustained proliferative capacity is a hallmark of cancer.  In mammalian cells proliferation is controlled by the cell cycle, where cyclin-dependent kinases (CDKs) regulate crit. checkpoints.  CDK4 and CDK6 are considered highly validated anticancer drug targets due to their essential role regulating cell cycle progression at the G1 restriction point.  This review provides an overview of recent advances on cyclin dependent kinase inhibitors in general with special emphasis on CDK4 and CDK6 inhibitors and compds. under clin. evaluation.  Chem. structures, structure activity relationships, and relevant preclin. properties will be described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwE7MEzEetPbVg90H21EOLACvtfcHk0li8qYZlo27j9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVeis7fN&md5=d4451fdbfd0ef0b08165105b9c8a38dc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.100%26sid%3Dliteratum%253Aachs%26aulast%3DS%25C3%25A1nchez-Mart%25C3%25ADnez%26aufirst%3DC.%26aulast%3DGelbert%26aufirst%3DL.%2BM.%26aulast%3DLallena%26aufirst%3DM.%2BJ.%26aulast%3Dde%2BDios%26aufirst%3DA.%26atitle%3DCyclin%2520Dependent%2520Kinase%2520%2528CDK%2529%2520Inhibitors%2520as%2520Anticancer%2520Drugs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3420%26epage%3D3435%26doi%3D10.1016%2Fj.bmcl.2015.05.100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tetsu, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span> </span><span class="NLM_article-title">Proliferation of Cancer Cells Despite CDK2 Inhibition</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">233</span><span class="NLM_x">–</span> <span class="NLM_lpage">245</span><span class="refDoi"> DOI: 10.1016/S1535-6108(03)00053-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2FS1535-6108%2803%2900053-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=12676582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD3sXislOrtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=233-245&author=O.+Tetsuauthor=F.+McCormick&title=Proliferation+of+Cancer+Cells+Despite+CDK2+Inhibition&doi=10.1016%2FS1535-6108%2803%2900053-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Proliferation of cancer cells despite CDK2 inhibition</span></div><div class="casAuthors">Tetsu, Osamu; McCormick, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">233-245</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The authors have investigated the contribution of CDK4 and CDK2 inhibition to G1 arrest in colon cancers following inhibition of the MEK/MAP kinase pathway.  CDK4 inhibition is sufficient to cause arrest, but inhibition of CDK2 by p27 Kip1 redistribution or ectopic expression has no effect on proliferation.  Likewise, inhibition of CDK2 through expression of dominant-neg. (DN) CDK2 or antisense oligonucleotides did not prevent cell proliferation in these cells.  The authors therefore tested whether CDK2 activity is dispensable in other cells.  Surprisingly, osteosarcomas and Rb-neg. cervical cancers continued to proliferate after depletion of CDK2 through antisense oligonucleotides or small interfering (si) RNA.  Here the authors report sustained cell proliferation in the absence of CDK2, and the authors suggest that CDK2 is not a suitable target for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUlrtla8E307Vg90H21EOLACvtfcHk0ljI5iSSFpTndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXislOrtb0%253D&md5=a4c67cbe660ff486912ab5113cfe53bb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS1535-6108%2803%2900053-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1535-6108%252803%252900053-9%26sid%3Dliteratum%253Aachs%26aulast%3DTetsu%26aufirst%3DO.%26aulast%3DMcCormick%26aufirst%3DF.%26atitle%3DProliferation%2520of%2520Cancer%2520Cells%2520Despite%2520CDK2%2520Inhibition%26jtitle%3DCancer%2520Cell%26date%3D2003%26volume%3D3%26spage%3D233%26epage%3D245%26doi%3D10.1016%2FS1535-6108%2803%2900053-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ortega, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prieto, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Odajima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubus, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotillo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbero, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malumbres, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbacid, M.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase 2 is Essential for Meiosis but not for Mitotic Cell Division in Mice</span> <span class="citation_source-journal">Nat. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">31</span><span class="refDoi"> DOI: 10.1038/ng1232</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fng1232" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=12923533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2003&pages=25-31&author=S.+Ortegaauthor=I.+Prietoauthor=J.+Odajimaauthor=A.+Martinauthor=P.+Dubusauthor=R.+Sotilloauthor=J.+L.+Barberoauthor=M.+Malumbresauthor=M.+Barbacid&title=Cyclin-Dependent+Kinase+2+is+Essential+for+Meiosis+but+not+for+Mitotic+Cell+Division+in+Mice&doi=10.1038%2Fng1232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice</span></div><div class="casAuthors">Ortega, Sagrario; Prieto, Ignacio; Odajima, Junko; Martin, Alberto; Dubus, Pierre; Sotillo, Rocio; Barbero, Jose Luis; Malumbres, Marcos; Barbacid, Mariano</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-31</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We targeted the locus encoding the cyclin-dependent kinase 2 (CDK2) by homologous recombination in mouse embryonic stem (ES) cells.  Embryonic fibroblasts lacking CDK2 proliferate normally and become immortal after continuous passage in culture.  Elimination of a conditional Cdk2 allele in immortal cells does not have a significant effect on proliferation.  Cdk2-/- mice are viable and survive for up to two years, indicating that CDK2 is also dispensable for proliferation and survival of most cell types.  But CDK2 is essential for completion of prophase I during meiotic cell division in male and female germ cells, an unforeseen role for this cell cycle kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5r24x7syf9bVg90H21EOLACvtfcHk0ljI5iSSFpTndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmslelsrw%253D&md5=7f2898209c25b5b663626897ec956a2f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fng1232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1232%26sid%3Dliteratum%253Aachs%26aulast%3DOrtega%26aufirst%3DS.%26aulast%3DPrieto%26aufirst%3DI.%26aulast%3DOdajima%26aufirst%3DJ.%26aulast%3DMartin%26aufirst%3DA.%26aulast%3DDubus%26aufirst%3DP.%26aulast%3DSotillo%26aufirst%3DR.%26aulast%3DBarbero%26aufirst%3DJ.%2BL.%26aulast%3DMalumbres%26aufirst%3DM.%26aulast%3DBarbacid%26aufirst%3DM.%26atitle%3DCyclin-Dependent%2520Kinase%25202%2520is%2520Essential%2520for%2520Meiosis%2520but%2520not%2520for%2520Mitotic%2520Cell%2520Division%2520in%2520Mice%26jtitle%3DNat.%2520Genet.%26date%3D2003%26volume%3D35%26spage%3D25%26epage%3D31%26doi%3D10.1038%2Fng1232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Berthet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleem, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppola, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tessarollo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaldis, P.</span><span> </span><span class="NLM_article-title">Cdk2 Knockout Mice are Viable</span> <span class="citation_source-journal">Curr. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1775</span><span class="NLM_x">–</span> <span class="NLM_lpage">1785</span><span class="refDoi"> DOI: 10.1016/j.cub.2003.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.cub.2003.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=14561402" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1775-1785&author=C.+Berthetauthor=E.+Aleemauthor=V.+Coppolaauthor=L.+Tessarolloauthor=P.+Kaldis&title=Cdk2+Knockout+Mice+are+Viable&doi=10.1016%2Fj.cub.2003.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cdk2 Knockout Mice Are Viable</span></div><div class="casAuthors">Berthet, Cyril; Aleem, Eiman; Coppola, Vincenzo; Tessarollo, Lino; Kaldis, Philipp</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">1775-1785</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Background: Cyclin-dependent kinases (Cdks) and their cyclin regulatory subunits control cell growth and division.  Cdk2/cyclin E complexes are thought to be required because they phosphorylate the retinoblastoma protein and drive cells through the G1/S transition into the S phase of the cell cycle.  In addn., Cdk2 assocs. with cyclin A, which itself is essential for cell proliferation during early embryonic development.  Results: In order to study the functions of Cdk2 in vivo, we generated Cdk2 knockout mice.  Surprisingly, these mice are viable, and therefore Cdk2 is not an essential gene in the mouse.  However, Cdk2 is required for germ cell development; both male and female Cdk2-/- mice are sterile.  Immunoppts. of cyclin E1 complexes from Cdk2-/- spleen exts. displayed no activity toward histone H1.  Cyclin A2 complexes were active in primary mouse embryonic fibroblasts (MEFs), embryo exts. and in spleen exts. from young animals.  In contrast, there was little cyclin A2 kinase activity in immortalized MEFs and spleen exts. from adult animals.  Cdk2-/- MEFs proliferate but enter delayed into S phase.  Ectopic expression of Cdk2 in Cdk2-/- MEFs rescued the delayed entry into S phase.  Conclusions: Although Cdk2 is not an essential gene in the mouse, it is required for germ cell development and meiosis.  Loss of Cdk2 affects the timing of S phase, suggesting that Cdk2 is involved in regulating progression through the mitotic cell cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0o-n-kcfSW7Vg90H21EOLACvtfcHk0ljI5iSSFpTndw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXot12itbk%253D&md5=8bb2c819e566952895434253f667454c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2003.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2003.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DBerthet%26aufirst%3DC.%26aulast%3DAleem%26aufirst%3DE.%26aulast%3DCoppola%26aufirst%3DV.%26aulast%3DTessarollo%26aufirst%3DL.%26aulast%3DKaldis%26aufirst%3DP.%26atitle%3DCdk2%2520Knockout%2520Mice%2520are%2520Viable%26jtitle%3DCurr.%2520Biol.%26date%3D2003%26volume%3D13%26spage%3D1775%26epage%3D1785%26doi%3D10.1016%2Fj.cub.2003.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Horiuchi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huskey, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kusdra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wohlbold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrick, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creasman, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span> </span><span class="NLM_article-title">Chemical-Genetic Analysis of Cyclin Dependent Kinase 2 Function Reveals an Important Role in Cellular Transformation by Multiple Oncogenic Pathways</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">E1019</span><span class="NLM_x">–</span> <span class="NLM_lpage">E1027</span><span class="refDoi"> DOI: 10.1073/pnas.1111317109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1073%2Fpnas.1111317109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=22474407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslGmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=E1019-E1027&author=D.+Horiuchiauthor=N.+E.+Huskeyauthor=L.+Kusdraauthor=L.+Wohlboldauthor=K.+A.+Merrickauthor=C.+Zhangauthor=K.+J.+Creasmanauthor=K.+M.+Shokatauthor=R.+P.+Fisherauthor=A.+Goga&title=Chemical-Genetic+Analysis+of+Cyclin+Dependent+Kinase+2+Function+Reveals+an+Important+Role+in+Cellular+Transformation+by+Multiple+Oncogenic+Pathways&doi=10.1073%2Fpnas.1111317109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical-genetic analysis of cyclin dependent kinase 2 function reveals an important role in cellular transformation by multiple oncogenic pathways</span></div><div class="casAuthors">Horiuchi, Dai; Huskey, Noelle E.; Kusdra, Leonard; Wohlbold, Lara; Merrick, Karl A.; Zhang, Chao; Creasman, Katelyn J.; Shokat, Kevan M.; Fisher, Robert P.; Goga, Andrei</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">E1019-E1027, SE1019/1-SE1019/4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A family of conserved serine/threonine kinases known as cyclin-dependent kinases (CDKs) drives orderly cell cycle progression in mammalian cells.  Prior studies have suggested that CDK2 regulates S-phase entry and progression, and frequently shows increased activity in a wide spectrum of human tumors.  Genetic KO/knockdown approaches, however, have suggested that lack of CDK2 protein does not prevent cellular proliferation, both during somatic development in mice as well as in human cancer cell lines.  Here, we use an alternative, chem.-genetic approach to achieve specific inhibition of CDK2 kinase activity in cells.  We directly compare small-mol. inhibition of CDK2 kinase activity with siRNA knockdown and show that small-mol. inhibition results in marked defects in proliferation of nontransformed cells, whereas siRNA knockdown does not, highlighting the differences between these two approaches.  In addn., CDK2 inhibition drastically diminishes anchorage-independent growth of human cancer cells and cells transformed with various oncogenes.  Our results establish that CDK2 activity is necessary for normal mammalian cell cycle progression and suggest that it might be a useful therapeutic target for treating cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr38-RTvuFoa7Vg90H21EOLACvtfcHk0lgJab2m_lKGrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslGmtLk%253D&md5=dcb463a6fc2696712617034313e8960a</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1111317109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1111317109%26sid%3Dliteratum%253Aachs%26aulast%3DHoriuchi%26aufirst%3DD.%26aulast%3DHuskey%26aufirst%3DN.%2BE.%26aulast%3DKusdra%26aufirst%3DL.%26aulast%3DWohlbold%26aufirst%3DL.%26aulast%3DMerrick%26aufirst%3DK.%2BA.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DCreasman%26aufirst%3DK.%2BJ.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DFisher%26aufirst%3DR.%2BP.%26aulast%3DGoga%26aufirst%3DA.%26atitle%3DChemical-Genetic%2520Analysis%2520of%2520Cyclin%2520Dependent%2520Kinase%25202%2520Function%2520Reveals%2520an%2520Important%2520Role%2520in%2520Cellular%2520Transformation%2520by%2520Multiple%2520Oncogenic%2520Pathways%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3DE1019%26epage%3DE1027%26doi%3D10.1073%2Fpnas.1111317109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Cheng, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charron, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houseman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zunder, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollok, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Q. W.</span><span> </span><span class="NLM_article-title">Dual Blockade of Lipid and Cyclin-Dependent Kinases Induces Synthetic Lethality in Malignant Glioma</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">12722</span><span class="NLM_x">–</span> <span class="NLM_lpage">12727</span><span class="refDoi"> DOI: 10.1073/pnas.1202492109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1073%2Fpnas.1202492109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=12722-12727&author=C.+K.+Chengauthor=W.+C.+Gustafsonauthor=E.+Charronauthor=B.+T.+Housemanauthor=E.+Zunderauthor=A.+Gogaauthor=N.+S.+Grayauthor=B.+Pollokauthor=S.+A.+Oakesauthor=C.+D.+Jamesauthor=K.+M.+Shokatauthor=W.+A.+Weissauthor=Q.+W.+Fan&title=Dual+Blockade+of+Lipid+and+Cyclin-Dependent+Kinases+Induces+Synthetic+Lethality+in+Malignant+Glioma&doi=10.1073%2Fpnas.1202492109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1202492109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1202492109%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DC.%2BK.%26aulast%3DGustafson%26aufirst%3DW.%2BC.%26aulast%3DCharron%26aufirst%3DE.%26aulast%3DHouseman%26aufirst%3DB.%2BT.%26aulast%3DZunder%26aufirst%3DE.%26aulast%3DGoga%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DPollok%26aufirst%3DB.%26aulast%3DOakes%26aufirst%3DS.%2BA.%26aulast%3DJames%26aufirst%3DC.%2BD.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DWeiss%26aufirst%3DW.%2BA.%26aulast%3DFan%26aufirst%3DQ.%2BW.%26atitle%3DDual%2520Blockade%2520of%2520Lipid%2520and%2520Cyclin-Dependent%2520Kinases%2520Induces%2520Synthetic%2520Lethality%2520in%2520Malignant%2520Glioma%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D12722%26epage%3D12727%26doi%3D10.1073%2Fpnas.1202492109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Deans, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khanna, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNees, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercurio, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heierhorst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McArthur, G. A.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase 2 Functions in Normal DNA Repair and is a Therapeutic Target in BRCA1-Deficient Cancers</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">8219</span><span class="NLM_x">–</span> <span class="NLM_lpage">8226</span><span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-3945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1158%2F0008-5472.CAN-05-3945" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=8219-8226&author=A.+J.+Deansauthor=K.+K.+Khannaauthor=C.+J.+McNeesauthor=C.+Mercurioauthor=J.+Heierhorstauthor=G.+A.+McArthur&title=Cyclin-Dependent+Kinase+2+Functions+in+Normal+DNA+Repair+and+is+a+Therapeutic+Target+in+BRCA1-Deficient+Cancers&doi=10.1158%2F0008-5472.CAN-05-3945"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-3945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-3945%26sid%3Dliteratum%253Aachs%26aulast%3DDeans%26aufirst%3DA.%2BJ.%26aulast%3DKhanna%26aufirst%3DK.%2BK.%26aulast%3DMcNees%26aufirst%3DC.%2BJ.%26aulast%3DMercurio%26aufirst%3DC.%26aulast%3DHeierhorst%26aufirst%3DJ.%26aulast%3DMcArthur%26aufirst%3DG.%2BA.%26atitle%3DCyclin-Dependent%2520Kinase%25202%2520Functions%2520in%2520Normal%2520DNA%2520Repair%2520and%2520is%2520a%2520Therapeutic%2520Target%2520in%2520BRCA1-Deficient%2520Cancers%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8219%26epage%3D8226%26doi%3D10.1158%2F0008-5472.CAN-05-3945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Molenaar, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ebus, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geerts, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koster, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamers, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valentijn, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westerhout, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Versteeg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caron, H. N.</span><span> </span><span class="NLM_article-title">Inactivation of CDK2 is Synthetically Lethal to MYCN Over-Expressing Cancer Cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">12968</span><span class="NLM_x">–</span> <span class="NLM_lpage">12973</span><span class="refDoi"> DOI: 10.1073/pnas.0901418106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1073%2Fpnas.0901418106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=19525400" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVKru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=12968-12973&author=J.+J.+Molenaarauthor=M.+E.+Ebusauthor=D.+Geertsauthor=J.+Kosterauthor=F.+Lamersauthor=L.+J.+Valentijnauthor=E.+M.+Westerhoutauthor=R.+Versteegauthor=H.+N.+Caron&title=Inactivation+of+CDK2+is+Synthetically+Lethal+to+MYCN+Over-Expressing+Cancer+Cells&doi=10.1073%2Fpnas.0901418106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells</span></div><div class="casAuthors">Molenaar, Jan J.; Ebus, Marli E.; Geerts, Dirk; Koster, Jan; Lamers, Fieke; Valentijn, Linda J.; Westerhout, Ellen M.; Versteeg, Rogier; Caron, Huib N.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">106</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">12968-12973</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Two genes have a synthetically lethal relationship when the silencing or inhibiting of 1 gene is only lethal in the context of a mutation or activation of the second gene.  This situation offers an attractive therapeutic strategy, as inhibition of such a gene will only trigger cell death in tumor cells with an activated second oncogene but spare normal cells without activation of the second oncogene.  Here we present evidence that CDK2 is synthetically lethal to neuroblastoma cells with MYCN amplification and over-expression.  Neuroblastomas are childhood tumors with an often lethal outcome.  Twenty percent of the tumors have MYCN amplification, and these tumors are ultimately refractory to any therapy.  Targeted silencing of CDK2 by 3 RNA interference techniques induced apoptosis in MYCN-amplified neuroblastoma cell lines, but not in MYCN single copy cells.  Silencing of MYCN abrogated this apoptotic response in MYCN-amplified cells.  Inversely, silencing of CDK2 in MYCN single copy cells did not trigger apoptosis, unless a MYCN transgene was activated.  The MYCN induced apoptosis after CDK2 silencing was accompanied by nuclear stabilization of P53, and mRNA profiling showed up-regulation of P53 target genes.  Silencing of P53 rescued the cells from MYCN-driven apoptosis.  The synthetic lethality of CDK2 silencing in MYCN activated neuroblastoma cells can also be triggered by inhibition of CDK2 with a small mol. drug.  Treatment of neuroblastoma cells with roscovitine, a CDK inhibitor, at clin. achievable concns. induced MYCN-dependent apoptosis.  The synthetically lethal relationship between CDK2 and MYCN indicates CDK2 inhibitors as potential MYCN-selective cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr48u4K0MeszLVg90H21EOLACvtfcHk0lgJab2m_lKGrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVKru77P&md5=016ebf4ccc1f5c6e3b965e999cca58c7</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0901418106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0901418106%26sid%3Dliteratum%253Aachs%26aulast%3DMolenaar%26aufirst%3DJ.%2BJ.%26aulast%3DEbus%26aufirst%3DM.%2BE.%26aulast%3DGeerts%26aufirst%3DD.%26aulast%3DKoster%26aufirst%3DJ.%26aulast%3DLamers%26aufirst%3DF.%26aulast%3DValentijn%26aufirst%3DL.%2BJ.%26aulast%3DWesterhout%26aufirst%3DE.%2BM.%26aulast%3DVersteeg%26aufirst%3DR.%26aulast%3DCaron%26aufirst%3DH.%2BN.%26atitle%3DInactivation%2520of%2520CDK2%2520is%2520Synthetically%2520Lethal%2520to%2520MYCN%2520Over-Expressing%2520Cancer%2520Cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D12968%26epage%3D12973%26doi%3D10.1073%2Fpnas.0901418106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jing, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase 2 is an Ideal Target for Ovary Tumors with Elevated Cyclin E1 Expression</span> <span class="citation_source-journal">Oncotarget</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">20801</span><span class="NLM_x">–</span> <span class="NLM_lpage">20812</span><span class="refDoi"> DOI: 10.18632/oncotarget.4600</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.18632%2Foncotarget.4600" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=20801-20812&author=L.+Yangauthor=D.+Fangauthor=H.+Chenauthor=Y.+Luauthor=Z.+Dongauthor=H.+F.+Dingauthor=Q.+Jingauthor=S.+B.+Suauthor=S.+Huang&title=Cyclin-Dependent+Kinase+2+is+an+Ideal+Target+for+Ovary+Tumors+with+Elevated+Cyclin+E1+Expression&doi=10.18632%2Foncotarget.4600"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4600&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4600%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DFang%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DZ.%26aulast%3DDing%26aufirst%3DH.%2BF.%26aulast%3DJing%26aufirst%3DQ.%26aulast%3DSu%26aufirst%3DS.%2BB.%26aulast%3DHuang%26aufirst%3DS.%26atitle%3DCyclin-Dependent%2520Kinase%25202%2520is%2520an%2520Ideal%2520Target%2520for%2520Ovary%2520Tumors%2520with%2520Elevated%2520Cyclin%2520E1%2520Expression%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D20801%26epage%3D20812%26doi%3D10.18632%2Foncotarget.4600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Guha, M.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase Inhibitors Move into Phase III</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">892</span><span class="NLM_x">–</span> <span class="NLM_lpage">894</span><span class="refDoi"> DOI: 10.1038/nrd3908</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrd3908" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=892-894&author=M.+Guha&title=Cyclin-Dependent+Kinase+Inhibitors+Move+into+Phase+III&doi=10.1038%2Fnrd3908"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2Fnrd3908&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3908%26sid%3Dliteratum%253Aachs%26aulast%3DGuha%26aufirst%3DM.%26atitle%3DCyclin-Dependent%2520Kinase%2520Inhibitors%2520Move%2520into%2520Phase%2520III%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D892%26epage%3D894%26doi%3D10.1038%2Fnrd3908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Galons, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oumata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gloulou, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span> </span><span class="NLM_article-title">Cyclin-Dependent Kinase Inhibitors Closer to Market Launch?</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">945</span><span class="NLM_x">–</span> <span class="NLM_lpage">963</span><span class="refDoi"> DOI: 10.1517/13543776.2013.789861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543776.2013.789861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=23600454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=945-963&author=H.+Galonsauthor=N.+Oumataauthor=O.+Gloulouauthor=L.+Meijer&title=Cyclin-Dependent+Kinase+Inhibitors+Closer+to+Market+Launch%3F&doi=10.1517%2F13543776.2013.789861"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclin-dependent kinase inhibitors closer to market launch?</span></div><div class="casAuthors">Galons, Herve; Oumata, Nassima; Gloulou, Olfa; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">945-963</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Interest in cyclin-dependent kinase (CDK) inhibitors was stimulated by the demonstration that their pharmacol. activities could lead to therapies for numerous diseases.  Until now, despite the clin. introduction of a dozen compds. belonging to other classes of kinase inhibitors, no CDK inhibitor has reached the marketplace.  Areas covered: This review covers CDK inhibitor patents published between 2009 and Sept. 2012.  It presents compds. currently undergoing clin. development, along with our earlier (2010) review of the same topic, as well as descriptions of recently published compds. not disclosed in the patent literature.  It provides the reader with an update of all chem. structures of current interest in the CDK inhibitor field.  Expert opinion: Though cancer remains the most obvious application for CDK inhibition, other indications, such as HIV infection, could potentially be treated with CDK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO3flHndUPMrVg90H21EOLACvtfcHk0lioyNtjfeZyqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3K&md5=6bd4f5033c6dc3627d4baf1f9ddf214c</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.789861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.789861%26sid%3Dliteratum%253Aachs%26aulast%3DGalons%26aufirst%3DH.%26aulast%3DOumata%26aufirst%3DN.%26aulast%3DGloulou%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DCyclin-Dependent%2520Kinase%2520Inhibitors%2520Closer%2520to%2520Market%2520Launch%253F%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D945%26epage%3D963%26doi%3D10.1517%2F13543776.2013.789861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Santo, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raje, N.</span><span> </span><span class="NLM_article-title">Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers</span> <span class="citation_source-journal">Semin. Oncol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">788</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span><span class="refDoi"> DOI: 10.1053/j.seminoncol.2015.09.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1053%2Fj.seminoncol.2015.09.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=26615126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFWksL7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=788-800&author=L.+Santoauthor=K.+T.+Siuauthor=N.+Raje&title=Targeting+Cyclin-Dependent+Kinases+and+Cell+Cycle+Progression+in+Human+Cancers&doi=10.1053%2Fj.seminoncol.2015.09.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers</span></div><div class="casAuthors">Santo, Loredana; Siu, Ka Tat; Raje, Noopur</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">788-800</span>CODEN:
                <span class="NLM_cas:coden">SOLGAV</span>;
        ISSN:<span class="NLM_cas:issn">0093-7754</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Uncontrolled cell division is a defining characteristic of cancer cells.  Cyclin-dependent kinases (Cdks) are crit. regulators of cell cycle progression.  Deregulated Cdk activities as a result of gene amplification, translocation, or point mutations of Cdks or cyclins, have been reported in a majority of human cancers.  These kinases, therefore, represent potential therapeutic targets for the treatment of cancer.  In this review, we offer an overview of Cdk functions in driving cell cycle progression and transcriptional regulation, a highlight of the DNA damage checkpoints, and an outline of the most relevant Cdk inhibitors currently in clin. trials with an emphasis on the Cdk inhibitors used for treatment of multiple myeloma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBLbVHqlZ2OrVg90H21EOLACvtfcHk0lioyNtjfeZyqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFWksL7J&md5=ee57a7c9b080ae0ad3860a4d8b2dd691</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1053%2Fj.seminoncol.2015.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.seminoncol.2015.09.024%26sid%3Dliteratum%253Aachs%26aulast%3DSanto%26aufirst%3DL.%26aulast%3DSiu%26aufirst%3DK.%2BT.%26aulast%3DRaje%26aufirst%3DN.%26atitle%3DTargeting%2520Cyclin-Dependent%2520Kinases%2520and%2520Cell%2520Cycle%2520Progression%2520in%2520Human%2520Cancers%26jtitle%3DSemin.%2520Oncol.%26date%3D2015%26volume%3D42%26spage%3D788%26epage%3D800%26doi%3D10.1053%2Fj.seminoncol.2015.09.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garman, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lawrie, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sausville, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, W.</span><span> </span><span class="NLM_article-title">Identification of Novel Purine and Pyrimidine Cyclin-Dependent Kinase Inhibitors with Distinct Molecular Interactions and Tumor Cell Growth Inhibition Profiles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">2797</span><span class="NLM_x">–</span> <span class="NLM_lpage">2804</span><span class="refDoi"> DOI: 10.1021/jm990628o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990628o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=2797-2804&author=C.+E.+Arrisauthor=F.+T.+Boyleauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=E.+F.+Garmanauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=A.+M.+Lawrieauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=E.+A.+Sausvilleauthor=R.+Schultzauthor=W.+Yu&title=Identification+of+Novel+Purine+and+Pyrimidine+Cyclin-Dependent+Kinase+Inhibitors+with+Distinct+Molecular+Interactions+and+Tumor+Cell+Growth+Inhibition+Profiles&doi=10.1021%2Fjm990628o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm990628o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990628o%26sid%3Dliteratum%253Aachs%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGarman%26aufirst%3DE.%2BF.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DLawrie%26aufirst%3DA.%2BM.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DSchultz%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DW.%26atitle%3DIdentification%2520of%2520Novel%2520Purine%2520and%2520Pyrimidine%2520Cyclin-Dependent%2520Kinase%2520Inhibitors%2520with%2520Distinct%2520Molecular%2520Interactions%2520and%2520Tumor%2520Cell%2520Growth%2520Inhibition%2520Profiles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D2797%26epage%3D2804%26doi%3D10.1021%2Fjm990628o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Davies, T.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A.-E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M.-E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H.-J.</span><span> </span><span class="NLM_article-title">Structure-Based Design of a Potent Purine-Based Cyclin-Dependent Kinase Inhibitor</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">745</span><span class="NLM_x">–</span> <span class="NLM_lpage">749</span><span class="refDoi"> DOI: 10.1038/nsb842</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnsb842" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=745-749&author=T.-G.+Daviesauthor=J.+Bentleyauthor=C.-E.+Arrisauthor=F.+T.+Boyleauthor=N.-J.+Curtinauthor=J.-A.+Endicottauthor=A.-E.+Gibsonauthor=B.-T.+Goldingauthor=R.-J.+Griffinauthor=I.-R.+Hardcastleauthor=P.+Jewsburyauthor=L.-N.+Johnsonauthor=V.+Mesguicheauthor=D.-R.+Newellauthor=M.-E.+M.+Nobleauthor=J.-A.+Tuckerauthor=L.+Wangauthor=H.-J.+Whitfield&title=Structure-Based+Design+of+a+Potent+Purine-Based+Cyclin-Dependent+Kinase+Inhibitor&doi=10.1038%2Fnsb842"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fnsb842&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb842%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DT.-G.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DArris%26aufirst%3DC.-E.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.-J.%26aulast%3DEndicott%26aufirst%3DJ.-A.%26aulast%3DGibson%26aufirst%3DA.-E.%26aulast%3DGolding%26aufirst%3DB.-T.%26aulast%3DGriffin%26aufirst%3DR.-J.%26aulast%3DHardcastle%26aufirst%3DI.-R.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.-N.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.-R.%26aulast%3DNoble%26aufirst%3DM.-E.%2BM.%26aulast%3DTucker%26aufirst%3DJ.-A.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWhitfield%26aufirst%3DH.-J.%26atitle%3DStructure-Based%2520Design%2520of%2520a%2520Potent%2520Purine-Based%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D745%26epage%3D749%26doi%3D10.1038%2Fnsb842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menyerol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">N2-Substituted O6-Cyclohexylmethylguanine Derivatives: Potent Inhibitors of Cyclin-Dependent Kinases 1 and 2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">3710</span><span class="NLM_x">–</span> <span class="NLM_lpage">3722</span><span class="refDoi"> DOI: 10.1021/jm0311442</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0311442" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD2cXks1Gisbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=3710-3722&author=I.+R.+Hardcastleauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=Y.+Chenauthor=N.+J.+Curtinauthor=J.+A.+Endicottauthor=A.+E.+Gibsonauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=J.+Menyerolauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=D.+J.+Prattauthor=L.+Z.+Wangauthor=H.+J.+Whitfield&title=N2-Substituted+O6-Cyclohexylmethylguanine+Derivatives%3A+Potent+Inhibitors+of+Cyclin-Dependent+Kinases+1+and+2&doi=10.1021%2Fjm0311442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N2-Substituted O6-Cyclohexylmethylguanine Derivatives: Potent Inhibitors of Cyclin-Dependent Kinases 1 and 2</span></div><div class="casAuthors">Hardcastle, Ian R.; Arris, Christine E.; Bentley, Johanne; Boyle, F. Thomas; Chen, Yuzhu; Curtin, Nicola J.; Endicott, Jane A.; Gibson, Ashleigh E.; Golding, Bernard T.; Griffin, Roger J.; Jewsbury, Philip; Menyerol, Jerome; Mesguiche, Veronique; Newell, David R.; Noble, Martin E. M.; Pratt, David J.; Wang, Lan-Zhen; Whitfield, Hayley J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3710-3722</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ATP competitive cyclin-dependent kinase inhibitor O6-cyclohexylmethylguanine (NU2058, 1) has been employed as the lead in a structure-based drug discovery program resulting in the discovery of the potent CDK1 and -2 inhibitor NU6102 (3, IC50 = 9.5 nM and 5.4 nM vs CDK1/cyclin B and CDK2/cyclin A3, resp.).  The SAR for this series have been explored further by the synthesis and evaluation of 45 N2-substituted analogs of NU2058.  These studies have confirmed the requirement for the hydrogen bonding N2-NH group and the requirement for an arom. N2-substituent to confer potency in the series.  Addnl. potency is conferred by the presence of a group capable of donating a hydrogen bond at the 4'-position, for example, the 4'-hydroxy deriv. (25, IC50 = 94 nM and 69 nM vs. CDK1/cyclinB and CDK2/cyclin A3, resp.), 4'-monomethylsulfonamide deriv. (28, IC50 = 9 nM and 7.0 nM vs. CDK1/cyclinB and CDK2/cyclin A3, resp.), and 4'-carboxamide deriv. (34, IC50 = 67 nM and 64 nM vs. CDK1/cyclinB and CDK2/cyclin A3, resp.).  X-ray crystal structures have been obtained for key compds. and have been used to explain the obsd. trends in activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDB9D6YHzKLVg90H21EOLACvtfcHk0lj-SORP1I5fLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXks1Gisbg%253D&md5=305eef50961c3f1ffad033cf9ab18c3f</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0311442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0311442%26sid%3Dliteratum%253Aachs%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DMenyerol%26aufirst%3DJ.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DN2-Substituted%2520O6-Cyclohexylmethylguanine%2520Derivatives%253A%2520Potent%2520Inhibitors%2520of%2520Cyclin-Dependent%2520Kinases%25201%2520and%25202%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D3710%26epage%3D3722%26doi%3D10.1021%2Fjm0311442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Marchetti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haggerty, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsons, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Payne, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of 5-Substituted O4-Alkylpyrimidines as CDK2 Inhibitors</span> <span class="citation_source-journal">Org. Biomol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2397</span><span class="NLM_x">–</span> <span class="NLM_lpage">2407</span><span class="refDoi"> DOI: 10.1039/b925481a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1039%2Fb925481a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2010&pages=2397-2407&author=F.+Marchettiauthor=C.+Canoauthor=N.+J.+Curtinauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=K.+Haggertyauthor=D.+R.+Newellauthor=R.+J.+Parsonsauthor=S.+L.+Payneauthor=L.+Z.+Wangauthor=I.+R.+Hardcastle&title=Synthesis+and+Biological+Evaluation+of+5-Substituted+O4-Alkylpyrimidines+as+CDK2+Inhibitors&doi=10.1039%2Fb925481a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1039%2Fb925481a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb925481a%26sid%3Dliteratum%253Aachs%26aulast%3DMarchetti%26aufirst%3DF.%26aulast%3DCano%26aufirst%3DC.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHaggerty%26aufirst%3DK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DParsons%26aufirst%3DR.%2BJ.%26aulast%3DPayne%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%2BZ.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%25205-Substituted%2520O4-Alkylpyrimidines%2520as%2520CDK2%2520Inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2010%26volume%3D8%26spage%3D2397%26epage%3D2407%26doi%3D10.1039%2Fb925481a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Jonkers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lis, J. T.</span><span> </span><span class="NLM_article-title">Getting up to Speed with Transcription Elongation by RNA Polymerase II</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">167</span><span class="NLM_x">–</span> <span class="NLM_lpage">177</span><span class="refDoi"> DOI: 10.1038/nrm3953</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnrm3953" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25693130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtFemsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=167-177&author=I.+Jonkersauthor=J.+T.+Lis&title=Getting+up+to+Speed+with+Transcription+Elongation+by+RNA+Polymerase+II&doi=10.1038%2Fnrm3953"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Getting up to speed with transcription elongation by RNA polymerase II</span></div><div class="casAuthors">Jonkers, Iris; Lis, John T.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">167-177</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Recent advances in sequencing techniques that measure nascent transcripts and that reveal the positioning of RNA polymerase II (Pol II) have shown that the pausing of Pol II in promoter-proximal regions and its release to initiate a phase of productive elongation are key steps in transcription regulation.  Moreover, after the release of Pol II from the promoter-proximal region, elongation rates are highly dynamic throughout the transcription of a gene, and vary on a gene-by-gene basis.  Interestingly, Pol II elongation rates affect co-transcriptional processes such as splicing, termination and genome stability.  Increasing nos. of factors and regulatory mechanisms have been assocd. with the steps of transcription elongation by Pol II, revealing that elongation is a highly complex process.  Elongation is thus now recognized as a key phase in the regulation of transcription by Pol II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmoGYHNxHU1bVg90H21EOLACvtfcHk0lhwdwuauDSPqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtFemsrw%253D&md5=6b8aa1cef47c37a0fd26a83f60cbab49</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Fnrm3953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3953%26sid%3Dliteratum%253Aachs%26aulast%3DJonkers%26aufirst%3DI.%26aulast%3DLis%26aufirst%3DJ.%2BT.%26atitle%3DGetting%2520up%2520to%2520Speed%2520with%2520Transcription%2520Elongation%2520by%2520RNA%2520Polymerase%2520II%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2015%26volume%3D16%26spage%3D167%26epage%3D177%26doi%3D10.1038%2Fnrm3953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Fischer, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gianella-Borradori, A.</span><span> </span><span class="NLM_article-title">Recent Progress in the Discovery and Development of Cyclin-Dependent Kinase Inhibitors</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">477</span><span class="refDoi"> DOI: 10.1517/13543784.14.4.457</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1517%2F13543784.14.4.457" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=457-477&author=P.+M.+Fischerauthor=A.+Gianella-Borradori&title=Recent+Progress+in+the+Discovery+and+Development+of+Cyclin-Dependent+Kinase+Inhibitors&doi=10.1517%2F13543784.14.4.457"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1517%2F13543784.14.4.457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.14.4.457%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DP.%2BM.%26aulast%3DGianella-Borradori%26aufirst%3DA.%26atitle%3DRecent%2520Progress%2520in%2520the%2520Discovery%2520and%2520Development%2520of%2520Cyclin-Dependent%2520Kinase%2520Inhibitors%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26spage%3D457%26epage%3D477%26doi%3D10.1517%2F13543784.14.4.457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Parry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prabhavalkar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doll, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nomeir, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Windsor, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oft, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschmeier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lees, E. M.</span><span> </span><span class="NLM_article-title">Dinaciclib (SCH 727965), A Novel and Potent Cyclin-Dependent Kinase Inhibitor</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">2344</span><span class="NLM_x">–</span> <span class="NLM_lpage">2353</span><span class="refDoi"> DOI: 10.1158/1535-7163.MCT-10-0324</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1158%2F1535-7163.MCT-10-0324" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=20663931" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=2344-2353&author=D.+Parryauthor=T.+Guziauthor=F.+Shanahanauthor=N.+Davisauthor=D.+Prabhavalkarauthor=D.+Wiswellauthor=W.+Seghezziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=R.+Dollauthor=A.+Nomeirauthor=W.+Windsorauthor=T.+Fischmannauthor=Y.+Wangauthor=M.+Oftauthor=T.+Chenauthor=P.+Kirschmeierauthor=E.+M.+Lees&title=Dinaciclib+%28SCH+727965%29%2C+A+Novel+and+Potent+Cyclin-Dependent+Kinase+Inhibitor&doi=10.1158%2F1535-7163.MCT-10-0324"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Dinaciclib (SCH 727965), a Novel and Potent Cyclin-Dependent Kinase Inhibitor</span></div><div class="casAuthors">Parry, David; Guzi, Timothy; Shanahan, Frances; Davis, Nicole; Prabhavalkar, Deepa; Wiswell, Derek; Seghezzi, Wolfgang; Paruch, Kamil; Dwyer, Michael P.; Doll, Ronald; Nomeir, Amin; Windsor, William; Fischmann, Thierry; Wang, Yaolin; Oft, Martin; Chen, Taiying; Kirschmeier, Paul; Lees, Emma M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2344-2353</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Cyclin-dependent kinases (CDK) are key pos. regulators of cell cycle progression and attractive targets in oncol.  SCH 727965 inhibits CDK2, CDK5, CDK1, and CDK9 activity in vitro with IC50 values of 1, 1, 3, and 4 nmol/L, resp.  SCH 727965 was selected as a clin. candidate using a functional screen in vivo that integrated both efficacy and safety parameters.  Compared with flavopiridol, SCH 727965 exhibits superior activity with an improved therapeutic index.  In cell-based assays, SCH 727965 completely suppressed retinoblastoma phosphorylation, which correlated with apoptosis onset and total inhibition of bromodeoxyuridine incorporation in >100 tumor cell lines of diverse origin and background.  Moreover, short exposures to SCH 727965 were sufficient for long-lasting cellular effects.  SCH 727965 induced regression of established solid tumors in a range of mouse models following intermittent scheduling of doses below the maximally tolerated level.  This was assocd. with modulation of pharmacodynamic biomarkers in skin punch biopsies and rapidly reversible, mechanism-based effects on hematol. parameters.  These results suggest that SCH 727965 is a potent and selective CDK inhibitor and a novel cytotoxic agent.  Mol Cancer Ther; 9(8); 2344-53.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxn1NtmEAh7LVg90H21EOLACvtfcHk0lhwdwuauDSPqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVOjtrw%253D&md5=bd2d30fdfdca0f2bceb3f5c0b44b8630</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0324&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0324%26sid%3Dliteratum%253Aachs%26aulast%3DParry%26aufirst%3DD.%26aulast%3DGuzi%26aufirst%3DT.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DPrabhavalkar%26aufirst%3DD.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DDoll%26aufirst%3DR.%26aulast%3DNomeir%26aufirst%3DA.%26aulast%3DWindsor%26aufirst%3DW.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DOft%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DT.%26aulast%3DKirschmeier%26aufirst%3DP.%26aulast%3DLees%26aufirst%3DE.%2BM.%26atitle%3DDinaciclib%2520%2528SCH%2520727965%2529%252C%2520A%2520Novel%2520and%2520Potent%2520Cyclin-Dependent%2520Kinase%2520Inhibitor%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D2344%26epage%3D2353%26doi%3D10.1158%2F1535-7163.MCT-10-0324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Pratt, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span> </span><span class="NLM_article-title">Dissecting the Determinants of Cyclin-Dependent Kinase 2 and Cyclin-Dependent Kinase 4 Inhibitor Selectivity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5470</span><span class="NLM_x">–</span> <span class="NLM_lpage">5477</span><span class="refDoi"> DOI: 10.1021/jm060216x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060216x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD28XnvFOqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5470-5477&author=D.+J.+Prattauthor=J.+Bentleyauthor=P.+Jewsburyauthor=F.+T.+Boyleauthor=J.+A.+Endicottauthor=M.+E.+Noble&title=Dissecting+the+Determinants+of+Cyclin-Dependent+Kinase+2+and+Cyclin-Dependent+Kinase+4+Inhibitor+Selectivity&doi=10.1021%2Fjm060216x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting the Determinants of Cyclin-Dependent Kinase 2 and Cyclin-Dependent Kinase 4 Inhibitor Selectivity</span></div><div class="casAuthors">Pratt, David J.; Bentley, Jo; Jewsbury, Philip; Boyle, F. Tom; Endicott, Jane A.; Noble, Martin E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5470-5477</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclin dependent kinases are a key family of kinases involved in cell cycle regulation and are an attractive target for cancer chemotherapy.  The roles of four residues of the cyclin-dependent kinase active site in inhibitor selectivity were investigated by producing cyclin-dependent kinase 2 mutants bearing equiv. cyclin-dependent kinase 4 residues, namely F82H, L83V, H84D, and K89T.  Assay of the mutants with a cyclin-dependent kinase 4-selective bisanilinopyrimidine shows that the K89T mutation is primarily responsible for the selectivity of this compd.  Use of the cyclin-dependent kinase 2-selective 6-cyclohexylmethoxy-2-(4'-sulfamoylanilino)purine (NU6102) shows that K89T has no role in the selectivity, while the remaining three mutations have a cumulative influence.  The results indicate that certain residues that are not frequently considered in structure-aided kinase inhibitor design have an important role to play.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYKIfTcMWw2LVg90H21EOLACvtfcHk0ljQA6rCkarSYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnvFOqs7g%253D&md5=9c34770c007482e690fa7414974f9279</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm060216x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060216x%26sid%3Dliteratum%253Aachs%26aulast%3DPratt%26aufirst%3DD.%2BJ.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26atitle%3DDissecting%2520the%2520Determinants%2520of%2520Cyclin-Dependent%2520Kinase%25202%2520and%2520Cyclin-Dependent%2520Kinase%25204%2520Inhibitor%2520Selectivity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5470%26epage%3D5477%26doi%3D10.1021%2Fjm060216x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Gibson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jewsbury, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mesguiche, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tucker, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitfield, H. J.</span><span> </span><span class="NLM_article-title">Probing the ATP Ribose-Binding Domain of Cyclin-Dependent Kinases 1 and 2 with O(6)-Substituted Guanine Derivatives</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3381</span><span class="NLM_x">–</span> <span class="NLM_lpage">3393</span><span class="refDoi"> DOI: 10.1021/jm020056z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm020056z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3381-3393&author=A.+E.+Gibsonauthor=C.+E.+Arrisauthor=J.+Bentleyauthor=F.+T.+Boyleauthor=N.+J.+Curtinauthor=T.+G.+Daviesauthor=J.+A.+Endicottauthor=B.+T.+Goldingauthor=S.+Grantauthor=R.+J.+Griffinauthor=P.+Jewsburyauthor=L.+N.+Johnsonauthor=V.+Mesguicheauthor=D.+R.+Newellauthor=M.+E.+Nobleauthor=J.+A.+Tuckerauthor=H.+J.+Whitfield&title=Probing+the+ATP+Ribose-Binding+Domain+of+Cyclin-Dependent+Kinases+1+and+2+with+O%286%29-Substituted+Guanine+Derivatives&doi=10.1021%2Fjm020056z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm020056z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020056z%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DA.%2BE.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DJewsbury%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DL.%2BN.%26aulast%3DMesguiche%26aufirst%3DV.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%26aulast%3DTucker%26aufirst%3DJ.%2BA.%26aulast%3DWhitfield%26aufirst%3DH.%2BJ.%26atitle%3DProbing%2520the%2520ATP%2520Ribose-Binding%2520Domain%2520of%2520Cyclin-Dependent%2520Kinases%25201%2520and%25202%2520with%2520O%25286%2529-Substituted%2520Guanine%2520Derivatives%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3381%26epage%3D3393%26doi%3D10.1021%2Fjm020056z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Montgomery, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewson, K.</span><span> </span><span class="NLM_article-title">Synthesis of Potential Anticancer Agents XX. 2-Fluoropurines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span><span class="refDoi"> DOI: 10.1021/ja01487a055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01487a055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1960&pages=463-468&author=J.+A.+Montgomeryauthor=K.+Hewson&title=Synthesis+of+Potential+Anticancer+Agents+XX.+2-Fluoropurines&doi=10.1021%2Fja01487a055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fja01487a055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01487a055%26sid%3Dliteratum%253Aachs%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26aulast%3DHewson%26aufirst%3DK.%26atitle%3DSynthesis%2520of%2520Potential%2520Anticancer%2520Agents%2520XX.%25202-Fluoropurines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1960%26volume%3D82%26spage%3D463%26epage%3D468%26doi%3D10.1021%2Fja01487a055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Carbain, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coxon, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebraud, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matheson, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meschini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roberts, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cano, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Trifluoroacetic Acid in 2,2,2-Trifluoroethanol Facilitates S<sub>N</sub>Ar Reactions of Heterocycles with Arylamines</span> <span class="citation_source-journal">Chem. - Eur. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2311</span><span class="NLM_x">–</span> <span class="NLM_lpage">2317</span><span class="refDoi"> DOI: 10.1002/chem.201304336</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fchem.201304336" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=24458729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12jurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2014&pages=2311-2317&author=B.+Carbainauthor=C.+R.+Coxonauthor=H.+Lebraudauthor=K.+J.+Elliottauthor=C.+J.+Mathesonauthor=E.+Meschiniauthor=A.+R.+Robertsauthor=D.+M.+Turnerauthor=C.+Wongauthor=C.+Canoauthor=R.+J.+Griffinauthor=I.+R.+Hardcastleauthor=B.+T.+Golding&title=Trifluoroacetic+Acid+in+2%2C2%2C2-Trifluoroethanol+Facilitates+SNAr+Reactions+of+Heterocycles+with+Arylamines&doi=10.1002%2Fchem.201304336"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Trifluoroacetic Acid in 2,2,2-Trifluoroethanol Facilitates SNAr Reactions of Heterocycles with Arylamines</span></div><div class="casAuthors">Carbain, Benoit; Coxon, Christopher R.; Lebraud, Honorine; Elliott, Kristopher J.; Matheson, Christopher J.; Meschini, Elisa; Roberts, Amy R.; Turner, David M.; Wong, Christopher; Cano, Celine; Griffin, Roger J.; Hardcastle, Ian R.; Golding, Bernard T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2311-2317</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Small-mol. drug discovery requires reliable synthetic methods for attaching amino compds. to heterocyclic scaffolds.  Trifluoroacetic acid-2,2,2-trifluoroethanol (TFA-TFE) is as an effective combination for achieving SNAr reactions between anilines and heterocycles (e.g., purines and pyrimidines) substituted with a leaving group (fluoro-, chloro-, bromo- or alkylsulfonyl).  This method provides a variety of compds. contg. a "kinase-privileged fragment" assocd. with potent inhibition of kinases.  TFE is an advantageous solvent because of its low nucleophilicity, ease of removal and ability to solubilize polar substrates.  Furthermore, TFE may assist the breakdown of the Meisenheimer-Jackson intermediate by solvating the leaving group.  TFA is a necessary and effective acidic catalyst, which activates the heterocycle by N-protonation without deactivating the aniline by conversion into an anilinium species.  The TFA-TFE methodol. is compatible with a variety of functional groups and complements organometallic alternatives, which are often disadvantageous because of the expense of reagents, the frequent need to explore diverse sets of reaction conditions, and problems with product purifn.  In contrast, product isolation from TFA-TFE reactions is straightforward: evapn. of the reaction mixt., basification and chromatog. affords anal. pure material.  A total of 45 examples, e.g., I, are described with seven discrete heterocyclic scaffolds and 2-, 3- and 4-substituted anilines giving product yields that are normally in the range 50-90 %.  Reactions can be performed with either conventional heating or microwave irradn., with the latter often giving improved yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaJWXELf9ezbVg90H21EOLACvtfcHk0ljQA6rCkarSYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12jurk%253D&md5=9340e85c3e81fe52595359a90c6bcbe2</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fchem.201304336&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201304336%26sid%3Dliteratum%253Aachs%26aulast%3DCarbain%26aufirst%3DB.%26aulast%3DCoxon%26aufirst%3DC.%2BR.%26aulast%3DLebraud%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DK.%2BJ.%26aulast%3DMatheson%26aufirst%3DC.%2BJ.%26aulast%3DMeschini%26aufirst%3DE.%26aulast%3DRoberts%26aufirst%3DA.%2BR.%26aulast%3DTurner%26aufirst%3DD.%2BM.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DCano%26aufirst%3DC.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DTrifluoroacetic%2520Acid%2520in%25202%252C2%252C2-Trifluoroethanol%2520Facilitates%2520SNAr%2520Reactions%2520of%2520Heterocycles%2520with%2520Arylamines%26jtitle%3DChem.%2520-%2520Eur.%2520J.%26date%3D2014%26volume%3D20%26spage%3D2311%26epage%3D2317%26doi%3D10.1002%2Fchem.201304336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Lembicz, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clegg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Facilitation of Displacements at the 6-Position of Purines by the Use of 1,4-Diazabicyclo[2.2.2.]octane as Leaving Group</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span><span class="refDoi"> DOI: 10.1039/a608207f</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1039%2Fa608207f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&pages=185-186&author=N.+K.+Lembiczauthor=S.+Grantauthor=W.+Cleggauthor=R.+J.+Griffinauthor=S.+L.+Heathauthor=B.+T.+Golding&title=Facilitation+of+Displacements+at+the+6-Position+of+Purines+by+the+Use+of+1%2C4-Diazabicyclo%5B2.2.2.%5Doctane+as+Leaving+Group&doi=10.1039%2Fa608207f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1039%2Fa608207f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fa608207f%26sid%3Dliteratum%253Aachs%26aulast%3DLembicz%26aufirst%3DN.%2BK.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DClegg%26aufirst%3DW.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DHeath%26aufirst%3DS.%2BL.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DFacilitation%2520of%2520Displacements%2520at%2520the%25206-Position%2520of%2520Purines%2520by%2520the%2520Use%2520of%25201%252C4-Diazabicyclo%255B2.2.2.%255Doctane%2520as%2520Leaving%2520Group%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1997%26spage%3D185%26epage%3D186%26doi%3D10.1039%2Fa608207f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kato, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Breton, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Roch, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagle, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursulaya, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNamara, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plouffe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramachandran, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peters, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chatterjee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harper, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winzeler, E. A.</span><span> </span><span class="NLM_article-title">Gene Expression Signatures and Small-Molecule Compounds Link a Protein Kinase to Plasmodium Falciparum Motility</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">347</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1038/nchembio.87</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fnchembio.87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=18454143" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlvFOisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=347-356&author=N.+Katoauthor=T.+Sakataauthor=G.+Bretonauthor=K.+G.+Le+Rochauthor=A.+Nagleauthor=C.+Andersenauthor=B.+Bursulayaauthor=K.+Hensonauthor=J.+Johnsonauthor=K.+A.+Kumarauthor=F.+Marrauthor=D.+Masonauthor=C.+McNamaraauthor=D.+Plouffeauthor=V.+Ramachandranauthor=M.+Spoonerauthor=T.+Tuntlandauthor=Y.+Zhouauthor=E.+C.+Petersauthor=A.+Chatterjeeauthor=P.+G.+Schultzauthor=G.+E.+Wardauthor=N.+Grayauthor=J.+Harperauthor=E.+A.+Winzeler&title=Gene+Expression+Signatures+and+Small-Molecule+Compounds+Link+a+Protein+Kinase+to+Plasmodium+Falciparum+Motility&doi=10.1038%2Fnchembio.87"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Gene expression signatures and small-molecule compounds link a protein kinase to Plasmodium falciparum motility</span></div><div class="casAuthors">Kato, Nobutaka; Sakata, Tomoyo; Breton, Ghislain; Le Roch, Karine G.; Nagle, Advait; Andersen, Carsten; Bursulaya, Badry; Henson, Kerstin; Johnson, Jeffrey; Kumar, Kota Arun; Marr, Felix; Mason, Daniel; McNamara, Case; Plouffe, David; Ramachandran, Vandana; Spooner, Muriel; Tuntland, Tove; Zhou, Yingyao; Peters, Eric C.; Chatterjee, Arnab; Schultz, Peter G.; Ward, Gary E.; Gray, Nathanael; Harper, Jeffrey; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">347-356</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Calcium-dependent protein kinases play a crucial role in intracellular calcium signaling in plants, some algae and protozoa.  In Plasmodium falciparum, calcium-dependent protein kinase 1 (PfCDPK1) is expressed during schizogony in the erythrocytic stage as well as in the sporozoite stage.  It is coexpressed with genes that encode the parasite motor complex, a cellular component required for parasite invasion of host cells, parasite motility and potentially cytokinesis.  A targeted gene-disruption approach demonstrated that pfcdpk1 seems to be essential for parasite viability.  An in vitro biochem. screen using recombinant PfCDPK1 against a library of 20,000 compds. resulted in the identification of a series of structurally related 2,6,9-trisubstituted purines.  Compd. treatment caused sudden developmental arrest at the late schizont stage in P. falciparum and a large redn. in intracellular parasites in Toxoplasma gondii, which suggests a possible role for PfCDPK1 in regulation of parasite motility during egress and invasion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYtzj1uwvk0LVg90H21EOLACvtfcHk0lj4xwwjMRBDyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlvFOisro%253D&md5=79c632fdd4cc704b366e2fcd44c242c4</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.87%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DN.%26aulast%3DSakata%26aufirst%3DT.%26aulast%3DBreton%26aufirst%3DG.%26aulast%3DLe%2BRoch%26aufirst%3DK.%2BG.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DAndersen%26aufirst%3DC.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DHenson%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DK.%2BA.%26aulast%3DMarr%26aufirst%3DF.%26aulast%3DMason%26aufirst%3DD.%26aulast%3DMcNamara%26aufirst%3DC.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DRamachandran%26aufirst%3DV.%26aulast%3DSpooner%26aufirst%3DM.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DPeters%26aufirst%3DE.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DWard%26aufirst%3DG.%2BE.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DHarper%26aufirst%3DJ.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DGene%2520Expression%2520Signatures%2520and%2520Small-Molecule%2520Compounds%2520Link%2520a%2520Protein%2520Kinase%2520to%2520Plasmodium%2520Falciparum%2520Motility%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2008%26volume%3D4%26spage%3D347%26epage%3D356%26doi%3D10.1038%2Fnchembio.87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Molander, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormisky, P. E.</span><span> </span><span class="NLM_article-title">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">7481</span><span class="NLM_x">–</span> <span class="NLM_lpage">7485</span><span class="refDoi"> DOI: 10.1021/jo801269m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo801269m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=7481-7485&author=G.+A.+Molanderauthor=P.+E.+Gormisky&title=Cross-Coupling+of+Cyclopropyl-+and+Cyclobutyltrifluoroborates+with+Aryl+and+Heteroaryl+Chlorides&doi=10.1021%2Fjo801269m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Cross-Coupling of Cyclopropyl- and Cyclobutyltrifluoroborates with Aryl and Heteroaryl Chlorides</span></div><div class="casAuthors">Molander, Gary A.; Gormisky, Paul E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7481-7485</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Suitable conditions were found for the Suzuki-Miyaura cross-coupling reaction of potassium cyclopropyl- and cyclobutyltrifluoroborates with aryl chlorides.  Both of these secondary alkyl trifluoroborates coupled in moderate to excellent yield with electron-rich, electron-poor, and hindered aryl chlorides to give a variety of substituted aryl cyclopropanes and cyclobutanes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6VymYqSga5rVg90H21EOLACvtfcHk0lj4xwwjMRBDyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOqtLrF&md5=575a47623b0f8fd598563f41b81e3564</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo801269m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo801269m%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DGormisky%26aufirst%3DP.%2BE.%26atitle%3DCross-Coupling%2520of%2520Cyclopropyl-%2520and%2520Cyclobutyltrifluoroborates%2520with%2520Aryl%2520and%2520Heteroaryl%2520Chlorides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D7481%26epage%3D7485%26doi%3D10.1021%2Fjo801269m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Temple, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">Preparation of 2,5-Diamino-4,6-dichloropyrimidine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3141</span><span class="NLM_x">–</span> <span class="NLM_lpage">3142</span><span class="refDoi"> DOI: 10.1021/jo00909a030</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00909a030" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=3141-3142&author=C.+Templeauthor=B.+H.+Smithauthor=J.+A.+Montgomery&title=Preparation+of+2%2C5-Diamino-4%2C6-dichloropyrimidine&doi=10.1021%2Fjo00909a030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo00909a030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00909a030%26sid%3Dliteratum%253Aachs%26aulast%3DTemple%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DB.%2BH.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DPreparation%2520of%25202%252C5-Diamino-4%252C6-dichloropyrimidine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26spage%3D3141%26epage%3D3142%26doi%3D10.1021%2Fjo00909a030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Shealy, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clayton, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Dell, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">v-Triazolo[4,5-d]pyramidines. II. O-Substituted Derivatives of 8-Azaguanine and 8-Azahypoxanthine</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1962</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">4518</span><span class="NLM_x">–</span> <span class="NLM_lpage">4523</span><span class="refDoi"> DOI: 10.1021/jo01059a096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01059a096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1962&pages=4518-4523&author=Y.+F.+Shealyauthor=J.+D.+Claytonauthor=C.+A.+O%E2%80%99Dellauthor=J.+A.+Montgomery&title=v-Triazolo%5B4%2C5-d%5Dpyramidines.+II.+O-Substituted+Derivatives+of+8-Azaguanine+and+8-Azahypoxanthine&doi=10.1021%2Fjo01059a096"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo01059a096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01059a096%26sid%3Dliteratum%253Aachs%26aulast%3DShealy%26aufirst%3DY.%2BF.%26aulast%3DClayton%26aufirst%3DJ.%2BD.%26aulast%3DO%25E2%2580%2599Dell%26aufirst%3DC.%2BA.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3Dv-Triazolo%255B4%252C5-d%255Dpyramidines.%2520II.%2520O-Substituted%2520Derivatives%2520of%25208-Azaguanine%2520and%25208-Azahypoxanthine%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1962%26volume%3D27%26spage%3D4518%26epage%3D4523%26doi%3D10.1021%2Fjo01059a096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Seela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steker, H.</span><span> </span><span class="NLM_article-title">Synthesis of 2′-Deoxyribofuranosides of 8-Aza-7-deazaguanine and Related Pyrazolo[3,4-d]pyrimidines</span> <span class="citation_source-journal">Helv. Chim. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x">, </span> <span class="NLM_fpage">1602</span><span class="NLM_x">–</span> <span class="NLM_lpage">1613</span><span class="refDoi"> DOI: 10.1002/hlca.19860690714</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fhlca.19860690714" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1986&pages=1602-1613&author=F.+Seelaauthor=H.+Steker&title=Synthesis+of+2%E2%80%B2-Deoxyribofuranosides+of+8-Aza-7-deazaguanine+and+Related+Pyrazolo%5B3%2C4-d%5Dpyrimidines&doi=10.1002%2Fhlca.19860690714"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fhlca.19860690714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhlca.19860690714%26sid%3Dliteratum%253Aachs%26aulast%3DSeela%26aufirst%3DF.%26aulast%3DSteker%26aufirst%3DH.%26atitle%3DSynthesis%2520of%25202%25E2%2580%25B2-Deoxyribofuranosides%2520of%25208-Aza-7-deazaguanine%2520and%2520Related%2520Pyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DHelv.%2520Chim.%2520Acta%26date%3D1986%26volume%3D69%26spage%3D1602%26epage%3D1613%26doi%3D10.1002%2Fhlca.19860690714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Brückl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knochel, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carell, T.</span><span> </span><span class="NLM_article-title">Efficient Synthesis of Deazaguanosine-Derived tRNA Nucleosides PreQ0, PreQ1, and Archaeosine Using the Turbo-Grignard Method</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">2010</span><span class="NLM_x">, </span> <span class="NLM_fpage">6517</span><span class="NLM_x">–</span> <span class="NLM_lpage">6519</span><span class="refDoi"> DOI: 10.1002/ejoc.201000987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fejoc.201000987" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=6517-6519&author=T.+Br%C3%BCcklauthor=I.+Thomaauthor=A.+J.+Wagnerauthor=P.+Knochelauthor=T.+Carell&title=Efficient+Synthesis+of+Deazaguanosine-Derived+tRNA+Nucleosides+PreQ0%2C+PreQ1%2C+and+Archaeosine+Using+the+Turbo-Grignard+Method&doi=10.1002%2Fejoc.201000987"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201000987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201000987%26sid%3Dliteratum%253Aachs%26aulast%3DBr%25C3%25BCckl%26aufirst%3DT.%26aulast%3DThoma%26aufirst%3DI.%26aulast%3DWagner%26aufirst%3DA.%2BJ.%26aulast%3DKnochel%26aufirst%3DP.%26aulast%3DCarell%26aufirst%3DT.%26atitle%3DEfficient%2520Synthesis%2520of%2520Deazaguanosine-Derived%2520tRNA%2520Nucleosides%2520PreQ0%252C%2520PreQ1%252C%2520and%2520Archaeosine%2520Using%2520the%2520Turbo-Grignard%2520Method%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2010%26volume%3D2010%26spage%3D6517%26epage%3D6519%26doi%3D10.1002%2Fejoc.201000987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Revankar, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthews, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Synthesis and Antimicrobial Activity of Certain Imidazo[1,2-a]pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1253</span><span class="NLM_x">–</span> <span class="NLM_lpage">1255</span><span class="refDoi"> DOI: 10.1021/jm00246a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00246a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADyaE28XisFOltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1975&pages=1253-1255&author=G.+R.+Revankarauthor=T.+R.+Matthewsauthor=R.+K.+Robins&title=Synthesis+and+Antimicrobial+Activity+of+Certain+Imidazo%5B1%2C2-a%5Dpyrimidines&doi=10.1021%2Fjm00246a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and antimicrobial activity of certain imidazo[1,2-a]pyrimidines</span></div><div class="casAuthors">Revankar, Ganapathi R.; Matthews, Thomas R.; Robins, Roland K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1253-5</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of 5-substituted and 5,7-disubstituted imidazo[1,2-a]pyrimidines (I) were prepd. and the in vitro antimicrobial activity of these compds. against a variety of microorganisms tested.  5-N-octylaminoimidazo[1,2-a]pyrimidine [57473-44-6] exhibited significant activity against all the microorganisms tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkZLt9kjhi87Vg90H21EOLACvtfcHk0lhFDIIH8DsLMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XisFOltQ%253D%253D&md5=74622577085276ae6061326835a19a2e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fjm00246a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00246a018%26sid%3Dliteratum%253Aachs%26aulast%3DRevankar%26aufirst%3DG.%2BR.%26aulast%3DMatthews%26aufirst%3DT.%2BR.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520and%2520Antimicrobial%2520Activity%2520of%2520Certain%2520Imidazo%255B1%252C2-a%255Dpyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1975%26volume%3D18%26spage%3D1253%26epage%3D1255%26doi%3D10.1021%2Fjm00246a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Harada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoshino, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsukura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kabasawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niijima, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotake, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawata, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horizoe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minami, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abe, S.</span><span> </span><span class="NLM_article-title">2-Alkynyl-8-aryl-9-methyladenines as Novel Adenosine Receptor Antagonists: Their Synthesis and Structure-Activity Relationships Toward Hepatic Glucose Production Induced Via Agonism of the A(2B) Receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">170</span><span class="NLM_x">–</span> <span class="NLM_lpage">179</span><span class="refDoi"> DOI: 10.1021/jm990499b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990499b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=170-179&author=H.+Haradaauthor=O.+Asanoauthor=Y.+Hoshinoauthor=S.+Yoshikawaauthor=M.+Matsukuraauthor=Y.+Kabasawaauthor=J.+Niijimaauthor=Y.+Kotakeauthor=N.+Watanabeauthor=T.+Kawataauthor=T.+Inoueauthor=T.+Horizoeauthor=N.+Yasudaauthor=H.+Minamiauthor=K.+Nagataauthor=M.+Murakamiauthor=J.+Nagaokaauthor=S.+Kobayashiauthor=I.+Tanakaauthor=S.+Abe&title=2-Alkynyl-8-aryl-9-methyladenines+as+Novel+Adenosine+Receptor+Antagonists%3A+Their+Synthesis+and+Structure-Activity+Relationships+Toward+Hepatic+Glucose+Production+Induced+Via+Agonism+of+the+A%282B%29+Receptor&doi=10.1021%2Fjm990499b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm990499b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990499b%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DH.%26aulast%3DAsano%26aufirst%3DO.%26aulast%3DHoshino%26aufirst%3DY.%26aulast%3DYoshikawa%26aufirst%3DS.%26aulast%3DMatsukura%26aufirst%3DM.%26aulast%3DKabasawa%26aufirst%3DY.%26aulast%3DNiijima%26aufirst%3DJ.%26aulast%3DKotake%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DN.%26aulast%3DKawata%26aufirst%3DT.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DHorizoe%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DN.%26aulast%3DMinami%26aufirst%3DH.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DMurakami%26aufirst%3DM.%26aulast%3DNagaoka%26aufirst%3DJ.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DTanaka%26aufirst%3DI.%26aulast%3DAbe%26aufirst%3DS.%26atitle%3D2-Alkynyl-8-aryl-9-methyladenines%2520as%2520Novel%2520Adenosine%2520Receptor%2520Antagonists%253A%2520Their%2520Synthesis%2520and%2520Structure-Activity%2520Relationships%2520Toward%2520Hepatic%2520Glucose%2520Production%2520Induced%2520Via%2520Agonism%2520of%2520the%2520A%25282B%2529%2520Receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D170%26epage%3D179%26doi%3D10.1021%2Fjm990499b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Rao, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, D. E.</span><span> </span><span class="NLM_article-title">The Synthesis of Certain 5,7-Dihydroxyimidazo[1,2-α] pyrimidines</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1021</span><span class="NLM_x">–</span> <span class="NLM_lpage">1023</span><span class="refDoi"> DOI: 10.1002/jhet.5570100626</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1002%2Fjhet.5570100626" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1973&pages=1021-1023&author=R.+P.+Raoauthor=R.+K.+Robinsauthor=D.+E.+O%E2%80%99Brien&title=The+Synthesis+of+Certain+5%2C7-Dihydroxyimidazo%5B1%2C2-%CE%B1%5D+pyrimidines&doi=10.1002%2Fjhet.5570100626"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570100626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570100626%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DR.%2BP.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DD.%2BE.%26atitle%3DThe%2520Synthesis%2520of%2520Certain%25205%252C7-Dihydroxyimidazo%255B1%252C2-%25CE%25B1%255D%2520pyrimidines%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1973%26volume%3D10%26spage%3D1021%26epage%3D1023%26doi%3D10.1002%2Fjhet.5570100626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Revankar, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robins, R. K.</span><span> </span><span class="NLM_article-title">Synthesis and Biological Activity of some Nucleosides Resembling Guanosine: Imidazo[1,2-a]pyrimidine Nucleosides</span> <span class="citation_source-journal">Ann. N. Y. Acad. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">255</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span><span class="refDoi"> DOI: 10.1111/j.1749-6632.1975.tb29221.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1111%2Fj.1749-6632.1975.tb29221.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=255&publication_year=1975&pages=166-172&author=R.+R.+Revankarauthor=R.+K.+Robins&title=Synthesis+and+Biological+Activity+of+some+Nucleosides+Resembling+Guanosine%3A+Imidazo%5B1%2C2-a%5Dpyrimidine+Nucleosides&doi=10.1111%2Fj.1749-6632.1975.tb29221.x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.1975.tb29221.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.1975.tb29221.x%26sid%3Dliteratum%253Aachs%26aulast%3DRevankar%26aufirst%3DR.%2BR.%26aulast%3DRobins%26aufirst%3DR.%2BK.%26atitle%3DSynthesis%2520and%2520Biological%2520Activity%2520of%2520some%2520Nucleosides%2520Resembling%2520Guanosine%253A%2520Imidazo%255B1%252C2-a%255Dpyrimidine%2520Nucleosides%26jtitle%3DAnn.%2520N.%2520Y.%2520Acad.%2520Sci.%26date%3D1975%26volume%3D255%26spage%3D166%26epage%3D172%26doi%3D10.1111%2Fj.1749-6632.1975.tb29221.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Thomas, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.-Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roche, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bentley, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardcastle, I. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span> </span><span class="NLM_article-title">Preclinical In Vitro and In Vivo Evaluation of the Potent and Specific Cyclin-Dependent Kinase 2 Inhibitor NU6102 and a Water Soluble Prodrug NU6301</span> <span class="citation_source-journal">Eur. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2052</span><span class="NLM_x">–</span> <span class="NLM_lpage">2059</span><span class="refDoi"> DOI: 10.1016/j.ejca.2011.04.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2Fj.ejca.2011.04.008" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=2052-2059&author=H.+D.+Thomasauthor=L.-Z.+Wangauthor=C.+Rocheauthor=J.+Bentleyauthor=Y.+Chengauthor=I.+R.+Hardcastleauthor=B.+T.+Goldingauthor=R.+J.+Griffinauthor=N.+J.+Curtinauthor=D.+R.+Newell&title=Preclinical+In+Vitro+and+In+Vivo+Evaluation+of+the+Potent+and+Specific+Cyclin-Dependent+Kinase+2+Inhibitor+NU6102+and+a+Water+Soluble+Prodrug+NU6301&doi=10.1016%2Fj.ejca.2011.04.008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejca.2011.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejca.2011.04.008%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DH.%2BD.%26aulast%3DWang%26aufirst%3DL.-Z.%26aulast%3DRoche%26aufirst%3DC.%26aulast%3DBentley%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DHardcastle%26aufirst%3DI.%2BR.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26atitle%3DPreclinical%2520In%2520Vitro%2520and%2520In%2520Vivo%2520Evaluation%2520of%2520the%2520Potent%2520and%2520Specific%2520Cyclin-Dependent%2520Kinase%25202%2520Inhibitor%2520NU6102%2520and%2520a%2520Water%2520Soluble%2520Prodrug%2520NU6301%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2011%26volume%3D47%26spage%3D2052%26epage%3D2059%26doi%3D10.1016%2Fj.ejca.2011.04.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Brown, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korolchuk, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stanley, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moukhametzianov, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noble, M. E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endicott, J. A.</span><span> </span><span class="NLM_article-title">CDK1 Structures Reveal Conserved and Unique Features of the Essential Cell Cycle CDK</span> <span class="citation_source-journal">Nat. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">6769</span><span class="NLM_x">–</span> <span class="NLM_lpage">6780</span><span class="refDoi"> DOI: 10.1038/ncomms7769</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1038%2Fncomms7769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=25864384" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2itLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6769-6780&author=N.+R.+Brownauthor=S.+Korolchukauthor=M.+P.+Martinauthor=W.+A.+Stanleyauthor=R.+Moukhametzianovauthor=M.+E.+M.+Nobleauthor=J.+A.+Endicott&title=CDK1+Structures+Reveal+Conserved+and+Unique+Features+of+the+Essential+Cell+Cycle+CDK&doi=10.1038%2Fncomms7769"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">CDK1 structures reveal conserved and unique features of the essential cell cycle CDK</span></div><div class="casAuthors">Brown, Nicholas R.; Korolchuk, Svitlana; Martin, Mathew P.; Stanley, Will A.; Moukhametzianov, Rouslan; Noble, Martin E. M.; Endicott, Jane A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6769</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">CDK1 is the only essential cell cycle CDK in human cells and is required for successful completion of M-phase.  It is the founding member of the CDK family and is conserved across all eukaryotes.  Here we report the crystal structures of complexes of CDK1-Cks1 and CDK1-cyclin B-Cks2.  These structures confirm the conserved nature of the inactive monomeric CDK fold and its ability to be remodelled by cyclin binding.  Relative to CDK2-cyclin A, CDK1-cyclin B is less thermally stable, has a smaller interfacial surface, is more susceptible to activation segment dephosphorylation and shows differences in the substrate sequence features that det. activity.  Both CDK1 and CDK2 are potential cancer targets for which selective compds. are required.  We also describe the first structure of CDK1 bound to a potent ATP-competitive inhibitor and identify aspects of CDK1 structure and plasticity that might be exploited to develop CDK1-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojjBjB0sd2dLVg90H21EOLACvtfcHk0lhoU-oIZzpiIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2itLvM&md5=af77d3ad7127139a492cb631362712a5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1038%2Fncomms7769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7769%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DN.%2BR.%26aulast%3DKorolchuk%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DM.%2BP.%26aulast%3DStanley%26aufirst%3DW.%2BA.%26aulast%3DMoukhametzianov%26aufirst%3DR.%26aulast%3DNoble%26aufirst%3DM.%2BE.%2BM.%26aulast%3DEndicott%26aufirst%3DJ.%2BA.%26atitle%3DCDK1%2520Structures%2520Reveal%2520Conserved%2520and%2520Unique%2520Features%2520of%2520the%2520Essential%2520Cell%2520Cycle%2520CDK%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6769%26epage%3D6780%26doi%3D10.1038%2Fncomms7769" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Beach, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, H. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeong, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nampalli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Islam, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, C. K.</span><span> </span><span class="NLM_article-title">A Highly Stereoselective Synthesis of Anti-HIV 2′,3′-Dideoxy- and 2′,3′-Didehydro-2′,3′-dideoxynucleosides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">3887</span><span class="NLM_x">–</span> <span class="NLM_lpage">3894</span><span class="refDoi"> DOI: 10.1021/jo00040a031</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00040a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADyaK38Xkt1Ojsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=1992&pages=3887-3894&author=J.+W.+Beachauthor=H.+O.+Kimauthor=L.+S.+Jeongauthor=S.+Nampalliauthor=Q.+Islamauthor=S.+K.+Ahnauthor=J.+R.+Babuauthor=C.+K.+Chu&title=A+Highly+Stereoselective+Synthesis+of+Anti-HIV+2%E2%80%B2%2C3%E2%80%B2-Dideoxy-+and+2%E2%80%B2%2C3%E2%80%B2-Didehydro-2%E2%80%B2%2C3%E2%80%B2-dideoxynucleosides&doi=10.1021%2Fjo00040a031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">A highly stereoselective synthesis of anti-HIV 2',3'-dideoxy- and 2',3'-didehydro-2',3'-dideoxynucleosides</span></div><div class="casAuthors">Beach, J. Warren; Kim, Hea O.; Jeong, Lak S.; Nampalli, Satyanarayana; Islam, Qamrul; Ahn, Soon K.; Babu, J. Ramesh; Chu, Chung K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">3887-94</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A general total synthetic method for the stereocontrolled synthesis of 2',3'-dideoxy- and 2',3'-didehydro-2',3'-dideoxynucleosides, is presented.  Introduction of an α-phenylselenenyl group at the 2-position of 2,3-dideoxyribosyl acetate directs the glycosyl bond formation to give ≥95% β-isomer.  This 2'-phenylselenenyl nucleoside may be converted to either the 2',3'-dideoxynucleoside by treatment with n-Bu3SnH and Et3B at room temp. or to the unsatd. deriv. by treatment with H2O2/cat. pyridine.  The application of this method to the syntheses of pyrimidines (ddU, ddT, ddC), 6-substituted purines (ddA, ddT, 6-chloro-ddP, N6-Me-ddA), and 2,6-disubstituted pruines(2-F-ddA, 6-chloro-2-amino-ddP) as well as selected 2',3'-didehydro-2',3'-dideoxy derivs., is reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWpyT9XTv7X7Vg90H21EOLACvtfcHk0lhoU-oIZzpiIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK38Xkt1Ojsbg%253D&md5=c757042948e3dfc3fdc661b3774c545f</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fjo00040a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00040a031%26sid%3Dliteratum%253Aachs%26aulast%3DBeach%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DH.%2BO.%26aulast%3DJeong%26aufirst%3DL.%2BS.%26aulast%3DNampalli%26aufirst%3DS.%26aulast%3DIslam%26aufirst%3DQ.%26aulast%3DAhn%26aufirst%3DS.%2BK.%26aulast%3DBabu%26aufirst%3DJ.%2BR.%26aulast%3DChu%26aufirst%3DC.%2BK.%26atitle%3DA%2520Highly%2520Stereoselective%2520Synthesis%2520of%2520Anti-HIV%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Dideoxy-%2520and%25202%25E2%2580%25B2%252C3%25E2%2580%25B2-Didehydro-2%25E2%2580%25B2%252C3%25E2%2580%25B2-dideoxynucleosides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1992%26volume%3D57%26spage%3D3887%26epage%3D3894%26doi%3D10.1021%2Fjo00040a031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Baumgarten, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. M.</span><span> </span><span class="NLM_article-title">Reactions of Amines. V. Synthesis of α-Amino Ketones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">459</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span><span class="refDoi"> DOI: 10.1021/ja01487a054</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja01487a054" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1960&pages=459-463&author=H.+E.+Baumgartenauthor=J.+M.+Petersen&title=Reactions+of+Amines.+V.+Synthesis+of+%CE%B1-Amino+Ketones&doi=10.1021%2Fja01487a054"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fja01487a054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01487a054%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgarten%26aufirst%3DH.%2BE.%26aulast%3DPetersen%26aufirst%3DJ.%2BM.%26atitle%3DReactions%2520of%2520Amines.%2520V.%2520Synthesis%2520of%2520%25CE%25B1-Amino%2520Ketones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1960%26volume%3D82%26spage%3D459%26epage%3D463%26doi%3D10.1021%2Fja01487a054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Kos, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jongejan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Der Plas, H. C.</span><span> </span><span class="NLM_article-title">Deamination, Involving Ring Opening, in Reactions of 1-Aminopurinium Mesitylenesulfonates with Methanolic Ammonia</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4841</span><span class="NLM_x">–</span> <span class="NLM_lpage">4848</span><span class="refDoi"> DOI: 10.1016/S0040-4020(01)87667-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1016%2FS0040-4020%2801%2987667-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=4841-4848&author=N.+J.+Kosauthor=H.+Jongejanauthor=H.+C.+Van+Der+Plas&title=Deamination%2C+Involving+Ring+Opening%2C+in+Reactions+of+1-Aminopurinium+Mesitylenesulfonates+with+Methanolic+Ammonia&doi=10.1016%2FS0040-4020%2801%2987667-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2987667-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252987667-5%26sid%3Dliteratum%253Aachs%26aulast%3DKos%26aufirst%3DN.%2BJ.%26aulast%3DJongejan%26aufirst%3DH.%26aulast%3DVan%2BDer%2BPlas%26aufirst%3DH.%2BC.%26atitle%3DDeamination%252C%2520Involving%2520Ring%2520Opening%252C%2520in%2520Reactions%2520of%25201-Aminopurinium%2520Mesitylenesulfonates%2520with%2520Methanolic%2520Ammonia%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D4841%26epage%3D4848%26doi%3D10.1016%2FS0040-4020%2801%2987667-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Balsiger, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, J. A.</span><span> </span><span class="NLM_article-title">Synthesis of Potential Anticancer Agents. XXV. Preparation of 6-Alkoxy-2-aminopurines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1960</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1573</span><span class="NLM_x">–</span> <span class="NLM_lpage">1575</span><span class="refDoi"> DOI: 10.1021/jo01079a026</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo01079a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1960&pages=1573-1575&author=R.+W.+Balsigerauthor=J.+A.+Montgomery&title=Synthesis+of+Potential+Anticancer+Agents.+XXV.+Preparation+of+6-Alkoxy-2-aminopurines&doi=10.1021%2Fjo01079a026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Fjo01079a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo01079a026%26sid%3Dliteratum%253Aachs%26aulast%3DBalsiger%26aufirst%3DR.%2BW.%26aulast%3DMontgomery%26aufirst%3DJ.%2BA.%26atitle%3DSynthesis%2520of%2520Potential%2520Anticancer%2520Agents.%2520XXV.%2520Preparation%2520of%25206-Alkoxy-2-aminopurines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1960%26volume%3D25%26spage%3D1573%26epage%3D1575%26doi%3D10.1021%2Fjo01079a026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arris, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasdale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calvert, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curtin, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalby, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanugula, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lembicz, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pegg, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golding, B. T.</span><span> </span><span class="NLM_article-title">Resistance-Modifying Agents. 8. Inhibition of O(6)-Alkylguanine-DNA Alkyltransferase by O(6)-Alkenyl-, O(6)-Cycloalkenyl-, and O(6)-(2-Oxoalkyl)guanines and Potentiation of Temozolomide Cytotoxicity In Vitro by O(6)-(1-Cyclopentenylmethyl)guanine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">4071</span><span class="NLM_x">–</span> <span class="NLM_lpage">4083</span><span class="refDoi"> DOI: 10.1021/jm000961o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000961o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4071-4083&author=R.+J.+Griffinauthor=C.+E.+Arrisauthor=C.+Bleasdaleauthor=F.+T.+Boyleauthor=A.+H.+Calvertauthor=N.+J.+Curtinauthor=C.+Dalbyauthor=S.+Kanugulaauthor=N.+K.+Lembiczauthor=D.+R.+Newellauthor=A.+E.+Peggauthor=B.+T.+Golding&title=Resistance-Modifying+Agents.+8.+Inhibition+of+O%286%29-Alkylguanine-DNA+Alkyltransferase+by+O%286%29-Alkenyl-%2C+O%286%29-Cycloalkenyl-%2C+and+O%286%29-%282-Oxoalkyl%29guanines+and+Potentiation+of+Temozolomide+Cytotoxicity+In+Vitro+by+O%286%29-%281-Cyclopentenylmethyl%29guanine&doi=10.1021%2Fjm000961o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fjm000961o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000961o%26sid%3Dliteratum%253Aachs%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DArris%26aufirst%3DC.%2BE.%26aulast%3DBleasdale%26aufirst%3DC.%26aulast%3DBoyle%26aufirst%3DF.%2BT.%26aulast%3DCalvert%26aufirst%3DA.%2BH.%26aulast%3DCurtin%26aufirst%3DN.%2BJ.%26aulast%3DDalby%26aufirst%3DC.%26aulast%3DKanugula%26aufirst%3DS.%26aulast%3DLembicz%26aufirst%3DN.%2BK.%26aulast%3DNewell%26aufirst%3DD.%2BR.%26aulast%3DPegg%26aufirst%3DA.%2BE.%26aulast%3DGolding%26aufirst%3DB.%2BT.%26atitle%3DResistance-Modifying%2520Agents.%25208.%2520Inhibition%2520of%2520O%25286%2529-Alkylguanine-DNA%2520Alkyltransferase%2520by%2520O%25286%2529-Alkenyl-%252C%2520O%25286%2529-Cycloalkenyl-%252C%2520and%2520O%25286%2529-%25282-Oxoalkyl%2529guanines%2520and%2520Potentiation%2520of%2520Temozolomide%2520Cytotoxicity%2520In%2520Vitro%2520by%2520O%25286%2529-%25281-Cyclopentenylmethyl%2529guanine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4071%26epage%3D4083%26doi%3D10.1021%2Fjm000961o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Evans, P. R.</span><span> </span><span class="NLM_article-title">An Introduction to Data Reduction: Space-Group Determination, Scaling and Intensity Statistics</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span><span class="refDoi"> DOI: 10.1107/S090744491003982X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS090744491003982X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=282-292&author=P.+R.+Evans&title=An+Introduction+to+Data+Reduction%3A+Space-Group+Determination%2C+Scaling+and+Intensity+Statistics&doi=10.1107%2FS090744491003982X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">An introduction to data reduction: Space-group determination, scaling and intensity statistics</span></div><div class="casAuthors">Evans, Philip R.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">282-292</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  This paper presents an overview of how to run the CCP4 programs for data redn. (SCALA, POINTLESS and CTRUNCATE) through the CCP4 graphical interface ccp4i and points out some issues that need to be considered, together with a few examples.  It covers detn. of the point-group symmetry of the diffraction data (the Laue group), which is required for the subsequent scaling step, examn. of systematic absences, which in many cases will allow inference of the space group, putting multiple data sets on a common indexing system when there are alternatives, the scaling step itself, which produces a large set of data-quality indicators, estn. of |F| from intensity and finally examn. of intensity statistics to detect crystal pathologies such as twinning.  An appendix outlines the scoring schemes used by the program POINTLESS to assign probabilities to possible Laue and space groups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEq8RhfQOW8LVg90H21EOLACvtfcHk0lhvDiwLtKU3GA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtLo%253D&md5=f425388a87744d721d324118d50e4f9a</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1107%2FS090744491003982X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744491003982X%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26atitle%3DAn%2520Introduction%2520to%2520Data%2520Reduction%253A%2520Space-Group%2520Determination%252C%2520Scaling%2520and%2520Intensity%2520Statistics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D282%26epage%3D292%26doi%3D10.1107%2FS090744491003982X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keegan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krissinel, E. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McNicholas, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pannu, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potterton, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, K. S.</span><span> </span><span class="NLM_article-title">Overview of the CCP4 Suite and Current Developments</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">D67</span><span class="NLM_x">, </span> <span class="NLM_fpage">235</span><span class="NLM_x">–</span> <span class="NLM_lpage">242</span><span class="refDoi"> DOI: 10.1107/S0907444910045749</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444910045749" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D67&publication_year=2011&pages=235-242&author=M.+D.+Winnauthor=C.+C.+Ballardauthor=K.+D.+Cowtanauthor=E.+J.+Dodsonauthor=P.+Emsleyauthor=P.+R.+Evansauthor=R.+M.+Keeganauthor=E.+B.+Krissinelauthor=A.+G.+Leslieauthor=A.+J.+McCoyauthor=S.+J.+McNicholasauthor=G.+N.+Murshudovauthor=N.+S.+Pannuauthor=E.+A.+Pottertonauthor=H.+R.+Powellauthor=R.+J.+Readauthor=A.+A.+Vaginauthor=K.+S.+Wilson&title=Overview+of+the+CCP4+Suite+and+Current+Developments&doi=10.1107%2FS0907444910045749"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Overview of the CCP4 suite and current developments</span></div><div class="casAuthors">Winn, Martyn D.; Ballard, Charles C.; Cowtan, Kevin D.; Dodson, Eleanor J.; Emsley, Paul; Evans, Phil R.; Keegan, Ronan M.; Krissinel, Eugene B.; Leslie, Andrew G. W.; McCoy, Airlie; McNicholas, Stuart J.; Murshudov, Garib N.; Pannu, Navraj S.; Potterton, Elizabeth A.; Powell, Harold R.; Read, Randy J.; Vagin, Alexei; Wilson, Keith S.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">235-242</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  The CCP4 (Collaborative Computational Project, No. 4) software suite is a collection of programs and assocd. data and software libraries which can be used for macromol. structure detn. by X-ray crystallog.  The suite is designed to be flexible, allowing users a no. of methods of achieving their aims.  The programs are from a wide variety of sources but are connected by a common infrastructure provided by std. file formats, data objects and graphical interfaces.  Structure soln. by macromol. crystallog. is becoming increasingly automated and the CCP4 suite includes several automation pipelines.  After giving a brief description of the evolution of CCP4 over the last 30 years, an overview of the current suite is given.  While detailed descriptions are given in the accompanying articles, here it is shown how the individual programs contribute to a complete software package.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_wWMMIol6UrVg90H21EOLACvtfcHk0lhyRetEDO9fzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqt70%253D&md5=c407e4d47bef46864be336d60147c17d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1107%2FS0907444910045749&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910045749%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DBallard%26aufirst%3DC.%2BC.%26aulast%3DCowtan%26aufirst%3DK.%2BD.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DKeegan%26aufirst%3DR.%2BM.%26aulast%3DKrissinel%26aufirst%3DE.%2BB.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMcNicholas%26aufirst%3DS.%2BJ.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DPotterton%26aufirst%3DE.%2BA.%26aulast%3DPowell%26aufirst%3DH.%2BR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DWilson%26aufirst%3DK.%2BS.%26atitle%3DOverview%2520of%2520the%2520CCP4%2520Suite%2520and%2520Current%2520Developments%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3DD67%26spage%3D235%26epage%3D242%26doi%3D10.1107%2FS0907444910045749" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Potterton, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Briggs, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turkenburg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E.</span><span> </span><span class="NLM_article-title">A Graphical User Interface to the CCP4 Program Suite</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">D59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1131</span><span class="NLM_x">–</span> <span class="NLM_lpage">1137</span><span class="refDoi"> DOI: 10.1107/S0907444903008126</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444903008126" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D59&publication_year=2003&pages=1131-1137&author=E.+Pottertonauthor=P.+Briggsauthor=M.+Turkenburgauthor=E.+Dodson&title=A+Graphical+User+Interface+to+the+CCP4+Program+Suite&doi=10.1107%2FS0907444903008126"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1107%2FS0907444903008126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444903008126%26sid%3Dliteratum%253Aachs%26aulast%3DPotterton%26aufirst%3DE.%26aulast%3DBriggs%26aufirst%3DP.%26aulast%3DTurkenburg%26aufirst%3DM.%26aulast%3DDodson%26aufirst%3DE.%26atitle%3DA%2520Graphical%2520User%2520Interface%2520to%2520the%2520CCP4%2520Program%2520Suite%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2003%26volume%3DD59%26spage%3D1131%26epage%3D1137%26doi%3D10.1107%2FS0907444903008126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winn, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storoni, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span> </span><span class="NLM_article-title">Phaser Crystallographic Software</span> <span class="citation_source-journal">J. Appl. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">658</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span><span class="refDoi"> DOI: 10.1107/S0021889807021206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0021889807021206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=19461840" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2007&pages=658-674&author=A.+J.+McCoyauthor=R.+W.+Grosse-Kunstleveauthor=P.+D.+Adamsauthor=M.+D.+Winnauthor=L.+C.+Storoniauthor=R.+J.+Read&title=Phaser+Crystallographic+Software&doi=10.1107%2FS0021889807021206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Phaser crystallographic software</span></div><div class="casAuthors">McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.; Winn, Martyn D.; Storoni, Laurent C.; Read, Randy J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">658-674</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">0021-8898</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Phaser is a program for phasing macromol. crystal structures by both mol. replacement and exptl. phasing methods.  The novel phasing algorithms implemented in Phaser have been developed using max. likelihood and multivariate statistics.  For mol. replacement, the new algorithms have proved to be significantly better than traditional methods in discriminating correct solns. from noise, and for single-wavelength anomalous dispersion exptl. phasing, the new algorithms, which account for correlations between F+ and F-, give better phases (lower mean phase error with respect to the phases given by the refined structure) than those that use mean F and anomalous differences ΔF.  One of the design concepts of Phaser was that it be capable of a high degree of automation.  To this end, Phaser (written in C++) can be called directly from Python, although it can also be called using traditional CCP4 keyword-style input.  Phaser is a platform for future development of improved phasing methods and their release, including source code, to the crystallog. community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPeVyjN_FMGbVg90H21EOLACvtfcHk0lhyRetEDO9fzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXnslWqsLk%253D&md5=c63b722ae97e0a74e6a5a079d388f09f</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1107%2FS0021889807021206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0021889807021206%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DStoroni%26aufirst%3DL.%2BC.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26atitle%3DPhaser%2520Crystallographic%2520Software%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2007%26volume%3D40%26spage%3D658%26epage%3D674%26doi%3D10.1107%2FS0021889807021206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and Development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">D66</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span><span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+Development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lhyRetEDO9fzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520Development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3DD66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Murshudov, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vagin, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dodson, E. J.</span><span> </span><span class="NLM_article-title">Refinement of Macromolecular Structures by the Maximum-Liklihood Method</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">D53</span><span class="NLM_x">, </span> <span class="NLM_fpage">240</span><span class="NLM_x">–</span> <span class="NLM_lpage">255</span><span class="refDoi"> DOI: 10.1107/S0907444996012255</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;key=10.1107%2FS0907444996012255" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=D53&publication_year=1997&pages=240-255&author=G.+N.+Murshudovauthor=A.+A.+Vaginauthor=E.+J.+Dodson&title=Refinement+of+Macromolecular+Structures+by+the+Maximum-Liklihood+Method&doi=10.1107%2FS0907444996012255"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS0907444996012255&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444996012255%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26aulast%3DDodson%26aufirst%3DE.%2BJ.%26atitle%3DRefinement%2520of%2520Macromolecular%2520Structures%2520by%2520the%2520Maximum-Liklihood%2520Method%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D1997%26volume%3DD53%26spage%3D240%26epage%3D255%26doi%3D10.1107%2FS0907444996012255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQE" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQE','PDB','5LQE'); return false;">PDB: 5LQE</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQF" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQF','PDB','5LQF'); return false;">PDB: 5LQF</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EOS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EOS','PDB','4EOS'); return false;">PDB: 4EOS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TNW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3TNW','PDB','3TNW'); return false;">PDB: 3TNW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MY5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3MY5','PDB','3MY5'); return false;">PDB: 3MY5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YC3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YC3','PDB','4YC3'); return false;">PDB: 4YC3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HQ0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5HQ0','PDB','5HQ0'); return false;">PDB: 5HQ0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QMZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1QMZ','PDB','1QMZ'); return false;">PDB: 1QMZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y72" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4Y72','PDB','4Y72'); return false;">PDB: 4Y72</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-5"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i111"><a href="/doi/suppl/10.1021/acs.jmedchem.6b01254">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_86400"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.6b01254">10.1021/acs.jmedchem.6b01254</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Structure of compound <b>102</b> and associated crystal data and refinement statistics; <sup>1</sup>H NMR spectra for compounds <b>70</b>, <b>73</b>, <b>83</b>, <b>90</b>, <b>91</b>, and <b>98</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_001.pdf">jm6b01254_si_001.pdf (3.61 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.6b01254/suppl_file/jm6b01254_si_002.csv">jm6b01254_si_002.csv (5.4 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">CDK2-cyclin A in complex with compound <b>73</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQE">5LQE</a>), and CDK1-cyclin B-CKS2 in complex with compound <b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5LQF">5LQF</a>) have been deposited with the PDB and the atomic coordinates and experimental data will be released upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.6b01254&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.6b01254%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.6b01254" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997d9439fc195f","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
